Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

74265 475171 73 None -2 3 Human 6.0 pEC50 = 6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
CHEMBL99384 475171 73 None -2 3 Human 6.0 pEC50 = 6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
14434082 174770 20 None -1 3 Human 5.0 pEC50 = 5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
CHEMBL2205801 174770 20 None -1 3 Human 5.0 pEC50 = 5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
16726107 174492 2 None None None Human 6.0 pEC50 = 6.0 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 475 7 1 6 4.4 Cc1ccc(CN2CCC(CNC(=O)C3CCN(c4ccc(-c5cccs5)nn4)CC3)C2)cc1 10.1021/jm061389p
CHEMBL220199 174492 2 None None None Human 6.0 pEC50 = 6.0 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 475 7 1 6 4.4 Cc1ccc(CN2CCC(CNC(=O)C3CCN(c4ccc(-c5cccs5)nn4)CC3)C2)cc1 10.1021/jm061389p
14338 18716 77 None -3 3 Human 5.0 pEC50 = 5.0 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
CHEMBL101165 18716 77 None -3 3 Human 5.0 pEC50 = 5.0 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
14338 18716 77 None -3 3 Human 4.9 pEC50 = 4.9 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
CHEMBL101165 18716 77 None -3 3 Human 4.9 pEC50 = 4.9 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
16301115 164843 2 None None None Human 4.9 pEC50 = 4.9 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 435 7 1 6 3.8 Cc1ccc(-n2c(C)nnc2SCC(=O)NC2CCN(Cc3ccccc3)CC2)cc1 10.1021/jm061389p
CHEMBL219769 164843 2 None None None Human 4.9 pEC50 = 4.9 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 435 7 1 6 3.8 Cc1ccc(-n2c(C)nnc2SCC(=O)NC2CCN(Cc3ccccc3)CC2)cc1 10.1021/jm061389p
93149 216841 57 None -2 3 Human 5.8 pEC50 = 5.8 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 216841 57 None -2 3 Human 5.8 pEC50 = 5.8 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
3258407 175858 16 None None None Human 5.7 pEC50 = 5.7 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 389 9 1 5 4.9 C=C(C)Cc1c(C)c(C#N)c2nc3ccccc3n2c1NCCCN(CC)CC 10.1021/jm061389p
CHEMBL223686 175858 16 None None None Human 5.7 pEC50 = 5.7 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 389 9 1 5 4.9 C=C(C)Cc1c(C)c(C#N)c2nc3ccccc3n2c1NCCCN(CC)CC 10.1021/jm061389p
12987698 174777 3 None 2 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
CHEMBL2205809 174777 3 None 2 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
1474 310449 80 None 1 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
46936282 310449 80 None 1 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 310449 80 None 1 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
DB03871 310449 80 None 1 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
12987698 174777 3 None 2 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
CHEMBL2205809 174777 3 None 2 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
15783796 174779 3 None -3 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
CHEMBL2205810 174779 3 None -3 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
93149 216841 57 None -2 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 216841 57 None -2 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
2733927 174776 61 None -4 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
CHEMBL2205808 174776 61 None -4 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
1474 310449 80 None 1 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
46936282 310449 80 None 1 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 310449 80 None 1 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
DB03871 310449 80 None 1 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
16728788 164844 0 None None None Human 5.7 pEC50 = 5.7 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 450 7 1 7 3.4 Cc1cc(CN2CCN(C)CC2)ccc1NC(=O)CSc1nnc(C)n1-c1ccccc1 10.1021/jm061389p
CHEMBL219770 164844 0 None None None Human 5.7 pEC50 = 5.7 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 450 7 1 7 3.4 Cc1cc(CN2CCN(C)CC2)ccc1NC(=O)CSc1nnc(C)n1-c1ccccc1 10.1021/jm061389p
15783796 174779 3 None -3 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
CHEMBL2205810 174779 3 None -3 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
2733927 174776 61 None -4 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
CHEMBL2205808 174776 61 None -4 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
15664 174775 66 None 2 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
5403 174775 66 None 2 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
CHEMBL2205807 174775 66 None 2 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
DB11932 174775 66 None 2 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
137660245 315132 0 None None None Human 5.6 pEC50 = 5.6 Functional
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 461 7 1 4 4.4 CC(C)CN1CC(C(=O)Nc2ccc(CN(C)C3CCOCC3)cc2)=Cc2ccccc2C1=O 10.1016/j.ejmech.2017.04.046
CHEMBL4099473 315132 0 None None None Human 5.6 pEC50 = 5.6 Functional
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 461 7 1 4 4.4 CC(C)CN1CC(C(=O)Nc2ccc(CN(C)C3CCOCC3)cc2)=Cc2ccccc2C1=O 10.1016/j.ejmech.2017.04.046
15664 174775 66 None 2 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
5403 174775 66 None 2 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
CHEMBL2205807 174775 66 None 2 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
DB11932 174775 66 None 2 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
72792 433102 57 None -5 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
CHEMBL593442 433102 57 None -5 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
DB02586 433102 57 None -5 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
72792 433102 57 None -5 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
CHEMBL593442 433102 57 None -5 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
DB02586 433102 57 None -5 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
124734 473621 72 None -6 3 Human 4.5 pEC50 = 4.5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
70848 473621 72 None -6 3 Human 4.5 pEC50 = 4.5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 473621 72 None -6 3 Human 4.5 pEC50 = 4.5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
DB01912 473621 72 None -6 3 Human 4.5 pEC50 = 4.5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
1167892 164846 0 None None None Human 5.5 pEC50 = 5.5 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 463 9 1 6 4.7 Cc1ccc(NC(=O)CSc2nnc(CCN3CCCCC3)n2Cc2ccccc2)c(C)c1 10.1021/jm061389p
CHEMBL219781 164846 0 None None None Human 5.5 pEC50 = 5.5 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 463 9 1 6 4.7 Cc1ccc(NC(=O)CSc2nnc(CCN3CCCCC3)n2Cc2ccccc2)c(C)c1 10.1021/jm061389p
124734 473621 72 None -6 3 Human 4.5 pEC50 = 4.5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
70848 473621 72 None -6 3 Human 4.5 pEC50 = 4.5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 473621 72 None -6 3 Human 4.5 pEC50 = 4.5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
DB01912 473621 72 None -6 3 Human 4.5 pEC50 = 4.5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
10585 2226 1 None 4 2 Human 8.4 pEC50 = 8.4 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 2226 1 None 4 2 Human 8.4 pEC50 = 8.4 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 2226 1 None 4 2 Human 8.4 pEC50 = 8.4 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
12425 11 80 None -1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 11 80 None -1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 11 80 None -1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 11 80 None -1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
10585 2226 1 None 4 2 Human 8.3 pEC50 = 8.3 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 2226 1 None 4 2 Human 8.3 pEC50 = 8.3 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 2226 1 None 4 2 Human 8.3 pEC50 = 8.3 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
155491018 348149 1 None 6 2 Human 8.3 pEC50 = 8.3 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 348149 1 None 6 2 Human 8.3 pEC50 = 8.3 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
155491018 348149 1 None 6 2 Human 8.3 pEC50 = 8.3 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 348149 1 None 6 2 Human 8.3 pEC50 = 8.3 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
12425 11 80 None -1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 11 80 None -1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 11 80 None -1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 11 80 None -1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
155491018 348149 1 None 6 2 Human 8.2 pEC50 = 8.2 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 348149 1 None 6 2 Human 8.2 pEC50 = 8.2 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
155491018 348149 1 None 6 2 Human 8.2 pEC50 = 8.2 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 348149 1 None 6 2 Human 8.2 pEC50 = 8.2 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
65237 275021 69 None -40 2 Human 4.2 pEC50 = 4.2 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
CHEMBL375781 275021 69 None -40 2 Human 4.2 pEC50 = 4.2 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
65237 275021 69 None -40 2 Human 4.2 pEC50 = 4.2 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
CHEMBL375781 275021 69 None -40 2 Human 4.2 pEC50 = 4.2 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
183790 8163 6 None None None Human 8.2 pEC50 = 8.2 Functional
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
783 8163 6 None None None Human 8.2 pEC50 = 8.2 Functional
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
CHEMBL1178786 8163 6 None None None Human 8.2 pEC50 = 8.2 Functional
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
10585 2226 1 None 4 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 2226 1 None 4 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 2226 1 None 4 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
10585 2226 1 None 4 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 2226 1 None 4 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 2226 1 None 4 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
10585 2226 1 None 4 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 2226 1 None 4 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 2226 1 None 4 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
155491018 348149 1 None 6 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 348149 1 None 6 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
10585 2226 1 None 4 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 2226 1 None 4 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 2226 1 None 4 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
155491018 348149 1 None 6 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 348149 1 None 6 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
11151928 352668 0 None -5 4 Human 9.1 pED50 = 9.1 Functional
Antagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assayAntagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assay
ChEMBL 338 11 2 2 4.3 CCCCCCCCCCC(C)(C)C(=O)N[C@@H]1CCCCNC1=O 10.1021/jm900133w
11359715 352668 0 None -5 4 Human 9.1 pED50 = 9.1 Functional
Antagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assayAntagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assay
ChEMBL 338 11 2 2 4.3 CCCCCCCCCCC(C)(C)C(=O)N[C@@H]1CCCCNC1=O 10.1021/jm900133w
CHEMBL468720 352668 0 None -5 4 Human 9.1 pED50 = 9.1 Functional
Antagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assayAntagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assay
ChEMBL 338 11 2 2 4.3 CCCCCCCCCCC(C)(C)C(=O)N[C@@H]1CCCCNC1=O 10.1021/jm900133w
CHEMBL513863 352668 0 None -5 4 Human 9.1 pED50 = 9.1 Functional
Antagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assayAntagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assay
ChEMBL 338 11 2 2 4.3 CCCCCCCCCCC(C)(C)C(=O)N[C@@H]1CCCCNC1=O 10.1021/jm900133w
15941255 163201 0 None None None Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 527 9 2 6 4.5 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2Cl)CC1 10.1021/ml2002604
CHEMBL2164207 163201 0 None None None Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 527 9 2 6 4.5 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2Cl)CC1 10.1021/ml2002604
57402801 141483 0 None None None Human 10.1 pIC50 = 10.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 600 12 2 7 5.2 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C(=O)NC(C)C)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926899 141483 0 None None None Human 10.1 pIC50 = 10.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 600 12 2 7 5.2 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C(=O)NC(C)C)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
50993591 120006 0 None None None Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 497 6 1 6 3.9 COC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3cccc(F)c3)c2C1 10.1021/jm100978n
CHEMBL1649924 120006 0 None None None Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 497 6 1 6 3.9 COC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3cccc(F)c3)c2C1 10.1021/jm100978n
15940800 163196 0 None None None Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 561 10 1 7 3.9 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CN2CCOC2=O)CC1 10.1021/ml2002604
CHEMBL2164202 163196 0 None None None Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 561 10 1 7 3.9 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CN2CCOC2=O)CC1 10.1021/ml2002604
15941086 163204 0 None None None Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 518 9 2 7 3.7 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2Cl)CC1 10.1021/ml2002604
CHEMBL2164210 163204 0 None None None Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 518 9 2 7 3.7 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2Cl)CC1 10.1021/ml2002604
11285792 1815 36 None -3 6 Human 10.0 pIC50 = 10 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
801 1815 36 None -3 6 Human 10.0 pIC50 = 10 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
CHEMBL2110727 1815 36 None -3 6 Human 10.0 pIC50 = 10 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
DB11758 1815 36 None -3 6 Human 10.0 pIC50 = 10 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
62706107 163211 0 None None None Human 10.0 pIC50 = 10.0 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 554 9 2 6 5.5 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)Nc2cccnc2)CC1 10.1021/ml2002604
CHEMBL2164217 163211 0 None None None Human 10.0 pIC50 = 10.0 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 554 9 2 6 5.5 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)Nc2cccnc2)CC1 10.1021/ml2002604
11650548 213271 0 None None None Human 9.7 pIC50 = 9.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 697 17 1 8 8.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085308 213271 0 None None None Human 9.7 pIC50 = 9.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 697 17 1 8 8.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CC(C)C)cc1 10.1021/jm0509703
15947119 141477 0 None None None Human 9.7 pIC50 = 9.7 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 549 10 1 6 5.7 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926893 141477 0 None None None Human 9.7 pIC50 = 9.7 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 549 10 1 6 5.7 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
50993593 120008 0 None None None Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 497 6 1 6 3.9 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1cccc(F)c1 10.1021/jm100978n
CHEMBL1649926 120008 0 None None None Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 497 6 1 6 3.9 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1cccc(F)c1 10.1021/jm100978n
50992494 120009 0 None None None Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 6 1 7 4.1 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(=O)OC)CC3)C2)c1cccc(F)c1 10.1021/jm100978n
CHEMBL1649927 120009 0 None None None Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 6 1 7 4.1 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(=O)OC)CC3)C2)c1cccc(F)c1 10.1021/jm100978n
1635 193594 43 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/jm100978n
3002977 193594 43 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/jm100978n
CHEMBL256907 193594 43 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/jm100978n
1635 193594 43 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmc.2016.12.035
3002977 193594 43 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmc.2016.12.035
CHEMBL256907 193594 43 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmc.2016.12.035
11285792 1815 36 None -3 6 Human 9.7 pIC50 = 9.7 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
801 1815 36 None -3 6 Human 9.7 pIC50 = 9.7 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
CHEMBL2110727 1815 36 None -3 6 Human 9.7 pIC50 = 9.7 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
DB11758 1815 36 None -3 6 Human 9.7 pIC50 = 9.7 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
11513274 213272 0 None None None Human 9.7 pIC50 = 9.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
CHEMBL3085309 213272 0 None None None Human 9.7 pIC50 = 9.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
9810893 213270 0 None None None Human 9.6 pIC50 = 9.6 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085307 213270 0 None None None Human 9.6 pIC50 = 9.6 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
44511934 141480 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 10 1 6 5.2 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926896 141480 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 10 1 6 5.2 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
44512090 141482 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 540 10 1 7 5.0 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926898 141482 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 540 10 1 7 5.0 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
44512058 141491 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 551 10 1 8 4.5 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1927008 141491 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 551 10 1 8 4.5 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
44511938 141492 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 10 1 7 5.3 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1927009 141492 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 10 1 7 5.3 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
50992641 120005 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 479 6 1 6 3.8 COC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3ccccc3)c2C1 10.1021/jm100978n
CHEMBL1649922 120005 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 479 6 1 6 3.8 COC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3ccccc3)c2C1 10.1021/jm100978n
62706110 163197 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 491 8 2 5 4.2 CNC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164203 163197 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 491 8 2 5 4.2 CNC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
15940799 163199 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 493 8 3 6 4.0 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)NO)CC1 10.1021/ml2002604
CHEMBL2164205 163199 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 493 8 3 6 4.0 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)NO)CC1 10.1021/ml2002604
57384005 163200 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 507 9 2 6 4.2 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164206 163200 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 507 9 2 6 4.2 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
57384006 163205 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 551 12 2 7 4.2 COCCONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164211 163205 0 None None None Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 551 12 2 7 4.2 COCCONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
50915506 42900 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 11 2 6 8.2 CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)c(Cl)cc1F 10.1016/j.bmcl.2010.10.033
CHEMBL1288663 42900 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 11 2 6 8.2 CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)c(Cl)cc1F 10.1016/j.bmcl.2010.10.033
44455217 195787 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor by [35S]GTP-gamma-S binding assayAntagonist activity at CCR5 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 608 7 1 5 6.4 CC(=O)N1CCc2c(nc(C)n2[C@H]2C[C@@H]3CC[C@H](C2)N3CCCN(C(=O)Nc2ccc(C(F)(F)F)cc2)c2ccccc2)C1 10.1016/j.bmcl.2007.12.058
CHEMBL257000 195787 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor by [35S]GTP-gamma-S binding assayAntagonist activity at CCR5 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 608 7 1 5 6.4 CC(=O)N1CCc2c(nc(C)n2[C@H]2C[C@@H]3CC[C@H](C2)N3CCCN(C(=O)Nc2ccc(C(F)(F)F)cc2)c2ccccc2)C1 10.1016/j.bmcl.2007.12.058
50992577 120001 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 463 6 1 5 3.5 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649919 120001 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 463 6 1 5 3.5 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
50992639 120003 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 477 7 1 5 3.9 CCC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3ccccc3)c2C1 10.1021/jm100978n
CHEMBL1649920 120003 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 477 7 1 5 3.9 CCC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3ccccc3)c2C1 10.1021/jm100978n
50992640 120004 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 491 7 1 5 4.2 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(=O)C(C)C)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649921 120004 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 491 7 1 5 4.2 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(=O)C(C)C)CC3)C2)c1ccccc1 10.1021/jm100978n
59458228 163202 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 558 11 3 7 3.6 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C(=O)NC(C)C)nc2C)CC1 10.1021/ml2002604
CHEMBL2164208 163202 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 558 11 3 7 3.6 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C(=O)NC(C)C)nc2C)CC1 10.1021/ml2002604
59458061 163203 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 543 9 2 6 3.7 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)[n+]([O-])c2Cl)CC1 10.1021/ml2002604
CHEMBL2164209 163203 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 543 9 2 6 3.7 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)[n+]([O-])c2Cl)CC1 10.1021/ml2002604
15941083 163213 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 506 10 1 6 4.1 COCC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164219 163213 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 506 10 1 6 4.1 COCC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
15940801 163214 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 501 9 1 6 4.3 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC#N)CC1 10.1021/ml2002604
CHEMBL2164220 163214 0 None None None Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 501 9 1 6 4.3 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC#N)CC1 10.1021/ml2002604
5275766 8155 37 None None None Human 9.4 pIC50 = 9.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
800 8155 37 None None None Human 9.4 pIC50 = 9.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
CHEMBL207004 8155 37 None None None Human 9.4 pIC50 = 9.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
11700429 213274 0 None None None Human 9.3 pIC50 = 9.3 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085311 213274 0 None None None Human 9.3 pIC50 = 9.3 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
53325983 119995 0 None None None Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 416 6 1 4 4.8 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3ccccc31)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649913 119995 0 None None None Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 416 6 1 4 4.8 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3ccccc31)C2)c1ccccc1 10.1021/jm100978n
15940498 163206 0 None None None Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 611 11 3 6 5.5 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)NCc2ccc(C(=O)O)cc2)CC1 10.1021/ml2002604
CHEMBL2164212 163206 0 None None None Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 611 11 3 6 5.5 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)NCc2ccc(C(=O)O)cc2)CC1 10.1021/ml2002604
457871 200869 0 None None None Human 9.3 pIC50 = 9.3 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL292625 200869 0 None None None Human 9.3 pIC50 = 9.3 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
44511935 141484 0 None None None Human 9.2 pIC50 = 9.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 593 13 1 7 5.8 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926900 141484 0 None None None Human 9.2 pIC50 = 9.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 593 13 1 7 5.8 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
50993592 120007 0 None None None Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 479 6 1 6 3.8 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649925 120007 0 None None None Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 479 6 1 6 3.8 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
3008904 444496 0 None 1 2 Human 9.2 pIC50 = 9.2 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59511 444496 0 None 1 2 Human 9.2 pIC50 = 9.2 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
11614352 1138 1 None None None Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxis
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
7686 1138 1 None None None Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxis
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
CHEMBL1951914 1138 1 None None None Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxis
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
57392303 141475 0 None None None Human 9.2 pIC50 = 9.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ccnc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926891 141475 0 None None None Human 9.2 pIC50 = 9.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ccnc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
44512001 141493 0 None None None Human 9.2 pIC50 = 9.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 544 10 1 7 4.8 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1927010 141493 0 None None None Human 9.2 pIC50 = 9.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 544 10 1 7 4.8 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
62706106 163209 0 None None None Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 560 10 1 6 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC2CCOCC2)CC1 10.1021/ml2002604
CHEMBL2164215 163209 0 None None None Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 560 10 1 6 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC2CCOCC2)CC1 10.1021/ml2002604
3008917 467865 2 None -6 2 Human 9.2 pIC50 = 9.2 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL62152 467865 2 None -6 2 Human 9.2 pIC50 = 9.2 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
23725098 385028 4 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.ejmech.2023.115294
CHEMBL5413158 385028 4 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.ejmech.2023.115294
3002977 4997 43 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
806 4997 43 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL1201187 4997 43 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL584744 4997 43 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
DB04835 4997 43 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
44511871 141485 0 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 13 1 8 5.0 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926901 141485 0 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 13 1 8 5.0 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
72711958 183464 0 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435864 183464 0 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711740 183509 0 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435909 183509 0 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
62706109 163195 0 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 551 10 1 7 4.5 Cc1cc(C#N)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC2CCOCC2)CC1 10.1021/ml2002604
CHEMBL2164201 163195 0 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 551 10 1 7 4.5 Cc1cc(C#N)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC2CCOCC2)CC1 10.1021/ml2002604
3008909 428612 0 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL58897 428612 0 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
3013701 158736 0 None None None Human 9.1 pIC50 = 9.1 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 643 10 0 6 4.7 CS(=O)(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL207487 158736 0 None None None Human 9.1 pIC50 = 9.1 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 643 10 0 6 4.7 CS(=O)(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
1635 193594 43 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00781
3002977 193594 43 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00781
CHEMBL256907 193594 43 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00781
5275766 8155 37 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assay
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1016/j.ejmech.2023.115294
800 8155 37 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assay
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1016/j.ejmech.2023.115294
CHEMBL207004 8155 37 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assay
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1016/j.ejmech.2023.115294
72711739 183507 0 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 551 8 1 4 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435907 183507 0 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 551 8 1 4 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
62706108 163212 0 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 476 8 1 5 4.4 CC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164218 163212 0 None None None Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 476 8 1 5 4.4 CC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
11636141 213273 0 None None None Human 9.0 pIC50 = 9.0 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 683 17 1 8 7.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085310 213273 0 None None None Human 9.0 pIC50 = 9.0 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 683 17 1 8 7.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
57402802 141488 0 None None None Human 9.0 pIC50 = 9.0 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 583 12 2 8 3.8 Cc1ccncc1CN(c1ccc(OCC(N)=O)cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2C)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926904 141488 0 None None None Human 9.0 pIC50 = 9.0 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 583 12 2 8 3.8 Cc1ccncc1CN(c1ccc(OCC(N)=O)cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2C)CC1 10.1016/j.bmcl.2011.09.133
46225532 432707 0 None None None Human 9.0 pIC50 = 9 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 547 6 0 5 3.8 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593042 432707 0 None None None Human 9.0 pIC50 = 9 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 547 6 0 5 3.8 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008928 466307 0 None -1 2 Human 9.0 pIC50 = 9 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61424 466307 0 None -1 2 Human 9.0 pIC50 = 9 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3013575 157435 0 None None None Human 9.0 pIC50 = 9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL204821 157435 0 None None None Human 9.0 pIC50 = 9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
73331746 389390 0 None None None Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assay
ChEMBL 618 9 1 5 4.7 CC(=O)N1CCC(C(=O)N(CCCN2C3CCC2CC(NS(=O)(=O)c2ccc(F)cc2)C3)c2ccc(C)c(Cl)c2)CC1 10.1016/j.ejmech.2023.115294
CHEMBL5438380 389390 0 None None None Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assay
ChEMBL 618 9 1 5 4.7 CC(=O)N1CCC(C(=O)N(CCCN2C3CCC2CC(NS(=O)(=O)c2ccc(F)cc2)C3)c2ccc(C)c(Cl)c2)CC1 10.1016/j.ejmech.2023.115294
49798082 25101 0 None None None Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 579 9 1 5 5.5 C=CCN(C(=O)OCc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172043 25101 0 None None None Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 579 9 1 5 5.5 C=CCN(C(=O)OCc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
44194590 25106 0 None None None Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 612 9 2 4 5.4 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172048 25106 0 None None None Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 612 9 2 4 5.4 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
11353001 121592 0 None None None Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688239 121592 0 None None None Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
11597 1388 8 None -11 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
23725180 1388 8 None -11 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
CHEMBL4781426 1388 8 None -11 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
51039119 350183 37 None 1 3 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
CHEMBL4594419 350183 37 None 1 3 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
DB16240 350183 37 None 1 3 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
3008927 424050 0 None -2 2 Human 9.0 pIC50 = 9.0 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58387 424050 0 None -2 2 Human 9.0 pIC50 = 9.0 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008909 428612 0 None None None Human 9.0 pIC50 = 9.0 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL58897 428612 0 None None None Human 9.0 pIC50 = 9.0 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
72711956 183462 0 None None None Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435862 183462 0 None None None Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
3009355 8651 20 None -1 2 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
807 8651 20 None -1 2 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
CHEMBL82301 8651 20 None -1 2 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
DB06652 8651 20 None -1 2 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
11605997 121594 0 None None None Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 515 3 0 5 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(C(F)(F)F)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688240 121594 0 None None None Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 515 3 0 5 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(C(F)(F)F)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
71458736 163207 0 None None None Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 507 10 1 7 4.8 COc1ccc(N(Cc2ccsc2)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1021/ml2002604
CHEMBL2164213 163207 0 None None None Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 507 10 1 7 4.8 COc1ccc(N(Cc2ccsc2)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1021/ml2002604
183790 8163 6 None -1 5 Human 8.9 pIC50 = 8.9 Functional
Inhibition of chemotactic protein to CCR5Inhibition of chemotactic protein to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm010468s
783 8163 6 None -1 5 Human 8.9 pIC50 = 8.9 Functional
Inhibition of chemotactic protein to CCR5Inhibition of chemotactic protein to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm010468s
CHEMBL1178786 8163 6 None -1 5 Human 8.9 pIC50 = 8.9 Functional
Inhibition of chemotactic protein to CCR5Inhibition of chemotactic protein to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm010468s
44512349 141486 0 None None None Human 8.9 pIC50 = 8.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 577 13 1 7 5.2 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926902 141486 0 None None None Human 8.9 pIC50 = 8.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 577 13 1 7 5.2 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
72711742 183460 0 None None None Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435860 183460 0 None None None Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
49864971 39673 0 None None None Human 8.9 pIC50 = 8.9 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 630 9 2 4 5.5 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222769 39673 0 None None None Human 8.9 pIC50 = 8.9 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 630 9 2 4 5.5 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
49768863 119994 0 None None None Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nc(C(C)C)n([C@@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)n1 10.1021/jm100978n
CHEMBL1649912 119994 0 None None None Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nc(C(C)C)n([C@@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)n1 10.1021/jm100978n
3008913 202080 0 None -1 2 Human 8.9 pIC50 = 8.9 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL301454 202080 0 None -1 2 Human 8.9 pIC50 = 8.9 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
183790 8163 6 None -1 5 Human 8.9 pIC50 = 8.9 Functional
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00347-4
783 8163 6 None -1 5 Human 8.9 pIC50 = 8.9 Functional
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00347-4
CHEMBL1178786 8163 6 None -1 5 Human 8.9 pIC50 = 8.9 Functional
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00347-4
183790 8163 6 None -1 5 Human 8.9 pIC50 = 8.9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
783 8163 6 None -1 5 Human 8.9 pIC50 = 8.9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
CHEMBL1178786 8163 6 None -1 5 Human 8.9 pIC50 = 8.9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
5275759 158758 0 None None None Human 8.9 pIC50 = 8.9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 590 9 0 5 5.2 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C#N)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207630 158758 0 None None None Human 8.9 pIC50 = 8.9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 590 9 0 5 5.2 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C#N)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
9810893 213270 0 None None None Human 8.9 pIC50 = 8.9 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085307 213270 0 None None None Human 8.9 pIC50 = 8.9 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL5084989 479119 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 553 9 1 4 5.3 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1021/acs.jmedchem.1c00781
57395817 141478 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cccnc2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926894 141478 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cccnc2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
72714078 183485 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435885 183485 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72714079 183486 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435886 183486 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
49871007 121597 22 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 assessed as inhibition of receptor internalizationAntagonist activity at CCR5 assessed as inhibition of receptor internalization
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 121597 22 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 assessed as inhibition of receptor internalizationAntagonist activity at CCR5 assessed as inhibition of receptor internalization
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
DB12960 121597 22 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 assessed as inhibition of receptor internalizationAntagonist activity at CCR5 assessed as inhibition of receptor internalization
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
44194588 25168 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 622 11 2 6 3.2 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172625 25168 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 622 11 2 6 3.2 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
57394057 141481 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 519 10 1 6 4.9 COc1ccc(N(Cc2cccnc2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926897 141481 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 519 10 1 6 4.9 COc1ccc(N(Cc2cccnc2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
49798089 25108 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 580 9 2 4 4.7 C=CCN(C(=O)NCc1ccc(F)cc1F)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172050 25108 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 580 9 2 4 4.7 C=CCN(C(=O)NCc1ccc(F)cc1F)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
49798090 25109 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 580 9 2 4 4.7 C=CCN(C(=O)NCc1ccc(F)c(F)c1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172051 25109 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 580 9 2 4 4.7 C=CCN(C(=O)NCc1ccc(F)c(F)c1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
50915506 42900 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 11 2 6 8.2 CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)c(Cl)cc1F 10.1016/j.bmcl.2010.10.033
CHEMBL1288663 42900 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 11 2 6 8.2 CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)c(Cl)cc1F 10.1016/j.bmcl.2010.10.033
49798085 25103 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 562 9 2 4 4.5 C=CCN(C(=O)NCc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172045 25103 0 None None None Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 562 9 2 4 4.5 C=CCN(C(=O)NCc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
72711741 183459 0 None None None Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435859 183459 0 None None None Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
11505350 333435 0 None None None Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 565 8 0 4 6.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Sc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL437494 333435 0 None None None Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 565 8 0 4 6.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Sc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
46225515 432591 0 None None None Human 8.0 pIC50 = 8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 551 6 0 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592940 432591 0 None None None Human 8.0 pIC50 = 8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 551 6 0 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
172447334 388102 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assay
ChEMBL 4060 155 47 57 -9.1 CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)c1ccc(S(=O)(=O)NC2CC3CCC(C2)N3CCCN(C(=O)C2CCN(C(C)=O)CC2)c2ccc(C)c(Cl)c2)cc1)C(N)=O)[C@@H](C)CC 10.1016/j.ejmech.2023.115294
CHEMBL5410204 388102 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assay
ChEMBL 4060 155 47 57 -9.1 CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)c1ccc(S(=O)(=O)NC2CC3CCC(C2)N3CCCN(C(=O)C2CCN(C(C)=O)CC2)c2ccc(C)c(Cl)c2)cc1)C(N)=O)[C@@H](C)CC 10.1016/j.ejmech.2023.115294
3008904 444496 0 None 1 2 Human 8.0 pIC50 = 8.0 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59511 444496 0 None 1 2 Human 8.0 pIC50 = 8.0 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
118727180 236231 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 592 8 0 5 4.2 CC(=O)N1CCC(C(=O)N(CCCN2CCN(S(=O)(=O)c3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397991 236231 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 592 8 0 5 4.2 CC(=O)N1CCC(C(=O)N(CCCN2CCN(S(=O)(=O)c3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
44511967 141472 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 516 10 1 7 4.5 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926888 141472 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 516 10 1 7 4.5 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
44511967 141472 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 516 10 1 7 4.5 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1021/ml2002604
CHEMBL1926888 141472 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 516 10 1 7 4.5 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1021/ml2002604
3008907 466474 0 None None None Human 7.0 pIC50 = 7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 405 4 1 3 4.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61465 466474 0 None None None Human 7.0 pIC50 = 7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 405 4 1 3 4.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccccc3)CC2)CC1 10.1021/jm031046g
505868 61445 0 None None None Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137072 61445 0 None None None Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44357072 198758 0 None None None Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 553 12 1 7 4.7 CCCN(c1nccc(OC)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL275998 198758 0 None None None Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 553 12 1 7 4.7 CCCN(c1nccc(OC)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
505878 237962 0 None None None Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 518 10 1 5 5.5 CCCN(c1ccccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343160 237962 0 None None None Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 518 10 1 5 5.5 CCCN(c1ccccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44356944 237993 1 None None None Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 509 10 1 6 4.3 CCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343366 237993 1 None None None Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 509 10 1 6 4.3 CCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44357078 238159 0 None None None Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 591 11 1 6 5.7 CCCN(c1ncc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL344641 238159 0 None None None Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 591 11 1 6 5.7 CCCN(c1ncc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
46225346 444913 0 None None None Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 551 7 1 6 3.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)CO)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595570 444913 0 None None None Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 551 7 1 6 3.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)CO)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46837554 24948 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 516 9 1 4 5.6 COC(=O)C1(Cc2ccccc2)CCN(CC[C@H](NC(=O)C2CCC2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.ejmech.2010.03.003
CHEMBL1170529 24948 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 516 9 1 4 5.6 COC(=O)C1(Cc2ccccc2)CCN(CC[C@H](NC(=O)C2CCC2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.ejmech.2010.03.003
46837425 213142 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 547 7 1 5 6.8 Cc1nc2cccnc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)c1ccc(F)cc1)c1cccc2ccccc12 10.1016/j.ejmech.2010.03.003
CHEMBL3084746 213142 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 547 7 1 5 6.8 Cc1nc2cccnc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)c1ccc(F)cc1)c1cccc2ccccc12 10.1016/j.ejmech.2010.03.003
53389085 138758 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852138 138758 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
53389085 138758 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1852138 138758 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.ejmech.2012.07.049
46226118 38042 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 531 10 1 4 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198032 38042 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 531 10 1 4 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
44395365 252496 0 None None None Human 5.0 pIC50 = 5 Functional
Inhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 386 7 2 7 1.8 CC(OC(=O)/C=C/c1ccc(O)cc1)C(=O)[C@H]1C[C@@H]1[C@H](O)[C@H]1CC=CC(=O)O1 10.1016/j.bmcl.2004.08.021
CHEMBL363999 252496 0 None None None Human 5.0 pIC50 = 5 Functional
Inhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 386 7 2 7 1.8 CC(OC(=O)/C=C/c1ccc(O)cc1)C(=O)[C@H]1C[C@@H]1[C@H](O)[C@H]1CC=CC(=O)O1 10.1016/j.bmcl.2004.08.021
53389085 138758 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852138 138758 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
54752873 155052 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2078840 155052 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
54752873 155052 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2078840 155052 0 None None None Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
46225343 445578 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 521 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596299 445578 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 521 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008911 201120 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
CHEMBL294271 201120 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
3008925 201056 0 None None None Human 7.0 pIC50 = 7.0 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
CHEMBL293900 201056 0 None None None Human 7.0 pIC50 = 7.0 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
90656325 220583 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 431 7 1 6 3.8 CC(C)Oc1ccc(N2CCN(Cc3ccccc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263023 220583 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 431 7 1 6 3.8 CC(C)Oc1ccc(N2CCN(Cc3ccccc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
70690766 158810 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2078746 158810 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
178319624 467717 0 None 28 2 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 529 6 3 10 4.4 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc(Cl)cc2Cl)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6192332 467717 0 None 28 2 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 529 6 3 10 4.4 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc(Cl)cc2Cl)c1O 10.1016/j.ejmech.2025.117600
57397596 141464 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 646 12 2 6 7.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Oc3ccc(C(=O)O)cc3)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926878 141464 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 646 12 2 6 7.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Oc3ccc(C(=O)O)cc3)cc2)CC1 10.1016/j.bmcl.2011.09.133
49798132 25012 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 547 9 1 4 4.4 C=CCN(C(=O)Cc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1171029 25012 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 547 9 1 4 4.4 C=CCN(C(=O)Cc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
52948296 42930 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 13 2 6 7.6 CCCCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288924 42930 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 13 2 6 7.6 CCCCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
44357379 61799 0 None None None Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 535 11 1 6 4.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ncccn3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00988-5
CHEMBL137327 61799 0 None None None Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 535 11 1 6 4.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ncccn3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00988-5
505869 61927 0 None None None Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137419 61927 0 None None None Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44357375 234936 0 None None None Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1cncnc1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL335562 234936 0 None None None Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1cncnc1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
9914742 331451 0 None None None Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL428104 331451 0 None None None Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
3008927 424050 0 None -2 2 Human 8.0 pIC50 = 8.0 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58387 424050 0 None -2 2 Human 8.0 pIC50 = 8.0 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
53325460 121283 0 None -2 2 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human CCR5 receptor by chemotaxis assayAntagonist activity at human CCR5 receptor by chemotaxis assay
ChEMBL 538 6 1 6 3.6 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](CC(F)(F)F)(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683190 121283 0 None -2 2 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human CCR5 receptor by chemotaxis assayAntagonist activity at human CCR5 receptor by chemotaxis assay
ChEMBL 538 6 1 6 3.6 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](CC(F)(F)F)(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)C1 10.1016/j.bmcl.2011.01.015
3008934 411637 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58101 411637 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
49864972 39674 0 None None None Human 8.0 pIC50 = 8.0 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 640 11 2 6 3.3 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222770 39674 0 None None None Human 8.0 pIC50 = 8.0 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 640 11 2 6 3.3 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
49864975 39677 0 None None None Human 7.9 pIC50 = 7.9 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 695 11 2 6 4.3 C=CCN(C(=O)NCc1ccc(S(=O)(=O)N(C)C)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222773 39677 0 None None None Human 7.9 pIC50 = 7.9 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 695 11 2 6 4.3 C=CCN(C(=O)NCc1ccc(S(=O)(=O)N(C)C)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
52943424 42919 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 833 12 2 7 6.8 C=CCN(C(=O)Nc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288913 42919 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 833 12 2 7 6.8 C=CCN(C(=O)Nc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
73346388 183478 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435878 183478 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
118727176 236227 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3cccc(F)c3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397987 236227 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3cccc(F)c3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
168279183 373986 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 541 9 1 8 5.2 COC(=O)C1CCC(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)CC1 10.1021/acs.jmedchem.2c01383
CHEMBL5185201 373986 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 541 9 1 8 5.2 COC(=O)C1CCC(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)CC1 10.1021/acs.jmedchem.2c01383
145967391 329197 0 None None None Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 589 7 0 5 6.9 Cc1nc2cnccc2n1C1CCN(CCC2(c3ccc(Cl)c(Cl)c3)CCCN(C(=O)Cc3ccccc3)C2)CC1 10.1021/acs.jmedchem.8b00180
CHEMBL4211358 329197 0 None None None Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 589 7 0 5 6.9 Cc1nc2cnccc2n1C1CCN(CCC2(c3ccc(Cl)c(Cl)c3)CCCN(C(=O)Cc3ccccc3)C2)CC1 10.1021/acs.jmedchem.8b00180
178292188 467710 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 545 7 3 11 4.0 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc(OC(F)(F)F)cc2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6192166 467710 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 545 7 3 11 4.0 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc(OC(F)(F)F)cc2)c1O 10.1016/j.ejmech.2025.117600
76327885 213140 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS bindingAntagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS binding
ChEMBL 418 6 0 6 4.3 COC(=O)[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3cccnc31)C2)c1ccccc1 10.1016/j.bmcl.2010.02.023
CHEMBL3084729 213140 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS bindingAntagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS binding
ChEMBL 418 6 0 6 4.3 COC(=O)[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3cccnc31)C2)c1ccccc1 10.1016/j.bmcl.2010.02.023
44194496 25099 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 587 9 1 8 4.3 C=CCN(C(=O)OCc1ccc2nonc2c1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172041 25099 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 587 9 1 8 4.3 C=CCN(C(=O)OCc1ccc2nonc2c1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
178321738 467671 0 None None None Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 467 6 3 10 3.1 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2NC2CCCCC2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6191234 467671 0 None None None Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 467 6 3 10 3.1 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2NC2CCCCC2)c1O 10.1016/j.ejmech.2025.117600
57397595 141463 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 581 10 1 5 5.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C(=O)N(C)C)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926877 141463 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 581 10 1 5 5.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C(=O)N(C)C)cc2)CC1 10.1016/j.bmcl.2011.09.133
46225348 445787 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 515 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596519 445787 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 515 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008936 411715 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58109 411715 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
57401042 141471 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 9 1 6 5.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(C#N)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926887 141471 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 9 1 6 5.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(C#N)cc2)CC1 10.1016/j.bmcl.2011.09.133
126567277 330515 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 553 8 1 6 6.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(Cl)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4243842 330515 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 553 8 1 6 6.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(Cl)s1 10.1021/acs.jmedchem.8b01077
3008930 410787 0 None 1 2 Human 7.9 pIC50 = 7.9 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58004 410787 0 None 1 2 Human 7.9 pIC50 = 7.9 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
11527582 158082 0 None None None Human 7.9 pIC50 = 7.9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 664 10 1 5 5.9 CC(C)(C)NC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL205964 158082 0 None None None Human 7.9 pIC50 = 7.9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 664 10 1 5 5.9 CC(C)(C)NC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
505875 59664 0 None None None Human 7.9 pIC50 = 7.9 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL135432 59664 0 None None None Human 7.9 pIC50 = 7.9 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505873 61609 0 None None None Human 7.9 pIC50 = 7.9 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137206 61609 0 None None None Human 7.9 pIC50 = 7.9 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
3008913 202080 0 None -1 2 Human 7.9 pIC50 = 7.9 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL301454 202080 0 None -1 2 Human 7.9 pIC50 = 7.9 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
57395816 141476 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3cnc(Cl)cc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926892 141476 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3cnc(Cl)cc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
72712159 183467 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435867 183467 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
73352463 183446 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1cccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)c1 10.1021/jm401101p
CHEMBL2435846 183446 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1cccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)c1 10.1021/jm401101p
11569805 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
16728785 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
491775 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1188408 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1188807 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1196449 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
10117348 28171 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
CHEMBL1196455 28171 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
10117348 28171 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1196455 28171 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmc.2010.05.057
10117348 28171 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1196455 28171 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmcl.2009.11.018
16728326 25096 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 589 9 1 7 4.5 C=CCN(C(=O)OCc1ccc2c(c1)OCO2)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172037 25096 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 589 9 1 7 4.5 C=CCN(C(=O)OCc1ccc2c(c1)OCO2)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
76317388 214308 0 None None None Human 6.9 pIC50 = 6.9 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 614 11 0 4 5.8 CCN(CCc1ccc(Cl)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104693 214308 0 None None None Human 6.9 pIC50 = 6.9 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 614 11 0 4 5.8 CCN(CCc1ccc(Cl)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL5071060 477459 0 None -3 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1021/acs.jmedchem.1c00408
89702731 218968 0 None -3 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1039/c3md00080j
CHEMBL3219777 218968 0 None -3 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1039/c3md00080j
162650661 346788 0 None -3 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4748891 346788 0 None -3 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
89702731 218968 0 None -3 2 Human 6.9 pIC50 = 6.9 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 nan
CHEMBL3219777 218968 0 None -3 2 Human 6.9 pIC50 = 6.9 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 nan
CHEMBL5074037 478514 0 None -1 2 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 1183 28 7 15 5.2 CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
3008936 411715 0 None None None Human 6.9 pIC50 = 6.9 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58109 411715 0 None None None Human 6.9 pIC50 = 6.9 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
122185609 241474 0 None None None Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 514 6 2 2 5.7 Cc1c(CNC(=O)c2ccc3ccccc3c2)c(C)[n+]2c(c1CNC(=O)c1ccc3ccccc3c1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606029 241474 0 None None None Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 514 6 2 2 5.7 Cc1c(CNC(=O)c2ccc3ccccc3c2)c(C)[n+]2c(c1CNC(=O)c1ccc3ccccc3c1)CCC2 10.1016/j.bmcl.2015.06.029
162677279 366816 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1cccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1 10.1016/j.bmc.2016.09.059
CHEMBL4799343 366816 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1cccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1 10.1016/j.bmc.2016.09.059
46225344 445084 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 535 5 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595760 445084 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 535 5 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
122185613 241482 0 None None None Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 578 8 2 2 7.5 Cc1c(CNC(=O)c2ccc(C3CCCCC3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C3CCCCC3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606076 241482 0 None None None Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 578 8 2 2 7.5 Cc1c(CNC(=O)c2ccc(C3CCCCC3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C3CCCCC3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
21064283 38245 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1200019 38245 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
21064283 38245 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200019 38245 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226132 38039 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 575 11 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C(=O)O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198014 38039 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 575 11 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C(=O)O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
1635 193594 43 None 2 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmc.2014.12.052
3002977 193594 43 None 2 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmc.2014.12.052
CHEMBL256907 193594 43 None 2 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmc.2014.12.052
3008930 410787 0 None 1 2 Human 7.9 pIC50 = 7.9 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58004 410787 0 None 1 2 Human 7.9 pIC50 = 7.9 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
72713860 183513 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435913 183513 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
57395818 141487 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 548 10 1 7 4.2 Cc1ccncc1CN(c1ccc([S+](C)[O-])cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926903 141487 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 548 10 1 7 4.2 Cc1ccncc1CN(c1ccc([S+](C)[O-])cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1016/j.bmcl.2011.09.133
11569805 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728785 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
491775 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188408 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188807 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196449 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
11569805 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
16728785 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
491775 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188408 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188807 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1196449 27094 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
21064293 38241 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 547 10 1 5 5.9 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200015 38241 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 547 10 1 5 5.9 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226126 38036 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 561 11 1 5 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(OC)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198011 38036 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 561 11 1 5 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(OC)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
23577409 138710 0 None None None Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851891 138710 0 None None None Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
162660215 346796 0 None -79 2 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)c1 10.1016/j.bmc.2016.09.059
CHEMBL4761273 346796 0 None -79 2 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)c1 10.1016/j.bmc.2016.09.059
122185641 241488 0 None None None Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 414 6 2 2 3.4 Cc1c(CNC(=O)c2ccccc2)c(C)[n+]2c(c1CNC(=O)c1ccccc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606113 241488 0 None None None Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 414 6 2 2 3.4 Cc1c(CNC(=O)c2ccccc2)c(C)[n+]2c(c1CNC(=O)c1ccccc1)CCC2 10.1016/j.bmcl.2015.06.029
46225350 452144 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 515 7 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)CC4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL603325 452144 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 515 7 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)CC4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
70694942 158838 0 None None None Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079186 158838 0 None None None Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
168283795 373968 0 None None None Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 586 10 2 9 4.2 COc1ccc(S(N)(=O)=O)cc1C(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1cccs1 10.1021/acs.jmedchem.2c01383
CHEMBL5184978 373968 0 None None None Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 586 10 2 9 4.2 COc1ccc(S(N)(=O)=O)cc1C(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1cccs1 10.1021/acs.jmedchem.2c01383
90666578 218971 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 528 8 2 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(N)cc1 10.1039/c3md00080j
CHEMBL3219780 218971 0 None None None Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 528 8 2 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(N)cc1 10.1039/c3md00080j
112500049 260353 0 None None None Human 7.9 pIC50 = 7.9 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 642 11 2 7 6.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COC(C)(C)C)cc1 nan
CHEMBL3697626 260353 0 None None None Human 7.9 pIC50 = 7.9 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 642 11 2 7 6.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COC(C)(C)C)cc1 nan
71458737 163210 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 563 9 2 6 5.2 Cc1ccncc1CN(C(=O)Nc1cccnc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164216 163210 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 563 9 2 6 5.2 Cc1ccncc1CN(C(=O)Nc1cccnc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
49864974 39680 0 None None None Human 7.8 pIC50 = 7.8 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 656 9 2 4 6.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)[C@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222776 39680 0 None None None Human 7.8 pIC50 = 7.8 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 656 9 2 4 6.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)[C@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
76316949 213141 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS bindingAntagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS binding
ChEMBL 511 8 1 5 5.5 Cc1nc2cccnc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](C(=O)NCc1ccc(F)cc1)c1ccccc1 10.1016/j.bmcl.2010.02.023
CHEMBL3084731 213141 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS bindingAntagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS binding
ChEMBL 511 8 1 5 5.5 Cc1nc2cccnc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](C(=O)NCc1ccc(F)cc1)c1ccccc1 10.1016/j.bmcl.2010.02.023
3008913 202080 0 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytes
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL301454 202080 0 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytes
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008917 467865 2 None -6 2 Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL62152 467865 2 None -6 2 Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
49798130 25149 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 559 10 1 5 4.3 C=CCN(C(=O)Cc1ccc(OC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172438 25149 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 559 10 1 5 4.3 C=CCN(C(=O)Cc1ccc(OC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
3008902 466725 0 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytes
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61536 466725 0 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytes
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008902 466725 0 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61536 466725 0 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008905 412980 0 None None None Human 6.9 pIC50 = 6.9 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58248 412980 0 None None None Human 6.9 pIC50 = 6.9 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
23577386 138664 0 None None None Human 5.9 pIC50 = 5.9 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851672 138664 0 None None None Human 5.9 pIC50 = 5.9 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
178319422 467729 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 517 6 3 11 3.4 CC1Cc2cc(Nc3nc4nonc4nc3Nc3ccc(Cl)c(S(=O)(=O)N(C)C)c3O)ccc2O1 10.1016/j.ejmech.2025.117600
CHEMBL6192594 467729 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 517 6 3 11 3.4 CC1Cc2cc(Nc3nc4nonc4nc3Nc3ccc(Cl)c(S(=O)(=O)N(C)C)c3O)ccc2O1 10.1016/j.ejmech.2025.117600
178293815 467757 0 None 15 2 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 479 6 3 10 3.2 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2cccc(F)c2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6193497 467757 0 None 15 2 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 479 6 3 10 3.2 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2cccc(F)c2)c1O 10.1016/j.ejmech.2025.117600
52944616 42920 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 827 13 2 7 6.9 C=CCN(C(=O)NCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288914 42920 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 827 13 2 7 6.9 C=CCN(C(=O)NCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
72714077 183484 0 None None None Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435884 183484 0 None None None Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
3008911 201120 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
CHEMBL294271 201120 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
49798157 25165 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 597 9 1 4 5.3 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172622 25165 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 597 9 1 4 5.3 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
72711281 183501 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 547 8 1 6 4.6 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)n1 10.1021/jm401101p
CHEMBL2435901 183501 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 547 8 1 6 4.6 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)n1 10.1021/jm401101p
72711048 183493 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
CHEMBL2435893 183493 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
52944586 42907 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 12 1 6 8.6 C=CCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288873 42907 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 12 1 6 8.6 C=CCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225347 444925 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 559 5 0 5 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595584 444925 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 559 5 0 5 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225530 432664 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 550 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592997 432664 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 550 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
122668134 373433 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 415 7 1 6 4.2 CC(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1cccs1 10.1021/acs.jmedchem.2c01383
CHEMBL5176665 373433 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 415 7 1 6 4.2 CC(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1cccs1 10.1021/acs.jmedchem.2c01383
118727172 236223 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 524 8 0 4 4.8 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccccc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397983 236223 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 524 8 0 4 4.8 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccccc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
72712373 183473 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 502 6 0 4 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(N3CCOCC3)cc2)CC1 10.1021/jm401101p
CHEMBL2435873 183473 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 502 6 0 4 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(N3CCOCC3)cc2)CC1 10.1021/jm401101p
3008917 467865 2 None -6 2 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL62152 467865 2 None -6 2 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008935 467536 0 None None None Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61828 467536 0 None None None Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008914 451132 0 None None None Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL60225 451132 0 None None None Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
126567253 330389 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 537 8 1 6 6.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4240763 330389 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 537 8 1 6 6.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)s1 10.1021/acs.jmedchem.8b01077
72712597 183476 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
CHEMBL2435876 183476 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
122668182 373342 3 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 573 7 1 6 5.4 CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccsc2)C1 10.1021/acs.jmedchem.2c01383
CHEMBL5175220 373342 3 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 573 7 1 6 5.4 CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccsc2)C1 10.1021/acs.jmedchem.2c01383
52943426 42929 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 751 13 1 6 6.1 C=CCN(C(=O)CCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288923 42929 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 751 13 1 6 6.1 C=CCN(C(=O)CCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
10186729 28196 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728786 28196 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196666 28196 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196759 28196 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
76310165 214307 0 None None None Human 6.8 pIC50 = 6.8 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 598 11 0 4 5.3 CCN(CCc1ccc(F)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104692 214307 0 None None None Human 6.8 pIC50 = 6.8 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 598 11 0 4 5.3 CCN(CCc1ccc(F)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
56673134 138733 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852005 138733 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
56673134 138733 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852005 138733 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
72714319 183489 0 None None None Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
CHEMBL2435889 183489 0 None None None Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
72711050 183495 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435895 183495 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
90666579 218972 0 None None None Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 628 9 2 7 7.3 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)OC(C)(C)C)cc1 10.1039/c3md00080j
CHEMBL3219781 218972 0 None None None Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 628 9 2 7 7.3 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)OC(C)(C)C)cc1 10.1039/c3md00080j
57397603 141490 0 None None None Human 5.8 pIC50 = 5.8 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 10 1 7 5.6 Cc1ccncc1CN(c1ccc(N2CCOCC2)cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1927007 141490 0 None None None Human 5.8 pIC50 = 5.8 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 10 1 7 5.6 Cc1ccncc1CN(c1ccc(N2CCOCC2)cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1016/j.bmcl.2011.09.133
72712375 183475 0 None None None Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 514 6 0 3 6.5 Cc1ccccc1N1CCC(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435875 183475 0 None None None Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 514 6 0 3 6.5 Cc1ccccc1N1CCC(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
49871007 121597 22 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 assessed as inhibition of intracellular calcium mobilizationAntagonist activity at CCR5 assessed as inhibition of intracellular calcium mobilization
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 121597 22 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 assessed as inhibition of intracellular calcium mobilizationAntagonist activity at CCR5 assessed as inhibition of intracellular calcium mobilization
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
DB12960 121597 22 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 assessed as inhibition of intracellular calcium mobilizationAntagonist activity at CCR5 assessed as inhibition of intracellular calcium mobilization
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
3008929 391088 0 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL556314 391088 0 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
145983513 330436 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 457 8 1 6 5.2 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C(C)C)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4242034 330436 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 457 8 1 6 5.2 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C(C)C)s1 10.1021/acs.jmedchem.8b01077
10278617 195556 3 None 1 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR5 expressed in L1.2 cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at human CCR5 expressed in L1.2 cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 195556 3 None 1 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR5 expressed in L1.2 cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at human CCR5 expressed in L1.2 cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008931 466271 0 None None None Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61374 466271 0 None None None Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
464990 38298 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 2 4 4.5 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c[nH]c(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200254 38298 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 2 4 4.5 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c[nH]c(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
46225343 445578 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 521 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596299 445578 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 521 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
178321678 467550 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 529 6 3 10 4.4 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc3c(c2)CCCCC3)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6188382 467550 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 529 6 3 10 4.4 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc3c(c2)CCCCC3)c1O 10.1016/j.ejmech.2025.117600
118727191 236242 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 535 7 0 5 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(c3ccc(C#N)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3398002 236242 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 535 7 0 5 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(c3ccc(C#N)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
62707284 158828 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2079027 158828 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
62707284 158828 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079027 158828 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
70688700 158834 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079127 158834 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
178293019 467604 0 None 11 2 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 479 6 3 10 3.2 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc(F)cc2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6189645 467604 0 None 11 2 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 479 6 3 10 3.2 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc(F)cc2)c1O 10.1016/j.ejmech.2025.117600
178322429 467625 0 None 13 2 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 529 6 3 10 4.4 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc(Cl)c(Cl)c2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6190039 467625 0 None 13 2 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 529 6 3 10 4.4 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc(Cl)c(Cl)c2)c1O 10.1016/j.ejmech.2025.117600
46225346 444913 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 551 7 1 6 3.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)CO)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595570 444913 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 551 7 1 6 3.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)CO)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225529 432871 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 591 6 0 5 4.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593195 432871 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 591 6 0 5 4.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008912 451632 0 None None None Human 5.8 pIC50 = 5.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
CHEMBL60279 451632 0 None None None Human 5.8 pIC50 = 5.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
90656328 220584 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 476 8 1 8 3.7 CC(C)Oc1ccc(N2CCN(Cc3ccccc3[N+](=O)[O-])CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263025 220584 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 476 8 1 8 3.7 CC(C)Oc1ccc(N2CCN(Cc3ccccc3[N+](=O)[O-])CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
72712160 183469 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
CHEMBL2435869 183469 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
52943389 42910 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 13 1 8 7.0 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288876 42910 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 13 1 8 7.0 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46191233 432691 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 575 6 0 5 4.6 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593027 432691 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 575 6 0 5 4.6 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
118727184 236235 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 578 9 0 5 4.4 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)C2CCN(S(C)(=O)=O)CC2)cc1Cl 10.1016/j.bmc.2014.12.052
CHEMBL3397995 236235 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 578 9 0 5 4.4 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)C2CCN(S(C)(=O)=O)CC2)cc1Cl 10.1016/j.bmc.2014.12.052
15950679 183468 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435868 183468 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
49798156 24854 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 607 9 1 4 5.0 C=CCN(C(=O)Cc1ccc(Br)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1169819 24854 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 607 9 1 4 5.0 C=CCN(C(=O)Cc1ccc(Br)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
72712161 183470 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435870 183470 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
10280945 27104 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1188557 27104 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
10277467 27344 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
CHEMBL1190217 27344 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
21064331 38290 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Sc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200224 38290 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Sc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226120 38065 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Sc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198114 38065 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Sc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
178319878 467734 0 None 17 2 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 479 6 3 10 3.2 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccccc2F)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6192672 467734 0 None 17 2 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 479 6 3 10 3.2 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccccc2F)c1O 10.1016/j.ejmech.2025.117600
122185611 241476 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 566 8 2 2 6.7 Cc1c(CNC(=O)c2ccc(-c3ccccc3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(-c3ccccc3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606030 241476 0 None None None Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 566 8 2 2 6.7 Cc1c(CNC(=O)c2ccc(-c3ccccc3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(-c3ccccc3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
52945865 42926 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 13 1 6 7.9 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288920 42926 0 None None None Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 13 1 6 7.9 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
168271219 373518 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 483 8 1 6 5.7 Cc1ccsc1[C@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)NC(=O)C1CCCC1 10.1021/acs.jmedchem.2c01383
CHEMBL5178121 373518 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 483 8 1 6 5.7 Cc1ccsc1[C@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)NC(=O)C1CCCC1 10.1021/acs.jmedchem.2c01383
11237537 375137 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 509 7 1 5 4.3 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1 10.1021/acs.jmedchem.2c01383
CHEMBL5203084 375137 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 509 7 1 5 4.3 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1 10.1021/acs.jmedchem.2c01383
10277467 27344 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1190217 27344 0 None None None Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1016/j.bmcl.2009.11.018
53324598 116540 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
6320546 116540 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739382 116540 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739500 116540 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
178321489 467651 0 None 2 2 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 539 6 3 11 4.1 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc3c(c2)C(F)OC3F)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6190588 467651 0 None 2 2 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 539 6 3 11 4.1 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc3c(c2)C(F)OC3F)c1O 10.1016/j.ejmech.2025.117600
178320061 467633 0 None None None Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 439 7 3 10 2.2 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2NCC2CC2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6190141 467633 0 None None None Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 439 7 3 10 2.2 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2NCC2CC2)c1O 10.1016/j.ejmech.2025.117600
46225512 464179 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 489 5 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL605727 464179 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 489 5 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
122185639 241487 0 None None None Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 442 6 2 2 4.0 Cc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(C)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3606112 241487 0 None None None Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 442 6 2 2 4.0 Cc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(C)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
11466794 141461 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 9 1 5 5.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C#N)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926875 141461 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 9 1 5 5.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C#N)cc2)CC1 10.1016/j.bmcl.2011.09.133
172449421 388301 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assay
ChEMBL 3969 154 46 55 -8.1 CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(C(C)=O)CC3)c3ccc(C)c(Cl)c3)CC2)cc1)C(N)=O)[C@@H](C)CC 10.1016/j.ejmech.2023.115294
CHEMBL5414303 388301 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 60 mins by Fluo-4 AM calcium flux based FLIPR assay
ChEMBL 3969 154 46 55 -8.1 CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(C(C)=O)CC3)c3ccc(C)c(Cl)c3)CC2)cc1)C(N)=O)[C@@H](C)CC 10.1016/j.ejmech.2023.115294
122185633 241484 0 None None None Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 506 8 2 4 4.8 CSc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(SC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3606102 241484 0 None None None Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 506 8 2 4 4.8 CSc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(SC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
46225428 444316 0 None None None Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 503 5 0 5 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL594914 444316 0 None None None Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 503 5 0 5 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
76335572 214304 0 None None None Human 6.7 pIC50 = 6.7 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 570 10 1 4 4.5 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccc(F)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104689 214304 0 None None None Human 6.7 pIC50 = 6.7 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 570 10 1 4 4.5 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccc(F)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
90656340 220645 0 None None None Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 461 8 1 7 3.8 COc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263319 220645 0 None None None Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 461 8 1 7 3.8 COc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
57402800 141469 0 None None None Human 8.7 pIC50 = 8.7 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 10 1 6 5.9 COc1ccc(N(Cc2cccc(C#N)c2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926885 141469 0 None None None Human 8.7 pIC50 = 8.7 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 10 1 6 5.9 COc1ccc(N(Cc2cccc(C#N)c2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
53319405 120000 0 None None None Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 499 7 1 6 2.9 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(S(C)(=O)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649918 120000 0 None None None Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 499 7 1 6 2.9 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(S(C)(=O)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
46191232 432713 0 None None None Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 618 6 0 4 5.7 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593046 432713 0 None None None Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 618 6 0 4 5.7 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008902 466725 0 None -1 2 Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61536 466725 0 None -1 2 Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008908 466479 0 None None None Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL61466 466479 0 None None None Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
11570778 278187 0 None None None Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3cccc(C(N)=O)c3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL382252 278187 0 None None None Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3cccc(C(N)=O)c3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
44194589 25167 0 None None None Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 608 10 2 6 2.9 C=CCN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172624 25167 0 None None None Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 608 10 2 6 2.9 C=CCN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
1635 193594 43 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmc.2016.09.059
3002977 193594 43 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmc.2016.09.059
CHEMBL256907 193594 43 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmc.2016.09.059
3013689 158685 0 None None None Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 583 9 0 4 5.5 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207190 158685 0 None None None Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 583 9 0 4 5.5 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
11700429 213274 0 None None None Human 8.7 pIC50 = 8.7 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085311 213274 0 None None None Human 8.7 pIC50 = 8.7 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
1635 193594 43 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1039/c3md00080j
3002977 193594 43 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1039/c3md00080j
CHEMBL256907 193594 43 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1039/c3md00080j
457871 200869 0 None None None Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL292625 200869 0 None None None Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
3008928 466307 0 None -1 2 Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61424 466307 0 None -1 2 Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
1635 193594 43 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
3002977 193594 43 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
CHEMBL256907 193594 43 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
5275765 275610 0 None None None Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL377026 275610 0 None None None Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
145984727 330443 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 6 5.8 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4242114 330443 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 6 5.8 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1cccs1 10.1021/acs.jmedchem.8b01077
145986021 330663 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 505 8 1 6 5.6 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4248009 330663 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 505 8 1 6 5.6 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
59458103 183506 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435906 183506 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
3008927 424050 0 None -2 2 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58387 424050 0 None -2 2 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008914 451132 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL60225 451132 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
11513274 213272 0 None None None Human 8.6 pIC50 = 8.6 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
CHEMBL3085309 213272 0 None None None Human 8.6 pIC50 = 8.6 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
57397598 141474 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 515 10 1 6 5.1 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ccnc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926890 141474 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 515 10 1 6 5.1 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ccnc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
59458247 183512 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 571 8 1 5 6.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435912 183512 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 571 8 1 5 6.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
3008923 424554 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
CHEMBL58441 424554 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
3008908 466479 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL61466 466479 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
168268916 373105 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 549 10 1 7 5.9 COCc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.2c01383
CHEMBL5171331 373105 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 549 10 1 7 5.9 COCc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.2c01383
122668213 330459 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 6 5.7 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4242489 330459 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 6 5.7 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCC2)s1 10.1021/acs.jmedchem.8b01077
145984502 330478 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 517 8 1 6 5.8 Cc1nnc(C2CC2)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.8b01077
CHEMBL4242913 330478 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 517 8 1 6 5.8 Cc1nnc(C2CC2)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.8b01077
145984829 330684 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 491 8 1 6 5.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(F)(F)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4248472 330684 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 491 8 1 6 5.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(F)(F)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
52948296 42930 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 13 2 6 7.6 CCCCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288924 42930 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 13 2 6 7.6 CCCCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008917 467865 2 None -6 2 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL62152 467865 2 None -6 2 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
49798086 25104 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 578 9 2 4 5.0 C=CCN(C(=O)NCc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172046 25104 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 578 9 2 4 5.0 C=CCN(C(=O)NCc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
11577846 158762 0 None None None Human 8.6 pIC50 = 8.6 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 581 8 0 4 5.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC([S+]([O-])c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207654 158762 0 None None None Human 8.6 pIC50 = 8.6 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 581 8 0 4 5.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC([S+]([O-])c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
145985461 330375 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 505 8 1 6 5.5 CCc1nnc(C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.8b01077
CHEMBL4240475 330375 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 505 8 1 6 5.5 CCc1nnc(C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.8b01077
126567264 330675 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4248282 330675 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
3008932 466270 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 466270 0 None None None Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008904 444496 0 None 1 2 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59511 444496 0 None 1 2 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
145983733 330351 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 571 8 1 6 6.5 O=C(N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@@H](n1c(C3CC3)nnc1C(F)(F)F)C2)c1ccsc1)C1CCC(F)(F)CC1 10.1021/acs.jmedchem.8b01077
CHEMBL4239790 330351 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 571 8 1 6 6.5 O=C(N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@@H](n1c(C3CC3)nnc1C(F)(F)F)C2)c1ccsc1)C1CCC(F)(F)CC1 10.1021/acs.jmedchem.8b01077
145982775 330425 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 7 4.6 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(=O)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4241721 330425 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 7 4.6 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(=O)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
145985042 330539 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 517 8 1 6 5.8 Cc1nnc(C2CC2)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4244672 330539 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 517 8 1 6 5.8 Cc1nnc(C2CC2)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
72711955 183461 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccn3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435861 183461 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccn3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
16663418 25094 28 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172035 25094 28 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
3008930 410787 0 None 1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58004 410787 0 None 1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
16663418 25094 28 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1172035 25094 28 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.046
44194676 25110 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 637 11 3 6 3.3 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172052 25110 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 637 11 3 6 3.3 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
49864973 39675 0 None None None Human 8.5 pIC50 = 8.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 640 11 2 6 3.3 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222771 39675 0 None None None Human 8.5 pIC50 = 8.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 640 11 2 6 3.3 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
3500 3139 14 None 245 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
491774 3139 14 None 245 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
CHEMBL1196395 3139 14 None 245 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
49798083 25102 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 623 9 1 5 5.6 C=CCN(C(=O)OCc1ccc(Br)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172044 25102 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 623 9 1 5 5.6 C=CCN(C(=O)OCc1ccc(Br)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
52948295 42917 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 780 11 2 6 7.3 C=CCN(C(=O)Nc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288911 42917 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 780 11 2 6 7.3 C=CCN(C(=O)Nc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
145983844 330668 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 484 8 2 7 3.5 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)[C@@H]1CCC(=O)N1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4248119 330668 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 484 8 2 7 3.5 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)[C@@H]1CCC(=O)N1)c1cccs1 10.1021/acs.jmedchem.8b01077
72713859 183511 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435911 183511 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
3008919 200910 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
CHEMBL292894 200910 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
10184169 27070 0 None None None Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
10205915 27070 0 None None None Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188208 27070 0 None None None Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188324 27070 0 None None None Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
56661526 138704 0 None None None Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 562 8 3 6 3.5 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851866 138704 0 None None None Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 562 8 3 6 3.5 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
57331340 214294 0 None None None Human 6.7 pIC50 = 6.7 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 580 10 0 4 5.4 CCN(Cc1ccc(C)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104677 214294 0 None None None Human 6.7 pIC50 = 6.7 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 580 10 0 4 5.4 CCN(Cc1ccc(C)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
118727182 236233 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 511 8 0 3 6.2 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)c2ccc(F)cc2)cc1Cl 10.1016/j.bmc.2014.12.052
CHEMBL3397993 236233 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 511 8 0 3 6.2 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)c2ccc(F)cc2)cc1Cl 10.1016/j.bmc.2014.12.052
46191232 432713 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 618 6 0 4 5.7 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593046 432713 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 618 6 0 4 5.7 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
21927139 38292 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 518 9 1 5 5.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)nc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200232 38292 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 518 9 1 5 5.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)nc1)CC2 10.1016/j.bmc.2010.05.057
168293785 375212 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 576 9 1 8 4.2 Cc1csc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)c1 10.1021/acs.jmedchem.2c01383
CHEMBL5204027 375212 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 576 9 1 8 4.2 Cc1csc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)c1 10.1021/acs.jmedchem.2c01383
52944618 42927 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 797 13 2 6 6.1 C=CCN(C(=O)Cc1ccc(C(N)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288921 42927 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 797 13 2 6 6.1 C=CCN(C(=O)Cc1ccc(C(N)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
10186729 28196 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728786 28196 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196666 28196 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196759 28196 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
56678576 138918 0 None None None Human 4.7 pIC50 = 4.7 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1852754 138918 0 None None None Human 4.7 pIC50 = 4.7 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
118727181 236232 0 None None None Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 431 7 0 3 4.7 CC(=O)N(CCCN1CCN(Cc2ccc(F)cc2)CC1C)c1ccc(C)c(Cl)c1 10.1016/j.bmc.2014.12.052
CHEMBL3397992 236232 0 None None None Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 431 7 0 3 4.7 CC(=O)N(CCCN1CCN(Cc2ccc(F)cc2)CC1C)c1ccc(C)c(Cl)c1 10.1016/j.bmc.2014.12.052
3008911 201120 0 None None None Human 5.7 pIC50 = 5.7 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
CHEMBL294271 201120 0 None None None Human 5.7 pIC50 = 5.7 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
52947063 42908 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 788 12 1 6 7.7 C=CCN(C(=O)OCc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288874 42908 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 788 12 1 6 7.7 C=CCN(C(=O)OCc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225533 432740 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 590 6 0 4 4.9 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593080 432740 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 590 6 0 4 4.9 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
73355478 183477 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435877 183477 0 None None None Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
49798081 25100 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 563 9 1 5 5.0 C=CCN(C(=O)OCc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172042 25100 0 None None None Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 563 9 1 5 5.0 C=CCN(C(=O)OCc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
178319120 467628 0 None 6 2 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 539 6 3 10 3.9 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc(Br)cc2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6190066 467628 0 None 6 2 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 539 6 3 10 3.9 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc(Br)cc2)c1O 10.1016/j.ejmech.2025.117600
10208679 27106 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
16659334 27106 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188565 27106 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1197042 27106 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
3008931 466271 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61374 466271 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
90656333 220586 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 509 7 1 6 4.6 CC(C)Oc1ccc(N2CCN(Cc3ccc(Br)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263029 220586 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 509 7 1 6 4.6 CC(C)Oc1ccc(N2CCN(Cc3ccc(Br)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
56678574 138671 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 593 10 4 7 3.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCC(O)CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851694 138671 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 593 10 4 7 3.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCC(O)CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56664937 138703 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 8 3 6 3.8 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851865 138703 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 8 3 6 3.8 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
118727190 236241 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 521 7 0 5 4.3 CC(=O)N1CCC(C(=O)N(CCCN2CCN(c3ccc(C#N)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3398001 236241 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 521 7 0 5 4.3 CC(=O)N1CCC(C(=O)N(CCCN2CCN(c3ccc(C#N)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
122185637 241486 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 470 8 2 2 4.5 CCc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(CC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3606111 241486 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 470 8 2 2 4.5 CCc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(CC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
52948264 42906 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 815 13 1 8 7.5 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288872 42906 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 815 13 1 8 7.5 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225532 432707 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 547 6 0 5 3.8 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593042 432707 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 547 6 0 5 3.8 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
44404643 144441 0 None None None Human 7.6 pIC50 = 7.6 Functional
Inhibition of MIP-1beta stimulated calcium transients in CCR5-expressing CHO cellsInhibition of MIP-1beta stimulated calcium transients in CCR5-expressing CHO cells
ChEMBL 611 12 1 6 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198114 144441 0 None None None Human 7.6 pIC50 = 7.6 Functional
Inhibition of MIP-1beta stimulated calcium transients in CCR5-expressing CHO cellsInhibition of MIP-1beta stimulated calcium transients in CCR5-expressing CHO cells
ChEMBL 611 12 1 6 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
3008930 410787 0 None 1 2 Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58004 410787 0 None 1 2 Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
145983159 330791 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 497 8 1 7 4.8 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2=CCOCC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4250560 330791 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 497 8 1 7 4.8 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2=CCOCC2)s1 10.1021/acs.jmedchem.8b01077
3008932 466270 0 None None None Human 7.6 pIC50 = 7.6 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 466270 0 None None None Human 7.6 pIC50 = 7.6 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
72711506 183502 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 511 8 1 4 4.8 CCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435902 183502 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 511 8 1 4 4.8 CCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
178292791 467727 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 529 6 3 10 4.1 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc(C(F)(F)F)cc2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6192546 467727 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 529 6 3 10 4.1 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc(C(F)(F)F)cc2)c1O 10.1016/j.ejmech.2025.117600
162674876 366678 0 None -109 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1169 26 7 15 5.8 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4797451 366678 0 None -109 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1169 26 7 15 5.8 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
46225428 444316 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 503 5 0 5 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL594914 444316 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 503 5 0 5 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
52948295 42917 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 780 11 2 6 7.3 C=CCN(C(=O)Nc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288911 42917 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 780 11 2 6 7.3 C=CCN(C(=O)Nc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
118727173 236224 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 538 8 0 4 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(C)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397984 236224 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 538 8 0 4 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(C)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
118727178 236229 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 528 8 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2cccc(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397989 236229 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 528 8 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2cccc(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
1635 193594 43 None 2 2 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.ejmech.2013.11.013
3002977 193594 43 None 2 2 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.ejmech.2013.11.013
CHEMBL256907 193594 43 None 2 2 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.ejmech.2013.11.013
57331278 214301 0 None None None Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(Cl)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104684 214301 0 None None None Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(Cl)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
3008908 466479 0 None None None Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL61466 466479 0 None None None Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
57331274 214299 0 None None None Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 538 9 1 4 4.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104682 214299 0 None None None Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 538 9 1 4 4.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
56661524 138723 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851951 138723 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
16124598 25010 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR5Antagonist activity at CCR5
ChEMBL 472 6 2 5 5.3 O=C(O)c1ccccc1Oc1ncc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2010.04.142
CHEMBL1171008 25010 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR5Antagonist activity at CCR5
ChEMBL 472 6 2 5 5.3 O=C(O)c1ccccc1Oc1ncc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2010.04.142
145986205 330533 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 532 8 1 6 5.5 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)nc1 10.1021/acs.jmedchem.8b01077
CHEMBL4244470 330533 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 532 8 1 6 5.5 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)nc1 10.1021/acs.jmedchem.8b01077
76313867 214309 0 None None None Human 6.6 pIC50 = 6.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 566 10 0 4 4.9 CCN(C(=O)Cc1ccccc1)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104694 214309 0 None None None Human 6.6 pIC50 = 6.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 566 10 0 4 4.9 CCN(C(=O)Cc1ccccc1)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
46837553 213143 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 569 10 1 6 6.2 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)COc1ccccc1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2010.03.003
CHEMBL3084747 213143 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 569 10 1 6 6.2 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)COc1ccccc1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2010.03.003
90656342 220647 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 488 8 2 7 3.8 CC(=O)Nc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263321 220647 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 488 8 2 7 3.8 CC(=O)Nc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
135441310 467747 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 391 5 3 9 2.9 CN(C)C(=O)c1cccc(Nc2nc3nonc3nc2Nc2ccccc2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6193128 467747 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 391 5 3 9 2.9 CN(C)C(=O)c1cccc(Nc2nc3nonc3nc2Nc2ccccc2)c1O 10.1016/j.ejmech.2025.117600
118727183 236234 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)C1 10.1016/j.bmc.2014.12.052
CHEMBL3397994 236234 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)C1 10.1016/j.bmc.2014.12.052
178320785 467568 0 None 6 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 539 6 3 10 3.9 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccccc2Br)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6188861 467568 0 None 6 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 539 6 3 10 3.9 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccccc2Br)c1O 10.1016/j.ejmech.2025.117600
11433338 141460 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 594 10 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926874 141460 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 594 10 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
52944616 42920 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 827 13 2 7 6.9 C=CCN(C(=O)NCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288914 42920 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 827 13 2 7 6.9 C=CCN(C(=O)NCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008934 411637 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58101 411637 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
11693007 157919 0 None None None Human 7.6 pIC50 = 7.6 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 548 8 1 4 5.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Nc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL205851 157919 0 None None None Human 7.6 pIC50 = 7.6 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 548 8 1 4 5.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Nc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
57331307 214306 0 None None None Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 580 11 0 4 5.1 CCN(CCc1ccccc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104691 214306 0 None None None Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 580 11 0 4 5.1 CCN(CCc1ccccc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
23577386 138664 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851672 138664 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
178320337 467703 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 501 6 3 10 3.6 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc3c(c2)CCC3)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6191940 467703 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 501 6 3 10 3.6 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc3c(c2)CCC3)c1O 10.1016/j.ejmech.2025.117600
178293146 467701 0 None 8 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 495 6 3 10 3.8 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc(Cl)cc2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6191848 467701 0 None 8 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 495 6 3 10 3.8 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccc(Cl)cc2)c1O 10.1016/j.ejmech.2025.117600
178293874 467660 0 None 9 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 495 6 3 10 3.8 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2cccc(Cl)c2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6190855 467660 0 None 9 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 495 6 3 10 3.8 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2cccc(Cl)c2)c1O 10.1016/j.ejmech.2025.117600
178321773 467748 0 None 3 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 509 6 3 10 4.1 Cc1ccc(Nc2nc3nonc3nc2Nc2ccc(Cl)c(S(=O)(=O)N(C)C)c2O)cc1Cl 10.1016/j.ejmech.2025.117600
CHEMBL6193139 467748 0 None 3 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 509 6 3 10 4.1 Cc1ccc(Nc2nc3nonc3nc2Nc2ccc(Cl)c(S(=O)(=O)N(C)C)c2O)cc1Cl 10.1016/j.ejmech.2025.117600
122185617 241478 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 498 8 2 2 5.6 Cc1c(CNC(=O)c2ccc(C(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606050 241478 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 498 8 2 2 5.6 Cc1c(CNC(=O)c2ccc(C(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
52949523 42912 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 854 13 1 7 8.4 C=CCN(C(=O)OCc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288878 42912 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 854 13 1 7 8.4 C=CCN(C(=O)OCc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225514 443613 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 537 7 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(S(=O)(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL594208 443613 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 537 7 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(S(=O)(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225512 464179 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 489 5 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL605727 464179 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 489 5 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
126567281 330387 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 520 8 1 7 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cscn1 10.1021/acs.jmedchem.8b01077
CHEMBL4240742 330387 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 520 8 1 7 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cscn1 10.1021/acs.jmedchem.8b01077
49864977 39681 0 None None None Human 7.6 pIC50 = 7.6 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 681 11 3 6 4.0 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)[C@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222777 39681 0 None None None Human 7.6 pIC50 = 7.6 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 681 11 3 6 4.0 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)[C@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
3008909 428612 0 None None None Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL58897 428612 0 None None None Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
491773 27092 0 None 67 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188399 27092 0 None 67 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
11598797 27141 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
11634966 27141 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188808 27141 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1189134 27141 0 None None None Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
491773 27092 0 None 67 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188399 27092 0 None 67 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
90656339 220644 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 446 7 2 7 3.4 CC(C)Oc1ccc(N2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263318 220644 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 446 7 2 7 3.4 CC(C)Oc1ccc(N2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
178322882 467573 0 None 8 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 539 6 3 10 3.9 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2cccc(Br)c2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6189043 467573 0 None 8 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 539 6 3 10 3.9 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2cccc(Br)c2)c1O 10.1016/j.ejmech.2025.117600
46225515 432591 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 551 6 0 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592940 432591 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 551 6 0 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225350 452144 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 515 7 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)CC4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL603325 452144 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 515 7 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)CC4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
10280945 27104 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188557 27104 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
10280945 27104 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188557 27104 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
10280945 27104 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188557 27104 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
21064281 38244 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 596 10 2 6 4.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200018 38244 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 596 10 2 6 4.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
10280945 27104 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1188557 27104 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
457871 200869 0 None None None Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL292625 200869 0 None None None Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
3008918 430698 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59101 430698 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
23577370 138656 0 None None None Human 5.6 pIC50 = 5.6 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851623 138656 0 None None None Human 5.6 pIC50 = 5.6 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
73351059 183604 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 459 8 1 5 5.6 CCOc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436819 183604 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 459 8 1 5 5.6 CCOc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
56678576 138918 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1852754 138918 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
90656343 220648 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 474 8 1 7 3.9 CC(C)Oc1ccc(N2CCN(Cc3ccc(N(C)C)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263322 220648 0 None None None Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 474 8 1 7 3.9 CC(C)Oc1ccc(N2CCN(Cc3ccc(N(C)C)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
3008926 465322 0 None None None Human 6.6 pIC50 = 6.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c[nH]c3ccccc23)CC1 10.1021/jm031046g
CHEMBL60711 465322 0 None None None Human 6.6 pIC50 = 6.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c[nH]c3ccccc23)CC1 10.1021/jm031046g
73355550 183584 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 445 7 1 5 5.2 COc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436720 183584 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 445 7 1 5 5.2 COc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
50993435 119996 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 511 8 1 5 5.2 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(Cc1ccccc1)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649914 119996 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 511 8 1 5 5.2 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(Cc1ccccc1)CC3)C2)c1ccccc1 10.1021/jm100978n
10272003 121663 1 None -4 3 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assayAntagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assay
ChEMBL 395 2 2 5 3.4 Cc1nn(C)c2ncc(C(=O)NC(=O)Nc3ccc(F)c(C(F)(F)F)c3)cc12 10.1021/jm1012903
CHEMBL1688888 121663 1 None -4 3 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assayAntagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assay
ChEMBL 395 2 2 5 3.4 Cc1nn(C)c2ncc(C(=O)NC(=O)Nc3ccc(F)c(C(F)(F)F)c3)cc12 10.1021/jm1012903
145983098 330606 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 7 1 7 4.3 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)N2CCN(C)CC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4246290 330606 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 7 1 7 4.3 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)N2CCN(C)CC2)s1 10.1021/acs.jmedchem.8b01077
118727189 236240 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)C[C@@H]2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3398000 236240 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)C[C@@H]2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
57402799 141468 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 603 9 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926884 141468 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 603 9 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
57397597 141470 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 619 10 1 6 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926886 141470 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 619 10 1 6 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
10106 1803 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
91820689 1803 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
CHEMBL4249798 1803 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
145985672 330274 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 501 8 1 6 5.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4237964 330274 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 501 8 1 6 5.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
49871007 121597 22 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 assessed as inhibition of ERK phosphorylationAntagonist activity at CCR5 assessed as inhibition of ERK phosphorylation
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 121597 22 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 assessed as inhibition of ERK phosphorylationAntagonist activity at CCR5 assessed as inhibition of ERK phosphorylation
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
DB12960 121597 22 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 assessed as inhibition of ERK phosphorylationAntagonist activity at CCR5 assessed as inhibition of ERK phosphorylation
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
49871007 121597 22 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 121597 22 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
DB12960 121597 22 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
50992575 119999 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 463 7 1 5 4.4 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)C)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649917 119999 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 463 7 1 5 4.4 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)C)CC3)C2)c1ccccc1 10.1021/jm100978n
46225533 432740 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 590 6 0 4 4.9 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593080 432740 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 590 6 0 4 4.9 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008935 467536 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61828 467536 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008913 202080 0 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL301454 202080 0 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3013684 158682 0 None None None Human 8.5 pIC50 = 8.5 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 547 8 0 3 6.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207182 158682 0 None None None Human 8.5 pIC50 = 8.5 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 547 8 0 3 6.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
122668190 330280 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 469 8 1 6 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4238063 330280 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 469 8 1 6 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1cccs1 10.1021/acs.jmedchem.8b01077
49798087 25105 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 589 10 2 6 4.3 C=CCN(C(=O)NCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172047 25105 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 589 10 2 6 4.3 C=CCN(C(=O)NCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
52941648 42923 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 822 12 1 5 8.0 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288917 42923 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 822 12 1 5 8.0 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008929 391088 0 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL556314 391088 0 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
44194587 25169 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 636 11 1 6 3.5 C=CCN(C(=O)Cc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172626 25169 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 636 11 1 6 3.5 C=CCN(C(=O)Cc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
73347894 183463 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435863 183463 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
3008929 391088 0 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL556314 391088 0 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
49798129 25119 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 529 9 1 4 4.2 C=CCN(C(=O)Cc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172157 25119 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 529 9 1 4 4.2 C=CCN(C(=O)Cc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
16663418 25094 28 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced calcium elevationAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced calcium elevation
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172035 25094 28 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced calcium elevationAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced calcium elevation
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
53319838 121596 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 545 4 0 6 4.4 CO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688242 121596 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 545 4 0 6 4.4 CO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
3008923 424554 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
CHEMBL58441 424554 0 None None None Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
59458245 183466 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435866 183466 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711508 183505 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 539 7 1 4 5.6 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435905 183505 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 539 7 1 4 5.6 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
49798133 25013 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 563 9 1 4 4.9 C=CCN(C(=O)Cc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1171030 25013 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 563 9 1 4 4.9 C=CCN(C(=O)Cc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
52947091 42918 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 794 12 2 6 7.0 C=CCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288912 42918 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 794 12 2 6 7.0 C=CCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008924 432950 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 503 5 0 3 7.1 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm031046g
CHEMBL59328 432950 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 503 5 0 3 7.1 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm031046g
3008905 412980 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58248 412980 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
52947091 42918 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 794 12 2 6 7.0 C=CCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288912 42918 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 794 12 2 6 7.0 C=CCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
11585418 157670 0 None None None Human 8.4 pIC50 = 8.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 597 8 0 5 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(S(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL205539 157670 0 None None None Human 8.4 pIC50 = 8.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 597 8 0 5 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(S(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
49864977 39679 0 None None None Human 8.4 pIC50 = 8.4 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 681 11 3 6 4.0 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222775 39679 0 None None None Human 8.4 pIC50 = 8.4 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 681 11 3 6 4.0 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
118727179 236230 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 556 7 0 4 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCN(C(=O)c3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397990 236230 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 556 7 0 4 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCN(C(=O)c3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
11399408 141465 1 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 622 9 1 4 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(Cl)c2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926880 141465 1 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 622 9 1 4 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(Cl)c2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
46225528 432661 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 619 6 0 5 5.1 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592993 432661 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 619 6 0 5 5.1 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225526 433181 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 523 6 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593520 433181 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 523 6 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
49864968 39670 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 608 10 1 7 4.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222766 39670 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 608 10 1 7 4.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
49864976 39678 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 606 9 2 4 5.2 C=CCN(C(=O)NCc1ccc(F)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222774 39678 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 606 9 2 4 5.2 C=CCN(C(=O)NCc1ccc(F)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
3008932 466270 0 None None None Human 7.5 pIC50 = 7.5 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 466270 0 None None None Human 7.5 pIC50 = 7.5 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
118727175 236226 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccccc3F)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397986 236226 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccccc3F)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
11598797 27141 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
11634966 27141 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188808 27141 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1189134 27141 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
10143882 38258 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 511 8 1 4 5.4 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(Cc2ccccc2)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1200078 38258 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 511 8 1 4 5.4 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(Cc2ccccc2)C1=O 10.1016/j.bmc.2010.05.057
505866 62083 0 None None None Human 6.5 pIC50 = 6.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137524 62083 0 None None None Human 6.5 pIC50 = 6.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505865 62934 0 None None None Human 6.5 pIC50 = 6.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 516 8 0 4 6.0 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138282 62934 0 None None None Human 6.5 pIC50 = 6.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 516 8 0 4 6.0 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505867 63356 0 None None None Human 6.5 pIC50 = 6.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138645 63356 0 None None None Human 6.5 pIC50 = 6.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
72711280 183500 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccn2)CC1 10.1021/jm401101p
CHEMBL2435900 183500 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccn2)CC1 10.1021/jm401101p
10184169 27070 0 None None None Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
10205915 27070 0 None None None Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188208 27070 0 None None None Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188324 27070 0 None None None Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
10116073 38317 0 None None None Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 469 7 1 4 4.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(C(=O)OCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200300 38317 0 None None None Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 469 7 1 4 4.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(C(=O)OCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
23577448 138917 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 9 3 6 4.2 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1852753 138917 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 9 3 6 4.2 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
11947758 915 28 None -75857 4 Rabbit 4.5 pIC50 = 4.5 Functional
Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
3001322 915 28 None -75857 4 Rabbit 4.5 pIC50 = 4.5 Functional
Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 915 28 None -75857 4 Rabbit 4.5 pIC50 = 4.5 Functional
Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 915 28 None -75857 4 Rabbit 4.5 pIC50 = 4.5 Functional
Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1739499 915 28 None -75857 4 Rabbit 4.5 pIC50 = 4.5 Functional
Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 915 28 None -75857 4 Rabbit 4.5 pIC50 = 4.5 Functional
Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
178319866 467732 0 None 2 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 515 6 3 10 3.5 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2cc(F)c(F)c(F)c2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6192641 467732 0 None 2 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 515 6 3 10 3.5 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2cc(F)c(F)c(F)c2)c1O 10.1016/j.ejmech.2025.117600
122185615 241477 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 526 6 2 2 6.0 Cc1c(CNC(=O)c2ccc(C(C)(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606049 241477 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 526 6 2 2 6.0 Cc1c(CNC(=O)c2ccc(C(C)(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
3008925 201056 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
CHEMBL293900 201056 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
3008931 466271 0 None None None Human 7.5 pIC50 = 7.5 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61374 466271 0 None None None Human 7.5 pIC50 = 7.5 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
71451541 163208 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 569 10 1 6 4.9 Cc1ccncc1CN(C(=O)CC1CCOCC1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164214 163208 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 569 10 1 6 4.9 Cc1ccncc1CN(C(=O)CC1CCOCC1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
168286382 374790 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 570 10 2 8 4.4 CNS(=O)(=O)c1cccc(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)c1 10.1021/acs.jmedchem.2c01383
CHEMBL5197247 374790 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 570 10 2 8 4.4 CNS(=O)(=O)c1cccc(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)c1 10.1021/acs.jmedchem.2c01383
46225513 463163 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 505 7 1 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)CO)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL604680 463163 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 505 7 1 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)CO)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
52943425 42921 0 None None None Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 812 13 3 6 6.2 C=CCN(C(=O)NCc1ccc(C(N)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288915 42921 0 None None None Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 812 13 3 6 6.2 C=CCN(C(=O)NCc1ccc(C(N)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
49864967 39669 0 None None None Human 6.5 pIC50 = 6.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 620 11 1 8 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(OC)c2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222765 39669 0 None None None Human 6.5 pIC50 = 6.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 620 11 1 8 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(OC)c2)CC1 10.1016/j.bmcl.2010.05.046
118727177 236228 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 494 8 0 4 4.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccccc2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397988 236228 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 494 8 0 4 4.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccccc2)CC1 10.1016/j.bmc.2014.12.052
72711049 183494 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
CHEMBL2435894 183494 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
49798920 38255 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 423 6 1 5 2.4 COCC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(C)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1200062 38255 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 423 6 1 5 2.4 COCC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(C)C1=O 10.1016/j.bmc.2010.05.057
57331277 214295 0 None None None Human 6.5 pIC50 = 6.5 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 584 10 0 4 5.2 CCN(Cc1ccc(F)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104678 214295 0 None None None Human 6.5 pIC50 = 6.5 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 584 10 0 4 5.2 CCN(Cc1ccc(F)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
10182763 27304 0 None None None Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
10204589 27304 0 None None None Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
CHEMBL1189988 27304 0 None None None Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
CHEMBL1196226 27304 0 None None None Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
56681915 138709 1 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851889 138709 1 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
72714317 183487 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 546 8 1 5 5.2 Cc1ccccc1C1CN(C2CCCCC2)C(=O)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1021/jm401101p
CHEMBL2435887 183487 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 546 8 1 5 5.2 Cc1ccccc1C1CN(C2CCCCC2)C(=O)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1021/jm401101p
122668167 330737 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 523 9 1 6 5.9 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)Cc2ccc(F)cc2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4249259 330737 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 523 9 1 6 5.9 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)Cc2ccc(F)cc2)s1 10.1021/acs.jmedchem.8b01077
10208679 27106 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16659334 27106 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188565 27106 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1197042 27106 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
21064295 38242 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 574 10 2 5 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200016 38242 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 574 10 2 5 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
505870 61292 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 500 8 0 4 5.6 O=C(C1CCCCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ccccn3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00988-5
CHEMBL136977 61292 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 500 8 0 4 5.6 O=C(C1CCCCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ccccn3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00988-5
505880 61388 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137038 61388 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505879 62306 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137728 62306 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505881 63105 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 537 10 1 6 5.0 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138437 63105 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 537 10 1 6 5.0 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44357063 237921 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1ccncn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL342842 237921 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1ccncn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44357079 238101 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 541 11 1 6 4.8 CCCN(c1ncc(F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL344261 238101 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 541 11 1 6 4.8 CCCN(c1ncc(F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
118727185 236236 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 604 9 0 4 6.3 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)C2CCN(C(=O)c3ccccc3)CC2)cc1Cl 10.1016/j.bmc.2014.12.052
CHEMBL3397996 236236 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 604 9 0 4 6.3 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)C2CCN(C(=O)c3ccccc3)CC2)cc1Cl 10.1016/j.bmc.2014.12.052
10118535 38234 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 8 1 4 4.8 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(CC(C)C)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1199972 38234 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 8 1 4 4.8 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(CC(C)C)C1=O 10.1016/j.bmc.2010.05.057
23577409 138710 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851891 138710 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
23577328 138726 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1851967 138726 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
46225345 444898 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 549 6 0 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)CC(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595559 444898 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 549 6 0 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)CC(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
11192476 141458 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 578 9 1 4 7.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926872 141458 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 578 9 1 4 7.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
52947090 42915 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 773 11 2 5 7.6 C=CCN(C(=O)Nc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288909 42915 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 773 11 2 5 7.6 C=CCN(C(=O)Nc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
11597 1388 8 None -11 2 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
23725180 1388 8 None -11 2 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
CHEMBL4781426 1388 8 None -11 2 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
11947758 915 28 None -616 4 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
3001322 915 28 None -616 4 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 915 28 None -616 4 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 915 28 None -616 4 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1739499 915 28 None -616 4 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 915 28 None -616 4 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
23577388 138670 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 611 10 2 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851692 138670 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 611 10 2 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
178322252 467709 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 506 7 3 12 3.0 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2cccc([N+](=O)[O-])c2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6192135 467709 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 506 7 3 12 3.0 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2cccc([N+](=O)[O-])c2)c1O 10.1016/j.ejmech.2025.117600
52943424 42919 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 833 12 2 7 6.8 C=CCN(C(=O)Nc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288913 42919 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 833 12 2 7 6.8 C=CCN(C(=O)Nc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
21926130 38297 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 519 8 1 5 4.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c(C)nn(-c3ccccc3)c1C)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200253 38297 0 None None None Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 519 8 1 5 4.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c(C)nn(-c3ccccc3)c1C)CC2 10.1016/j.bmc.2010.05.057
57331276 214300 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 556 9 1 4 4.5 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(F)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104683 214300 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 556 9 1 4 4.5 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(F)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
3008905 412980 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58248 412980 0 None None None Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
23577362 138668 0 None None None Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851690 138668 0 None None None Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56678578 138695 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 618 12 3 6 5.0 CCCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851823 138695 0 None None None Human 4.5 pIC50 = 4.5 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 618 12 3 6 5.0 CCCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
46225429 445203 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 527 5 0 5 4.2 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595902 445203 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 527 5 0 5 4.2 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225348 445787 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 515 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596519 445787 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 515 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225347 444925 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 559 5 0 5 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595584 444925 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 559 5 0 5 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
44356876 61705 0 None None None Human 7.4 pIC50 = 7.4 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 554 8 0 4 6.4 C=CCN(c1ccc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137272 61705 0 None None None Human 7.4 pIC50 = 7.4 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 554 8 0 4 6.4 C=CCN(c1ccc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44129650 25098 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 623 10 1 7 4.2 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172040 25098 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 623 10 1 7 4.2 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
49798084 25089 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 544 9 2 4 4.4 C=CCN(C(=O)NCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1171966 25089 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 544 9 2 4 4.4 C=CCN(C(=O)NCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
56676455 138743 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852060 138743 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
56676455 138743 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852060 138743 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
46225530 432664 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 550 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592997 432664 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 550 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225527 432860 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 571 6 0 6 3.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593184 432860 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 571 6 0 6 3.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
49864970 39672 0 None None None Human 7.4 pIC50 = 7.4 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 630 9 2 4 5.5 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222768 39672 0 None None None Human 7.4 pIC50 = 7.4 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 630 9 2 4 5.5 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
11947758 915 28 None -616 4 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
3001322 915 28 None -616 4 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
805 915 28 None -616 4 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
CHEMBL1255794 915 28 None -616 4 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
CHEMBL1739499 915 28 None -616 4 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
DB06497 915 28 None -616 4 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
23577382 138730 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851977 138730 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
122185619 241479 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 570 6 2 2 4.9 Cc1c(CNC(=O)c2ccc(Br)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Br)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606051 241479 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 570 6 2 2 4.9 Cc1c(CNC(=O)c2ccc(Br)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Br)cc1)CCC2 10.1016/j.bmcl.2015.06.029
57392302 141466 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 618 10 1 5 6.8 COc1cccc(CN(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.09.133
CHEMBL1926882 141466 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 618 10 1 5 6.8 COc1cccc(CN(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.09.133
73355553 183601 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 417 6 2 6 3.7 COc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436816 183601 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 417 6 2 6 3.7 COc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
56681917 138728 0 None None None Human 5.4 pIC50 = 5.4 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851972 138728 0 None None None Human 5.4 pIC50 = 5.4 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
23577360 138665 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 10 3 6 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(N)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851675 138665 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 10 3 6 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(N)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
162659856 355092 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 914 27 5 11 5.6 CNC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4761614 355092 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 914 27 5 11 5.6 CNC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
162658125 354955 0 None -100 3 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting methodAntagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting method
ChEMBL 471 6 2 4 5.9 O=C(O)c1ccc(Oc2ccc(Cl)cc2NS(=O)(=O)c2ccc(Cl)c(Cl)c2)cc1 10.1021/acs.jmedchem.0c01137
CHEMBL4760108 354955 0 None -100 3 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting methodAntagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting method
ChEMBL 471 6 2 4 5.9 O=C(O)c1ccc(Oc2ccc(Cl)cc2NS(=O)(=O)c2ccc(Cl)c(Cl)c2)cc1 10.1021/acs.jmedchem.0c01137
162666730 356101 1 None -562 3 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting methodAntagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting method
ChEMBL 589 9 2 6 6.5 N#CSCCNC(=O)c1ccc(Oc2ccc(Cl)cc2NS(=O)(=O)c2ccc(Cl)c(C(F)(F)F)c2)cc1 10.1021/acs.jmedchem.0c01137
CHEMBL4783861 356101 1 None -562 3 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting methodAntagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting method
ChEMBL 589 9 2 6 6.5 N#CSCCNC(=O)c1ccc(Oc2ccc(Cl)cc2NS(=O)(=O)c2ccc(Cl)c(C(F)(F)F)c2)cc1 10.1021/acs.jmedchem.0c01137
145984591 330783 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 587 8 1 6 7.0 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C(C)C)nnc2C(F)(F)F)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4250366 330783 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 587 8 1 6 7.0 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C(C)C)nnc2C(F)(F)F)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
49798158 25166 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 607 10 1 6 3.6 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172623 25166 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 607 10 1 6 3.6 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
11585625 158726 0 None None None Human 8.4 pIC50 = 8.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 648 10 1 6 4.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NS(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207447 158726 0 None None None Human 8.4 pIC50 = 8.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 648 10 1 6 4.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NS(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
72712598 183448 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 591 5 0 4 6.6 Cc1cc(Cl)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435848 183448 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 591 5 0 4 6.6 Cc1cc(Cl)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
50992246 121261 6 None -1 5 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human CCR5 receptor by chemotaxis assayAntagonist activity at human CCR5 receptor by chemotaxis assay
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683074 121261 6 None -1 5 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human CCR5 receptor by chemotaxis assayAntagonist activity at human CCR5 receptor by chemotaxis assay
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
168276745 373683 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 503 8 1 6 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1ccsc1Cl 10.1021/acs.jmedchem.2c01383
CHEMBL5180628 373683 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 503 8 1 6 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1ccsc1Cl 10.1021/acs.jmedchem.2c01383
72714076 183483 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435883 183483 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
52943390 42911 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 795 12 1 7 7.4 C=CCN(C(=O)OCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288877 42911 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 795 12 1 7 7.4 C=CCN(C(=O)OCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
52943389 42910 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 13 1 8 7.0 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288876 42910 0 None None None Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 13 1 8 7.0 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
145986145 330367 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 573 8 1 6 6.7 CC(C)c1nnc(C(F)(F)F)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4240242 330367 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 573 8 1 6 6.7 CC(C)c1nnc(C(F)(F)F)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
72711277 183497 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435897 183497 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
44511861 141479 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 549 10 1 6 5.7 COc1ccc(N(Cc2cnccc2C)C2CCN([C@@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926895 141479 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 549 10 1 6 5.7 COc1ccc(N(Cc2cnccc2C)C2CCN([C@@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
52944586 42907 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 12 1 6 8.6 C=CCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288873 42907 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 12 1 6 8.6 C=CCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
21064299 38243 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 610 11 2 6 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200017 38243 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 610 11 2 6 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
168275071 373538 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 534 9 2 7 5.5 CC(=O)Nc1cccc(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)c1 10.1021/acs.jmedchem.2c01383
CHEMBL5178495 373538 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 534 9 2 7 5.5 CC(=O)Nc1cccc(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)c1 10.1021/acs.jmedchem.2c01383
70685193 145333 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 410 6 0 4 5.6 Cc1nc2cnccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.8b00180
CHEMBL2011438 145333 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 410 6 0 4 5.6 Cc1nc2cnccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.8b00180
9956238 122970 0 None -3 4 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assayAntagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assay
ChEMBL 467 8 2 8 3.0 Cc1nn(C)c2nc(N(C)CCN(C)C)c(C(=O)NC(=O)Nc3cccc(OC(C)C)c3)cc12 10.1021/jm1012903
CHEMBL1739922 122970 0 None -3 4 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assayAntagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assay
ChEMBL 467 8 2 8 3.0 Cc1nn(C)c2nc(N(C)CCN(C)C)c(C(=O)NC(=O)Nc3cccc(OC(C)C)c3)cc12 10.1021/jm1012903
10208679 27106 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16659334 27106 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188565 27106 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1197042 27106 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
3008921 332945 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 459 5 0 3 6.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)C2CCCCC2)CC1 10.1021/jm031046g
CHEMBL433635 332945 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 459 5 0 3 6.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)C2CCCCC2)CC1 10.1021/jm031046g
52940989 42909 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 828 13 1 8 7.3 C=CCN(C(=O)OCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288875 42909 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 828 13 1 8 7.3 C=CCN(C(=O)OCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008933 464348 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 531 6 0 4 6.5 Cc1cc(C)c(S(=O)(=O)N2CCC(C)(N3CCC(N(c4ccccc4)c4ccccc4)CC3)CC2)c(C)c1 10.1021/jm031046g
CHEMBL60589 464348 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 531 6 0 4 6.5 Cc1cc(C)c(S(=O)(=O)N2CCC(C)(N3CCC(N(c4ccccc4)c4ccccc4)CC3)CC2)c(C)c1 10.1021/jm031046g
90656335 220588 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 475 8 2 7 3.5 CC(C)Oc1ccc(N2CCN(Cc3ccc(C(=O)O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263031 220588 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 475 8 2 7 3.5 CC(C)Oc1ccc(N2CCN(Cc3ccc(C(=O)O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
52944587 42914 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 837 12 2 5 8.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288880 42914 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 837 12 2 5 8.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
49799711 38320 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200303 38320 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226128 38034 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198003 38034 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
3008922 412346 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 513 7 0 5 6.0 COc1cccc(OC)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58176 412346 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 513 7 0 5 6.0 COc1cccc(OC)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
52942223 42928 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 14 1 6 7.1 C=CCN(C(=O)CCc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288922 42928 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 14 1 6 7.1 C=CCN(C(=O)CCc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008912 451632 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
CHEMBL60279 451632 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
72712371 183471 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435871 183471 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
10278617 195556 3 None 1 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 195556 3 None 1 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
72712372 183472 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 499 6 0 6 4.7 Cn1nnc(-c2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)n1 10.1021/jm401101p
CHEMBL2435872 183472 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 499 6 0 6 4.7 Cn1nnc(-c2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)n1 10.1021/jm401101p
178321184 467686 0 None -1 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 515 6 3 10 3.9 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2N[C@H]2CCCc3ccccc32)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6191623 467686 0 None -1 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 515 6 3 10 3.9 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2N[C@H]2CCCc3ccccc32)c1O 10.1016/j.ejmech.2025.117600
73355554 183608 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 431 7 2 6 4.1 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436824 183608 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 431 7 2 6 4.1 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
178294141 467673 0 None 3 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 475 6 3 10 3.4 Cc1cccc(Nc2nc3nonc3nc2Nc2ccc(Cl)c(S(=O)(=O)N(C)C)c2O)c1 10.1016/j.ejmech.2025.117600
CHEMBL6191289 467673 0 None 3 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 475 6 3 10 3.4 Cc1cccc(Nc2nc3nonc3nc2Nc2ccc(Cl)c(S(=O)(=O)N(C)C)c2O)c1 10.1016/j.ejmech.2025.117600
53324598 116540 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
6320546 116540 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739382 116540 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739500 116540 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
5275761 158760 0 None None None Human 7.4 pIC50 = 7.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 609 10 1 5 5.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207633 158760 0 None None None Human 7.4 pIC50 = 7.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 609 10 1 5 5.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
16014614 106032 6 None 7 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LDF8beta-induced intracellular calcium fluxAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LDF8beta-induced intracellular calcium flux
ChEMBL 420 4 2 7 5.5 Cc1ccc(Nc2nc3nonc3nc2Nc2cccc(C(F)(F)F)c2)cc1Cl 10.1016/j.ejmech.2025.117600
CHEMBL1595162 106032 6 None 7 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LDF8beta-induced intracellular calcium fluxAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LDF8beta-induced intracellular calcium flux
ChEMBL 420 4 2 7 5.5 Cc1ccc(Nc2nc3nonc3nc2Nc2cccc(C(F)(F)F)c2)cc1Cl 10.1016/j.ejmech.2025.117600
53324598 116540 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
6320546 116540 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1739382 116540 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1739500 116540 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
53324598 116540 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
6320546 116540 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739382 116540 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739500 116540 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
168295761 375490 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 497 9 1 10 3.2 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)Cn2cnnn2)s1 10.1021/acs.jmedchem.2c01383
CHEMBL5208613 375490 0 None None None Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 497 9 1 10 3.2 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)Cn2cnnn2)s1 10.1021/acs.jmedchem.2c01383
21064338 38313 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 506 8 1 5 5.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1nc(-c3ccccc3)oc1C)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200293 38313 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 506 8 1 5 5.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1nc(-c3ccccc3)oc1C)CC2 10.1016/j.bmc.2010.05.057
44356952 238044 0 None None None Human 6.4 pIC50 = 6.4 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 591 11 1 6 5.7 CCCN(c1nccc(C(F)(F)F)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343745 238044 0 None None None Human 6.4 pIC50 = 6.4 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 591 11 1 6 5.7 CCCN(c1nccc(C(F)(F)F)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
73349498 183576 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 8 1 5 6.0 CC(C)Oc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436712 183576 0 None None None Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 8 1 5 6.0 CC(C)Oc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
3008919 200910 0 None None None Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
CHEMBL292894 200910 0 None None None Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
178321198 467718 0 None 4 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 461 6 3 10 3.1 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccccc2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6192382 467718 0 None 4 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 461 6 3 10 3.1 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccccc2)c1O 10.1016/j.ejmech.2025.117600
46225514 443613 0 None None None Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 537 7 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(S(=O)(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL594208 443613 0 None None None Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 537 7 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(S(=O)(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
90656337 220589 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 509 8 1 8 3.2 CC(C)Oc1ccc(N2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263033 220589 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 509 8 1 8 3.2 CC(C)Oc1ccc(N2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
90656338 220590 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 445 7 1 6 4.1 Cc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263034 220590 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 445 7 1 6 4.1 Cc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
52944086 42916 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 787 12 2 5 7.3 C=CCN(C(=O)NCc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288910 42916 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 787 12 2 5 7.3 C=CCN(C(=O)NCc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225349 444948 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 539 6 0 5 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595610 444948 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 539 6 0 5 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
11947758 915 28 None -616 4 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
3001322 915 28 None -616 4 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 915 28 None -616 4 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 915 28 None -616 4 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1739499 915 28 None -616 4 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 915 28 None -616 4 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
3008910 432508 0 None None None Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 481 5 1 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL59285 432508 0 None None None Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 481 5 1 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm031046g
53389083 138738 0 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852020 138738 0 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
53389083 138738 0 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852020 138738 0 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
56661530 138729 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 616 8 3 6 4.0 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CC(F)(F)F)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1851975 138729 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 616 8 3 6 4.0 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CC(F)(F)F)cc2)cc1 10.1016/j.bmc.2011.05.022
122185621 241480 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 482 6 2 2 4.7 Cc1c(CNC(=O)c2ccc(Cl)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Cl)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606052 241480 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 482 6 2 2 4.7 Cc1c(CNC(=O)c2ccc(Cl)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Cl)cc1)CCC2 10.1016/j.bmcl.2015.06.029
11947758 915 28 None -616 4 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
3001322 915 28 None -616 4 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
805 915 28 None -616 4 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
CHEMBL1255794 915 28 None -616 4 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
CHEMBL1739499 915 28 None -616 4 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
DB06497 915 28 None -616 4 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
73346462 183609 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 8 2 6 4.5 CCOc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436825 183609 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 8 2 6 4.5 CCOc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
57331308 214297 0 None None None Human 6.3 pIC50 = 6.3 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 591 10 0 5 5.0 CCN(Cc1ccc(C#N)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104680 214297 0 None None None Human 6.3 pIC50 = 6.3 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 591 10 0 5 5.0 CCN(Cc1ccc(C#N)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
3008926 465322 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c[nH]c3ccccc23)CC1 10.1021/jm031046g
CHEMBL60711 465322 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c[nH]c3ccccc23)CC1 10.1021/jm031046g
3008937 445322 0 None None None Human 7.3 pIC50 = 7.3 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59602 445322 0 None None None Human 7.3 pIC50 = 7.3 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
15942352 163198 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 505 8 1 5 4.6 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)N(C)C)CC1 10.1021/ml2002604
CHEMBL2164204 163198 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 505 8 1 5 4.6 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)N(C)C)CC1 10.1021/ml2002604
86294766 220203 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 502 10 1 7 4.7 CCN(CC)c1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3259855 220203 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 502 10 1 7 4.7 CCN(CC)c1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
23577362 138668 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851690 138668 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
10230510 138708 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 537 10 3 6 3.7 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851888 138708 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 537 10 3 6 3.7 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56659272 138763 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852160 138763 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
56659272 138763 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852160 138763 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
54581479 123648 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 9 1 4 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1762313 123648 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 9 1 4 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
118727188 236239 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)C[C@H]2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397999 236239 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)C[C@H]2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
44194675 25111 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 651 11 2 6 3.6 C=CCN(C(=O)NCc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172053 25111 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 651 11 2 6 3.6 C=CCN(C(=O)NCc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
50992574 119998 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 435 6 1 5 3.6 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649916 119998 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 435 6 1 5 3.6 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C)CC3)C2)c1ccccc1 10.1021/jm100978n
46225528 432661 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 619 6 0 5 5.1 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592993 432661 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 619 6 0 5 5.1 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
72714321 183491 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
CHEMBL2435891 183491 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
3008902 466725 0 None -1 2 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61536 466725 0 None -1 2 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
145985889 330275 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 498 8 1 7 3.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(=O)N(C)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4238007 330275 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 498 8 1 7 3.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(=O)N(C)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
59458213 183504 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 525 8 1 4 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435904 183504 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 525 8 1 4 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
49798131 25150 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 574 10 1 6 4.2 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172439 25150 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 574 10 1 6 4.2 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
3013575 157435 0 None None None Human 8.3 pIC50 = 8.3 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL204821 157435 0 None None None Human 8.3 pIC50 = 8.3 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
168273684 373480 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 553 8 1 6 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1Cl 10.1021/acs.jmedchem.2c01383
CHEMBL5177519 373480 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 553 8 1 6 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1Cl 10.1021/acs.jmedchem.2c01383
145984717 330411 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 511 8 1 6 5.8 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C(C)(C)C(F)(F)F)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4241284 330411 0 None None None Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 511 8 1 6 5.8 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C(C)(C)C(F)(F)F)c1cccs1 10.1021/acs.jmedchem.8b01077
11947758 915 28 None -616 4 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
3001322 915 28 None -616 4 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
805 915 28 None -616 4 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
CHEMBL1255794 915 28 None -616 4 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
CHEMBL1739499 915 28 None -616 4 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
DB06497 915 28 None -616 4 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
51039119 350183 37 None 1 3 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
CHEMBL4594419 350183 37 None 1 3 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
DB16240 350183 37 None 1 3 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
25024699 183447 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 558 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435847 183447 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 558 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
72711047 183492 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435892 183492 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
11947758 915 28 None -616 4 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxis
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
3001322 915 28 None -616 4 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxis
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 915 28 None -616 4 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxis
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 915 28 None -616 4 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxis
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1739499 915 28 None -616 4 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxis
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 915 28 None -616 4 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxis
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
5275762 158735 0 None None None Human 8.2 pIC50 = 8.2 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207485 158735 0 None None None Human 8.2 pIC50 = 8.2 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
57402798 141459 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 540 10 1 5 6.1 COc1ccc(N(Cc2ccccc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926873 141459 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 540 10 1 5 6.1 COc1ccc(N(Cc2ccccc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
10208080 27323 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
CHEMBL1190106 27323 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
10228759 38260 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 9 1 4 4.7 CCCCN1C(=O)C(CCC)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200080 38260 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 9 1 4 4.7 CCCCN1C(=O)C(CCC)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
3500 3139 14 None 245 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1016/j.bmcl.2009.11.018
491774 3139 14 None 245 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1016/j.bmcl.2009.11.018
CHEMBL1196395 3139 14 None 245 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1016/j.bmcl.2009.11.018
10228761 28172 0 None None None Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1196469 28172 0 None None None Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
10228761 28172 0 None None None Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1196469 28172 0 None None None Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
56664935 138683 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 7 3 6 3.4 CN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851773 138683 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 7 3 6 3.4 CN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
178293522 467560 0 None 6 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 495 6 3 10 3.8 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccccc2Cl)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6188726 467560 0 None 6 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 495 6 3 10 3.8 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2ccccc2Cl)c1O 10.1016/j.ejmech.2025.117600
53324598 116540 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
6320546 116540 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739382 116540 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739500 116540 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
122668161 330480 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 491 8 1 6 5.8 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)c2ccccc2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4242946 330480 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 491 8 1 6 5.8 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)c2ccccc2)s1 10.1021/acs.jmedchem.8b01077
90656341 220646 0 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 477 8 1 7 4.6 CSc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263320 220646 0 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 477 8 1 7 4.6 CSc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
53324598 116540 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
6320546 116540 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1739382 116540 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1739500 116540 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
3008919 200910 0 None None None Human 6.3 pIC50 = 6.3 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
CHEMBL292894 200910 0 None None None Human 6.3 pIC50 = 6.3 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
73351060 183606 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 487 10 1 6 5.4 CCOc1ccc(C2CCN(Cc3ccc(N(CC)CC)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436822 183606 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 487 10 1 6 5.4 CCOc1ccc(C2CCN(Cc3ccc(N(CC)CC)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
52941008 42924 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 772 12 1 5 7.1 C=CCN(C(=O)Cc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288918 42924 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 772 12 1 5 7.1 C=CCN(C(=O)Cc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
21926948 38236 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 503 9 1 4 5.5 CCCCN1C(=O)C(CC2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1199991 38236 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 503 9 1 4 5.5 CCCCN1C(=O)C(CC2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
56681915 138709 1 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851889 138709 1 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
57331305 214310 0 None None None Human 6.3 pIC50 = 6.3 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 566 10 0 4 5.1 CCN(Cc1ccccc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104695 214310 0 None None None Human 6.3 pIC50 = 6.3 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 566 10 0 4 5.1 CCN(Cc1ccccc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
52941648 42923 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 822 12 1 5 8.0 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288917 42923 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 822 12 1 5 8.0 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
16728787 27107 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188566 27107 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728787 27107 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188566 27107 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
46225531 445792 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 522 6 0 4 3.9 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596523 445792 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 522 6 0 4 3.9 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
21927225 38254 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 473 7 1 4 4.2 CC#CCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200061 38254 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 473 7 1 4 4.2 CC#CCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
6479877 26781 2 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1186558 26781 2 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
6479877 26781 2 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1186558 26781 2 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
162660784 355121 0 None -25 2 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1225 30 7 15 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4761986 355121 0 None -25 2 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1225 30 7 15 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
6479877 26781 2 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1186558 26781 2 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
46225395 462517 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 503 6 0 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL604070 462517 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 503 6 0 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL5078769 478772 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 5550 203 66 78 -14.1 CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(C(C)=O)CC3)c3ccc(C)c(Cl)c3)CC2)cc1)C(N)=O 10.1021/acs.jmedchem.1c00781
178321902 467551 0 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 529 6 3 10 4.1 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2cccc(C(F)(F)F)c2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6188402 467551 0 None None None Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 529 6 3 10 4.1 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2Nc2cccc(C(F)(F)F)c2)c1O 10.1016/j.ejmech.2025.117600
9978318 240929 0 None None None Human 5.3 pIC50 = 5.3 Functional
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C/C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
CHEMBL359986 240929 0 None None None Human 5.3 pIC50 = 5.3 Functional
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C/C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
46225395 462517 0 None None None Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 503 6 0 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL604070 462517 0 None None None Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 503 6 0 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225513 463163 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 505 7 1 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)CO)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL604680 463163 0 None None None Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 505 7 1 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)CO)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
11947758 915 28 None -616 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
3001322 915 28 None -616 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 915 28 None -616 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 915 28 None -616 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1739499 915 28 None -616 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 915 28 None -616 4 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
73349506 183599 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 9 1 6 5.0 CCN(CC)c1ccc(CN2CCC(c3ccc(OC)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436814 183599 0 None None None Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 9 1 6 5.0 CCN(CC)c1ccc(CN2CCC(c3ccc(OC)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
49799707 38240 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 544 9 2 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)Nc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200014 38240 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 544 9 2 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)Nc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL5074744 478529 0 None -1 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 1211 30 7 15 6.0 CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
21925890 38289 0 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 508 8 1 5 5.2 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1csc(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200223 38289 0 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 508 8 1 5 5.2 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1csc(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
3008921 332945 0 None None None Human 6.2 pIC50 = 6.2 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 459 5 0 3 6.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)C2CCCCC2)CC1 10.1021/jm031046g
CHEMBL433635 332945 0 None None None Human 6.2 pIC50 = 6.2 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 459 5 0 3 6.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)C2CCCCC2)CC1 10.1021/jm031046g
46225344 445084 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 535 5 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595760 445084 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 535 5 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
21927257 38235 0 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 569 11 1 6 5.1 CCCCN1C(=O)C(CC(=O)OCc2ccccc2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1199989 38235 0 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 569 11 1 6 5.1 CCCCN1C(=O)C(CC(=O)OCc2ccccc2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
73352534 183602 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 459 7 2 6 4.1 COc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436817 183602 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 459 7 2 6 4.1 COc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
56657984 138680 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 548 7 3 6 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4C)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1851766 138680 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 548 7 3 6 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4C)cc2)cc1 10.1016/j.bmc.2011.05.022
72714320 183490 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435890 183490 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
49798080 25097 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 629 10 1 6 5.7 C=CCN(C(=O)OCc1ccc(OC(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172039 25097 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 629 10 1 6 5.7 C=CCN(C(=O)OCc1ccc(OC(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
49798088 25107 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 628 10 2 5 5.3 C=CCN(C(=O)NCc1ccc(OC(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172049 25107 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 628 10 2 5 5.3 C=CCN(C(=O)NCc1ccc(OC(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
3008914 451132 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL60225 451132 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
16728325 25095 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 575 10 1 6 4.8 C=CCN(C(=O)OCc1ccc(OC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172036 25095 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 575 10 1 6 4.8 C=CCN(C(=O)OCc1ccc(OC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
59458159 183508 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 567 8 1 5 5.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435908 183508 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 567 8 1 5 5.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
56647076 183481 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435881 183481 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
11692945 158187 0 None None None Human 8.2 pIC50 = 8.2 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3C(N)=O)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL206088 158187 0 None None None Human 8.2 pIC50 = 8.2 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3C(N)=O)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
118727174 236225 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397985 236225 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
49864974 39676 0 None None None Human 8.2 pIC50 = 8.2 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 656 9 2 4 6.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222772 39676 0 None None None Human 8.2 pIC50 = 8.2 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 656 9 2 4 6.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
126567286 330259 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1csc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1 10.1021/acs.jmedchem.8b01077
CHEMBL4237581 330259 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1csc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1 10.1021/acs.jmedchem.8b01077
145986277 330761 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 549 9 1 7 6.0 COc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4249941 330761 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 549 9 1 7 6.0 COc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
56647023 183480 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435880 183480 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
52944587 42914 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 837 12 2 5 8.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288880 42914 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 837 12 2 5 8.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
52944617 42922 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 813 12 2 7 7.4 C=CCN(C(=O)Nc1ccc(OC(C)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288916 42922 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 813 12 2 7 7.4 C=CCN(C(=O)Nc1ccc(OC(C)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225531 445792 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 522 6 0 4 3.9 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596523 445792 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 522 6 0 4 3.9 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
44395386 251226 0 None None None Human 5.2 pIC50 = 5.2 Functional
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C\C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
CHEMBL366260 251226 0 None None None Human 5.2 pIC50 = 5.2 Functional
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C\C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
3008934 411637 0 None None None Human 7.2 pIC50 = 7.2 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58101 411637 0 None None None Human 7.2 pIC50 = 7.2 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
73352529 183579 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 501 10 1 6 5.7 CCN(CC)c1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436715 183579 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 501 10 1 6 5.7 CCN(CC)c1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
73346461 183607 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 461 8 1 7 4.4 CCOc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436823 183607 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 461 8 1 7 4.4 CCOc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
3008937 445322 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59602 445322 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
178293231 467676 0 None 2 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 475 6 3 10 3.4 Cc1ccc(Nc2nc3nonc3nc2Nc2ccc(Cl)c(S(=O)(=O)N(C)C)c2O)cc1 10.1016/j.ejmech.2025.117600
CHEMBL6191451 467676 0 None 2 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 475 6 3 10 3.4 Cc1ccc(Nc2nc3nonc3nc2Nc2ccc(Cl)c(S(=O)(=O)N(C)C)c2O)cc1 10.1016/j.ejmech.2025.117600
90666577 218970 0 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
CHEMBL3219779 218970 0 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
101577042 365815 0 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4795179 365815 0 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
112500047 252493 0 None None None Human 6.2 pIC50 = 6.2 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 643 13 3 8 4.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(N)=O)cc1 nan
CHEMBL3639964 252493 0 None None None Human 6.2 pIC50 = 6.2 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 643 13 3 8 4.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(N)=O)cc1 nan
118727192 236243 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 430 7 1 4 4.5 N#Cc1ccc(N2CCN(CCC(NC(=O)C3CCCCC3)c3ccccc3)CC2)cc1 10.1016/j.bmc.2014.12.052
CHEMBL3398003 236243 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 430 7 1 4 4.5 N#Cc1ccc(N2CCN(CCC(NC(=O)C3CCCCC3)c3ccccc3)CC2)cc1 10.1016/j.bmc.2014.12.052
90656330 220585 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 465 7 1 6 4.5 CC(C)Oc1ccc(N2CCN(Cc3ccc(Cl)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263026 220585 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 465 7 1 6 4.5 CC(C)Oc1ccc(N2CCN(Cc3ccc(Cl)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
49798349 25072 1 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5Antagonist activity at CCR5
ChEMBL 471 6 2 4 5.9 O=C(O)c1ccccc1Oc1ccc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2010.04.142
CHEMBL1171786 25072 1 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5Antagonist activity at CCR5
ChEMBL 471 6 2 4 5.9 O=C(O)c1ccccc1Oc1ccc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2010.04.142
73347961 183605 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 429 7 2 4 5.3 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436820 183605 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 429 7 2 4 5.3 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
73347961 183605 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 429 7 2 4 5.3 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.bmcl.2014.03.073
CHEMBL2436820 183605 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 429 7 2 4 5.3 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.bmcl.2014.03.073
10416 3843 37 None -309 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assayAntagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assay
ChEMBL 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 10.1021/jm301572h
46861584 3843 37 None -309 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assayAntagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assay
ChEMBL 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 10.1021/jm301572h
CHEMBL2018969 3843 37 None -309 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assayAntagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assay
ChEMBL 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 10.1021/jm301572h
52947064 42913 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 823 11 2 5 8.5 C=CCN(C(=O)Nc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288879 42913 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 823 11 2 5 8.5 C=CCN(C(=O)Nc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
10278617 195556 3 None -1 2 Crab-eating macaque 7.2 pIC50 = 7.2 Functional
Antagonist activity at cynomolgus monkey CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at cynomolgus monkey CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 195556 3 None -1 2 Crab-eating macaque 7.2 pIC50 = 7.2 Functional
Antagonist activity at cynomolgus monkey CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at cynomolgus monkey CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
57331304 214298 0 None None None Human 7.2 pIC50 = 7.2 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 552 9 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)N(C)Cc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104681 214298 0 None None None Human 7.2 pIC50 = 7.2 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 552 9 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)N(C)Cc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
73357100 183603 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 485 10 1 4 6.6 CCOc1ccc(C2CCN(Cc3ccc(N(CC)CC)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436818 183603 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 485 10 1 4 6.6 CCOc1ccc(C2CCN(Cc3ccc(N(CC)CC)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
90656326 220582 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 476 8 1 8 3.7 CC(C)Oc1ccc(N2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263022 220582 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 476 8 1 8 3.7 CC(C)Oc1ccc(N2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
52949553 42925 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 832 13 1 7 6.4 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288919 42925 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 832 13 1 7 6.4 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225394 445395 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 501 6 0 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596081 445395 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 501 6 0 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
16658856 135868 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852220 135868 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
16658856 135868 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1852220 135868 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
16658856 135868 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852220 135868 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
73349499 183580 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 475 8 1 7 4.8 CC(C)Oc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436716 183580 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 475 8 1 7 4.8 CC(C)Oc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
46225529 432871 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 591 6 0 5 4.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593195 432871 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 591 6 0 5 4.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
145961982 317073 0 None -10 2 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in CHOK1 cells co-expressing Ga16 assessed as inhibition of Rantes-induced intracellular Ca2+ mobilization preincubated for 10 mins followed by Rantes addition by fluo-4 AM dye based assayAntagonist activity at CCR5 (unknown origin) expressed in CHOK1 cells co-expressing Ga16 assessed as inhibition of Rantes-induced intracellular Ca2+ mobilization preincubated for 10 mins followed by Rantes addition by fluo-4 AM dye based assay
ChEMBL 553 8 1 6 4.3 CN(C1CCN(CCCN2CCCc3c(ccnc3Nc3ccc(Cl)c(Cl)c3)C2=O)CC1)S(C)(=O)=O 10.1016/j.bmc.2018.05.027
CHEMBL4128498 317073 0 None -10 2 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in CHOK1 cells co-expressing Ga16 assessed as inhibition of Rantes-induced intracellular Ca2+ mobilization preincubated for 10 mins followed by Rantes addition by fluo-4 AM dye based assayAntagonist activity at CCR5 (unknown origin) expressed in CHOK1 cells co-expressing Ga16 assessed as inhibition of Rantes-induced intracellular Ca2+ mobilization preincubated for 10 mins followed by Rantes addition by fluo-4 AM dye based assay
ChEMBL 553 8 1 6 4.3 CN(C1CCN(CCCN2CCCc3c(ccnc3Nc3ccc(Cl)c(Cl)c3)C2=O)CC1)S(C)(=O)=O 10.1016/j.bmc.2018.05.027
56661524 138723 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851951 138723 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
73354018 183577 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 443 7 2 4 5.7 CC(C)Oc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436713 183577 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 443 7 2 4 5.7 CC(C)Oc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
46225394 445395 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 501 6 0 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596081 445395 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 501 6 0 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008918 430698 0 None None None Human 7.2 pIC50 = 7.2 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59101 430698 0 None None None Human 7.2 pIC50 = 7.2 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
126567281 330387 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 520 8 1 7 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cscn1 10.1021/acs.jmedchem.2c01383
CHEMBL4240742 330387 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 520 8 1 7 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cscn1 10.1021/acs.jmedchem.2c01383
122185625 241473 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 504 8 2 6 3.2 Cc1c(CNC(=O)c2ccc([N+](=O)[O-])cc2)c(C)[n+]2c(c1CNC(=O)c1ccc([N+](=O)[O-])cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606026 241473 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 504 8 2 6 3.2 Cc1c(CNC(=O)c2ccc([N+](=O)[O-])cc2)c(C)[n+]2c(c1CNC(=O)c1ccc([N+](=O)[O-])cc1)CCC2 10.1016/j.bmcl.2015.06.029
168284187 373932 0 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 519 7 1 6 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C(F)(F)F)c1csc2ccccc12 10.1021/acs.jmedchem.2c01383
CHEMBL5184527 373932 0 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 519 7 1 6 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C(F)(F)F)c1csc2ccccc12 10.1021/acs.jmedchem.2c01383
178321552 467746 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 445 5 3 9 3.7 CN(C)C(=O)c1cccc(Nc2nc3nonc3nc2N[C@H]2CCCc3ccccc32)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6193113 467746 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 445 5 3 9 3.7 CN(C)C(=O)c1cccc(Nc2nc3nonc3nc2N[C@H]2CCCc3ccccc32)c1O 10.1016/j.ejmech.2025.117600
23577370 138656 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851623 138656 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56681917 138728 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851972 138728 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
46225429 445203 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 527 5 0 5 4.2 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595902 445203 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 527 5 0 5 4.2 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
21926618 38253 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 475 8 1 4 4.8 C/C=C/CN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200060 38253 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 475 8 1 4 4.8 C/C=C/CN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
122185635 241485 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 474 8 2 4 3.4 COc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(OC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3606103 241485 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 474 8 2 4 3.4 COc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(OC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
44511966 141473 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 515 10 1 6 5.1 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cncc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926889 141473 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 515 10 1 6 5.1 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cncc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
57394058 141489 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 510 9 1 6 5.0 Cc1ccncc1CN(c1ccccc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2C)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926905 141489 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 510 9 1 6 5.0 Cc1ccncc1CN(c1ccccc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2C)CC1 10.1016/j.bmcl.2011.09.133
21867666 317557 52 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) by HTS assayAntagonist activity at CCR5 (unknown origin) by HTS assay
ChEMBL 112 0 2 2 -0.6 C1NCC2CNCC12 10.1016/j.ejmech.2018.01.085
CHEMBL4160473 317557 52 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) by HTS assayAntagonist activity at CCR5 (unknown origin) by HTS assay
ChEMBL 112 0 2 2 -0.6 C1NCC2CNCC12 10.1016/j.ejmech.2018.01.085
76313867 214309 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in CHO cell membranes assessed as inhibition of RANTES-stimulated [35S]-GTPgammaS binding after 1 hr by liquid scintillation counting analysisAntagonist activity at CCR5 (unknown origin) expressed in CHO cell membranes assessed as inhibition of RANTES-stimulated [35S]-GTPgammaS binding after 1 hr by liquid scintillation counting analysis
ChEMBL 566 10 0 4 4.9 CCN(C(=O)Cc1ccccc1)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104694 214309 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in CHO cell membranes assessed as inhibition of RANTES-stimulated [35S]-GTPgammaS binding after 1 hr by liquid scintillation counting analysisAntagonist activity at CCR5 (unknown origin) expressed in CHO cell membranes assessed as inhibition of RANTES-stimulated [35S]-GTPgammaS binding after 1 hr by liquid scintillation counting analysis
ChEMBL 566 10 0 4 4.9 CCN(C(=O)Cc1ccccc1)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
5275760 158706 0 None None None Human 8.2 pIC50 = 8.2 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 623 10 0 6 5.1 COC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL207301 158706 0 None None None Human 8.2 pIC50 = 8.2 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 623 10 0 6 5.1 COC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
72711278 183498 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435898 183498 0 None None None Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
3008935 467536 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61828 467536 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
73346389 183479 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435879 183479 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
72711507 183503 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435903 183503 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
16728787 27107 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188566 27107 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
3008918 430698 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59101 430698 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
183790 8163 6 None -1 5 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
783 8163 6 None -1 5 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
CHEMBL1178786 8163 6 None -1 5 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
3008932 466270 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5Antagonistic activity against human C-C chemokine receptor type 5
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 466270 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5Antagonistic activity against human C-C chemokine receptor type 5
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008932 466270 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 466270 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008923 424554 0 None None None Human 8.1 pIC50 = 8.1 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
CHEMBL58441 424554 0 None None None Human 8.1 pIC50 = 8.1 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
3008928 466307 0 None -1 2 Human 8.1 pIC50 = 8.1 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61424 466307 0 None -1 2 Human 8.1 pIC50 = 8.1 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
168296928 375275 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 576 9 1 8 4.2 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)s1 10.1021/acs.jmedchem.2c01383
CHEMBL5205216 375275 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 576 9 1 8 4.2 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)s1 10.1021/acs.jmedchem.2c01383
72711051 183496 0 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccc(Br)cc2)CC1 10.1021/jm401101p
CHEMBL2435896 183496 0 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccc(Br)cc2)CC1 10.1021/jm401101p
73346454 183586 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 457 7 2 4 5.3 COc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436722 183586 0 None None None Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 457 7 2 4 5.3 COc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
49799680 38294 1 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 502 8 1 4 5.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(-c3cccnc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200241 38294 1 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 502 8 1 4 5.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(-c3cccnc3)cc1)CC2 10.1016/j.bmc.2010.05.057
23577378 138724 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851957 138724 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
3013673 158603 0 None None None Human 7.1 pIC50 = 7.1 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 461 8 0 3 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3)CC2)c2ccccc2)CC1 10.1021/jm051034q
CHEMBL207085 158603 0 None None None Human 7.1 pIC50 = 7.1 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 461 8 0 3 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3)CC2)c2ccccc2)CC1 10.1021/jm051034q
122668217 375300 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 454 8 1 7 4.4 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)CC#N)s1 10.1021/acs.jmedchem.2c01383
CHEMBL5205626 375300 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 454 8 1 7 4.4 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)CC#N)s1 10.1021/acs.jmedchem.2c01383
44395365 252496 0 None None None Human 5.1 pIC50 = 5.1 Functional
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 386 7 2 7 1.8 CC(OC(=O)/C=C/c1ccc(O)cc1)C(=O)[C@H]1C[C@@H]1[C@H](O)[C@H]1CC=CC(=O)O1 10.1016/j.bmcl.2004.08.021
CHEMBL363999 252496 0 None None None Human 5.1 pIC50 = 5.1 Functional
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 386 7 2 7 1.8 CC(OC(=O)/C=C/c1ccc(O)cc1)C(=O)[C@H]1C[C@@H]1[C@H](O)[C@H]1CC=CC(=O)O1 10.1016/j.bmcl.2004.08.021
73355552 183600 0 None None None Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 447 7 1 7 4.0 COc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436815 183600 0 None None None Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 447 7 1 7 4.0 COc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
23577382 138730 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851977 138730 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
3008916 317854 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 509 7 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)Cc3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL416512 317854 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 509 7 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)Cc3ccccc3)CC2)CC1 10.1021/jm031046g
57331339 214302 0 None None None Human 7.1 pIC50 = 7.1 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 563 9 1 5 4.2 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(C#N)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104685 214302 0 None None None Human 7.1 pIC50 = 7.1 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 563 9 1 5 4.2 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(C#N)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
57331275 214303 0 None None None Human 7.1 pIC50 = 7.1 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 552 10 1 4 4.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104688 214303 0 None None None Human 7.1 pIC50 = 7.1 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 552 10 1 4 4.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
10182763 27304 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
10204589 27304 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
CHEMBL1189988 27304 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
CHEMBL1196226 27304 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
73347956 183585 0 None None None Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 415 6 2 4 4.9 COc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436721 183585 0 None None None Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 415 6 2 4 4.9 COc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
73355549 183581 0 None None None Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 445 7 2 6 4.5 CC(C)Oc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436717 183581 0 None None None Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 445 7 2 6 4.5 CC(C)Oc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
16728787 27107 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1188566 27107 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56669616 138756 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852129 138756 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
56669616 138756 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1852129 138756 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
56669616 138756 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852129 138756 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
16728784 27062 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188107 27062 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
21064126 38259 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 1 4 5.4 CCCCN1C(=O)[C@H](CC(C)(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200079 38259 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 1 4 5.4 CCCCN1C(=O)[C@H](CC(C)(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
21064297 38318 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 531 9 1 4 6.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200301 38318 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 531 9 1 4 6.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226124 38038 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 545 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198013 38038 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 545 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
90666580 218973 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 657 13 3 8 4.7 CNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
CHEMBL3219782 218973 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 657 13 3 8 4.7 CNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
178320821 467649 0 None 1 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 489 7 3 10 3.5 C[C@H](Nc1nc2nonc2nc1Nc1ccc(Cl)c(S(=O)(=O)N(C)C)c1O)c1ccccc1 10.1016/j.ejmech.2025.117600
CHEMBL6190514 467649 0 None 1 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 489 7 3 10 3.5 C[C@H](Nc1nc2nonc2nc1Nc1ccc(Cl)c(S(=O)(=O)N(C)C)c1O)c1ccccc1 10.1016/j.ejmech.2025.117600
57390535 141467 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 613 9 1 5 6.7 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926883 141467 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 613 9 1 5 6.7 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
1635 193594 43 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.8b01077
3002977 193594 43 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.8b01077
CHEMBL256907 193594 43 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.8b01077
1635 193594 43 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.2c01383
3002977 193594 43 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.2c01383
CHEMBL256907 193594 43 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.2c01383
145985237 330401 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1cscc1[C@H](CCN1[C@H]2CC[C@@H]1C[C@@H](n1c(C)nnc1C(C)C)C2)NC(=O)C1CCC(F)(F)CC1 10.1021/acs.jmedchem.8b01077
CHEMBL4241066 330401 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1cscc1[C@H](CCN1[C@H]2CC[C@@H]1C[C@@H](n1c(C)nnc1C(C)C)C2)NC(=O)C1CCC(F)(F)CC1 10.1021/acs.jmedchem.8b01077
3008937 445322 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59602 445322 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
5275764 157695 0 None None None Human 8.1 pIC50 = 8.1 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 636 10 0 5 5.0 CN(C)C(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL205706 157695 0 None None None Human 8.1 pIC50 = 8.1 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 636 10 0 5 5.0 CN(C)C(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
118727171 236222 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 549 8 0 5 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(C#N)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397982 236222 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 549 8 0 5 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(C#N)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
122668179 375524 3 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 601 8 1 6 6.0 Cc1nc2c(n1[C@@H]1C[C@H]3CC[C@@H](C1)N3CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1)CCN(C(=O)C(C)C)C2 10.1021/acs.jmedchem.2c01383
CHEMBL5209067 375524 3 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 601 8 1 6 6.0 Cc1nc2c(n1[C@@H]1C[C@H]3CC[C@@H](C1)N3CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1)CCN(C(=O)C(C)C)C2 10.1021/acs.jmedchem.2c01383
3008931 466271 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61374 466271 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
52948264 42906 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 815 13 1 8 7.5 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288872 42906 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 815 13 1 8 7.5 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
16728324 25088 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 545 9 1 5 4.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1171965 25088 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 545 9 1 5 4.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
118727186 236237 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 540 8 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2C[C@@H]3C[C@H]2CN3Cc2ccc(F)cc2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397997 236237 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 540 8 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2C[C@@H]3C[C@H]2CN3Cc2ccc(F)cc2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
49864969 39671 0 None None None Human 8.1 pIC50 = 8.1 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 608 10 1 7 4.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222767 39671 0 None None None Human 8.1 pIC50 = 8.1 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 608 10 1 7 4.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
3008924 432950 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 503 5 0 3 7.1 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm031046g
CHEMBL59328 432950 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 503 5 0 3 7.1 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm031046g
3008903 328178 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3C#N)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL418120 328178 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3C#N)c3ccccc3)CC2)CC1 10.1021/jm031046g
72712158 183465 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 609 9 2 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC(C(=O)O)CC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435865 183465 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 609 9 2 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC(C(=O)O)CC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
122185627 241483 0 None None None Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 450 6 2 2 3.7 Cc1c(CNC(=O)c2ccc(F)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(F)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606099 241483 0 None None None Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 450 6 2 2 3.7 Cc1c(CNC(=O)c2ccc(F)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(F)cc1)CCC2 10.1016/j.bmcl.2015.06.029
49799705 38314 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 529 9 1 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200294 38314 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 529 9 1 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
56661522 138941 0 None None None Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 10 3 6 3.4 CCCCN1C(=O)[C@@H]([C@H](O)C2CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1852861 138941 0 None None None Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 10 3 6 3.4 CCCCN1C(=O)[C@@H]([C@H](O)C2CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
126567273 330705 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 514 8 1 6 5.3 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccnc1 10.1021/acs.jmedchem.8b01077
CHEMBL4248733 330705 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 514 8 1 6 5.3 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccnc1 10.1021/acs.jmedchem.8b01077
72711279 183499 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccnc2)CC1 10.1021/jm401101p
CHEMBL2435899 183499 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccnc2)CC1 10.1021/jm401101p
11569805 27094 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728785 27094 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
491775 27094 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188408 27094 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188807 27094 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196449 27094 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
10208679 27106 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
16659334 27106 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188565 27106 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1197042 27106 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
11569805 27094 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
16728785 27094 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
491775 27094 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188408 27094 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188807 27094 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1196449 27094 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
56683103 138765 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852172 138765 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
56683103 138765 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1852172 138765 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.ejmech.2012.07.049
56683103 138765 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852172 138765 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
72713858 183510 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435910 183510 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
46225349 444948 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 539 6 0 5 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595610 444948 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 539 6 0 5 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
11569805 27094 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
16728785 27094 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
491775 27094 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188408 27094 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188807 27094 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1196449 27094 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
21064329 38252 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 565 9 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(S(=O)(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200059 38252 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 565 9 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(S(=O)(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226122 38033 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 579 10 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(S(=O)(=O)c3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198002 38033 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 579 10 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(S(=O)(=O)c3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
76310164 214305 0 None None None Human 7.1 pIC50 = 7.1 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 586 10 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccc(Cl)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104690 214305 0 None None None Human 7.1 pIC50 = 7.1 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 586 10 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccc(Cl)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
52945865 42926 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 13 1 6 7.9 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288920 42926 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 13 1 6 7.9 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
21064283 38245 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1200019 38245 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
145984103 330734 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 541 7 1 7 4.3 CC(=O)N1CCN(C(=O)N[C@@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)c2ccc(C)s2)CC1 10.1021/acs.jmedchem.8b01077
CHEMBL4249241 330734 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 541 7 1 7 4.3 CC(=O)N1CCN(C(=O)N[C@@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)c2ccc(C)s2)CC1 10.1021/acs.jmedchem.8b01077
9978318 240929 0 None None None Human 5.1 pIC50 = 5.1 Functional
Inhibition of 50% of RANTES co-receptor of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of 50% of RANTES co-receptor of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C/C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
CHEMBL359986 240929 0 None None None Human 5.1 pIC50 = 5.1 Functional
Inhibition of 50% of RANTES co-receptor of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of 50% of RANTES co-receptor of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C/C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
44395386 251226 0 None None None Human 5.1 pIC50 = 5.1 Functional
Inhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C\C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
CHEMBL366260 251226 0 None None None Human 5.1 pIC50 = 5.1 Functional
Inhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C\C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
73349500 183582 0 None None None Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 487 8 2 6 4.9 CC(=O)Nc1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436718 183582 0 None None None Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 487 8 2 6 4.9 CC(=O)Nc1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
178320114 467741 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 475 6 3 10 3.4 Cc1ccccc1Nc1nc2nonc2nc1Nc1ccc(Cl)c(S(=O)(=O)N(C)C)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6192956 467741 0 None None None Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assayAntagonist activity at CCR5 in human U87/CD4/CCR5 cells assessed as inhibition of LD78beta-induced intracellular calcium flux preincubated with compound for 1 mins and measured after 10 mins by FLIPR calcium-6 assay
ChEMBL 475 6 3 10 3.4 Cc1ccccc1Nc1nc2nonc2nc1Nc1ccc(Cl)c(S(=O)(=O)N(C)C)c1O 10.1016/j.ejmech.2025.117600
50993436 119997 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 421 6 2 5 3.3 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CNCC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649915 119997 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 421 6 2 5 3.3 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CNCC3)C2)c1ccccc1 10.1021/jm100978n
3008936 411715 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58109 411715 0 None None None Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
126567306 330549 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4244935 330549 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
122668196 375003 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 501 8 1 6 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccc(F)s1 10.1021/acs.jmedchem.2c01383
CHEMBL5200961 375003 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 501 8 1 6 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccc(F)s1 10.1021/acs.jmedchem.2c01383
145985894 330288 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 569 8 1 6 7.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1csc2ccccc12 10.1021/acs.jmedchem.8b01077
CHEMBL4238266 330288 0 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 569 8 1 6 7.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1csc2ccccc12 10.1021/acs.jmedchem.8b01077
5275763 197118 0 None None None Human 8.0 pIC50 = 8.0 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 622 10 1 5 4.7 CNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL264832 197118 0 None None None Human 8.0 pIC50 = 8.0 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 622 10 1 5 4.7 CNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
3008925 201056 0 None None None Human 8.0 pIC50 = 8 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
CHEMBL293900 201056 0 None None None Human 8.0 pIC50 = 8 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
57401041 141462 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 568 10 1 6 5.9 COC(=O)c1ccc(N(Cc2ccccc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926876 141462 0 None None None Human 7.1 pIC50 = 7.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 568 10 1 6 5.9 COC(=O)c1ccc(N(Cc2ccccc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
10159218 28178 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1196504 28178 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
10159218 28178 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1196504 28178 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
10159218 28178 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1196504 28178 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmcl.2009.11.018
73351055 183583 0 None None None Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 471 9 1 4 6.2 CCN(CC)c1ccc(CN2CCC(c3ccc(OC)c(NC(=O)c4ccccc4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436719 183583 0 None None None Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 471 9 1 4 6.2 CCN(CC)c1ccc(CN2CCC(c3ccc(OC)c(NC(=O)c4ccccc4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
118727187 236238 0 None None None Human 6.0 pIC50 = 6.0 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCCN(Cc3ccc(F)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397998 236238 0 None None None Human 6.0 pIC50 = 6.0 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCCN(Cc3ccc(F)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
72712374 183474 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
CHEMBL2435874 183474 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
72714318 183488 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
CHEMBL2435888 183488 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
3008912 451632 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
CHEMBL60279 451632 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
23577378 138724 0 None None None Human 4.0 pIC50 = 4.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851957 138724 0 None None None Human 4.0 pIC50 = 4.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
21064289 38315 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 535 9 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(F)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200295 38315 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 535 9 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(F)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226130 38035 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 549 10 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(F)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198009 38035 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 549 10 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(F)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
46225527 432860 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 571 6 0 6 3.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593184 432860 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 571 6 0 6 3.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
54752875 155053 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2079028 155053 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
62707282 158815 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2078850 158815 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
54752875 155053 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079028 155053 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
62707282 158815 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2078850 158815 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
70692903 158845 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079297 158845 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
73352528 183578 0 None None None Human 4.0 pIC50 = 4.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 485 8 2 4 6.1 CC(=O)Nc1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4ccccc4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436714 183578 0 None None None Human 4.0 pIC50 = 4.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 485 8 2 4 6.1 CC(=O)Nc1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4ccccc4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
46225526 433181 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 523 6 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593520 433181 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 523 6 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
57331306 214296 0 None None None Human 7.0 pIC50 = 7.0 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 600 10 0 4 5.7 CCN(Cc1ccc(Cl)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104679 214296 0 None None None Human 7.0 pIC50 = 7.0 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 600 10 0 4 5.7 CCN(Cc1ccc(Cl)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
11569805 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728785 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
491775 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188408 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188807 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196449 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
11569805 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
16728785 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
491775 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188408 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188807 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1196449 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
11569805 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
16728785 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
491775 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188408 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188807 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1196449 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
11569805 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
16728785 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
491775 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1188408 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1188807 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1196449 27094 0 None None None Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
162677463 366910 0 None None None Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 857 23 5 11 4.1 CNC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4800480 366910 0 None None None Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 857 23 5 11 4.1 CNC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL5089300 479370 0 None -13 2 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 1239 32 7 15 6.8 CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
90656334 220587 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 489 8 1 8 3.6 COC(=O)c1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263030 220587 0 None None None Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 489 8 1 8 3.6 COC(=O)c1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
23577328 138726 0 None None None Human 4.0 pIC50 = 4.0 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1851967 138726 0 None None None Human 4.0 pIC50 = 4.0 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
60196353 155188 0 None None None Human 8.8 pKd = 8.8 Functional
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1C[C@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.6b01801
CHEMBL2163486 155188 0 None None None Human 8.8 pKd = 8.8 Functional
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1C[C@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.6b01801
137643501 314267 0 None None None Human 8.0 pKd = 8 Functional
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 471 6 1 5 4.5 Cc1nnc2n1[C@@H]1CCN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@@H]1CC2 10.1021/acs.jmedchem.6b01801
CHEMBL4089991 314267 0 None None None Human 8.0 pKd = 8 Functional
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 471 6 1 5 4.5 Cc1nnc2n1[C@@H]1CCN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@@H]1CC2 10.1021/acs.jmedchem.6b01801
137631641 312530 0 None None None Human 6.5 pKd = 6.5 Functional
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 471 6 1 5 4.5 Cc1nnc2n1[C@H]1CCN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@H]1CC2 10.1021/acs.jmedchem.6b01801
CHEMBL4068906 312530 0 None None None Human 6.5 pKd = 6.5 Functional
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 471 6 1 5 4.5 Cc1nnc2n1[C@H]1CCN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@H]1CC2 10.1021/acs.jmedchem.6b01801
3009353 332765 0 None None None Human 9.0 pKi = 9.0 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 531 6 0 5 5.7 CCC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm0304515
CHEMBL432170 332765 0 None None None Human 9.0 pKi = 9.0 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 531 6 0 5 5.7 CCC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm0304515
3009354 470132 0 None None None Human 8.9 pKi = 8.9 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 579 6 0 5 6.1 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](Cc3ccccc3)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
CHEMBL79061 470132 0 None None None Human 8.9 pKi = 8.9 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 579 6 0 5 6.1 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](Cc3ccccc3)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
3009356 215316 0 None None None Human 8.8 pKi = 8.8 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 543 6 0 5 5.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](CC3CC3)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
CHEMBL312344 215316 0 None None None Human 8.8 pKi = 8.8 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 543 6 0 5 5.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](CC3CC3)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
3009355 8651 20 None None None Human 8.6 pKi = 8.6 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm0304515
807 8651 20 None None None Human 8.6 pKi = 8.6 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm0304515
CHEMBL82301 8651 20 None None None Human 8.6 pKi = 8.6 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm0304515
DB06652 8651 20 None None None Human 8.6 pKi = 8.6 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm0304515
483747 215103 1 None None None Human 8.6 pKi = 8.6 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
CHEMBL311795 215103 1 None None None Human 8.6 pKi = 8.6 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
10436045 7148 4 None None None Human 5.4 pKi = 5.4 Functional
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 499 9 3 3 6.4 O=C(/C=C/c1ccc(c(c1)Cl)Cl)NCCCCCN1CCC(CC1)c1c[nH]c2c1cc(O)cc2 10.1016/s0960-894x(00)00347-4
782 7148 4 None None None Human 5.4 pKi = 5.4 Functional
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 499 9 3 3 6.4 O=C(/C=C/c1ccc(c(c1)Cl)Cl)NCCCCCN1CCC(CC1)c1c[nH]c2c1cc(O)cc2 10.1016/s0960-894x(00)00347-4
CHEMBL432713 7148 4 None None None Human 5.4 pKi = 5.4 Functional
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 499 9 3 3 6.4 O=C(/C=C/c1ccc(c(c1)Cl)Cl)NCCCCCN1CCC(CC1)c1c[nH]c2c1cc(O)cc2 10.1016/s0960-894x(00)00347-4
3009352 196973 0 None None None Human 8.3 pKi = 8.3 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 517 5 0 5 5.3 CC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm0304515
CHEMBL263555 196973 0 None None None Human 8.3 pKi = 8.3 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 517 5 0 5 5.3 CC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm0304515
15664 174775 66 None 2 3 Human 8.3 pEC50 = 8.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
5403 174775 66 None 2 3 Human 8.3 pEC50 = 8.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
CHEMBL2205807 174775 66 None 2 3 Human 8.3 pEC50 = 8.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
DB11932 174775 66 None 2 3 Human 8.3 pEC50 = 8.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
10585 2226 1 None -39 2 Human 7.1 pIC50 = 7.1 Functional
Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.
Guide to Pharmacology 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 31742400
145996522 2226 1 None -39 2 Human 7.1 pIC50 = 7.1 Functional
Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.
Guide to Pharmacology 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 31742400
CHEMBL4531005 2226 1 None -39 2 Human 7.1 pIC50 = 7.1 Functional
Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.
Guide to Pharmacology 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 31742400
10106 1803 0 None None None Human 8.5 pIC50 = 8.5 Functional
In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.
Guide to Pharmacology 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 30234300
91820689 1803 0 None None None Human 8.5 pIC50 = 8.5 Functional
In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.
Guide to Pharmacology 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 30234300
CHEMBL4249798 1803 0 None None None Human 8.5 pIC50 = 8.5 Functional
In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.
Guide to Pharmacology 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 30234300
10750 5246 0 None -5011 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 5 2 5 6.3 Clc1ccc(cc1)C1(O)CCN(CC1(C)C)CC/C=C\1/c2cc(ccc2OCc2c1cccn2)C(O)(C)C 17715391
18437138 5246 0 None -5011 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 5 2 5 6.3 Clc1ccc(cc1)C1(O)CCN(CC1(C)C)CC/C=C\1/c2cc(ccc2OCc2c1cccn2)C(O)(C)C 17715391
11597 1388 8 None -11 2 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 34141082
23725180 1388 8 None -11 2 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 34141082
CHEMBL4781426 1388 8 None -11 2 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 34141082
769 1710 0 None -14 3 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10477718
P51671 1710 0 None -14 3 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10477718
3002977 4997 43 None None None Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
806 4997 43 None None None Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
CHEMBL1201187 4997 43 None None None Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
CHEMBL584744 4997 43 None None None Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
DB04835 4997 43 None None None Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
486830 8678 0 None -6 5 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 1308 22 19 19 -5.9 NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC1=O)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)C(C)C)C(=O)O)[C@H](O)C 9287217
768 8678 0 None -6 5 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 1308 22 19 19 -5.9 NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC1=O)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)C(C)C)C(=O)O)[C@H](O)C 9287217
68764898 1384 3 None -3 2 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 25893046
9430 1384 3 None -3 2 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 25893046
CHEMBL3577945 1384 3 None -3 2 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 25893046
3500 3139 14 None 245 2 Human 8.7 pIC50 = 8.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 11454872
491774 3139 14 None 245 2 Human 8.7 pIC50 = 8.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 11454872
CHEMBL1196395 3139 14 None 245 2 Human 8.7 pIC50 = 8.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 11454872
5275766 8155 37 None None None Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 16640339
800 8155 37 None None None Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 16640339
CHEMBL207004 8155 37 None None None Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 16640339
11285792 1815 36 None -3 6 Human 8.6 pIC50 None 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 16251299
801 1815 36 None -3 6 Human 8.6 pIC50 None 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 16251299
CHEMBL2110727 1815 36 None -3 6 Human 8.6 pIC50 None 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 16251299
DB11758 1815 36 None -3 6 Human 8.6 pIC50 None 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 16251299




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

CHEMBL2372983 485920 0 None None None Human 9.7 pEC50 = 9.7 Binding
Effective concentration for antagonistic activity by inhibition of T-tropic strain of HIV-1 through its specific binding to a chemokine receptorEffective concentration for antagonistic activity by inhibition of T-tropic strain of HIV-1 through its specific binding to a chemokine receptor
ChEMBL 2022 46 30 27 -7.0 NCCCC[C@@H]1NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N)c2ccc3ccccc3c2)CSSC[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]2CCCN2C1=O 10.1016/s0960-894x(00)00664-8
1635 193594 43 None None None Human 9.0 pEC50 = 9 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1039/C6MD00311G
3002977 193594 43 None None None Human 9.0 pEC50 = 9 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1039/C6MD00311G
CHEMBL256907 193594 43 None None None Human 9.0 pEC50 = 9 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1039/C6MD00311G
129908110 311882 0 None None None Human 5.0 pEC50 = 5.0 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 485 9 1 6 5.3 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc(C)cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4061273 311882 0 None None None Human 5.0 pEC50 = 5.0 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 485 9 1 6 5.3 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc(C)cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908195 314654 0 None None None Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 493 11 1 7 4.9 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)Cc3cccs3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4094196 314654 0 None None None Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 493 11 1 7 4.9 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)Cc3cccs3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908301 312615 0 None None None Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 516 10 1 8 4.9 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
132519568 312615 0 None None None Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 516 10 1 8 4.9 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4069939 312615 0 None None None Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 516 10 1 8 4.9 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908428 314809 0 None None None Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 417 8 3 5 4.6 COc1ccc(C(=O)Nc2ccc(CCC(=O)/C=C/c3ccc(O)c(O)c3)cc2)cc1 10.1039/C6MD00311G
CHEMBL4095938 314809 0 None None None Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 417 8 3 5 4.6 COc1ccc(C(=O)Nc2ccc(CCC(=O)/C=C/c3ccc(O)c(O)c3)cc2)cc1 10.1039/C6MD00311G
129908452 311958 0 None None None Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 518 11 1 8 4.8 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4062349 311958 0 None None None Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 518 11 1 8 4.8 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
3002977 4997 43 None None None Human 7.8 pEC50 = 7.8 Binding
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
806 4997 43 None None None Human 7.8 pEC50 = 7.8 Binding
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL1201187 4997 43 None None None Human 7.8 pEC50 = 7.8 Binding
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL584744 4997 43 None None None Human 7.8 pEC50 = 7.8 Binding
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
DB04835 4997 43 None None None Human 7.8 pEC50 = 7.8 Binding
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
129908456 313760 0 None None None Human 4.7 pEC50 = 4.7 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 395 8 3 4 4.8 O=C(CCc1ccc(NC(=O)C2CCCCC2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL4083941 313760 0 None None None Human 4.7 pEC50 = 4.7 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 395 8 3 4 4.8 O=C(CCc1ccc(NC(=O)C2CCCCC2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
129908453 313772 0 None None None Human 4.7 pEC50 = 4.7 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 479 10 1 6 5.2 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)C3CCCCC3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4084066 313772 0 None None None Human 4.7 pEC50 = 4.7 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 479 10 1 6 5.2 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)C3CCCCC3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908111 313564 0 None None None Human 4.7 pEC50 = 4.7 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 501 10 1 7 5.0 COc1ccc(C(=O)Nc2ccc(CCC(=O)/C=C/c3ccc(OC(C)=O)c(OC(C)=O)c3)cc2)cc1 10.1039/C6MD00311G
CHEMBL4081563 313564 0 None None None Human 4.7 pEC50 = 4.7 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 501 10 1 7 5.0 COc1ccc(C(=O)Nc2ccc(CCC(=O)/C=C/c3ccc(OC(C)=O)c(OC(C)=O)c3)cc2)cc1 10.1039/C6MD00311G
129908196 312940 0 None None None Human 4.6 pEC50 = 4.6 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 389 8 3 4 4.5 O=C(CCc1ccc(NC(=O)c2ccccc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL4073567 312940 0 None None None Human 4.6 pEC50 = 4.6 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 389 8 3 4 4.5 O=C(CCc1ccc(NC(=O)c2ccccc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
129908454 313966 0 None None None Human 4.6 pEC50 = 4.6 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 487 10 1 6 5.2 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccc(C)cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4086440 313966 0 None None None Human 4.6 pEC50 = 4.6 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 487 10 1 6 5.2 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccc(C)cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908109 314217 0 None None None Human 4.5 pEC50 = 4.5 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 477 9 1 6 5.3 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)C3CCCCC3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4089429 314217 0 None None None Human 4.5 pEC50 = 4.5 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 477 9 1 6 5.3 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)C3CCCCC3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908455 312185 0 None None None Human 4.5 pEC50 = 4.5 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 503 11 1 7 4.9 COc1ccc(C(=O)Nc2ccc(CCC(=O)CCc3ccc(OC(C)=O)c(OC(C)=O)c3)cc2)cc1 10.1039/C6MD00311G
CHEMBL4064975 312185 0 None None None Human 4.5 pEC50 = 4.5 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 503 11 1 7 4.9 COc1ccc(C(=O)Nc2ccc(CCC(=O)CCc3ccc(OC(C)=O)c(OC(C)=O)c3)cc2)cc1 10.1039/C6MD00311G
129908558 312097 0 None None None Human 4.4 pEC50 = 4.4 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 403 8 3 4 4.8 Cc1ccc(C(=O)Nc2ccc(CCC(=O)CCc3ccc(O)c(O)c3)cc2)cc1 10.1039/C6MD00311G
CHEMBL4063935 312097 0 None None None Human 4.4 pEC50 = 4.4 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 403 8 3 4 4.8 Cc1ccc(C(=O)Nc2ccc(CCC(=O)CCc3ccc(O)c(O)c3)cc2)cc1 10.1039/C6MD00311G
129907953 315344 0 None None None Human 4.4 pEC50 = 4.4 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 434 9 3 6 4.4 O=C(CCc1ccc(NC(=O)c2ccc([N+](=O)[O-])cc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
132519569 315344 0 None None None Human 4.4 pEC50 = 4.4 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 434 9 3 6 4.4 O=C(CCc1ccc(NC(=O)c2ccc([N+](=O)[O-])cc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL4101931 315344 0 None None None Human 4.4 pEC50 = 4.4 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 434 9 3 6 4.4 O=C(CCc1ccc(NC(=O)c2ccc([N+](=O)[O-])cc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
129908281 314444 0 None None None Human 5.3 pEC50 = 5.3 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 473 10 1 6 4.9 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccccc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4091826 314444 0 None None None Human 5.3 pEC50 = 5.3 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 473 10 1 6 4.9 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccccc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908560 312844 0 None None None Human 4.3 pEC50 = 4.3 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 409 9 3 5 4.5 O=C(CCc1ccc(NC(=O)Cc2cccs2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL4072528 312844 0 None None None Human 4.3 pEC50 = 4.3 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 409 9 3 5 4.5 O=C(CCc1ccc(NC(=O)Cc2cccs2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL5074744 478529 0 None None None Human 7.0 pEC50 = 7.0 Binding
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 1211 30 7 15 6.0 CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
483747 215103 1 None None None Human 11.0 pIC50 = 11 Binding
Inhibition of 0.1 nM of MIP-1beta induced migration of recombinant mouse pro-B cell line BA/F3 expressing human CCR5Inhibition of 0.1 nM of MIP-1beta induced migration of recombinant mouse pro-B cell line BA/F3 expressing human CCR5
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL311795 215103 1 None None None Human 11.0 pIC50 = 11 Binding
Inhibition of 0.1 nM of MIP-1beta induced migration of recombinant mouse pro-B cell line BA/F3 expressing human CCR5Inhibition of 0.1 nM of MIP-1beta induced migration of recombinant mouse pro-B cell line BA/F3 expressing human CCR5
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
44590586 350769 0 None None None Human 10.3 pIC50 = 10.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.3 CCN(C(=O)Cc1ccc(Cl)c(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460845 350769 0 None None None Human 10.3 pIC50 = 10.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.3 CCN(C(=O)Cc1ccc(Cl)c(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
10076141 159952 0 None None None Human 10.2 pIC50 = 10.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21106 159952 0 None None None Human 10.2 pIC50 = 10.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
10076141 159952 0 None None None Human 10.2 pIC50 = 10.2 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL21106 159952 0 None None None Human 10.2 pIC50 = 10.2 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL181276 484885 50 None None None Human 10.2 pIC50 = 10.2 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HOS cells co-expressing HIV-1 FITC-gp120 Bal assessed inhibition of CD4 dependent gp120 Bal binding to CCR5 by western blot analysisAntagonist activity at CCR5 (unknown origin) expressed in human HOS cells co-expressing HIV-1 FITC-gp120 Bal assessed inhibition of CD4 dependent gp120 Bal binding to CCR5 by western blot analysis
ChEMBL 856 24 16 16 -8.4 C[C@@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O 10.1016/j.ejmech.2020.112819
DB16290 484885 50 None None None Human 10.2 pIC50 = 10.2 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HOS cells co-expressing HIV-1 FITC-gp120 Bal assessed inhibition of CD4 dependent gp120 Bal binding to CCR5 by western blot analysisAntagonist activity at CCR5 (unknown origin) expressed in human HOS cells co-expressing HIV-1 FITC-gp120 Bal assessed inhibition of CD4 dependent gp120 Bal binding to CCR5 by western blot analysis
ChEMBL 856 24 16 16 -8.4 C[C@@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O 10.1016/j.ejmech.2020.112819
10076141 159952 0 None None None Human 10.2 pIC50 = 10.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21106 159952 0 None None None Human 10.2 pIC50 = 10.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44590681 349191 0 None None None Human 10.2 pIC50 = 10.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 553 11 1 5 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL457043 349191 0 None None None Human 10.2 pIC50 = 10.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 553 11 1 5 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44273531 156700 0 None None None Human 10.0 pIC50 = 10 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 1 4 6.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20345 156700 0 None None None Human 10.0 pIC50 = 10 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 1 4 6.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
501062 159356 0 None None None Human 10.0 pIC50 = 10 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20896 159356 0 None None None Human 10.0 pIC50 = 10 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
501062 159356 0 None None None Human 10.0 pIC50 = 10 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL20896 159356 0 None None None Human 10.0 pIC50 = 10 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44273531 156700 0 None None None Human 10.0 pIC50 = 10 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 11 1 4 6.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL20345 156700 0 None None None Human 10.0 pIC50 = 10 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 11 1 4 6.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44332684 216821 0 None None None Human 10.0 pIC50 = 10 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 474 11 1 3 5.7 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL316475 216821 0 None None None Human 10.0 pIC50 = 10 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 474 11 1 3 5.7 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501060 218188 0 None None None Human 10.0 pIC50 = 10 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 474 10 1 3 5.7 O=C(O)[C@@H](C1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL320386 218188 0 None None None Human 10.0 pIC50 = 10 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 474 10 1 3 5.7 O=C(O)[C@@H](C1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501055 18957 0 None None None Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 502 10 1 3 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL102826 18957 0 None None None Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 502 10 1 3 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501062 159356 0 None None None Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL20896 159356 0 None None None Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44332684 216821 0 None None None Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 474 11 1 3 5.7 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL316475 216821 0 None None None Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 474 11 1 3 5.7 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501060 218188 0 None None None Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 474 10 1 3 5.7 O=C(O)[C@@H](C1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL320386 218188 0 None None None Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 474 10 1 3 5.7 O=C(O)[C@@H](C1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
490018 221117 0 None None None Human 10.0 pIC50 = 10 Binding
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 568 11 0 6 6.1 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1021/acs.jmedchem.6b01309
CHEMBL328445 221117 0 None None None Human 10.0 pIC50 = 10 Binding
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 568 11 0 6 6.1 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1021/acs.jmedchem.6b01309
490018 221117 0 None None None Human 10.0 pIC50 = 10 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 568 11 0 6 6.1 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL328445 221117 0 None None None Human 10.0 pIC50 = 10 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 568 11 0 6 6.1 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
3002976 474181 0 None None None Human 10.0 pIC50 = 10 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 634 14 0 7 5.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@](C)(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL93139 474181 0 None None None Human 10.0 pIC50 = 10 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 634 14 0 7 5.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@](C)(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44373756 103855 0 None None None Human 9.9 pIC50 = 9.9 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN3OC4(CCCCC4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL157491 103855 0 None None None Human 9.9 pIC50 = 9.9 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN3OC4(CCCCC4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
11988311 353231 0 None None None Human 9.9 pIC50 = 9.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 451 8 1 5 5.2 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL473558 353231 0 None None None Human 9.9 pIC50 = 9.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 451 8 1 5 5.2 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
44590750 350853 0 None None None Human 9.8 pIC50 = 9.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 490 10 2 3 5.1 CCN(C(=O)NCc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL461687 350853 0 None None None Human 9.8 pIC50 = 9.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 490 10 2 3 5.1 CCN(C(=O)NCc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
71451877 163995 0 None None None Human 9.8 pIC50 = 9.8 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 638 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCC(S(C)(=O)=O)CC2)CC1 10.1021/jm300682j
CHEMBL2178577 163995 0 None None None Human 9.8 pIC50 = 9.8 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 638 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCC(S(C)(=O)=O)CC2)CC1 10.1021/jm300682j
44274043 158206 0 None None None Human 9.7 pIC50 = 9.7 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 1 3 6.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20622 158206 0 None None None Human 9.7 pIC50 = 9.7 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 1 3 6.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
44273830 161086 0 None None None Human 9.7 pIC50 = 9.7 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 574 11 1 3 7.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(C(F)(F)F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL21147 161086 0 None None None Human 9.7 pIC50 = 9.7 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 574 11 1 3 7.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(C(F)(F)F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
1635 193594 43 None None None Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
1635 193594 43 None None None Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.009
3002977 193594 43 None None None Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
3002977 193594 43 None None None Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.009
CHEMBL256907 193594 43 None None None Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
CHEMBL256907 193594 43 None None None Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.009
10414981 217758 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL319593 217758 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
44332341 219217 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 556 10 1 7 5.3 Cn1nnnc1-c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
CHEMBL322422 219217 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 556 10 1 7 5.3 Cn1nnnc1-c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
44274043 158206 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 11 1 3 6.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL20622 158206 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 11 1 3 6.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44273830 161086 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 11 1 3 7.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(C(F)(F)F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21147 161086 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 11 1 3 7.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(C(F)(F)F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
10414981 217758 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL319593 217758 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
501063 475246 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 10 1 3 6.1 O=C(O)[C@@H](C1CCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL99909 475246 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 10 1 3 6.1 O=C(O)[C@@H](C1CCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
10414981 217758 0 None None None Human 9.7 pIC50 = 9.7 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00606-6
CHEMBL319593 217758 0 None None None Human 9.7 pIC50 = 9.7 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00606-6
501063 475246 0 None None None Human 9.7 pIC50 = 9.7 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 488 10 1 3 6.1 O=C(O)[C@@H](C1CCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL99909 475246 0 None None None Human 9.7 pIC50 = 9.7 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 488 10 1 3 6.1 O=C(O)[C@@H](C1CCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501055 18957 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 502 10 1 3 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL102826 18957 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 502 10 1 3 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516310 122386 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 642 12 1 6 7.1 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL171958 122386 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 642 12 1 6 7.1 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516257 122759 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5ccccc5c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL173400 122759 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5ccccc5c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516288 123165 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 9 1 5 7.2 CCn1nc(Cc2cccc3ccccc23)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174927 123165 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 9 1 5 7.2 CCn1nc(Cc2cccc3ccccc23)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516256 256583 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc5ccccc45)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366770 256583 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc5ccccc45)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516289 259428 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 9 1 5 7.2 CCn1nc(Cc2ccc3ccccc3c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369235 259428 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 9 1 5 7.2 CCn1nc(Cc2ccc3ccccc3c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
490023 221995 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 574 10 0 6 5.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL329893 221995 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 574 10 0 6 5.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490019 332726 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 582 10 0 6 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL431852 332726 0 None None None Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 582 10 0 6 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
9916998 161447 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 614 11 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL212731 161447 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 614 11 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
3010274 365940 0 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 543 10 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511493 365940 0 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 543 10 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010273 366013 0 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 529 10 1 5 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL520091 366013 0 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 529 10 1 5 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44342962 220730 0 None None None Human 9.6 pIC50 = 9.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 529 10 1 5 5.9 O=C(O)C(CC1CC1)N1CC(c2ccccc2)[C@@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL326487 220730 0 None None None Human 9.6 pIC50 = 9.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 529 10 1 5 5.9 O=C(O)C(CC1CC1)N1CC(c2ccccc2)[C@@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)C1 10.1016/j.bmcl.2004.04.078
44342961 233542 0 None None None Human 9.6 pIC50 = 9.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 543 10 1 5 6.3 O=C(O)C(CC1CCC1)N1CC(c2ccccc2)[C@@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL333619 233542 0 None None None Human 9.6 pIC50 = 9.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 543 10 1 5 6.3 O=C(O)C(CC1CCC1)N1CC(c2ccccc2)[C@@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)C1 10.1016/j.bmcl.2004.04.078
3010274 365940 0 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 543 10 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511493 365940 0 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 543 10 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010273 366013 0 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 529 10 1 5 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL520091 366013 0 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 529 10 1 5 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
11285792 1815 36 None None None Mouse 9.6 pIC50 = 9.6 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1016/j.ejmech.2018.01.085
801 1815 36 None None None Mouse 9.6 pIC50 = 9.6 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1016/j.ejmech.2018.01.085
CHEMBL2110727 1815 36 None None None Mouse 9.6 pIC50 = 9.6 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1016/j.ejmech.2018.01.085
DB11758 1815 36 None None None Mouse 9.6 pIC50 = 9.6 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1016/j.ejmech.2018.01.085
11614352 1138 1 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
7686 1138 1 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
CHEMBL1951914 1138 1 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
3010264 367135 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480503 367135 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010264 367135 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480503 367135 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010264 367135 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL480503 367135 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
10347790 160014 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21117 160014 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565720 348384 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 11 1 3 7.5 O=C(O)[C@@H](CC1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL455073 348384 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 11 1 3 7.5 O=C(O)[C@@H](CC1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
20672370 159611 0 None None None Human 9.5 pIC50 = 9.5 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 531 11 1 4 6.1 N#Cc1ccc(CCCC2CCN(C[C@H]3CN([C@H](CC4CCC4)C(=O)O)C[C@@H]3c3cccc(F)c3)CC2)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL20988 159611 0 None None None Human 9.5 pIC50 = 9.5 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 531 11 1 4 6.1 N#Cc1ccc(CCCC2CCN(C[C@H]3CN([C@H](CC4CCC4)C(=O)O)C[C@@H]3c3cccc(F)c3)CC2)cc1 10.1016/s0960-894x(02)00829-6
10347790 160014 0 None None None Human 9.5 pIC50 = 9.5 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL21117 160014 0 None None None Human 9.5 pIC50 = 9.5 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
20672362 199639 0 None None None Human 9.5 pIC50 = 9.5 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 556 10 1 3 7.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL282921 199639 0 None None None Human 9.5 pIC50 = 9.5 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 556 10 1 3 7.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
10369469 142593 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 522 8 1 5 5.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(F)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL194497 142593 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 522 8 1 5 5.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(F)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
489315 216986 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 474 9 1 3 6.1 OC1(CCCc2ccccc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL317710 216986 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 474 9 1 3 6.1 OC1(CCCc2ccccc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
10347790 160014 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21117 160014 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565720 348384 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 11 1 3 7.5 O=C(O)[C@@H](CC1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL455073 348384 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 11 1 3 7.5 O=C(O)[C@@H](CC1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
72712598 183448 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 591 5 0 4 6.6 Cc1cc(Cl)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435848 183448 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 591 5 0 4 6.6 Cc1cc(Cl)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
516231 122631 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5ccccc5c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL172894 122631 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5ccccc5c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516245 122638 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 13 1 6 6.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL172916 122638 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 13 1 6 6.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516235 122989 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 12 1 5 7.7 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(-c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL174004 122989 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 12 1 5 7.7 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(-c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516224 124413 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 13 1 6 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL177127 124413 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 13 1 6 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516234 199233 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 5 7.3 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL279992 199233 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 5 7.3 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516216 251272 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 13 1 6 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369059 251272 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 13 1 6 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516233 256614 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 12 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366868 256614 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 12 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516202 258189 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 11 1 5 7.3 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367987 258189 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 11 1 5 7.3 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516314 258577 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 662 11 1 5 8.2 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368329 258577 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 662 11 1 5 8.2 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516262 331187 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 9 1 5 7.0 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL427493 331187 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 9 1 5 7.0 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516232 333205 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 574 11 1 5 6.3 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL435472 333205 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 574 11 1 5 6.3 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL181276 484885 50 None None None Human 9.5 pIC50 = 9.5 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HOS cells co-expressing HIV-1 FITC-gp120 CM235 assessed inhibition of CD4 dependent gp120 CM235 binding to CCR5 by western blot analysisAntagonist activity at CCR5 (unknown origin) expressed in human HOS cells co-expressing HIV-1 FITC-gp120 CM235 assessed inhibition of CD4 dependent gp120 CM235 binding to CCR5 by western blot analysis
ChEMBL 856 24 16 16 -8.4 C[C@@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O 10.1016/j.ejmech.2020.112819
DB16290 484885 50 None None None Human 9.5 pIC50 = 9.5 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HOS cells co-expressing HIV-1 FITC-gp120 CM235 assessed inhibition of CD4 dependent gp120 CM235 binding to CCR5 by western blot analysisAntagonist activity at CCR5 (unknown origin) expressed in human HOS cells co-expressing HIV-1 FITC-gp120 CM235 assessed inhibition of CD4 dependent gp120 CM235 binding to CCR5 by western blot analysis
ChEMBL 856 24 16 16 -8.4 C[C@@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O 10.1016/j.ejmech.2020.112819
16007088 161437 27 None None None Human 9.5 pIC50 = 9.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1021/jm300682j
CHEMBL212689 161437 27 None None None Human 9.5 pIC50 = 9.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1021/jm300682j
DB11804 161437 27 None None None Human 9.5 pIC50 = 9.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1021/jm300682j
16007088 161437 27 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL212689 161437 27 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
DB11804 161437 27 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
16007088 161437 27 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL212689 161437 27 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2011.12.117
DB11804 161437 27 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2011.12.117
3010271 367173 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480693 367173 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44590633 350169 0 None None None Human 9.5 pIC50 = 9.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 509 10 1 3 5.6 CCN(C(=O)Cc1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459384 350169 0 None None None Human 9.5 pIC50 = 9.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 509 10 1 3 5.6 CCN(C(=O)Cc1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
3010271 367173 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480693 367173 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010271 367173 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL480693 367173 0 None None None Human 9.5 pIC50 = 9.5 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
44401488 142322 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 9 1 5 5.6 CCc1ccn2c(C3CCN(C[C@H]4CN([C@H](CC5CCC5)C(=O)O)C[C@@H]4c4cccc(F)c4)CC3)cnc2c1 10.1016/j.bmcl.2005.02.030
CHEMBL193984 142322 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 9 1 5 5.6 CCc1ccn2c(C3CCN(C[C@H]4CN([C@H](CC5CCC5)C(=O)O)C[C@@H]4c4cccc(F)c4)CC3)cnc2c1 10.1016/j.bmcl.2005.02.030
53260398 125599 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 512 5 0 4 6.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
CHEMBL1784385 125599 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 512 5 0 4 6.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
1635 193594 43 None None None Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
3002977 193594 43 None None None Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
CHEMBL256907 193594 43 None None None Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
44565038 370120 0 None None None Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489513 370120 0 None None None Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
3010268 160235 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 10 2 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3c[nH]c(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112559 160235 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 10 2 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3c[nH]c(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
44273996 157227 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL20453 157227 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565673 346739 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 556 10 1 7 5.3 Cn1nnc(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL464132 346739 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 556 10 1 7 5.3 Cn1nnc(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/j.ejmech.2008.01.040
44273996 157227 0 None None None Human 9.4 pIC50 = 9.4 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20453 157227 0 None None None Human 9.4 pIC50 = 9.4 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44273888 199014 0 None None None Human 9.4 pIC50 = 9.4 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 558 11 1 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CC[S+]([O-])c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL278117 199014 0 None None None Human 9.4 pIC50 = 9.4 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 558 11 1 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CC[S+]([O-])c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44357079 238101 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 541 11 1 6 4.8 CCCN(c1ncc(F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL344261 238101 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 541 11 1 6 4.8 CCCN(c1ncc(F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
11947758 915 28 None None None Mouse 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.ejmech.2018.01.085
3001322 915 28 None None None Mouse 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.ejmech.2018.01.085
805 915 28 None None None Mouse 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.ejmech.2018.01.085
CHEMBL1255794 915 28 None None None Mouse 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.ejmech.2018.01.085
CHEMBL1739499 915 28 None None None Mouse 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.ejmech.2018.01.085
DB06497 915 28 None None None Mouse 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.ejmech.2018.01.085
44332489 19094 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 557 10 2 5 4.7 C[n+]1n[nH]c(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/s0960-894x(02)00605-4
CHEMBL103790 19094 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 557 10 2 5 4.7 C[n+]1n[nH]c(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/s0960-894x(02)00605-4
44273996 157227 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL20453 157227 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565673 346739 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 556 10 1 7 5.3 Cn1nnc(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL464132 346739 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 556 10 1 7 5.3 Cn1nnc(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/j.ejmech.2008.01.040
58834969 183457 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 586 8 1 6 5.9 Cc1nc(Sc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435857 183457 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 586 8 1 6 5.9 Cc1nc(Sc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
516292 123047 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 9 1 5 7.3 CCn1nc(Cc2ccc(C(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174214 123047 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 9 1 5 7.3 CCn1nc(Cc2ccc(C(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516201 123230 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 608 12 1 6 6.2 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
CHEMBL175348 123230 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 608 12 1 6 6.2 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
516246 123833 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 13 1 6 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CCC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176459 123833 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 13 1 6 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CCC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516255 124042 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 13 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
CHEMBL176669 124042 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 13 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
516279 196818 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 11 1 6 7.8 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL262402 196818 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 11 1 6 7.8 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516230 256409 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc5ccccc45)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366611 256409 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc5ccccc45)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516274 256616 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 6 6.6 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366873 256616 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 6 6.6 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516221 260434 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 13 1 6 7.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(Oc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369812 260434 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 13 1 6 7.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(Oc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516271 332966 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
CHEMBL433793 332966 0 None None None Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
20664161 160499 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL2113086 160499 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
1635 193594 43 None None None Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
3002977 193594 43 None None None Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
CHEMBL256907 193594 43 None None None Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
57391721 143294 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 617 11 0 6 4.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(C)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951913 143294 0 None None None Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 617 11 0 6 4.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(C)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
3009355 8651 20 None None None Human 9.4 pIC50 = 9.4 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm300682j
807 8651 20 None None None Human 9.4 pIC50 = 9.4 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm300682j
CHEMBL82301 8651 20 None None None Human 9.4 pIC50 = 9.4 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm300682j
DB06652 8651 20 None None None Human 9.4 pIC50 = 9.4 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm300682j
44590634 348840 0 None None None Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.0 CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL456226 348840 0 None None None Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.0 CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44565080 370335 0 None None None Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN([C@H](C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491319 370335 0 None None None Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN([C@H](C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
20672360 158950 0 None None None Human 9.3 pIC50 = 9.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 534 10 1 3 6.4 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20831 158950 0 None None None Human 9.3 pIC50 = 9.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 534 10 1 3 6.4 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
20672386 199004 0 None None None Human 9.3 pIC50 = 9.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 506 11 1 3 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL278085 199004 0 None None None Human 9.3 pIC50 = 9.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 506 11 1 3 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44273888 199014 0 None None None Human 9.3 pIC50 = 9.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 558 11 1 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CC[S+]([O-])c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL278117 199014 0 None None None Human 9.3 pIC50 = 9.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 558 11 1 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CC[S+]([O-])c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44590440 353100 0 None None None Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 6 0 3 5.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)C(=O)C3CC3)CC2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL472464 353100 0 None None None Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 6 0 3 5.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)C(=O)C3CC3)CC2)CC1 10.1016/j.bmcl.2009.01.012
44357078 238159 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 591 11 1 6 5.7 CCCN(c1ncc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL344641 238159 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 591 11 1 6 5.7 CCCN(c1ncc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44401956 271055 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 572 8 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4c(Cl)cc(Cl)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL371177 271055 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 572 8 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4c(Cl)cc(Cl)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
20672386 199004 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 506 11 1 3 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL278085 199004 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 506 11 1 3 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565742 353020 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 548 11 1 3 6.8 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471920 353020 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 548 11 1 3 6.8 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
10163007 195473 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255429 195473 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501046 18620 0 None None None Human 9.3 pIC50 = 9.3 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501050 18620 0 None None None Human 9.3 pIC50 = 9.3 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL100596 18620 0 None None None Human 9.3 pIC50 = 9.3 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL322603 18620 0 None None None Human 9.3 pIC50 = 9.3 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
72714079 183486 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435886 183486 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
516311 122688 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 11 1 6 7.7 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173091 122688 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 11 1 6 7.7 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516312 122778 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 678 12 1 6 8.4 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173479 122778 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 678 12 1 6 8.4 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516192 122805 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL173583 122805 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516282 123172 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 11 1 6 6.6 CCn1nc(Cc2ccc(OC(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174996 123172 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 11 1 6 6.6 CCn1nc(Cc2ccc(OC(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516228 123187 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 615 12 1 7 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(C#N)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL175079 123187 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 615 12 1 7 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(C#N)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516227 123228 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 7 5.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5c(c4)OCO5)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL175341 123228 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 7 5.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5c(c4)OCO5)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516313 123892 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 10 2 6 6.3 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176528 123892 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 10 2 6 6.3 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
44385583 124258 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 578 9 1 5 6.2 CCn1nc(Cc2ccccc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177071 124258 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 578 9 1 5 6.2 CCn1nc(Cc2ccccc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516251 193631 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 13 1 6 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL265723 193631 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 13 1 6 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516259 251250 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 12 1 5 7.7 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(-c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL367416 251250 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 12 1 5 7.7 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(-c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516248 251252 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 14 1 6 7.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL368000 251252 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 14 1 6 7.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516205 256408 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 11 1 5 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366610 256408 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 11 1 5 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
44384782 258104 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 589 12 2 6 6.1 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(NC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL367897 258104 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 589 12 2 6 6.1 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(NC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516198 259706 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 612 12 1 6 6.2 CCn1nc(Cc2ccc(OC(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369398 259706 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 612 12 1 6 6.2 CCn1nc(Cc2ccc(OC(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516237 259783 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 11 1 5 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369478 259783 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 11 1 5 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516249 259989 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 13 1 6 7.8 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(Oc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369593 259989 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 13 1 6 7.8 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(Oc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
3010272 372579 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL513564 372579 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010272 372579 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL513564 372579 0 None None None Human 9.3 pIC50 = 9.3 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
3010272 372579 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL513564 372579 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44564930 353255 0 None None None Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 465 8 1 5 5.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCCCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL473759 353255 0 None None None Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 465 8 1 5 5.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCCCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
57391722 143296 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 637 11 0 6 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951917 143296 0 None None None Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 637 11 0 6 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
44565761 371530 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 11 2 4 6.1 CCc1nc(Cc2ccccc2)[nH]c1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL500631 371530 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 11 2 4 6.1 CCc1nc(Cc2ccccc2)[nH]c1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010275 160234 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 572 11 2 4 6.2 CCc1[nH]c(Cc2ccccc2)nc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
CHEMBL2112558 160234 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 572 11 2 4 6.2 CCc1[nH]c(Cc2ccccc2)nc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
44565761 371530 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 11 2 4 6.1 CCc1nc(Cc2ccccc2)[nH]c1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL500631 371530 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 11 2 4 6.1 CCc1nc(Cc2ccccc2)[nH]c1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44565762 353092 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 10 2 4 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472412 353092 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 10 2 4 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44401965 143548 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 549 9 1 7 4.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc([N+](=O)[O-])cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL195753 143548 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 549 9 1 7 4.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc([N+](=O)[O-])cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
44565762 353092 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 10 2 4 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472412 353092 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 10 2 4 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3008904 444496 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL59511 444496 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
58834906 183453 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 8 1 6 6.2 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435853 183453 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 8 1 6 6.2 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1 10.1021/jm401101p
3010276 160233 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 578 10 2 4 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112557 160233 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 578 10 2 4 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2004.04.078
516337 258089 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 596 12 1 5 7.0 CCCn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL367837 258089 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 596 12 1 5 7.0 CCCn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516333 239003 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.6 CCn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL352981 239003 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.6 CCn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516293 122473 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 10 1 5 7.7 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172296 122473 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 10 1 5 7.7 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516194 122727 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 12 1 6 6.6 CCn1nc(Cc2ccc(OC3CCC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173254 122727 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 12 1 6 6.6 CCn1nc(Cc2ccc(OC3CCC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516280 123828 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 10 1 6 6.9 CCn1nc(Cc2ccc(OC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176426 123828 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 10 1 6 6.9 CCn1nc(Cc2ccc(OC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516223 124138 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 13 1 6 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176933 124138 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 13 1 6 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516199 196854 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 562 10 2 6 5.3 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL262663 196854 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 562 10 2 6 5.3 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516291 196971 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 10 1 5 7.2 CCn1nc(Cc2ccc(C(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL263529 196971 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 10 1 5 7.2 CCn1nc(Cc2ccc(C(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516252 251251 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 13 1 6 6.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL367560 251251 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 13 1 6 6.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516212 257999 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL367700 257999 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516209 258606 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 13 1 7 6.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(S(=O)(=O)c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL368467 258606 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 13 1 7 6.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(S(=O)(=O)c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516290 259811 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 574 9 1 5 6.3 CCn1nc(Cc2ccc(C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369494 259811 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 574 9 1 5 6.3 CCn1nc(Cc2ccc(C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516250 260013 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 12 1 6 6.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369659 260013 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 12 1 6 6.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516253 308810 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 2 6 5.7 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(O)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL408800 308810 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 2 6 5.7 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(O)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516196 330932 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 638 12 1 6 7.4 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL425845 330932 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 638 12 1 6 7.4 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516281 331130 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 11 1 6 7.0 CCn1nc(Cc2ccc(OCC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL427122 331130 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 11 1 6 7.0 CCn1nc(Cc2ccc(OCC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
3010261 375414 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL520755 375414 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010261 375414 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL520755 375414 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010261 375414 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL520755 375414 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
57403932 143293 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 621 11 0 6 3.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951912 143293 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 621 11 0 6 3.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
57396952 143295 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 655 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951915 143295 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 655 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
501056 217097 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318406 217097 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501056 217097 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318406 217097 0 None None None Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3008917 467865 2 None None None Crab-eating macaque 9.2 pIC50 = 9.2 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL62152 467865 2 None None None Crab-eating macaque 9.2 pIC50 = 9.2 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501056 217097 0 None None None Human 9.2 pIC50 = 9.2 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL318406 217097 0 None None None Human 9.2 pIC50 = 9.2 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
58835217 183456 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 9 1 6 5.8 CCc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435856 183456 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 9 1 6 5.8 CCc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
44415755 276054 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 451 9 2 3 4.0 O=C(Cc1ccc(F)cc1)NC1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
CHEMBL377914 276054 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 451 9 2 3 4.0 O=C(Cc1ccc(F)cc1)NC1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
3010279 160228 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 564 10 2 4 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112552 160228 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 564 10 2 4 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2004.04.078
516285 122481 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 9 1 7 5.8 CCn1nc(Cc2ccc3c(c2)OCO3)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172322 122481 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 9 1 7 5.8 CCn1nc(Cc2ccc3c(c2)OCO3)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516229 122739 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 13 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
CHEMBL173308 122739 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 13 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
516308 123235 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 13 1 6 7.4 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL175394 123235 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 13 1 6 7.4 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516275 124192 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 11 1 6 7.0 CCn1nc(Cc2ccc(OC3CCC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177033 124192 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 11 1 6 7.0 CCn1nc(Cc2ccc(OC3CCC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516220 124872 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 14 1 6 7.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL177648 124872 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 14 1 6 7.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516287 238687 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 11 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
CHEMBL349974 238687 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 11 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
516276 258558 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 11 1 6 6.8 CCn1nc(Cc2ccc(OC(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368204 258558 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 11 1 6 6.8 CCn1nc(Cc2ccc(OC(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516269 333217 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 10 1 6 6.0 CCn1nc(Cc2cccc(OC)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL435554 333217 0 None None None Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 10 1 6 6.0 CCn1nc(Cc2cccc(OC)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
3010267 160236 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 512 10 2 4 5.1 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3c[nH]c(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112560 160236 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 512 10 2 4 5.1 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3c[nH]c(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
44461741 332789 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 619 14 1 6 5.3 C=CCN(C(=O)NCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL432360 332789 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 619 14 1 6 5.3 C=CCN(C(=O)NCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
76330829 176548 0 None None None Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 605 13 1 6 5.6 C=CCN(C(=O)Nc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282506 176548 0 None None None Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 605 13 1 6 5.6 C=CCN(C(=O)Nc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
16073660 155178 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL211866 155178 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
44565853 352934 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 571 11 1 5 6.8 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL471251 352934 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 571 11 1 5 6.8 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010278 160229 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 589 11 1 5 7.0 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
CHEMBL2112553 160229 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 589 11 1 5 7.0 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
44565853 352934 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 571 11 1 5 6.8 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL471251 352934 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 571 11 1 5 6.8 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
76327166 176551 0 None None None Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282509 176551 0 None None None Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
501051 18835 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL101961 18835 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
516260 122619 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL172854 122619 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
44273960 199444 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL281607 199444 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565719 353018 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 530 11 1 4 6.4 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471909 353018 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 530 11 1 4 6.4 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
516342 372383 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511634 372383 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44274108 199377 0 None None None Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 516 10 1 4 6.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL281176 199377 0 None None None Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 516 10 1 4 6.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44273960 199444 0 None None None Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL281607 199444 0 None None None Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
490022 221090 0 None None None Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 10 0 6 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL328260 221090 0 None None None Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 10 0 6 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
44357072 198758 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 553 12 1 7 4.7 CCCN(c1nccc(OC)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL275998 198758 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 553 12 1 7 4.7 CCCN(c1nccc(OC)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
490020 221099 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL328297 221099 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
20664149 142092 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 580 9 1 5 6.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(-c5ccccc5)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL193822 142092 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 580 9 1 5 6.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(-c5ccccc5)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
516260 122619 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL172854 122619 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516236 327745 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 11 1 5 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
CHEMBL435538 327745 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 11 1 5 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
490020 221099 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL328297 221099 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
501051 18835 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL101961 18835 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
516260 122619 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL172854 122619 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
44273960 199444 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL281607 199444 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565719 353018 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 530 11 1 4 6.4 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471909 353018 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 530 11 1 4 6.4 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
516342 372383 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511634 372383 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44447734 195513 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 523 5 0 5 6.1 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255644 195513 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 523 5 0 5 6.1 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2008.01.108
10413034 195554 0 None None None Crab-eating macaque 9.1 pIC50 = 9.1 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255856 195554 0 None None None Crab-eating macaque 9.1 pIC50 = 9.1 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501051 18835 0 None None None Human 9.1 pIC50 = 9.1 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL101961 18835 0 None None None Human 9.1 pIC50 = 9.1 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
486605 214082 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL310106 214082 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
486605 214082 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of human CCR5 in PBMC cellInhibition of human CCR5 in PBMC cell
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1021/acs.jmedchem.6b01309
CHEMBL310106 214082 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of human CCR5 in PBMC cellInhibition of human CCR5 in PBMC cell
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1021/acs.jmedchem.6b01309
44384927 333233 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3oncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL435709 333233 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3oncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516197 122399 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 11 1 6 6.5 CCn1nc(Cc2ccc(OC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172013 122399 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 11 1 6 6.5 CCn1nc(Cc2ccc(OC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516309 122483 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 14 1 6 7.7 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL172327 122483 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 14 1 6 7.7 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516260 122619 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172854 122619 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516273 123239 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 13 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL175424 123239 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 13 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516218 124025 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 13 1 6 6.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176624 124025 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 13 1 6 6.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516244 124480 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 15 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL177168 124480 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 15 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516195 124519 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 11 1 6 6.8 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177204 124519 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 11 1 6 6.8 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516242 196993 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
CHEMBL263787 196993 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
516304 239139 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 726 12 1 7 7.4 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL354413 239139 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 726 12 1 7 7.4 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516272 239454 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 12 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL355809 239454 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 12 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516258 251233 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 5 7.3 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366742 251233 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 5 7.3 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516200 255995 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 601 11 1 7 5.5 CCn1nc(Cc2ccc(OC)c(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366492 255995 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 601 11 1 7 5.5 CCn1nc(Cc2ccc(OC)c(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516191 259498 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL369278 259498 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
44325665 220905 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 632 10 0 6 6.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL327241 220905 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 632 10 0 6 6.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490022 221090 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 588 10 0 6 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL328260 221090 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 588 10 0 6 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490020 221099 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL328297 221099 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44401760 333254 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 572 8 1 5 6.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(C(F)(F)F)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL435886 333254 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 572 8 1 5 6.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(C(F)(F)F)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
44565037 384935 0 None None None Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL522259 384935 0 None None None Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
20672384 141833 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 542 10 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL193440 141833 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 542 10 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44565852 337172 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 555 11 1 5 6.4 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL449758 337172 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 555 11 1 5 6.4 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44401751 142324 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 538 8 1 5 5.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(Cl)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL193988 142324 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 538 8 1 5 5.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(Cl)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
44565852 337172 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 555 11 1 5 6.4 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL449758 337172 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 555 11 1 5 6.4 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010277 160232 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 573 11 1 5 6.5 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
CHEMBL2112556 160232 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 573 11 1 5 6.5 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
516366 333236 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL435727 333236 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565718 352860 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 562 11 1 5 5.1 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470510 352860 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 562 11 1 5 5.1 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44274106 158177 0 None None None Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 548 10 1 5 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20602 158177 0 None None None Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 548 10 1 5 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
516203 123105 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 11 1 5 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
CHEMBL174457 123105 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 11 1 5 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
516366 333236 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
CHEMBL435727 333236 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
44205000 334753 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 594 8 0 6 7.0 COC(=O)C(c1ccc(F)cc1)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL444497 334753 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 594 8 0 6 7.0 COC(=O)C(c1ccc(F)cc1)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
516366 333236 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL435727 333236 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565718 352860 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 562 11 1 5 5.1 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470510 352860 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 562 11 1 5 5.1 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
10413034 195554 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255856 195554 0 None None None Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
16041411 183384 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 572 8 1 6 5.6 O=C(O)c1ccc(Sc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1 10.1021/jm401101p
CHEMBL2434978 183384 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 572 8 1 6 5.6 O=C(O)c1ccc(Sc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1 10.1021/jm401101p
58835113 183444 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 607 8 1 7 5.6 O=C(O)c1ccc(Sc2ncc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1 10.1021/jm401101p
CHEMBL2435844 183444 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 607 8 1 7 5.6 O=C(O)c1ccc(Sc2ncc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1 10.1021/jm401101p
58834946 183445 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 8 2 7 5.5 Cc1nc(Nc2ccc(C(=O)O)cc2)ncc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435845 183445 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 8 2 7 5.5 Cc1nc(Nc2ccc(C(=O)O)cc2)ncc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1 10.1021/jm401101p
72711741 183459 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435859 183459 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711739 183507 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 551 8 1 4 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435907 183507 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 551 8 1 4 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
59458247 183512 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 571 8 1 5 6.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435912 183512 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 571 8 1 5 6.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
516208 122279 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(C#N)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL171468 122279 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(C#N)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516286 123162 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 615 10 1 7 5.9 CCn1nc(Cc2ccc(OC)c(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174904 123162 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 615 10 1 7 5.9 CCn1nc(Cc2ccc(OC)c(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516270 123985 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 6 6.4 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL176604 123985 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 6 6.4 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516213 251240 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
CHEMBL367102 251240 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
516300 256404 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 10 1 5 7.2 CCn1nc(Cc2ccc(Cl)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366600 256404 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 10 1 5 7.2 CCn1nc(Cc2ccc(Cl)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516298 258578 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 10 1 5 6.8 CCn1nc(Cc2cc(F)cc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368332 258578 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 10 1 5 6.8 CCn1nc(Cc2cc(F)cc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516236 327745 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 560 11 1 5 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL435538 327745 0 None None None Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 560 11 1 5 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
3009355 8651 20 None None None Mouse 9.0 pIC50 = 9.0 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/j.ejmech.2018.01.085
807 8651 20 None None None Mouse 9.0 pIC50 = 9.0 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/j.ejmech.2018.01.085
CHEMBL82301 8651 20 None None None Mouse 9.0 pIC50 = 9.0 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/j.ejmech.2018.01.085
DB06652 8651 20 None None None Mouse 9.0 pIC50 = 9.0 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/j.ejmech.2018.01.085
44590635 350856 0 None None None Human 9.0 pIC50 = 9.0 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 493 10 1 3 5.1 CCN(C(=O)Cc1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL461690 350856 0 None None None Human 9.0 pIC50 = 9.0 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 493 10 1 3 5.1 CCN(C(=O)Cc1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
76335673 214498 0 None None None Human 9.0 pIC50 = 9.0 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 652 18 1 6 8.8 Cc1nnc(CCCCCCCCCCN=[N+]=[N-])n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
CHEMBL3109175 214498 0 None None None Human 9.0 pIC50 = 9.0 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 652 18 1 6 8.8 Cc1nnc(CCCCCCCCCCN=[N+]=[N-])n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
489315 216986 0 None None None Human 9.0 pIC50 = 9 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 474 9 1 3 6.1 OC1(CCCc2ccccc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00652-7
CHEMBL317710 216986 0 None None None Human 9.0 pIC50 = 9 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 474 9 1 3 6.1 OC1(CCCc2ccccc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00652-7
23650547 352980 0 None None None Human 9.0 pIC50 = 9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL471623 352980 0 None None None Human 9.0 pIC50 = 9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
44590394 367211 0 None None None Human 9.0 pIC50 = 9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 485 6 0 3 5.0 Cc1cccc(C)c1C(=O)N1[C@H]2CC[C@@H]1C[C@@H](N1CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C1)C2 10.1016/j.bmcl.2009.01.012
CHEMBL481068 367211 0 None None None Human 9.0 pIC50 = 9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 485 6 0 3 5.0 Cc1cccc(C)c1C(=O)N1[C@H]2CC[C@@H]1C[C@@H](N1CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C1)C2 10.1016/j.bmcl.2009.01.012
59959034 160501 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cnccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL2113088 160501 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cnccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
44332814 328641 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 556 11 2 6 5.2 OC1(CCCc2ccc(Cc3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL420465 328641 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 556 11 2 6 5.2 OC1(CCCc2ccc(Cc3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
16073662 276599 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 630 11 0 6 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL379082 276599 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 630 11 0 6 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2006.03.089
25132603 203335 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 546 5 0 4 7.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084499 203335 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 546 5 0 4 7.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm800598a
501045 18682 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501049 18682 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL100958 18682 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL99788 18682 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44565854 367193 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 559 11 1 5 6.7 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC(C)C)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL480890 367193 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 559 11 1 5 6.7 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC(C)C)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
10280445 195514 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 539 5 0 5 5.3 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)c[n+]([O-])cc2Cl)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255645 195514 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 539 5 0 5 5.3 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)c[n+]([O-])cc2Cl)CC1 10.1016/j.bmcl.2008.01.108
3008928 466307 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL61424 466307 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501045 18682 0 None None None Human 9.0 pIC50 = 9 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501049 18682 0 None None None Human 9.0 pIC50 = 9 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL100958 18682 0 None None None Human 9.0 pIC50 = 9 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL99788 18682 0 None None None Human 9.0 pIC50 = 9 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501043 19025 0 None None None Human 9.0 pIC50 = 9 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 504 10 2 4 5.5 OC[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL103343 19025 0 None None None Human 9.0 pIC50 = 9 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 504 10 2 4 5.5 OC[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501047 19098 0 None None None Human 9.0 pIC50 = 9 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 504 10 2 4 5.5 OC[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL103813 19098 0 None None None Human 9.0 pIC50 = 9 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 504 10 2 4 5.5 OC[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
72711958 183464 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435864 183464 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
59458245 183466 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435866 183466 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
3010280 160231 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 563 10 1 5 6.4 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
CHEMBL2112555 160231 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 563 10 1 5 6.4 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
516336 258525 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 568 10 1 5 6.1 Cn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL368183 258525 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 568 10 1 5 6.1 Cn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
3002976 474181 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 634 14 0 7 5.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@](C)(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
CHEMBL93139 474181 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 634 14 0 7 5.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@](C)(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
516307 122415 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 12 1 6 7.0 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL172079 122415 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 12 1 6 7.0 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
44384584 122611 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 9 1 6 5.9 CCn1nc(Cc2cccc(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172820 122611 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 9 1 6 5.9 CCn1nc(Cc2cccc(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516193 123813 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 12 1 6 6.2 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176337 123813 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 12 1 6 6.2 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516296 124520 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 10 1 5 6.7 CCn1nc(Cc2cccc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177205 124520 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 10 1 5 6.7 CCn1nc(Cc2cccc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516215 251263 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 15 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL368309 251263 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 15 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516190 257591 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 12 1 6 6.0 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL367383 257591 0 None None None Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 12 1 6 6.0 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
122668204 404385 0 None None None Human 9.0 pIC50 = 9.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 519 8 1 6 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 nan
CHEMBL5810758 404385 0 None None None Human 9.0 pIC50 = 9.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 519 8 1 6 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 nan
44273816 199274 0 None None None Human 9.0 pIC50 = 9.0 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 588 10 1 5 5.6 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL280344 199274 0 None None None Human 9.0 pIC50 = 9.0 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 588 10 1 5 5.6 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44357379 61799 0 None None None Human 9.0 pIC50 = 9.0 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 535 11 1 6 4.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ncccn3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00988-5
CHEMBL137327 61799 0 None None None Human 9.0 pIC50 = 9.0 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 535 11 1 6 4.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ncccn3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00988-5
16073670 278305 0 None None None Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 648 11 0 6 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(Cl)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL382435 278305 0 None None None Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 648 11 0 6 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(Cl)c2)CC1 10.1016/j.bmcl.2006.03.089
57400374 143288 0 None None None Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 603 11 0 6 3.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951906 143288 0 None None None Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 603 11 0 6 3.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
16728787 27107 0 None None None Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188566 27107 0 None None None Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
10163007 195473 0 None None None Crab-eating macaque 9.0 pIC50 = 9.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255429 195473 0 None None None Crab-eating macaque 9.0 pIC50 = 9.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008927 424050 0 None None None Crab-eating macaque 9.0 pIC50 = 9.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL58387 424050 0 None None None Crab-eating macaque 9.0 pIC50 = 9.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
58835114 183454 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 8 1 6 5.8 Cc1cccc([C@@H]2CN(C3CCOCC3)C(=O)N2C2CCN(Cc3ccc(Oc4ccc(C(=O)O)cc4)nc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435854 183454 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 8 1 6 5.8 Cc1cccc([C@@H]2CN(C3CCOCC3)C(=O)N2C2CCN(Cc3ccc(Oc4ccc(C(=O)O)cc4)nc3C)CC2)c1 10.1021/jm401101p
58834953 183458 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 569 8 1 6 4.9 Cc1nc(Oc2ccc(C(N)=O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435858 183458 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 569 8 1 6 4.9 Cc1nc(Oc2ccc(C(N)=O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711740 183509 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435909 183509 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
3010260 160230 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 543 8 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(-c4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112554 160230 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 543 8 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(-c4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516175 122152 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2ccc(F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL170829 122152 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2ccc(F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516283 122672 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 9 2 6 5.7 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173019 122672 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 9 2 6 5.7 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516261 122783 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 566 9 1 5 6.6 CCn1nc(CC2CCCCC2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173492 122783 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 566 9 1 5 6.6 CCn1nc(CC2CCCCC2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516178 123820 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2ccc(F)c(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176391 123820 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2ccc(F)c(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516295 257671 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 10 1 5 6.7 CCn1nc(Cc2ccc(F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367489 257671 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 10 1 5 6.7 CCn1nc(Cc2ccc(F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516267 258115 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 11 1 7 6.9 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367916 258115 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 11 1 7 6.9 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516278 258190 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 12 1 6 7.6 CCn1nc(Cc2ccc(OCc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367988 258190 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 12 1 6 7.6 CCn1nc(Cc2ccc(OCc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516240 259320 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 13 1 7 6.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(S(=O)(=O)c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369040 259320 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 13 1 7 6.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(S(=O)(=O)c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516214 259487 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL369277 259487 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516306 260007 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 6 6.6 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369632 260007 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 6 6.6 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516222 327786 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 12 1 6 6.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL440554 327786 0 None None None Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 12 1 6 6.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516361 122689 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL173095 122689 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
516362 123226 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL175327 123226 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
516172 239041 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL353331 239041 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516343 352968 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)on3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471542 352968 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)on3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44357063 237921 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1ccncn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL342842 237921 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1ccncn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44356952 238044 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 591 11 1 6 5.7 CCCN(c1nccc(C(F)(F)F)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343745 238044 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 591 11 1 6 5.7 CCCN(c1nccc(C(F)(F)F)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
516361 122689 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL173095 122689 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516362 123226 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL175327 123226 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516172 239041 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL353331 239041 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
11525100 174525 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 444 7 1 4 5.2 Cc1nc2ccccc2n1C1(C)CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203619 174525 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 444 7 1 4 5.2 Cc1nc2ccccc2n1C1(C)CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1111/j.1747-0285.2006.00376.x
516361 122689 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL173095 122689 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
516362 123226 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL175327 123226 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
516172 239041 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL353331 239041 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516343 352968 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)on3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471542 352968 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)on3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
72711742 183460 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435860 183460 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72714078 183485 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435885 183485 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
52946954 42237 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 549 7 0 6 3.4 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1271208 42237 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 549 7 0 6 3.4 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
3013684 158682 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 547 8 0 3 6.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207182 158682 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 547 8 0 3 6.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
44384875 122684 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL173064 122684 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516335 258026 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 10 2 4 6.1 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3CCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL367787 258026 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 10 2 4 6.1 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3CCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516204 121974 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 566 11 1 5 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(CC4CCCCC4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL170118 121974 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 566 11 1 5 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(CC4CCCCC4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516284 122607 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 11 1 7 6.0 CCn1nc(Cc2ccc(OC)c(OC)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172806 122607 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 11 1 7 6.0 CCn1nc(Cc2ccc(OC)c(OC)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516243 257997 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL367697 257997 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516211 333184 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 12 1 6 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL435347 333184 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 12 1 6 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516172 239041 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellInhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cell
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL353331 239041 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellInhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cell
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516172 239041 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsInhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL353331 239041 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsInhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.006
118219352 443655 0 None None None Human 8.9 pIC50 = 8.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 501 9 1 10 3.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cn1ncnn1)c1ccc(F)s1 nan
CHEMBL5942570 443655 0 None None None Human 8.9 pIC50 = 8.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 501 9 1 10 3.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cn1ncnn1)c1ccc(F)s1 nan
145967247 327551 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-labeled MIP-1alpha from human CCR5 expressed in CHO cell membranes after 240 mins by TopCount scintillation counting methodDisplacement of [125I]-labeled MIP-1alpha from human CCR5 expressed in CHO cell membranes after 240 mins by TopCount scintillation counting method
ChEMBL 574 11 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@@H]2C[C@@H](N(C)[C@H](C(=O)O)C(C)C)C[C@H]2c2cccc(F)c2)CC1 10.1021/acs.jmedchem.8b00180
CHEMBL4213499 327551 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-labeled MIP-1alpha from human CCR5 expressed in CHO cell membranes after 240 mins by TopCount scintillation counting methodDisplacement of [125I]-labeled MIP-1alpha from human CCR5 expressed in CHO cell membranes after 240 mins by TopCount scintillation counting method
ChEMBL 574 11 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@@H]2C[C@@H](N(C)[C@H](C(=O)O)C(C)C)C[C@H]2c2cccc(F)c2)CC1 10.1021/acs.jmedchem.8b00180
1635 193594 43 None None None Human 8.9 pIC50 = 8.9 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
3002977 193594 43 None None None Human 8.9 pIC50 = 8.9 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
CHEMBL256907 193594 43 None None None Human 8.9 pIC50 = 8.9 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
44565038 370120 0 None None None Human 8.9 pIC50 = 8.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489513 370120 0 None None None Human 8.9 pIC50 = 8.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
3010262 367212 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL481080 367212 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44447732 311099 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 504 5 0 4 6.5 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL401929 311099 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 504 5 0 4 6.5 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1016/j.bmcl.2008.01.108
58835000 183443 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 583 8 1 6 5.2 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)c(C)n2)cc1 10.1021/jm401101p
CHEMBL2435843 183443 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 583 8 1 6 5.2 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)c(C)n2)cc1 10.1021/jm401101p
58835027 183451 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 590 8 1 6 5.8 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1 10.1021/jm401101p
CHEMBL2435851 183451 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 590 8 1 6 5.8 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1 10.1021/jm401101p
3010262 367212 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL481080 367212 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516207 122779 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C#N)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL173482 122779 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C#N)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516217 123960 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 13 1 6 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CCC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176571 123960 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 13 1 6 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CCC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516176 124126 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2cccc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176850 124126 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2cccc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516219 124143 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 12 1 6 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176980 124143 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 12 1 6 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516187 124444 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 686 12 1 7 6.5 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177156 124444 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 686 12 1 7 6.5 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516189 238943 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 1 6 5.6 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL352511 238943 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 1 6 5.6 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516239 251247 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C#N)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL367246 251247 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C#N)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516264 257383 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 9 1 6 5.9 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367169 257383 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 9 1 6 5.9 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516181 260437 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 580 10 1 5 6.3 CCn1nc(Cc2ccc(Cl)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369822 260437 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 580 10 1 5 6.3 CCn1nc(Cc2ccc(Cl)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
126585500 426427 0 None None None Human 8.9 pIC50 = 8.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 513 10 3 10 2.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cc1nnn[nH]1)c1ccc(CO)s1 nan
CHEMBL5864641 426427 0 None None None Human 8.9 pIC50 = 8.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 513 10 3 10 2.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cc1nnn[nH]1)c1ccc(CO)s1 nan
118219335 463533 0 None None None Human 8.9 pIC50 = 8.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 541 9 1 8 5.7 CC(=O)Oc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCCC2)s1 nan
CHEMBL6050713 463533 0 None None None Human 8.9 pIC50 = 8.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 541 9 1 8 5.7 CC(=O)Oc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCCC2)s1 nan
183790 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2020.112311
783 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2020.112311
CHEMBL1178786 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2020.112311
49768863 212852 0 None None None Human 8.9 pIC50 = 8.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nc(C(C)C)n([C@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)n1 10.1016/j.bmcl.2009.01.008
CHEMBL3085107 212852 0 None None None Human 8.9 pIC50 = 8.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nc(C(C)C)n([C@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)n1 10.1016/j.bmcl.2009.01.008
183790 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm300682j
783 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm300682j
CHEMBL1178786 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm300682j
183790 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
783 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
CHEMBL1178786 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
3008913 202080 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL301454 202080 0 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
183790 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysis
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
783 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysis
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
CHEMBL1178786 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysis
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
1635 193594 43 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmcl.2010.01.080
3002977 193594 43 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmcl.2010.01.080
CHEMBL256907 193594 43 None None None Human 8.9 pIC50 = 8.9 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmcl.2010.01.080
183790 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCL5 binding to CCR5 expressed in CHO cellsInhibition of CCL5 binding to CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
783 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCL5 binding to CCR5 expressed in CHO cellsInhibition of CCL5 binding to CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
CHEMBL1178786 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCL5 binding to CCR5 expressed in CHO cellsInhibition of CCL5 binding to CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
183790 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2008.12.050
783 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2008.12.050
CHEMBL1178786 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2008.12.050
58835024 183452 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 570 8 1 6 5.5 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435852 183452 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 570 8 1 6 5.5 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
516225 258588 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 2 6 5.7 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(O)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL368375 258588 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 2 6 5.7 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(O)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
183790 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
783 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
CHEMBL1178786 8163 6 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
474160 26299 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 497 6 1 3 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1183361 26299 0 None None None Human 8.9 pIC50 = 8.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 497 6 1 3 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
118219269 410240 0 None None None Human 8.9 pIC50 = 8.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 487 8 1 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCC1)c1ccc(F)s1 nan
CHEMBL5794205 410240 0 None None None Human 8.9 pIC50 = 8.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 487 8 1 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCC1)c1ccc(F)s1 nan
44273872 199773 0 None None None Human 8.8 pIC50 = 8.8 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 568 12 1 5 5.7 COC(=O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL283788 199773 0 None None None Human 8.8 pIC50 = 8.8 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 568 12 1 5 5.7 COC(=O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
44356944 237993 1 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 509 10 1 6 4.3 CCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343366 237993 1 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 509 10 1 6 4.3 CCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
516173 123065 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL174304 123065 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516173 123065 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL174304 123065 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
44273872 199773 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 12 1 5 5.7 COC(=O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL283788 199773 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 12 1 5 5.7 COC(=O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/j.ejmech.2008.01.040
3010265 367237 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL481274 367237 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
58835155 183455 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 8 1 6 5.6 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(F)c2)CC1 10.1021/jm401101p
CHEMBL2435855 183455 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 8 1 6 5.6 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(F)c2)CC1 10.1021/jm401101p
486632 161035 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL2114183 161035 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
483369 327550 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL421342 327550 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
486604 461857 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL82168 461857 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
3010265 367237 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL481274 367237 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516226 122418 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 13 1 7 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL172090 122418 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 13 1 7 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516299 122714 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 10 1 5 6.8 CCn1nc(Cc2ccc(F)cc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173202 122714 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 10 1 5 6.8 CCn1nc(Cc2ccc(F)cc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516173 123065 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174304 123065 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516301 255996 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 654 10 1 5 7.6 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366494 255996 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 654 10 1 5 7.6 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516268 259246 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 10 1 6 6.0 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368823 259246 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 10 1 6 6.0 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
474168 25539 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 551 6 1 3 6.9 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C(F)(F)F)cc4)ccc3OCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL1179044 25539 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 551 6 1 3 6.9 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C(F)(F)F)cc4)ccc3OCC2)cc1)C1CCOCC1 10.1021/jm9906264
483369 327550 0 None None None Human 8.8 pIC50 = 8.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL421342 327550 0 None None None Human 8.8 pIC50 = 8.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461689 470478 0 None None None Human 8.8 pIC50 = 8.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccccc1C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL81926 470478 0 None None None Human 8.8 pIC50 = 8.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccccc1C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44590682 349193 0 None None None Human 8.8 pIC50 = 8.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 509 10 1 3 5.6 CCN(C(=O)Cc1cccc(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL457044 349193 0 None None None Human 8.8 pIC50 = 8.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 509 10 1 3 5.6 CCN(C(=O)Cc1cccc(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
118219297 462427 0 None None None Human 8.8 pIC50 = 8.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 474 8 1 7 4.8 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CC#N)c1ccc(Cl)s1 nan
CHEMBL6039700 462427 0 None None None Human 8.8 pIC50 = 8.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 474 8 1 7 4.8 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CC#N)c1ccc(Cl)s1 nan
44274090 158118 0 None None None Human 8.8 pIC50 = 8.8 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 540 11 2 4 5.6 CC(O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL20598 158118 0 None None None Human 8.8 pIC50 = 8.8 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 540 11 2 4 5.6 CC(O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
21341080 161201 0 None None None Human 8.8 pIC50 = 8.8 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 534 10 1 4 6.3 O=C(CCC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL21167 161201 0 None None None Human 8.8 pIC50 = 8.8 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 534 10 1 4 6.3 O=C(CCC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
1635 193594 43 None None None Human 8.8 pIC50 = 8.8 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
3002977 193594 43 None None None Human 8.8 pIC50 = 8.8 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
CHEMBL256907 193594 43 None None None Human 8.8 pIC50 = 8.8 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
505881 63105 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 537 10 1 6 5.0 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138437 63105 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 537 10 1 6 5.0 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
516367 122497 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 10 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@](C)(C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL172371 122497 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 10 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@](C)(C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516365 238944 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 540 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL352514 238944 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 540 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
516294 239040 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 586 10 1 5 6.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL353330 239040 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 586 10 1 5 6.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
57402175 143280 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 658 11 0 7 3.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)N2CCN(S(=O)(=O)C(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951898 143280 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 658 11 0 7 3.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)N2CCN(S(=O)(=O)C(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
44274090 158118 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 11 2 4 5.6 CC(O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL20598 158118 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 11 2 4 5.6 CC(O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/j.ejmech.2008.01.040
516365 238944 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL352514 238944 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010270 367136 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 513 10 1 5 5.4 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480504 367136 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 513 10 1 5 5.4 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010270 367136 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 513 10 1 5 5.4 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL480504 367136 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 513 10 1 5 5.4 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516294 239040 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 586 10 1 5 6.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL353330 239040 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 586 10 1 5 6.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516247 251230 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 12 1 6 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366328 251230 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 12 1 6 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516238 251255 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 11 1 5 8.1 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL368182 251255 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 11 1 5 8.1 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516266 257662 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 638 10 1 7 5.4 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367461 257662 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 638 10 1 7 5.4 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
118219320 443717 0 None None None Human 8.8 pIC50 = 8.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 511 9 1 6 6.3 CCc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCCC2)s1 nan
CHEMBL5943127 443717 0 None None None Human 8.8 pIC50 = 8.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 511 9 1 6 6.3 CCc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCCC2)s1 nan
118219306 447147 0 None None None Human 8.8 pIC50 = 8.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 554 9 1 7 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccc(C(=O)N(C)C)s1 nan
CHEMBL5980369 447147 0 None None None Human 8.8 pIC50 = 8.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 554 9 1 7 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccc(C(=O)N(C)C)s1 nan
44357375 234936 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1cncnc1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL335562 234936 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1cncnc1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
11635721 144452 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198150 144452 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
11635721 144452 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL198150 144452 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
9810893 213270 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085307 213270 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
11513274 213272 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
CHEMBL3085309 213272 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
10186910 195555 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 533 6 0 6 4.9 Cc1nc(CN(c2ccccc2)C2CCN(C3(C)CCN(C(=O)c4c(C)cc[n+]([O-])c4C)CC3)CC2)cs1 10.1016/j.bmcl.2008.01.108
CHEMBL255857 195555 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 533 6 0 6 4.9 Cc1nc(CN(c2ccccc2)C2CCN(C3(C)CCN(C(=O)c4c(C)cc[n+]([O-])c4C)CC3)CC2)cs1 10.1016/j.bmcl.2008.01.108
25024699 183447 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 558 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435847 183447 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 558 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
72711956 183462 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435862 183462 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
59458103 183506 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435906 183506 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
5275759 158758 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 590 9 0 5 5.2 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C#N)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207630 158758 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 590 9 0 5 5.2 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C#N)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
11505350 333435 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 565 8 0 4 6.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Sc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL437494 333435 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 565 8 0 4 6.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Sc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516185 255757 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 571 10 1 6 5.5 CCn1nc(Cc2cccc(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366400 255757 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 571 10 1 6 5.5 CCn1nc(Cc2cccc(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516302 258603 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 611 10 1 6 6.4 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368459 258603 0 None None None Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 611 10 1 6 6.4 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
118219319 448832 0 None None None Human 8.8 pIC50 = 8.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 562 9 1 8 3.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCN(S(C)(=O)=O)CC1)c1cccs1 nan
CHEMBL5998002 448832 0 None None None Human 8.8 pIC50 = 8.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 562 9 1 8 3.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCN(S(C)(=O)=O)CC1)c1cccs1 nan
126567275 445798 0 None None None Human 8.8 pIC50 = 8.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 503 6 1 7 4.0 COC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2ccc(F)s2)C1 nan
CHEMBL5965259 445798 0 None None None Human 8.8 pIC50 = 8.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 503 6 1 7 4.0 COC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2ccc(F)s2)C1 nan
9914742 331451 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL428104 331451 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
9914742 331451 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL428104 331451 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
9914742 331451 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL428104 331451 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
44447735 195515 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccn3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255646 195515 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccn3)CC2)CC1 10.1016/j.bmcl.2008.01.108
183790 8163 6 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
783 8163 6 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
CHEMBL1178786 8163 6 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
474167 26301 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 527 8 1 4 6.3 CCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1183370 26301 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 527 8 1 4 6.3 CCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
118219347 432047 0 None None None Human 8.7 pIC50 = 8.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 517 9 2 9 3.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cc1nnn[nH]1)c1ccc(Cl)s1 nan
CHEMBL5924018 432047 0 None None None Human 8.7 pIC50 = 8.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 517 9 2 9 3.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cc1nnn[nH]1)c1ccc(Cl)s1 nan
3013575 157435 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL204821 157435 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
122668160 423793 0 None None None Human 8.7 pIC50 = 8.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 519 8 1 6 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)c1cccs1 nan
CHEMBL5902608 423793 0 None None None Human 8.7 pIC50 = 8.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 519 8 1 6 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)c1cccs1 nan
76316241 176545 0 None None None Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 590 13 0 6 5.2 C=CCN(C(=O)c1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282503 176545 0 None None None Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 590 13 0 6 5.2 C=CCN(C(=O)c1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
486604 461857 0 None None None Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL82168 461857 0 None None None Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
11467704 470630 0 None None None Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 0 7 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL83335 470630 0 None None None Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 0 7 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
5275829 470818 0 None None None Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL85086 470818 0 None None None Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461628 214957 0 None None None Human 8.0 pIC50 = 8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.5 CCN(C(=O)Oc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL311532 214957 0 None None None Human 8.0 pIC50 = 8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.5 CCN(C(=O)Oc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461714 470199 0 None None None Human 8.0 pIC50 = 8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 543 14 0 5 5.6 CCCCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79667 470199 0 None None None Human 8.0 pIC50 = 8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 543 14 0 5 5.6 CCCCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
483344 19437 0 None None None Human 8.0 pIC50 = 8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 581 12 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105570 19437 0 None None None Human 8.0 pIC50 = 8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 581 12 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
44335765 19773 0 None None None Human 8.0 pIC50 = 8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 610 12 0 6 6.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(c2ccccc2)C2c3ccccc3C(=O)N2CC)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL107380 19773 0 None None None Human 8.0 pIC50 = 8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 610 12 0 6 6.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(c2ccccc2)C2c3ccccc3C(=O)N2CC)CC1 10.1016/s0960-894x(01)00655-2
5481702 470631 0 None None None Human 8.0 pIC50 = 8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00654-0
CHEMBL83338 470631 0 None None None Human 8.0 pIC50 = 8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00654-0
505867 63356 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138645 63356 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
54582105 125608 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 550 6 0 4 6.9 Cc1nc2cc(F)ccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784400 125608 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 550 6 0 4 6.9 Cc1nc2cc(F)ccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
44401731 335736 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 499 7 2 3 6.1 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3c[nH]c4ccccc34)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL445925 335736 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 499 7 2 3 6.1 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3c[nH]c4ccccc34)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
496972 217839 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
CHEMBL319689 217839 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
505867 63356 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL138645 63356 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
496972 217839 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL319689 217839 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/j.ejmech.2008.01.040
46882916 19974 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 537 7 0 4 6.7 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1077779 19974 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 537 7 0 4 6.7 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46883031 20060 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 554 7 0 6 5.4 CCCC[C@H]1CN(CC2CCCCO2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ccnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078335 20060 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 554 7 0 6 5.4 CCCC[C@H]1CN(CC2CCCCO2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ccnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
11786927 123729 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 624 10 1 7 5.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762463 123729 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 624 10 1 7 5.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2011.02.058
44461628 214957 0 None None None Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.5 CCN(C(=O)Oc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311532 214957 0 None None None Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.5 CCN(C(=O)Oc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461714 470199 0 None None None Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 543 14 0 5 5.6 CCCCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79667 470199 0 None None None Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 543 14 0 5 5.6 CCCCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481702 470631 0 None None None Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481702 470631 0 None None None Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL83338 470631 0 None None None Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83338 470631 0 None None None Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
16064151 239846 0 None None None Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 6 1 5 5.2 CC(C)[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
CHEMBL3577948 239846 0 None None None Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 6 1 5 5.2 CC(C)[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
5481702 470631 0 None None None Human 8.0 pIC50 = 8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL83338 470631 0 None None None Human 8.0 pIC50 = 8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
5275841 251397 0 None None None Human 8.0 pIC50 = 8 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 559 10 0 4 5.2 CN(C[C@@](C)(CCN1CCC2C(CCC(=O)N2Cc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL361585 251397 0 None None None Human 8.0 pIC50 = 8 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 559 10 0 4 5.2 CN(C[C@@](C)(CCN1CCC2C(CCC(=O)N2Cc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
118219322 407018 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 520 8 1 7 5.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1nccs1 nan
CHEMBL5761297 407018 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 520 8 1 7 5.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1nccs1 nan
118219367 423763 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 553 8 1 6 6.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(Cl)s1 nan
CHEMBL5895658 423763 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 553 8 1 6 6.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(Cl)s1 nan
72714321 183491 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
CHEMBL2435891 183491 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
76316185 176532 0 None None None Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 612 10 3 3 8.1 CCc1cccc(CC)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281968 176532 0 None None None Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 612 10 3 3 8.1 CCc1cccc(CC)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
76327120 176530 0 None None None Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 598 8 3 3 7.9 Cc1cc(C)c(NC(=O)NCC2(O)CCC(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)c(C)c1 10.1007/s00044-012-0118-7
CHEMBL2281966 176530 0 None None None Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 598 8 3 3 7.9 Cc1cc(C)c(NC(=O)NCC2(O)CCC(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)c(C)c1 10.1007/s00044-012-0118-7
478449 176546 0 None None None Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 547 12 0 4 5.5 CCCN(C(=O)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282504 176546 0 None None None Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 547 12 0 4 5.5 CCCN(C(=O)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
76309037 176549 0 None None None Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 562 12 1 4 5.2 CCN(C(=O)NCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282507 176549 0 None None None Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 562 12 1 4 5.2 CCN(C(=O)NCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461560 470162 0 None None None Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.2 COC(=O)N(Cc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79315 470162 0 None None None Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.2 COC(=O)N(Cc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
5481754 473432 0 None None None Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 604 9 0 4 6.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)Cc1ccccc1 10.1007/s00044-011-9863-2
CHEMBL88159 473432 0 None None None Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 604 9 0 4 6.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)Cc1ccccc1 10.1007/s00044-011-9863-2
489337 19952 0 None None None Human 7.0 pIC50 = 7 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 568 9 2 3 6.5 CC(CCN1CCC(c2ccccc2)CC1)(CN1C(=O)N[C@H](Cc2c[nH]c3ccccc23)C1=O)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
CHEMBL107749 19952 0 None None None Human 7.0 pIC50 = 7 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 568 9 2 3 6.5 CC(CCN1CCC(c2ccccc2)CC1)(CN1C(=O)N[C@H](Cc2c[nH]c3ccccc23)C1=O)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
5481704 329360 0 None None None Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL421356 329360 0 None None None Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
478496 473288 0 None None None Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 582 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCC1 10.1016/s0960-894x(00)00637-5
CHEMBL87167 473288 0 None None None Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 582 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCC1 10.1016/s0960-894x(00)00637-5
5481744 473506 0 None None None Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 596 8 0 4 6.2 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCCC1 10.1016/s0960-894x(00)00637-5
CHEMBL88644 473506 0 None None None Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 596 8 0 4 6.2 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCCC1 10.1016/s0960-894x(00)00637-5
5481750 473581 0 None None None Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 591 8 0 5 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccnc1 10.1016/s0960-894x(00)00637-5
CHEMBL89167 473581 0 None None None Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 591 8 0 5 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccnc1 10.1016/s0960-894x(00)00637-5
44392229 137925 0 None None None Human 7.0 pIC50 = 7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 441 8 1 2 5.5 CN(C(=O)NCc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183406 137925 0 None None None Human 7.0 pIC50 = 7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 441 8 1 2 5.5 CN(C(=O)NCc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54584053 125606 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 586 6 0 4 7.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(n2c(C(F)(F)F)nc4ccccc42)C3)(c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784398 125606 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 586 6 0 4 7.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(n2c(C(F)(F)F)nc4ccccc42)C3)(c2ccccc2)CC1 10.1021/jm200279v
44401734 141425 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc(=O)c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL192456 141425 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc(=O)c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
496970 19016 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccccc1CCCC1(O)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL103268 19016 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccccc1CCCC1(O)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
496970 19016 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccccc1CCCC1(O)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL103268 19016 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccccc1CCCC1(O)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44431977 178840 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 599 8 3 4 6.8 Cc1cc(C)c(NC(=O)NCC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)c(C)c1 10.1016/j.bmcl.2007.01.050
CHEMBL234208 178840 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 599 8 3 4 6.8 Cc1cc(C)c(NC(=O)NCC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)c(C)c1 10.1016/j.bmcl.2007.01.050
44455001 197947 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccccc1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL271076 197947 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccccc1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
46882871 20018 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 7 0 4 6.0 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3ccccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1077988 20018 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 7 0 4 6.0 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3ccccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46882985 20043 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078141 20043 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
54586339 123652 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 7.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2C#N)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762317 123652 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 7.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2C#N)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
478440 213980 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 534 11 2 4 4.4 CN(CC(CCN1CCC(NC(=O)NCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL309922 213980 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 534 11 2 4 4.4 CN(CC(CCN1CCC(NC(=O)NCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
44461831 461866 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 547 12 0 4 5.5 CCCN(C(=O)c1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL82879 461866 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 547 12 0 4 5.5 CCCN(C(=O)c1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461560 470162 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.2 COC(=O)N(Cc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79315 470162 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.2 COC(=O)N(Cc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481714 470188 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 538 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CC(O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79566 470188 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 538 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CC(O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481716 470666 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 0 4 5.2 CN1C(=O)c2ccccc2C12CCN(CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1cccc(Cl)c1)CC2 10.1016/s0960-894x(01)00491-7
CHEMBL83745 470666 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 0 4 5.2 CN1C(=O)c2ccccc2C12CCN(CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1cccc(Cl)c1)CC2 10.1016/s0960-894x(01)00491-7
5481704 329360 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL421356 329360 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479858 473652 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 480 9 0 3 5.5 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccc(F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL89715 473652 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 480 9 0 3 5.5 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccc(F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
482147 473819 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 528 8 0 5 4.7 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL90747 473819 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 528 8 0 5 4.7 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479877 473949 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 468 9 0 4 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL91522 473949 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 468 9 0 4 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44273846 159802 0 None None None Human 6.0 pIC50 = 6 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 2 4 4.8 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCP(=O)(O)c3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL21058 159802 0 None None None Human 6.0 pIC50 = 6 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 2 4 4.8 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCP(=O)(O)c3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
76315543 176214 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cncc2ccccc12 10.1007/s00044-011-9863-2
CHEMBL2259881 176214 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cncc2ccccc12 10.1007/s00044-011-9863-2
76322864 176215 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 504 8 0 6 3.2 C/C=C(\C)[C@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)CN(C)S(=O)(=O)c1cn(C)cn1 10.1007/s00044-011-9863-2
CHEMBL2259882 176215 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 504 8 0 6 3.2 C/C=C(\C)[C@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)CN(C)S(=O)(=O)c1cn(C)cn1 10.1007/s00044-011-9863-2
76334365 176519 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 425 4 0 3 4.6 Brc1ccc(COc2ccc(Br)cc2N2CCOCC2)cc1 10.1007/s00044-012-0118-7
CHEMBL2281892 176519 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 425 4 0 3 4.6 Brc1ccc(COc2ccc(Br)cc2N2CCOCC2)cc1 10.1007/s00044-012-0118-7
76319944 176550 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 500 11 1 4 4.0 CCCN(C(=O)NC)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282508 176550 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 500 11 1 4 4.0 CCCN(C(=O)NC)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461785 214172 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 459 9 1 5 3.3 COC(=O)NC1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL310369 214172 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 459 9 1 5 3.3 COC(=O)NC1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
5481746 222256 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 666 9 0 4 7.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1007/s00044-011-9863-2
CHEMBL330570 222256 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 666 9 0 4 7.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1007/s00044-011-9863-2
11188669 292114 2 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1007/s00044-012-0118-7
CHEMBL391379 292114 2 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1007/s00044-012-0118-7
44461790 329496 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 9 1 5 4.5 CN(C[C@@H](CCN1CCC(NC(=O)OC(C)(C)C)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
CHEMBL421527 329496 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 9 1 5 4.5 CN(C[C@@H](CCN1CCC(NC(=O)OC(C)(C)C)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
478412 332719 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 526 10 0 4 6.0 COc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
CHEMBL431795 332719 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 526 10 0 4 6.0 COc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
5481703 470601 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83107 470601 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
478499 473462 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc(Cl)c1 10.1007/s00044-011-9863-2
CHEMBL88344 473462 0 None None None Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc(Cl)c1 10.1007/s00044-011-9863-2
5481741 220981 0 None None None Human 6.0 pIC50 = 6 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 556 8 0 4 6.4 CN(Cc1ccccc1)C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
CHEMBL327703 220981 0 None None None Human 6.0 pIC50 = 6 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 556 8 0 4 6.4 CN(Cc1ccccc1)C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
5481705 328454 0 None None None Human 6.0 pIC50 = 6 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL420057 328454 0 None None None Human 6.0 pIC50 = 6 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
11502371 309267 3 None None None Human 6.0 pIC50 = 6 Binding
Displacement of MIP1-alpha from CCR5 receptorDisplacement of MIP1-alpha from CCR5 receptor
ChEMBL 407 5 1 2 5.0 C[N+](C)(Cc1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1)C1CCOCC1 10.1016/j.bmcl.2007.01.115
CHEMBL397647 309267 3 None None None Human 6.0 pIC50 = 6 Binding
Displacement of MIP1-alpha from CCR5 receptorDisplacement of MIP1-alpha from CCR5 receptor
ChEMBL 407 5 1 2 5.0 C[N+](C)(Cc1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1)C1CCOCC1 10.1016/j.bmcl.2007.01.115
57403173 140142 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 409 9 1 4 3.7 N#Cc1cccc(C(=O)NCCCN2CCC(COCc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2011.09.013
CHEMBL1910166 140142 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 409 9 1 4 3.7 N#Cc1cccc(C(=O)NCCCN2CCC(COCc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2011.09.013
6479877 26781 2 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-gp120 from human CCR5Displacement of [125I]-gp120 from human CCR5
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1186558 26781 2 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-gp120 from human CCR5Displacement of [125I]-gp120 from human CCR5
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
15485365 371851 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 604 8 1 4 6.3 O=C1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
CHEMBL503631 371851 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 604 8 1 4 6.3 O=C1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
11188669 292114 2 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL391379 292114 2 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1016/j.bmcl.2006.09.052
11188669 292114 2 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL391379 292114 2 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1016/j.bmcl.2007.01.050
6479877 26781 2 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1021/np049974l
CHEMBL1186558 26781 2 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1021/np049974l
53326700 121253 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683066 121253 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
11329244 143347 6 None None None Human 6.0 pIC50 = 6 Binding
Inhibition of C-C chemokine receptor type 5Inhibition of C-C chemokine receptor type 5
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
CHEMBL195433 143347 6 None None None Human 6.0 pIC50 = 6 Binding
Inhibition of C-C chemokine receptor type 5Inhibition of C-C chemokine receptor type 5
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
11272103 252399 0 None None None Human 6.0 pIC50 = 6 Binding
Inhibition of C-C chemokine receptor type 5Inhibition of C-C chemokine receptor type 5
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 252399 0 None None None Human 6.0 pIC50 = 6 Binding
Inhibition of C-C chemokine receptor type 5Inhibition of C-C chemokine receptor type 5
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
21148035 161037 0 None None None Human 6.0 pIC50 = 6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 471 9 0 5 3.4 CN(C[C@@H](CCN1CCC(N2CCOC2=O)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL2114185 161037 0 None None None Human 6.0 pIC50 = 6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 471 9 0 5 3.4 CN(C[C@@H](CCN1CCC(N2CCOC2=O)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
44461790 329496 0 None None None Human 6.0 pIC50 = 6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 9 1 5 4.5 CN(C[C@@H](CCN1CCC(NC(=O)OC(C)(C)C)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL421527 329496 0 None None None Human 6.0 pIC50 = 6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 9 1 5 4.5 CN(C[C@@H](CCN1CCC(NC(=O)OC(C)(C)C)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
478439 470673 0 None None None Human 6.0 pIC50 = 6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 458 9 2 4 2.9 CNC(=O)NC1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83773 470673 0 None None None Human 6.0 pIC50 = 6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 458 9 2 4 2.9 CNC(=O)NC1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481705 328454 0 None None None Human 6.0 pIC50 = 6 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL420057 328454 0 None None None Human 6.0 pIC50 = 6 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
478307 215509 0 None None None Human 5.0 pIC50 = 5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL312701 215509 0 None None None Human 5.0 pIC50 = 5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5482809 329217 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 588 9 0 4 7.3 CCN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL421168 329217 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 588 9 0 4 7.3 CCN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
11224188 178524 0 None None None Human 5.0 pIC50 = 5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 429 7 0 2 6.3 CN(Cc1ccccc1)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL233635 178524 0 None None None Human 5.0 pIC50 = 5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 429 7 0 2 6.3 CN(Cc1ccccc1)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
11224188 178524 0 None None None Human 5.0 pIC50 = 5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 429 7 0 2 6.3 CN(Cc1ccccc1)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL233635 178524 0 None None None Human 5.0 pIC50 = 5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 429 7 0 2 6.3 CN(Cc1ccccc1)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
44590849 350670 0 None None None Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1CC(N(C)C2CCN(C(c3ccccc3)c3ccccc3)CC2)C1 10.1016/j.bmcl.2009.01.012
CHEMBL459985 350670 0 None None None Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1CC(N(C)C2CCN(C(c3ccccc3)c3ccccc3)CC2)C1 10.1016/j.bmcl.2009.01.012
10393635 337124 0 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 8 1 4 5.9 O=C1CC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
CHEMBL449125 337124 0 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 8 1 4 5.9 O=C1CC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
44570307 352228 0 None None None Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 4 0 6 3.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC3(CC2)CCN(S(C)(=O)=O)CC3c2ccccc2)CC1 10.1016/j.bmcl.2008.10.115
CHEMBL465106 352228 0 None None None Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 4 0 6 3.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC3(CC2)CCN(S(C)(=O)=O)CC3c2ccccc2)CC1 10.1016/j.bmcl.2008.10.115
483362 38434 0 None None None Human 5.0 pIC50 = 5.0 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](C[C@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL120204 38434 0 None None None Human 5.0 pIC50 = 5.0 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](C[C@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44404656 272717 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 551 10 1 5 4.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(N)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372640 272717 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 551 10 1 5 4.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(N)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
3007227 122373 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against human CX3C chemokine receptor 5 when co-administered with compound 8gInhibitory activity against human CX3C chemokine receptor 5 when co-administered with compound 8g
ChEMBL 582 11 1 5 6.6 CCc1cc(CCc2ccccc2)nn1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL171911 122373 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against human CX3C chemokine receptor 5 when co-administered with compound 8gInhibitory activity against human CX3C chemokine receptor 5 when co-administered with compound 8g
ChEMBL 582 11 1 5 6.6 CCc1cc(CCc2ccccc2)nn1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
11204472 123733 0 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 638 10 1 7 6.6 COC(=O)c1cccc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
CHEMBL1762468 123733 0 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 638 10 1 7 6.6 COC(=O)c1cccc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
10186910 195555 0 None None None Crab-eating macaque 7.0 pIC50 = 7.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 533 6 0 6 4.9 Cc1nc(CN(c2ccccc2)C2CCN(C3(C)CCN(C(=O)c4c(C)cc[n+]([O-])c4C)CC3)CC2)cs1 10.1016/j.bmcl.2008.01.108
CHEMBL255857 195555 0 None None None Crab-eating macaque 7.0 pIC50 = 7.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 533 6 0 6 4.9 Cc1nc(CN(c2ccccc2)C2CCN(C3(C)CCN(C(=O)c4c(C)cc[n+]([O-])c4C)CC3)CC2)cs1 10.1016/j.bmcl.2008.01.108
53322809 121247 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@@H]2CCOC[C@@H]2C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683060 121247 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@@H]2CCOC[C@@H]2C)C1 10.1016/j.bmcl.2011.01.015
4716524 178343 1 None None None Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 353 6 1 2 4.8 CCNCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL233385 178343 1 None None None Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 353 6 1 2 4.8 CCNCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
44431965 180724 0 None None None Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 522 7 2 5 4.5 OC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1007/s00044-012-0118-7
CHEMBL237896 180724 0 None None None Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 522 7 2 5 4.5 OC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1007/s00044-012-0118-7
44374088 238766 0 None None None Human 8.0 pIC50 = 8.0 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 480 8 0 3 6.9 c1ccc(CCCC2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL350763 238766 0 None None None Human 8.0 pIC50 = 8.0 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 480 8 0 3 6.9 c1ccc(CCCC2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
25230970 371815 0 None None None Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 590 7 0 7 3.3 CCCCC1CN(S(=O)(=O)N2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL502927 371815 0 None None None Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 590 7 0 7 3.3 CCCCC1CN(S(=O)(=O)N2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
46888455 23079 0 None None None Human 8.0 pIC50 = 8.0 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 447 7 1 3 4.2 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C(C)C)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096447 23079 0 None None None Human 8.0 pIC50 = 8.0 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 447 7 1 3 4.2 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C(C)C)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44404644 272731 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 687 14 1 6 6.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(=O)(=O)Cc3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372733 272731 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 687 14 1 6 6.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(=O)(=O)Cc3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
44573335 370548 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 509 5 1 5 5.0 CN/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL492960 370548 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 509 5 1 5 5.0 CN/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
11569805 27094 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728785 27094 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
491775 27094 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188408 27094 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188807 27094 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196449 27094 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16730521 178697 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 613 10 3 4 7.0 CCc1cccc(CC)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL233847 178697 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 613 10 3 4 7.0 CCc1cccc(CC)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
52944537 42174 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 529 8 0 5 4.4 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cccc(F)c3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270693 42174 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 529 8 0 5 4.4 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cccc(F)c3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
11527582 158082 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 664 10 1 5 5.9 CC(C)(C)NC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL205964 158082 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 664 10 1 5 5.9 CC(C)(C)NC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
10208080 27323 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
CHEMBL1190106 27323 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
44384969 332989 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 594 10 1 5 6.9 CCn1ncc(C2(c3ccccc3)CC2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL433980 332989 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 594 10 1 5 6.9 CCn1ncc(C2(c3ccccc3)CC2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
5275835 232298 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 541 8 0 5 5.0 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL360667 232298 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 541 8 0 5 5.0 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
122668285 443553 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 484 7 1 7 3.4 CCC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(C)=O)C3)C2)c1nccs1 nan
CHEMBL5941463 443553 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 484 7 1 7 3.4 CCC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(C)=O)C3)C2)c1nccs1 nan
59458213 183504 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 525 8 1 4 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435904 183504 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 525 8 1 4 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
118219265 404413 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 569 8 1 6 7.2 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1csc2ccccc12 nan
CHEMBL5832369 404413 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 569 8 1 6 7.2 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1csc2ccccc12 nan
516357 371475 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1cc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)[nH]n1 10.1016/j.ejmech.2008.01.040
CHEMBL499793 371475 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1cc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)[nH]n1 10.1016/j.ejmech.2008.01.040
44384011 122731 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1c[nH]nc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL173262 122731 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1c[nH]nc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516357 371475 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1cc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)[nH]n1 10.1016/j.ejmech.2008.01.040
CHEMBL499793 371475 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1cc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)[nH]n1 10.1016/j.ejmech.2008.01.040
72714320 183490 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435890 183490 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
122668253 464691 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 493 8 1 6 5.5 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccsc2)CC1 nan
CHEMBL6062824 464691 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 493 8 1 6 5.5 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccsc2)CC1 nan
505875 59664 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL135432 59664 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
505868 61445 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137072 61445 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
20664115 353989 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL474838 353989 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44392220 137005 0 None None None Human 7.0 pIC50 = 7.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 11 1 3 6.1 C=CCN(C(=O)NCc1ccc(OC)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181858 137005 0 None None None Human 7.0 pIC50 = 7.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 11 1 3 6.1 C=CCN(C(=O)NCc1ccc(OC)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44392111 241087 0 None None None Human 7.0 pIC50 = 7.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 485 10 0 4 5.7 CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL360106 241087 0 None None None Human 7.0 pIC50 = 7.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 485 10 0 4 5.7 CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16073672 278307 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 638 12 0 6 5.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(C)C)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL382436 278307 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 638 12 0 6 5.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(C)C)c2)CC1 10.1016/j.bmcl.2006.03.089
479853 221501 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 544 8 0 6 4.4 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328908 221501 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 544 8 0 6 4.4 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479873 473434 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 494 9 0 3 5.8 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1F 10.1016/s0960-894x(00)00639-9
CHEMBL88164 473434 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 494 9 0 3 5.8 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1F 10.1016/s0960-894x(00)00639-9
479859 473715 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 10 0 3 5.9 CCc1cccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
CHEMBL90141 473715 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 10 0 3 5.9 CCc1cccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
479847 473919 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 606 8 0 5 5.6 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL91374 473919 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 606 8 0 5 5.6 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
474165 25565 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 481 6 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(CC[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1179191 25565 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 481 6 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(CC[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
44392147 331134 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 516 11 0 5 5.4 COc1cc(OC)c(OC)cc1CC(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL427144 331134 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 516 11 0 5 5.4 COc1cc(OC)c(OC)cc1CC(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728626 182020 0 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 396 5 3 3 4.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc2ccccc12 10.1016/j.bmcl.2006.09.052
CHEMBL239998 182020 0 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 396 5 3 3 4.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc2ccccc12 10.1016/j.bmcl.2006.09.052
4716524 178343 1 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 353 6 1 2 4.8 CCNCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL233385 178343 1 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 353 6 1 2 4.8 CCNCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
44431965 180724 0 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 522 7 2 5 4.5 OC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL237896 180724 0 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 522 7 2 5 4.5 OC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2007.01.050
474154 25561 0 None None None Human 6.0 pIC50 = 6.0 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 6 1 1 6.5 C[N+]1(CCc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
CHEMBL1179158 25561 0 None None None Human 6.0 pIC50 = 6.0 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 6 1 1 6.5 C[N+]1(CCc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
483356 26625 0 None None None Human 5.0 pIC50 = 5.0 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 647 14 0 7 7.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CC(C)(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL118544 26625 0 None None None Human 5.0 pIC50 = 5.0 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 647 14 0 7 7.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CC(C)(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
2600 8239 59 None None None Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
2608 8239 59 None None None Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
5405 8239 59 None None None Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
CHEMBL17157 8239 59 None None None Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
DB00342 8239 59 None None None Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
483332 19224 0 None None None Human 7.0 pIC50 = 7.0 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 9 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2nnc(-c3ccccc3)n2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104464 19224 0 None None None Human 7.0 pIC50 = 7.0 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 9 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2nnc(-c3ccccc3)n2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
483343 19457 0 None None None Human 7.0 pIC50 = 7.0 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 536 11 0 5 6.7 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105659 19457 0 None None None Human 7.0 pIC50 = 7.0 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 536 11 0 5 6.7 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
516346 259232 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL368757 259232 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
155491018 348149 1 None None None Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 348149 1 None None None Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
72711281 183501 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 547 8 1 6 4.6 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)n1 10.1021/jm401101p
CHEMBL2435901 183501 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 547 8 1 6 4.6 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)n1 10.1021/jm401101p
5481712 215591 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 523 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CNc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL312808 215591 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 523 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CNc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
16728630 297661 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 347 6 3 5 2.6 N=C(N)N/N=C/c1cc([N+](=O)[O-])ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL395843 297661 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 347 6 3 5 2.6 N=C(N)N/N=C/c1cc([N+](=O)[O-])ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
486595 470725 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 510 9 0 3 6.3 Cc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
CHEMBL84120 470725 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 510 9 0 3 6.3 Cc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
5481707 473555 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 612 8 0 6 5.7 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1007/s00044-011-9863-2
CHEMBL88976 473555 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 612 8 0 6 5.7 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1007/s00044-011-9863-2
25205767 21439 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 598 6 0 6 4.9 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085225 21439 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 598 6 0 6 4.9 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46890428 21548 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 599 6 0 7 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@@H]3c3ccccn3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085721 21548 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 599 6 0 7 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@@H]3c3ccccn3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888565 23027 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 499 7 1 5 4.0 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095827 23027 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 499 7 1 5 4.0 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888583 23300 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 557 8 1 5 4.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCC(F)(F)CC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098357 23300 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 557 8 1 5 4.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCC(F)(F)CC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
505875 59664 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL135432 59664 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505868 61445 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137072 61445 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44404724 272652 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 564 11 0 5 5.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(SC)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372134 272652 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 564 11 0 5 5.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(SC)cc2)CC1 10.1016/j.bmcl.2005.08.014
44401763 140903 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 487 8 1 6 4.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL191803 140903 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 487 8 1 6 4.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44401863 142454 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc4c3=O)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL194078 142454 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc4c3=O)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
496985 217015 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccncc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL317908 217015 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccncc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
505875 59664 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL135432 59664 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
505868 61445 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137072 61445 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
20664115 353989 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL474838 353989 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
46883029 20119 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 571 7 0 7 4.8 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(=O)oc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078712 20119 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 571 7 0 7 4.8 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(=O)oc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44447735 195515 0 None None None Crab-eating macaque 7.9 pIC50 = 7.9 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccn3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255646 195515 0 None None None Crab-eating macaque 7.9 pIC50 = 7.9 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccn3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008930 410787 0 None None None Crab-eating macaque 7.9 pIC50 = 7.9 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL58004 410787 0 None None None Crab-eating macaque 7.9 pIC50 = 7.9 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
11692945 158187 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3C(N)=O)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL206088 158187 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3C(N)=O)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516352 333214 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 574 9 2 5 6.2 COc1ccc(-c2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)[nH]n2)cc1 10.1016/j.bmcl.2003.12.004
CHEMBL435526 333214 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 574 9 2 5 6.2 COc1ccc(-c2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)[nH]n2)cc1 10.1016/j.bmcl.2003.12.004
490008 474305 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 537 7 0 4 5.9 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL93961 474305 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 537 7 0 4 5.9 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
122668242 446899 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 498 8 1 7 3.8 CCCC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2nccs2)C1 nan
CHEMBL5977447 446899 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 498 8 1 7 3.8 CCCC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2nccs2)C1 nan
122668233 409023 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 503 6 1 6 4.2 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(C)=O)C3)C2)c1ccc(Cl)s1 nan
CHEMBL5781548 409023 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 503 6 1 6 4.2 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(C)=O)C3)C2)c1ccc(Cl)s1 nan
118219285 433196 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 526 9 2 7 5.3 CC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCC2)s1 nan
CHEMBL5935402 433196 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 526 9 2 7 5.3 CC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCC2)s1 nan
489594 213061 0 None None None Human 6.9 pIC50 = 6.9 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00232-3
CHEMBL330528 213061 0 None None None Human 6.9 pIC50 = 6.9 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00232-3
5481752 216551 0 None None None Human 6.9 pIC50 = 6.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cnc2ccccc2c1 10.1016/s0960-894x(00)00637-5
CHEMBL314551 216551 0 None None None Human 6.9 pIC50 = 6.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cnc2ccccc2c1 10.1016/s0960-894x(00)00637-5
5481707 473555 0 None None None Human 6.9 pIC50 = 6.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 612 8 0 6 5.7 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(00)00637-5
CHEMBL88976 473555 0 None None None Human 6.9 pIC50 = 6.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 612 8 0 6 5.7 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(00)00637-5
54580468 123654 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 613 9 1 4 8.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2Cl)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762319 123654 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 613 9 1 4 8.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2Cl)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
44461623 327685 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 471 10 0 4 3.8 CCN(C(C)=O)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL430818 327685 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 471 10 0 4 3.8 CCN(C(C)=O)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481726 470575 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 564 9 0 3 7.0 CN(C[C@@H](CCN1CCC(c2cccc(C(F)(F)F)c2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL82838 470575 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 564 9 0 3 7.0 CN(C[C@@H](CCN1CCC(c2cccc(C(F)(F)F)c2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
486608 470739 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 486 10 1 4 3.6 CCN(C(=O)NC)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL84268 470739 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 486 10 1 4 3.6 CCN(C(=O)NC)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478308 220937 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 462 9 0 3 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL327484 220937 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 462 9 0 3 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
478418 176547 0 None None None Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 471 10 0 4 3.8 CCN(C(C)=O)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282505 176547 0 None None None Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 471 10 0 4 3.8 CCN(C(C)=O)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
478439 470673 0 None None None Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 458 9 2 4 2.9 CNC(=O)NC1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL83773 470673 0 None None None Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 458 9 2 4 2.9 CNC(=O)NC1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
16728630 297661 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 347 6 3 5 2.6 N=C(N)N/N=C/c1cc([N+](=O)[O-])ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL395843 297661 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 347 6 3 5 2.6 N=C(N)N/N=C/c1cc([N+](=O)[O-])ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
77281925 370987 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cellsDisplacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cells
ChEMBL 447 5 4 5 3.4 C/C=C(\C)[C@@H]1CC[C@@H]2C[C@H](C)C[C@H](C)[C@H]2[C@@H]1/C(O)=C1/C(=O)N[C@H](C[C@](C)(O)C(=O)O)C1=O 10.1021/np060121y
CHEMBL495654 370987 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cellsDisplacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cells
ChEMBL 447 5 4 5 3.4 C/C=C(\C)[C@@H]1CC[C@@H]2C[C@H](C)C[C@H](C)[C@H]2[C@@H]1/C(O)=C1/C(=O)N[C@H](C[C@](C)(O)C(=O)O)C1=O 10.1021/np060121y
474151 25572 0 None None None Human 5.9 pIC50 = 5.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 5 1 2 5.3 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCOCC1 10.1021/jm9906264
CHEMBL1179234 25572 0 None None None Human 5.9 pIC50 = 5.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 5 1 2 5.3 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCOCC1 10.1021/jm9906264
516346 259232 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL368757 259232 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516346 259232 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL368757 259232 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
54581478 123645 0 None None None Human 4.9 pIC50 = 4.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 538 6 1 5 5.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2=NOCc3cc(Br)ccc32)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762309 123645 0 None None None Human 4.9 pIC50 = 4.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 538 6 1 5 5.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2=NOCc3cc(Br)ccc32)CC1 10.1016/j.bmcl.2011.02.058
155554273 348271 0 None None None Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4548396 348271 0 None None None Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.9b00742
44590395 352864 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL470578 352864 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
66768640 239833 0 None None None Human 5.9 pIC50 = 5.9 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 515 13 6 5 2.6 CCC[C@H](O)[C@H](CNCC1CC1)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
CHEMBL3577934 239833 0 None None None Human 5.9 pIC50 = 5.9 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 515 13 6 5 2.6 CCC[C@H](O)[C@H](CNCC1CC1)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
25131901 203327 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 546 7 0 4 7.2 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084490 203327 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 546 7 0 4 7.2 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
3011725 143285 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 539 10 0 5 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951903 143285 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 539 10 0 5 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
44573098 370600 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 496 6 1 7 4.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(c2nnn[nH]2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL493312 370600 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 496 6 1 7 4.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(c2nnn[nH]2)CC1 10.1016/j.bmcl.2009.02.014
483347 217008 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 621 12 2 5 5.9 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL317860 217008 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 621 12 2 5 5.9 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
46888582 23024 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 507 8 1 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095816 23024 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 507 8 1 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
11421221 136100 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 530 11 0 4 5.3 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL180155 136100 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 530 11 0 4 5.3 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2005.08.014
44565874 352862 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3ncc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL470512 352862 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3ncc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
177372133 393773 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cellsDisplacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cells
ChEMBL 452 7 1 4 5.5 Cc1nc2ccccc2n1C1CCN(CC[C@H](NC(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2023.115586
CHEMBL5647394 393773 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cellsDisplacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cells
ChEMBL 452 7 1 4 5.5 Cc1nc2ccccc2n1C1CCN(CC[C@H](NC(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2023.115586
44573301 334220 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 554 6 0 6 6.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)SC(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL443730 334220 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 554 6 0 6 6.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)SC(C)C)CC1 10.1016/j.bmcl.2009.02.014
44573341 371546 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 604 8 0 6 7.5 COC(=O)C(c1cccc(C)c1C)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL500824 371546 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 604 8 0 6 7.5 COC(=O)C(c1cccc(C)c1C)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
44573252 385642 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 509 7 0 6 6.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ncco2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL522659 385642 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 509 7 0 6 6.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ncco2)CC1 10.1016/j.bmcl.2009.02.014
44565874 352862 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3ncc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470512 352862 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3ncc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
46880850 21799 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.9 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCOCC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
CHEMBL1087028 21799 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.9 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCOCC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
56647076 183481 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435881 183481 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
516188 124038 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 547 10 1 6 5.0 CCn1nc(Cc2cccnc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176655 124038 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 547 10 1 6 5.0 CCn1nc(Cc2cccnc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
122668131 446802 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 511 7 1 6 4.5 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cc(C)cs1 nan
CHEMBL5976385 446802 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 511 7 1 6 4.5 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cc(C)cs1 nan
118219351 463432 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 501 9 2 9 3.1 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cc1nnn[nH]1)c1ccc(F)s1 nan
CHEMBL6049662 463432 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 501 9 2 9 3.1 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cc1nnn[nH]1)c1ccc(F)s1 nan
73355478 183477 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435877 183477 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
44590717 372682 0 None None None Human 7.9 pIC50 = 7.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 475 10 1 3 5.0 CCN(C(=O)Cc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL514410 372682 0 None None None Human 7.9 pIC50 = 7.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 475 10 1 3 5.0 CCN(C(=O)Cc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
118219294 411357 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 497 9 1 10 3.2 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)Cn2ncnn2)s1 nan
CHEMBL5806669 411357 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 497 9 1 10 3.2 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)Cn2ncnn2)s1 nan
72714078 183485 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435885 183485 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
118219290 451897 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 576 9 2 7 5.4 CNC(=O)c1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 nan
CHEMBL6030753 451897 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 576 9 2 7 5.4 CNC(=O)c1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 nan
122668188 426654 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 522 7 1 7 4.1 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1ccc(C#N)s1 nan
CHEMBL5867098 426654 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 522 7 1 7 4.1 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1ccc(C#N)s1 nan
5482810 216655 0 None None None Human 6.9 pIC50 = 6.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 604 9 0 4 6.3 CCN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL315293 216655 0 None None None Human 6.9 pIC50 = 6.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 604 9 0 4 6.3 CCN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
44404641 144749 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 637 12 1 5 6.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL199119 144749 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 637 12 1 5 6.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
54585384 123643 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 554 9 1 5 5.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762307 123643 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 554 9 1 5 5.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
11410758 123647 1 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 589 9 1 4 7.2 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762312 123647 1 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 589 9 1 4 7.2 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
11193076 123731 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 648 9 1 5 7.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C(F)(F)F)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762466 123731 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 648 9 1 5 7.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C(F)(F)F)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
57398009 140144 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 460 6 0 4 4.4 COc1ccc(C)cc1S(=O)(=O)N1CCC(CN2CCC(c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2011.09.013
CHEMBL1910168 140144 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 460 6 0 4 4.4 COc1ccc(C)cc1S(=O)(=O)N1CCC(CN2CCC(c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2011.09.013
16728618 182605 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 404 6 3 5 2.6 COC(=O)c1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL241251 182605 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 404 6 3 5 2.6 COC(=O)c1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
11408704 177878 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 465 7 0 4 5.5 CCOC(=O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL232412 177878 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 465 7 0 4 5.5 CCOC(=O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44431953 179154 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 422 6 1 3 4.9 NCC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234844 179154 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 422 6 1 3 4.9 NCC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44431926 292112 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 379 5 0 2 5.3 Clc1ccc(COc2ccc(Br)cc2CN2CCCC2)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL391378 292112 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 379 5 0 2 5.3 Clc1ccc(COc2ccc(Br)cc2CN2CCCC2)cc1 10.1016/j.bmcl.2007.01.050
3377049 180841 1 None None None Human 5.9 pIC50 = 5.9 Binding
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 357 5 1 5 2.8 CC1CCCN(CC(O)COc2ccc3c4c(c(=O)oc3c2)CCC4)C1 10.1021/acs.jmedchem.6b01309
CHEMBL2381331 180841 1 None None None Human 5.9 pIC50 = 5.9 Binding
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 357 5 1 5 2.8 CC1CCCN(CC(O)COc2ccc3c4c(c(=O)oc3c2)CCC4)C1 10.1021/acs.jmedchem.6b01309
479838 221115 0 None None None Human 5.9 pIC50 = 5.9 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 572 8 0 5 5.0 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328438 221115 0 None None None Human 5.9 pIC50 = 5.9 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 572 8 0 5 5.0 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
11408704 177878 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 465 7 0 4 5.5 CCOC(=O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL232412 177878 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 465 7 0 4 5.5 CCOC(=O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
44431953 179154 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 422 6 1 3 4.9 NCC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234844 179154 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 422 6 1 3 4.9 NCC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
16728618 182605 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 404 6 3 5 2.6 COC(=O)c1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
CHEMBL241251 182605 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 404 6 3 5 2.6 COC(=O)c1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
44431926 292112 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 379 5 0 2 5.3 Clc1ccc(COc2ccc(Br)cc2CN2CCCC2)cc1 10.1007/s00044-012-0118-7
CHEMBL391378 292112 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 379 5 0 2 5.3 Clc1ccc(COc2ccc(Br)cc2CN2CCCC2)cc1 10.1007/s00044-012-0118-7
16073664 276104 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 626 12 0 7 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(OC)cc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL378035 276104 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 626 12 0 7 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(OC)cc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
73355478 183477 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435877 183477 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
52942058 42161 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 511 8 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270594 42161 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 511 8 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
66768099 239831 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 517 13 6 5 2.9 CCC[C@H](O)[C@H](CNCC(C)C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
CHEMBL3577932 239831 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 517 13 6 5 2.9 CCC[C@H](O)[C@H](CNCC(C)C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
16728643 289775 0 None None None Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 350 5 3 3 3.8 C/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL393274 289775 0 None None None Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 350 5 3 3 3.8 C/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
76323541 176536 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 367 6 0 2 5.5 CCN(CC)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL2281971 176536 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 367 6 0 2 5.5 CCN(CC)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
11350639 178929 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL234634 178929 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
5481751 216628 0 None None None Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2cccnc12 10.1007/s00044-011-9863-2
CHEMBL315084 216628 0 None None None Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2cccnc12 10.1007/s00044-011-9863-2
44373973 104402 0 None None None Human 7.9 pIC50 = 7.9 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL157983 104402 0 None None None Human 7.9 pIC50 = 7.9 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
44590583 348765 0 None None None Human 7.9 pIC50 = 7.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 517 11 1 4 5.1 CCN(C(=O)Cc1ccc(OC)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2009.01.009
CHEMBL456019 348765 0 None None None Human 7.9 pIC50 = 7.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 517 11 1 4 5.1 CCN(C(=O)Cc1ccc(OC)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2009.01.009
46888563 22980 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 475 7 1 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095517 22980 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 475 7 1 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888524 23201 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 7 1 3 5.4 O=C(N[C@@H](CCN1C[C@H]2CN(C(=O)c3c(Cl)cccc3Cl)C[C@H]2C1)c1ccccc1)C1CCCC1 10.1016/j.bmcl.2010.03.095
CHEMBL1097515 23201 0 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 7 1 3 5.4 O=C(N[C@@H](CCN1C[C@H]2CN(C(=O)c3c(Cl)cccc3Cl)C[C@H]2C1)c1ccccc1)C1CCCC1 10.1016/j.bmcl.2010.03.095
1635 193594 43 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmcl.2010.03.095
3002977 193594 43 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmcl.2010.03.095
CHEMBL256907 193594 43 None None None Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmcl.2010.03.095
505865 62934 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 516 8 0 4 6.0 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138282 62934 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 516 8 0 4 6.0 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44373973 104402 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL157983 104402 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
46882076 19942 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 567 7 0 7 4.5 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077358 19942 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 567 7 0 7 4.5 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
72714076 183483 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435883 183483 0 None None None Human 7.9 pIC50 = 7.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
122668194 414048 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 531 7 1 6 4.9 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1ccc(Cl)s1 nan
CHEMBL5836259 414048 0 None None None Human 7.9 pIC50 = 7.9 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 531 7 1 6 4.9 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1ccc(Cl)s1 nan
72711740 183509 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435909 183509 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
118219346 448199 0 None None None Human 7.8 pIC50 = 7.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 483 9 2 9 2.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cc1nnn[nH]1)c1cccs1 nan
CHEMBL5991433 448199 0 None None None Human 7.8 pIC50 = 7.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 483 9 2 9 2.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cc1nnn[nH]1)c1cccs1 nan
16728643 289775 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 350 5 3 3 3.8 C/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL393274 289775 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 350 5 3 3 3.8 C/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
11444710 123657 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 590 9 1 5 6.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccn2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762326 123657 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 590 9 1 5 6.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccn2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
54581480 123660 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1ccnc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.02.058
CHEMBL1762330 123660 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1ccnc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.02.058
11490468 123666 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ncccc2Cl)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762336 123666 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ncccc2Cl)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
489811 221002 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 454 6 0 3 5.4 COc1ccccc1C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL327800 221002 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 454 6 0 3 5.4 COc1ccccc1C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
489812 473992 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 454 6 0 3 5.4 COc1cccc(C(=O)N2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)c1 10.1016/s0960-894x(01)00545-5
CHEMBL91793 473992 0 None None None Human 6.9 pIC50 = 6.9 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 454 6 0 3 5.4 COc1cccc(C(=O)N2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)c1 10.1016/s0960-894x(01)00545-5
478495 473861 0 None None None Human 5.9 pIC50 = 5.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 626 14 0 4 7.2 CCCCCCCCS(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
CHEMBL91045 473861 0 None None None Human 5.9 pIC50 = 5.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 626 14 0 4 7.2 CCCCCCCCS(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
44392155 138135 0 None None None Human 5.9 pIC50 = 5.9 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1cccc(F)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183514 138135 0 None None None Human 5.9 pIC50 = 5.9 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1cccc(F)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11350639 178929 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL234634 178929 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
11350639 178929 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL234634 178929 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
16728648 182033 0 None None None Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 420 5 1 5 3.9 CN(/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1)C1=NCCN1 10.1016/j.bmcl.2006.09.052
CHEMBL240037 182033 0 None None None Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 420 5 1 5 3.9 CN(/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1)C1=NCCN1 10.1016/j.bmcl.2006.09.052
10483364 385617 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 580 7 1 5 5.6 O=C(c1ccco1)N1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL522493 385617 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 580 7 1 5 5.6 O=C(c1ccco1)N1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
16728788 164844 0 None None None Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 450 7 1 7 3.4 Cc1cc(CN2CCN(C)CC2)ccc1NC(=O)CSc1nnc(C)n1-c1ccccc1 10.1021/jm061389p
CHEMBL219770 164844 0 None None None Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 450 7 1 7 3.4 Cc1cc(CN2CCN(C)CC2)ccc1NC(=O)CSc1nnc(C)n1-c1ccccc1 10.1021/jm061389p
16728648 182033 0 None None None Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 420 5 1 5 3.9 CN(/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1)C1=NCCN1 10.1007/s00044-012-0118-7
CHEMBL240037 182033 0 None None None Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 420 5 1 5 3.9 CN(/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1)C1=NCCN1 10.1007/s00044-012-0118-7
118219356 442757 0 None None None Human 6.8 pIC50 = 6.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 532 8 1 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)nc1 nan
CHEMBL5982700 442757 0 None None None Human 6.8 pIC50 = 6.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 532 8 1 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)nc1 nan
25057602 20109 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 517 7 0 4 6.0 CCCCC1N(Cc2ccccc2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078647 20109 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 517 7 0 4 6.0 CCCCC1N(Cc2ccccc2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44590332 352951 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 7 1 3 4.8 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(CNC(=O)C3CC3)(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL471403 352951 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 7 1 3 4.8 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(CNC(=O)C3CC3)(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2009.01.012
91884571 355309 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 471 5 3 5 2.5 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cccc(C(C)(C)C)n2)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4764460 355309 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 471 5 3 5 2.5 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cccc(C(C)(C)C)n2)C1=O 10.1021/acsmedchemlett.1c00082
10053691 385183 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 6 1 5 5.2 O=C(c1ccco1)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL521699 385183 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 6 1 5 5.2 O=C(c1ccco1)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
11246827 178838 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 407 5 0 3 4.8 O=C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234206 178838 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 407 5 0 3 4.8 O=C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
11177360 293963 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 409 5 1 3 4.6 OC1CCCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1007/s00044-012-0118-7
CHEMBL392868 293963 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 409 5 1 3 4.6 OC1CCCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1007/s00044-012-0118-7
478494 473591 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 528 7 0 4 4.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(C)(=O)=O 10.1007/s00044-011-9863-2
CHEMBL89221 473591 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 528 7 0 4 4.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(C)(=O)=O 10.1007/s00044-011-9863-2
76308985 176522 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 570 8 3 3 7.3 Cc1ccc(NC(=O)NCC2(O)CCC(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)cc1 10.1007/s00044-012-0118-7
CHEMBL2281958 176522 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 570 8 3 3 7.3 Cc1ccc(NC(=O)NCC2(O)CCC(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)cc1 10.1007/s00044-012-0118-7
5481716 470666 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 551 8 0 4 5.2 CN1C(=O)c2ccccc2C12CCN(CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1cccc(Cl)c1)CC2 10.1007/s00044-011-9863-2
CHEMBL83745 470666 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 551 8 0 4 5.2 CN1C(=O)c2ccccc2C12CCN(CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1cccc(Cl)c1)CC2 10.1007/s00044-011-9863-2
483335 19953 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 13 0 8 5.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(CC#N)c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL107750 19953 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 13 0 8 5.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(CC#N)c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
483336 219219 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 562 13 0 9 5.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc([N+](=O)[O-])c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL322439 219219 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 562 13 0 9 5.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc([N+](=O)[O-])c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
483330 220098 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2ncc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL325357 220098 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2ncc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
46888454 23078 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 419 6 1 3 3.6 CC(=O)N[C@@H](CCN1C[C@H]2CN(C(=O)c3c(C)cccc3C)C[C@H]2C1)c1ccccc1 10.1016/j.bmcl.2010.03.095
CHEMBL1096446 23078 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 419 6 1 3 3.6 CC(=O)N[C@@H](CCN1C[C@H]2CN(C(=O)c3c(C)cccc3C)C[C@H]2C1)c1ccccc1 10.1016/j.bmcl.2010.03.095
46888497 23276 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 475 7 1 4 3.6 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098151 23276 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 475 7 1 4 3.6 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
122668226 404356 0 None None None Human 7.8 pIC50 = 7.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 415 7 1 6 4.2 CC(=O)NC(CCN1C2CCC1CC(n1c(C)nnc1C(C)C)C2)c1cccs1 nan
CHEMBL5783386 404356 0 None None None Human 7.8 pIC50 = 7.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 415 7 1 6 4.2 CC(=O)NC(CCN1C2CCC1CC(n1c(C)nnc1C(C)C)C2)c1cccs1 nan
57403931 143279 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 618 12 0 7 3.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(S(=O)(=O)CC)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951897 143279 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 618 12 0 7 3.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(S(=O)(=O)CC)CC2)CC1 10.1016/j.bmcl.2011.12.117
44454999 197946 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1cccc(Cl)c1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL271075 197946 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1cccc(Cl)c1)c1ccccc1 10.1016/j.bmcl.2007.12.058
46882077 19943 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 591 7 0 7 4.9 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077359 19943 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 591 7 0 7 4.9 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
44461559 213889 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 569 12 0 5 6.0 CCN(C(=O)OCC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL309657 213889 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 569 12 0 5 6.0 CCN(C(=O)OCC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461521 332620 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 515 12 0 5 4.8 CCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL431009 332620 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 515 12 0 5 4.8 CCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481703 470601 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83107 470601 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481703 470601 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL83107 470601 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
490011 220897 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 495 7 0 4 5.1 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL327186 220897 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 495 7 0 4 5.1 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44461559 213889 0 None None None Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 569 12 0 5 6.0 CCN(C(=O)OCC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL309657 213889 0 None None None Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 569 12 0 5 6.0 CCN(C(=O)OCC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461521 332620 0 None None None Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 515 12 0 5 4.8 CCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL431009 332620 0 None None None Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 515 12 0 5 4.8 CCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
73346389 183479 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435879 183479 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
118219282 447083 0 None None None Human 7.8 pIC50 = 7.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 484 8 1 7 5.2 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1nccs1 nan
CHEMBL5979677 447083 0 None None None Human 7.8 pIC50 = 7.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 484 8 1 7 5.2 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1nccs1 nan
16041594 183449 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 555 8 1 5 5.8 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435849 183449 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 555 8 1 5 5.8 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
25132254 125598 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784384 125598 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
54582110 125617 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 600 6 0 4 8.1 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm200279v
CHEMBL1784479 125617 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 600 6 0 4 8.1 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm200279v
25133962 203331 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 600 6 0 4 8.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084495 203331 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 600 6 0 4 8.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
122668184 423477 0 None None None Human 7.8 pIC50 = 7.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 573 7 1 6 5.4 CC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccsc2)C1 nan
CHEMBL5841204 423477 0 None None None Human 7.8 pIC50 = 7.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 573 7 1 6 5.4 CC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccsc2)C1 nan
478501 215664 0 None None None Human 6.8 pIC50 = 6.8 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1016/s0960-894x(00)00637-5
CHEMBL313072 215664 0 None None None Human 6.8 pIC50 = 6.8 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1016/s0960-894x(00)00637-5
44392130 240952 0 None None None Human 6.8 pIC50 = 6.8 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 471 9 0 4 5.3 CN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL360044 240952 0 None None None Human 6.8 pIC50 = 6.8 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 471 9 0 4 5.3 CN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11246827 178838 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 407 5 0 3 4.8 O=C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234206 178838 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 407 5 0 3 4.8 O=C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
11177360 293963 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 409 5 1 3 4.6 OC1CCCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1016/j.bmcl.2007.01.050
CHEMBL392868 293963 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 409 5 1 3 4.6 OC1CCCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1016/j.bmcl.2007.01.050
44461774 333725 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 473 9 0 5 3.6 COC(=O)N(C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL440137 333725 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 473 9 0 5 3.6 COC(=O)N(C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
489835 474675 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 428 6 0 2 5.9 Fc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
CHEMBL96217 474675 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 428 6 0 2 5.9 Fc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
44431969 180790 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 575 8 3 4 6.0 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1ccc(F)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL238118 180790 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 575 8 3 4 6.0 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1ccc(F)cc1 10.1016/j.bmcl.2007.01.050
483360 26581 0 None None None Human 4.8 pIC50 = 4.8 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 569 14 0 6 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CCC(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL118501 26581 0 None None None Human 4.8 pIC50 = 4.8 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 569 14 0 6 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CCC(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
3010252 232833 0 None None None Human 4.8 pIC50 = 4.8 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 585 14 0 7 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(=O)(=O)C(C)C)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL332458 232833 0 None None None Human 4.8 pIC50 = 4.8 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 585 14 0 7 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(=O)(=O)C(C)C)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44461774 333725 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 473 9 0 5 3.6 COC(=O)N(C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL440137 333725 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 473 9 0 5 3.6 COC(=O)N(C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
473305 221789 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 460 6 0 3 5.0 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL329131 221789 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 460 6 0 3 5.0 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
72714318 183488 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
CHEMBL2435888 183488 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
489807 474197 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 438 6 0 2 5.4 O=C(Cc1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93229 474197 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 438 6 0 2 5.4 O=C(Cc1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
155531379 336137 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 532 7 1 5 2.6 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](N(C)S(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL4465351 336137 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 532 7 1 5 2.6 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](N(C)S(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
54581070 125607 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 610 7 0 6 6.2 Cc1nc2cc(S(C)(=O)=O)ccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784399 125607 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 610 7 0 6 6.2 Cc1nc2cc(S(C)(=O)=O)ccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
23294214 333771 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 7 1 4 6.9 O=C(c1ccccc1)N1CCCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL440465 333771 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 7 1 4 6.9 O=C(c1ccccc1)N1CCCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
16728619 181460 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 404 6 3 5 2.6 COC(=O)c1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
CHEMBL238949 181460 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 404 6 3 5 2.6 COC(=O)c1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
483337 19438 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 585 12 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(Cl)c2Cl)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105572 19438 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 585 12 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(Cl)c2Cl)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
516345 122597 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 579 9 1 6 6.4 CCn1nc(-c2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL172761 122597 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 579 9 1 6 6.4 CCn1nc(-c2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3013673 158603 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 461 8 0 3 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3)CC2)c2ccccc2)CC1 10.1021/jm051034q
CHEMBL207085 158603 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 461 8 0 3 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3)CC2)c2ccccc2)CC1 10.1021/jm051034q
516349 122645 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 622 9 1 5 7.8 CCn1nc(-c2cccc3ccccc23)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL172944 122645 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 622 9 1 5 7.8 CCn1nc(-c2cccc3ccccc23)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.004
516345 122597 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 579 9 1 6 6.4 CCn1nc(-c2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL172761 122597 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 579 9 1 6 6.4 CCn1nc(-c2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
6320581 241354 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 527 8 0 5 4.8 CN(C[C@@H](CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL360522 241354 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 527 8 0 5 4.8 CN(C[C@@H](CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
118219316 410148 0 None None None Human 7.8 pIC50 = 7.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 470 8 1 7 4.8 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCC1)c1nccs1 nan
CHEMBL5793093 410148 0 None None None Human 7.8 pIC50 = 7.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 470 8 1 7 4.8 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCC1)c1nccs1 nan
72714076 183483 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435883 183483 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
122668269 448955 0 None None None Human 7.8 pIC50 = 7.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 470 6 1 7 3.0 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(C)=O)C3)C2)c1nccs1 nan
CHEMBL5999256 448955 0 None None None Human 7.8 pIC50 = 7.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 470 6 1 7 3.0 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(C)=O)C3)C2)c1nccs1 nan
5482811 222293 0 None None None Human 6.8 pIC50 = 6.8 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 620 9 0 5 6.0 CCN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL330734 222293 0 None None None Human 6.8 pIC50 = 6.8 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 620 9 0 5 6.0 CCN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
479868 474009 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 9 0 3 6.0 Cc1cc(C)cc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
CHEMBL91892 474009 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 9 0 3 6.0 Cc1cc(C)cc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
5482807 216517 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 560 8 1 4 6.6 O=S(=O)(NC[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL314486 216517 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 560 8 1 4 6.6 O=S(=O)(NC[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
16728619 181460 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 404 6 3 5 2.6 COC(=O)c1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
CHEMBL238949 181460 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 404 6 3 5 2.6 COC(=O)c1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
11534473 181516 0 None None None Human 5.8 pIC50 = 5.8 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 594 14 1 5 8.0 CCN(CC)CCCC(NC(=O)CCOc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1)C(C)C 10.1016/j.bmcl.2006.10.060
CHEMBL239144 181516 0 None None None Human 5.8 pIC50 = 5.8 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 594 14 1 5 8.0 CCN(CC)CCCC(NC(=O)CCOc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1)C(C)C 10.1016/j.bmcl.2006.10.060
57400373 143283 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 615 12 0 5 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951901 143283 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 615 12 0 5 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
42606792 219365 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 517 7 1 5 3.0 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL3233178 219365 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 517 7 1 5 3.0 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
44564931 372635 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 467 8 1 6 4.4 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCOCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL514000 372635 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 467 8 1 6 4.4 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCOCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
76319890 176529 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 662 8 3 3 8.3 Cc1cc(Br)cc(C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281965 176529 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 662 8 3 3 8.3 Cc1cc(Br)cc(C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
11267381 178695 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 325 4 1 2 4.1 NCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL233845 178695 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 325 4 1 2 4.1 NCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
16728622 181896 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 360 5 3 3 3.2 Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
CHEMBL239783 181896 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 360 5 3 3 3.2 Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
16728616 182378 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-012-0118-7
CHEMBL240638 182378 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-012-0118-7
16728625 294228 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 422 6 3 3 4.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(-c2ccccc2)cc1 10.1007/s00044-012-0118-7
CHEMBL393068 294228 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 422 6 3 3 4.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(-c2ccccc2)cc1 10.1007/s00044-012-0118-7
11690481 174524 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 428 7 1 4 4.5 Cc1nc2ccccc2n1C1[C@@H]2CN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)C[C@H]12 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203618 174524 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 428 7 1 4 4.5 Cc1nc2ccccc2n1C1[C@@H]2CN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)C[C@H]12 10.1111/j.1747-0285.2006.00376.x
10228761 28172 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1196469 28172 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
490010 474679 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 509 7 0 4 5.5 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL96242 474679 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 509 7 0 4 5.5 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
122668237 406144 0 None None None Human 7.8 pIC50 = 7.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 531 8 1 6 5.0 CCCC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2ccc(Cl)s2)C1 nan
CHEMBL5752217 406144 0 None None None Human 7.8 pIC50 = 7.8 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 531 8 1 6 5.0 CCCC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2ccc(Cl)s2)C1 nan
54581076 125620 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 562 7 0 5 6.8 COc1cccc(C(=O)N2CCC(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)c1 10.1021/jm200279v
CHEMBL1784483 125620 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 562 7 0 5 6.8 COc1cccc(C(=O)N2CCC(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)c1 10.1021/jm200279v
44590718 348837 0 None None None Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 505 11 1 4 5.0 CCN(C(=O)Cc1ccccc1OC)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL456224 348837 0 None None None Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 505 11 1 4 5.0 CCN(C(=O)Cc1ccccc1OC)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
489595 332640 0 None None None Human 6.8 pIC50 = 6.8 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 536 5 0 5 3.9 O=S1(=O)CC2(CCN(C[C@H]3CN(S(=O)(=O)c4ccccc4)C[C@@H]3c3ccccc3)CC2)c2ccccc21 10.1016/s0960-894x(01)00232-3
CHEMBL431111 332640 0 None None None Human 6.8 pIC50 = 6.8 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 536 5 0 5 3.9 O=S1(=O)CC2(CCN(C[C@H]3CN(S(=O)(=O)c4ccccc4)C[C@@H]3c3ccccc3)CC2)c2ccccc21 10.1016/s0960-894x(01)00232-3
44431976 294134 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 663 8 3 4 7.2 Cc1cc(Br)cc(C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL393002 294134 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 663 8 3 4 7.2 Cc1cc(Br)cc(C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
16728622 181896 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 360 5 3 3 3.2 Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
CHEMBL239783 181896 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 360 5 3 3 3.2 Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
16728616 182378 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc([N+](=O)[O-])c1 10.1016/j.bmcl.2006.09.052
CHEMBL240638 182378 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc([N+](=O)[O-])c1 10.1016/j.bmcl.2006.09.052
16728625 294228 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 422 6 3 3 4.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL393068 294228 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 422 6 3 3 4.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.09.052
11267381 178695 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 325 4 1 2 4.1 NCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL233845 178695 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 325 4 1 2 4.1 NCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
1167892 164846 0 None None None Human 4.8 pIC50 = 4.8 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 463 9 1 6 4.7 Cc1ccc(NC(=O)CSc2nnc(CCN3CCCCC3)n2Cc2ccccc2)c(C)c1 10.1021/jm061389p
CHEMBL219781 164846 0 None None None Human 4.8 pIC50 = 4.8 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 463 9 1 6 4.7 Cc1ccc(NC(=O)CSc2nnc(CCN3CCCCC3)n2Cc2ccccc2)c(C)c1 10.1021/jm061389p
54587374 123640 0 None None None Human 4.8 pIC50 = 4.8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 516 8 1 5 4.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762303 123640 0 None None None Human 4.8 pIC50 = 4.8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 516 8 1 5 4.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
72714317 183487 0 None None None Human 5.8 pIC50 = 5.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 546 8 1 5 5.2 Cc1ccccc1C1CN(C2CCCCC2)C(=O)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1021/jm401101p
CHEMBL2435887 183487 0 None None None Human 5.8 pIC50 = 5.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 546 8 1 5 5.2 Cc1ccccc1C1CN(C2CCCCC2)C(=O)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1021/jm401101p
72711050 183495 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435895 183495 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
44565035 370083 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 7 1 6 3.9 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)N2CCOCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489323 370083 0 None None None Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 7 1 6 3.9 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)N2CCOCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
54585369 123343 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 568 9 1 5 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1760024 123343 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 568 9 1 5 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
54580093 125616 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 550 6 0 4 6.9 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(F)cc2)CC1 10.1021/jm200279v
CHEMBL1784478 125616 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 550 6 0 4 6.9 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(F)cc2)CC1 10.1021/jm200279v
54583049 125601 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 526 5 0 5 5.7 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CC(=O)C1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
CHEMBL1784388 125601 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 526 5 0 5 5.7 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CC(=O)C1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
478495 473861 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 626 14 0 4 7.2 CCCCCCCCS(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1007/s00044-011-9863-2
CHEMBL91045 473861 0 None None None Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 626 14 0 4 7.2 CCCCCCCCS(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1007/s00044-011-9863-2
162668957 366143 0 None None None Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 495 5 3 7 3.1 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(C)(C)C)nc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4790208 366143 0 None None None Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 495 5 3 7 3.1 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(C)(C)C)nc23)C1=O 10.1021/acsmedchemlett.1c00082
25230826 334583 0 None None None Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 582 7 0 7 4.5 CCCCC1CN(S(=O)(=O)c2ccccn2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL444255 334583 0 None None None Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 582 7 0 7 4.5 CCCCC1CN(S(=O)(=O)c2ccccn2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
483345 19312 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 588 10 2 6 5.4 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(c2ccccc2)C2Nc3ccccc3S(=O)(=O)N2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104867 19312 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 588 10 2 6 5.4 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(c2ccccc2)C2Nc3ccccc3S(=O)(=O)N2)CC1 10.1016/s0960-894x(01)00655-2
44335765 19773 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 610 12 0 6 6.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(c2ccccc2)C2c3ccccc3C(=O)N2CC)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL107380 19773 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 610 12 0 6 6.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(c2ccccc2)C2c3ccccc3C(=O)N2CC)CC1 10.1016/s0960-894x(01)00655-2
46888496 23275 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 471 7 1 4 4.5 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)c3ccoc3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098150 23275 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 471 7 1 4 4.5 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)c3ccoc3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44404643 144441 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 611 12 1 6 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198114 144441 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 611 12 1 6 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
44392096 259667 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 518 10 0 4 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL369311 259667 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 518 10 0 4 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2005.08.014
56647023 183480 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435880 183480 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
44573299 372026 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 555 7 0 4 7.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)N(C(C)C)C(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL506788 372026 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 555 7 0 4 7.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)N(C(C)C)C(C)C)CC1 10.1016/j.bmcl.2009.02.014
46882872 20019 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 7 0 4 5.9 CCCCC1N(CC2CCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1077989 20019 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 7 0 4 5.9 CCCCC1N(CC2CCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46864993 20566 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.2 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1081486 20566 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.2 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
53321616 121250 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683063 121250 0 None None None Human 7.8 pIC50 = 7.8 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
68769802 239847 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 493 7 1 6 4.2 COC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
CHEMBL3577949 239847 0 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 493 7 1 6 4.2 COC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
3010256 372404 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511806 372404 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010256 372404 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligandInhibitory concentration against C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL511806 372404 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligandInhibitory concentration against C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
3010256 372404 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511806 372404 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
126595655 433141 0 None None None Human 7.7 pIC50 = 7.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 529 7 1 6 4.6 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C1CC1)C3)C2)c1ccc(Cl)s1 nan
CHEMBL5934820 433141 0 None None None Human 7.7 pIC50 = 7.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 529 7 1 6 4.6 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C1CC1)C3)C2)c1ccc(Cl)s1 nan
72711278 183498 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435898 183498 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
15950679 183468 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435868 183468 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
44392094 331108 0 None None None Human 6.8 pIC50 = 6.8 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 11 0 4 5.8 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL426960 331108 0 None None None Human 6.8 pIC50 = 6.8 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 11 0 4 5.8 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54586286 123585 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 516 9 1 5 4.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(CCCNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762143 123585 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 516 9 1 5 4.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(CCCNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
5481711 470753 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 522 8 0 3 6.1 CN(C[C@@H](CCN1CCC2(CCc3ccccc32)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL84374 470753 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 522 8 0 3 6.1 CN(C[C@@H](CCN1CCC2(CCc3ccccc32)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
479872 473445 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 494 9 0 3 5.8 Cc1cc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)ccc1F 10.1016/s0960-894x(00)00639-9
CHEMBL88219 473445 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 494 9 0 3 5.8 Cc1cc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)ccc1F 10.1016/s0960-894x(00)00639-9
479852 473741 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 528 8 0 5 4.7 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL90291 473741 0 None None None Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 528 8 0 5 4.7 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44392211 251372 3 None None None Human 5.8 pIC50 = 5.8 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 433 7 1 2 5.6 CN(C(=O)NC1CCCCC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL361444 251372 3 None None None Human 5.8 pIC50 = 5.8 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 433 7 1 2 5.6 CN(C(=O)NC1CCCCC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
72714077 183484 0 None None None Human 5.7 pIC50 = 5.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435884 183484 0 None None None Human 5.7 pIC50 = 5.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
44590944 372987 0 None None None Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 396 7 1 5 4.0 Cc1nnc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)o1 10.1016/j.bmcl.2009.01.009
CHEMBL516939 372987 0 None None None Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 396 7 1 5 4.0 Cc1nnc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)o1 10.1016/j.bmcl.2009.01.009
44565036 370119 0 None None None Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 481 7 1 6 3.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)N2CCN(C)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489512 370119 0 None None None Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 481 7 1 6 3.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)N2CCN(C)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
24794656 354743 0 None None None Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 450 4 3 6 2.0 CC(=O)N[C@@H]1C[C@H](N)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4757452 354743 0 None None None Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 450 4 3 6 2.0 CC(=O)N[C@@H]1C[C@H](N)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
9915724 158924 0 None None None Human 7.7 pIC50 = 7.7 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 556 12 1 5 5.4 COP(=O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccccc1 10.1016/s0960-894x(02)00829-6
CHEMBL20818 158924 0 None None None Human 7.7 pIC50 = 7.7 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 556 12 1 5 5.4 COP(=O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccccc1 10.1016/s0960-894x(02)00829-6
25230771 337080 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 581 7 0 6 5.1 CCCCC1CN(S(=O)(=O)c2ccccc2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL448610 337080 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 581 7 0 6 5.1 CCCCC1CN(S(=O)(=O)c2ccccc2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
25230773 346945 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 563 7 0 5 5.5 CCCCC1C(=O)N(Cc2ccc(F)cc2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL451400 346945 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 563 7 0 5 5.5 CCCCC1C(=O)N(Cc2ccc(F)cc2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44570267 351389 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 587 7 0 6 4.6 CCCC[C@H]1CN(S(=O)(=O)CC(F)(F)F)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL463874 351389 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 587 7 0 6 4.6 CCCC[C@H]1CN(S(=O)(=O)CC(F)(F)F)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
46888544 23088 0 None None None Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 464 7 1 5 3.7 Cc1noc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096486 23088 0 None None None Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 464 7 1 5 3.7 Cc1noc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44404650 271034 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 570 10 0 4 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(Cl)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL370998 271034 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 570 10 0 4 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(Cl)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
52942071 42190 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 547 8 0 5 4.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cc(F)cc(F)c3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270798 42190 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 547 8 0 5 4.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cc(F)cc(F)c3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
5275764 157695 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 636 10 0 5 5.0 CN(C)C(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL205706 157695 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 636 10 0 5 5.0 CN(C)C(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
44325489 216637 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 474 5 0 2 6.6 O=C(c1cccc2ccccc12)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL315159 216637 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 474 5 0 2 6.6 O=C(c1cccc2ccccc12)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
489825 474340 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 416 5 0 2 5.3 O=C(C1CCCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL94179 474340 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 416 5 0 2 5.3 O=C(C1CCCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
72711507 183503 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435903 183503 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
72711047 183492 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435892 183492 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
59458103 183506 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435906 183506 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72713860 183513 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435913 183513 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
478452 176544 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 575 14 0 4 5.8 CCCN(C(=O)CCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282502 176544 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 575 14 0 4 5.8 CCCN(C(=O)CCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
478448 213858 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 590 13 0 4 5.9 CCCN(C(=O)N(C)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL309447 213858 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 590 13 0 4 5.9 CCCN(C(=O)N(C)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461522 470224 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 11 0 5 4.4 CCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79907 470224 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 11 0 5 4.4 CCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
54580081 125609 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 533 6 0 5 6.2 Cc1nc2cccnc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784401 125609 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 533 6 0 5 6.2 Cc1nc2cccnc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
25132255 203330 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 524 6 0 4 6.7 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)C2CCCC2)CC1 10.1021/jm800598a
CHEMBL3084494 203330 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 524 6 0 4 6.7 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)C2CCCC2)CC1 10.1021/jm800598a
68772423 336491 0 None None None Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 541 7 1 7 3.6 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](CS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL4470701 336491 0 None None None Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 541 7 1 7 3.6 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](CS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
44392159 125652 0 None None None Human 6.7 pIC50 = 6.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 445 7 1 2 6.0 CN(C(=O)Nc1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL178477 125652 0 None None None Human 6.7 pIC50 = 6.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 445 7 1 2 6.0 CN(C(=O)Nc1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11353001 121592 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688239 121592 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
11753754 123659 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1cccnc1OC(c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762329 123659 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1cccnc1OC(c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
44392144 137509 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1ccccc1F)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182557 137509 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1ccccc1F)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728610 299325 8 None None None Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 346 5 3 3 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1 10.1016/j.bmcl.2006.09.052
CHEMBL397295 299325 8 None None None Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 346 5 3 3 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1 10.1016/j.bmcl.2006.09.052
17016126 180842 8 None None None Human 5.7 pIC50 = 5.7 Binding
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 497 7 1 5 5.3 COc1ccccc1C(CNC(=O)c1cc(-c2ccc(Br)cc2)on1)N1CCC(C)CC1 10.1021/acs.jmedchem.6b01309
CHEMBL2381332 180842 8 None None None Human 5.7 pIC50 = 5.7 Binding
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 497 7 1 5 5.3 COc1ccccc1C(CNC(=O)c1cc(-c2ccc(Br)cc2)on1)N1CCC(C)CC1 10.1021/acs.jmedchem.6b01309
16728610 299325 8 None None None Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 346 5 3 3 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1 10.1007/s00044-012-0118-7
CHEMBL397295 299325 8 None None None Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 346 5 3 3 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1 10.1007/s00044-012-0118-7
72714319 183489 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
CHEMBL2435889 183489 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
72712374 183474 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
CHEMBL2435874 183474 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
9869601 182577 0 None None None Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 394 5 3 3 3.9 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL241097 182577 0 None None None Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 394 5 3 3 3.9 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
44565559 372880 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL516027 372880 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
54581071 125611 0 None None None Human 5.7 pIC50 = 5.7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 562 8 0 5 6.9 CCOc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784403 125611 0 None None None Human 5.7 pIC50 = 5.7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 562 8 0 5 6.9 CCOc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
23294208 197465 0 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 8 1 4 6.8 O=C1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
CHEMBL26790 197465 0 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 8 1 4 6.8 O=C1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
25131900 203325 0 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 610 6 0 5 8.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084488 203325 0 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 610 6 0 5 8.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
16728614 182377 0 None None None Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 371 5 3 4 2.7 N#Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
CHEMBL240637 182377 0 None None None Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 371 5 3 4 2.7 N#Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
16728649 333626 0 None None None Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 420 5 2 5 4.0 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCCN2)cc1 10.1007/s00044-012-0118-7
CHEMBL439223 333626 0 None None None Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 420 5 2 5 4.0 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCCN2)cc1 10.1007/s00044-012-0118-7
5481726 470575 0 None None None Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 564 9 0 3 7.0 CN(C[C@@H](CCN1CCC(c2cccc(C(F)(F)F)c2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL82838 470575 0 None None None Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 564 9 0 3 7.0 CN(C[C@@H](CCN1CCC(c2cccc(C(F)(F)F)c2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
489308 19626 0 None None None Human 8.7 pIC50 = 8.7 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 587 13 0 5 7.3 CN(CC(CCN1CCC(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccc(-c2ccccn2)s1 10.1016/s0960-894x(01)00652-7
CHEMBL106569 19626 0 None None None Human 8.7 pIC50 = 8.7 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 587 13 0 5 7.3 CN(CC(CCN1CCC(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccc(-c2ccccn2)s1 10.1016/s0960-894x(01)00652-7
42623163 352773 0 None None None Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 437 8 1 5 4.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL469724 352773 0 None None None Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 437 8 1 5 4.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
489338 19513 0 None None None Human 8.7 pIC50 = 8.7 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 655 12 2 5 6.6 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL105975 19513 0 None None None Human 8.7 pIC50 = 8.7 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 655 12 2 5 6.6 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
496975 218152 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 546 12 2 4 6.1 O=C(O)CCc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
CHEMBL320149 218152 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 546 12 2 4 6.1 O=C(O)CCc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
25256856 385808 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 510 5 0 6 5.4 CO/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL524001 385808 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 510 5 0 6 5.4 CO/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
11503459 174295 1 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203615 174295 1 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
501052 217057 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 10 2 4 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318210 217057 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 10 2 4 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010263 372372 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511494 372372 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44447731 195474 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255430 195474 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008902 466725 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL61536 466725 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
183790 8163 6 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting methodDisplacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting method
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
783 8163 6 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting methodDisplacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting method
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
CHEMBL1178786 8163 6 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting methodDisplacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting method
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
501052 217057 0 None None None Human 8.7 pIC50 = 8.7 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 478 10 2 4 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL318210 217057 0 None None None Human 8.7 pIC50 = 8.7 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 478 10 2 4 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
483382 161036 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL2114184 161036 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461684 214600 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 604 14 0 6 5.1 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311248 214600 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 604 14 0 6 5.1 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
21147749 214992 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311549 214992 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
486606 470194 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79622 470194 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
486601 470398 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 597 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL81252 470398 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 597 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
44461707 470489 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 577 13 0 5 6.0 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL82048 470489 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 577 13 0 5 6.0 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
11467704 470630 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 620 14 0 7 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83335 470630 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 620 14 0 7 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5275829 470818 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL85086 470818 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44415800 161977 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
CHEMBL214818 161977 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
3010263 372372 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL511494 372372 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
6320582 125972 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 541 8 0 5 5.0 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL179141 125972 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 541 8 0 5 5.0 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
6320585 125984 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL179209 125984 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
5275829 470818 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
CHEMBL85086 470818 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
516182 122400 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 614 10 1 5 6.7 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172019 122400 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 614 10 1 5 6.7 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516277 259268 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 10 1 6 7.2 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368979 259268 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 10 1 6 7.2 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516172 239041 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL353331 239041 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
490017 332602 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 517 8 0 4 5.5 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL430867 332602 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 517 8 0 4 5.5 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490014 474285 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 559 8 0 4 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL93851 474285 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 559 8 0 4 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
118219317 410636 0 None None None Human 8.7 pIC50 = 8.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 497 9 1 6 5.9 CCc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCC2)s1 nan
CHEMBL5798622 410636 0 None None None Human 8.7 pIC50 = 8.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 497 9 1 6 5.9 CCc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCC2)s1 nan
516354 371453 1 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(C(F)(F)c4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL499483 371453 1 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(C(F)(F)c4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
516354 371453 1 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(C(F)(F)c4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL499483 371453 1 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(C(F)(F)c4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44383787 122083 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3C(F)(F)c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL170543 122083 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3C(F)(F)c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516206 122511 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 11 1 5 8.1 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL172436 122511 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 11 1 5 8.1 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516172 239041 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL353331 239041 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516325 122570 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL172659 122570 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
516325 122570 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL172659 122570 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
11636141 213273 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 683 17 1 8 7.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085310 213273 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 683 17 1 8 7.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
3008928 466307 0 None None None Crab-eating macaque 8.7 pIC50 = 8.7 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL61424 466307 0 None None None Crab-eating macaque 8.7 pIC50 = 8.7 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3013701 158736 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 643 10 0 6 4.7 CS(=O)(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL207487 158736 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 643 10 0 6 4.7 CS(=O)(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
516353 258090 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 600 11 1 5 6.8 CCn1nc(CCc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL367838 258090 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 600 11 1 5 6.8 CCn1nc(CCc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.004
516325 122570 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL172659 122570 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516177 257701 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2ccccc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367529 257701 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2ccccc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
474170 25557 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 564 7 1 3 7.5 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL1179149 25557 0 None None None Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 564 7 1 3 7.5 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
118219288 412389 0 None None None Human 8.7 pIC50 = 8.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 596 9 1 8 4.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCN(S(C)(=O)=O)CC1)c1ccc(Cl)s1 nan
CHEMBL5818070 412389 0 None None None Human 8.7 pIC50 = 8.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 596 9 1 8 4.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCN(S(C)(=O)=O)CC1)c1ccc(Cl)s1 nan
126585471 423631 0 None None None Human 8.7 pIC50 = 8.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 483 8 1 6 5.8 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1cccs1 nan
CHEMBL5871639 423631 0 None None None Human 8.7 pIC50 = 8.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 483 8 1 6 5.8 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1cccs1 nan
44404705 144274 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL197641 144274 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2005.08.014
516339 256410 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL366626 256410 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
3008927 424050 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL58387 424050 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
516339 256410 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL366626 256410 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
516263 124129 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 9 1 5 8.1 CCn1nc(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176859 124129 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 9 1 5 8.1 CCn1nc(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516303 124445 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 664 11 1 7 6.0 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177157 124445 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 664 11 1 7 6.0 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516174 259336 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 552 10 1 5 6.2 CCn1nc(CC2CCCCC2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369151 259336 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 552 10 1 5 6.2 CCn1nc(CC2CCCCC2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516339 256410 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL366626 256410 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
44590683 349577 0 None None None Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.3 CCN(C(=O)Cc1ccc(Cl)cc1Cl)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL457960 349577 0 None None None Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.3 CCN(C(=O)Cc1ccc(Cl)cc1Cl)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
122668147 423962 0 None None None Human 8.6 pIC50 = 8.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 519 8 1 6 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 nan
CHEMBL5930833 423962 0 None None None Human 8.6 pIC50 = 8.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 519 8 1 6 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 nan
68764898 1384 3 None None None Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
9430 1384 3 None None None Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
CHEMBL3577945 1384 3 None None None Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
3011734 143289 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 617 12 0 6 4.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(S(=O)(=O)CC)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951907 143289 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 617 12 0 6 4.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(S(=O)(=O)CC)CC2)CC1 10.1016/j.bmcl.2011.12.117
11650548 213271 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 697 17 1 8 8.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085308 213271 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 697 17 1 8 8.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CC(C)C)cc1 10.1021/jm0509703
68764898 1384 3 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
9430 1384 3 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
CHEMBL3577945 1384 3 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
486601 470398 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 597 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL81252 470398 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 597 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2003.12.004
118219323 404418 0 None None None Human 8.6 pIC50 = 8.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 576 9 1 8 4.2 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)s1 nan
CHEMBL5835592 404418 0 None None None Human 8.6 pIC50 = 8.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 576 9 1 8 4.2 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)s1 nan
10008665 333171 0 None None None Human 8.6 pIC50 = 8.6 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 596 10 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN3O[C@H](c4ccccc4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL435259 333171 0 None None None Human 8.6 pIC50 = 8.6 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 596 10 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN3O[C@H](c4ccccc4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
20664156 252637 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 500 7 1 5 5.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL364070 252637 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 500 7 1 5 5.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
20664156 252637 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 7 1 5 5.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL364070 252637 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 7 1 5 5.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
72711047 183492 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435892 183492 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
478445 470183 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 576 13 1 4 5.6 CCCN(C(=O)NCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79530 470183 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 576 13 1 4 5.6 CCCN(C(=O)NCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
3500 3139 14 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
491774 3139 14 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
CHEMBL1196395 3139 14 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
171349634 384969 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of wild type CCR5 (unknown origin)Inhibition of wild type CCR5 (unknown origin)
ChEMBL 455 9 2 3 4.6 CCCC[C@H]1C[C@@H](N(C)C(C)C)CC[C@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1 10.1021/acs.jmedchem.6b01309
CHEMBL5267875 384969 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of wild type CCR5 (unknown origin)Inhibition of wild type CCR5 (unknown origin)
ChEMBL 455 9 2 3 4.6 CCCC[C@H]1C[C@@H](N(C)C(C)C)CC[C@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1 10.1021/acs.jmedchem.6b01309
478440 213980 0 None None None Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 534 11 2 4 4.4 CN(CC(CCN1CCC(NC(=O)NCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
CHEMBL309922 213980 0 None None None Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 534 11 2 4 4.4 CN(CC(CCN1CCC(NC(=O)NCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
122668227 432890 0 None None None Human 8.6 pIC50 = 8.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 443 8 1 6 4.8 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCCC2)c2cccs2)CC1 nan
CHEMBL5932104 432890 0 None None None Human 8.6 pIC50 = 8.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 443 8 1 6 4.8 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCCC2)c2cccs2)CC1 nan
CHEMBL3109173 477881 0 None None None Human 8.6 pIC50 = 8.6 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 1072 35 1 15 8.9 Cc1nnc(CCCCCCCCCCn2cc(COCCOCCOCCOCCOCc3ccc(C(=O)N4CCC4=O)cc3)nn2)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
44401686 142279 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 9 1 5 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL193972 142279 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 9 1 5 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
3008917 467865 2 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL62152 467865 2 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
516254 251236 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 13 1 7 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366871 251236 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 13 1 7 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516179 258579 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2cc(F)cc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368333 258579 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2cc(F)cc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516241 160407 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 589 12 2 6 5.5 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(CN)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL2112951 160407 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 589 12 2 6 5.5 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(CN)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
20664163 333309 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL436290 333309 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
20664163 333309 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL436290 333309 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
20664163 333309 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL436290 333309 0 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3008904 444496 0 None None None Crab-eating macaque 8.6 pIC50 = 8.6 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL59511 444496 0 None None None Crab-eating macaque 8.6 pIC50 = 8.6 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
11570778 278187 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3cccc(C(N)=O)c3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL382252 278187 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3cccc(C(N)=O)c3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516364 122542 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 528 10 1 5 5.5 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL172551 122542 0 None None None Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 528 10 1 5 5.5 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
16663418 25094 28 None None None Mouse 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.ejmech.2018.01.085
CHEMBL1172035 25094 28 None None None Mouse 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.ejmech.2018.01.085
3008930 410787 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL58004 410787 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
11585418 157670 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 597 8 0 5 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(S(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL205539 157670 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 597 8 0 5 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(S(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516363 122166 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 542 11 1 5 5.9 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC(C)C)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL170892 122166 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 542 11 1 5 5.9 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC(C)C)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
501053 18935 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL102675 18935 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501059 217150 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318681 217150 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
496971 217198 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
CHEMBL318909 217198 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
516328 256054 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL366536 256054 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516332 258569 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL368265 258569 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44565791 354618 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL475606 354618 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44336415 332744 0 None None None Human 7.7 pIC50 = 7.7 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 524 9 1 5 5.0 O=S(=O)(c1cccs1)N1CC(CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL432010 332744 0 None None None Human 7.7 pIC50 = 7.7 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 524 9 1 5 5.0 O=S(=O)(c1cccs1)N1CC(CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
46890342 21438 0 None None None Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 588 6 1 6 4.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C[C@H]4CC[C@H](O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085224 21438 0 None None None Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 588 6 1 6 4.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C[C@H]4CC[C@H](O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
25205766 21442 0 None None None Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 574 6 0 6 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085229 21442 0 None None None Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 574 6 0 6 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888581 23023 0 None None None Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 511 8 1 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095815 23023 0 None None None Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 511 8 1 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
16073667 197149 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(F)c2F)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL265131 197149 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(F)c2F)CC1 10.1016/j.bmcl.2006.03.089
16073665 275946 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 664 11 0 6 5.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(F)(F)F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL377551 275946 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 664 11 0 6 5.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(F)(F)F)c2)CC1 10.1016/j.bmcl.2006.03.089
15958353 174523 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cellsDisplacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cells
ChEMBL 430 7 1 4 5.0 Cc1nc2ccccc2n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.ejmech.2023.115586
CHEMBL2203614 174523 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cellsDisplacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cells
ChEMBL 430 7 1 4 5.0 Cc1nc2ccccc2n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.ejmech.2023.115586
15958353 174523 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 430 7 1 4 5.0 Cc1nc2ccccc2n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203614 174523 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 430 7 1 4 5.0 Cc1nc2ccccc2n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1111/j.1747-0285.2006.00376.x
516338 122184 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1cc(Cc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL170987 122184 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1cc(Cc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
44455144 198210 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 486 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccccc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272490 198210 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 486 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccccc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
52918140 123668 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762338 123668 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
478448 213858 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 0 4 5.9 CCCN(C(=O)N(C)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL309447 213858 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 0 4 5.9 CCCN(C(=O)N(C)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461835 461865 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 14 0 4 5.8 CCCN(C(=O)CCc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL82786 461865 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 14 0 4 5.8 CCCN(C(=O)CCc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461522 470224 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 11 0 5 4.4 CCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79907 470224 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 11 0 5 4.4 CCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44415740 161640 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 458 9 1 5 4.9 O=C(N[C@@H](CCN1CCC(c2noc(Cc3ccccc3)n2)CC1)c1ccccc1)C1CCC1 10.1016/j.bmcl.2006.06.012
CHEMBL213541 161640 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 458 9 1 5 4.9 O=C(N[C@@H](CCN1CCC(c2noc(Cc3ccccc3)n2)CC1)c1ccccc1)C1CCC1 10.1016/j.bmcl.2006.06.012
11693007 157919 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 548 8 1 4 5.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Nc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL205851 157919 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 548 8 1 4 5.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Nc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
10277467 27344 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
CHEMBL1190217 27344 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
516338 122184 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1cc(Cc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL170987 122184 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1cc(Cc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
489324 217849 0 None None None Human 6.7 pIC50 = 6.7 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 555 8 1 4 5.6 O=C1CC2(CCN(CCC(CN3C(=O)N[C@H](Cc4ccccc4)C3=O)c3cccc(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(01)00654-0
CHEMBL319697 217849 0 None None None Human 6.7 pIC50 = 6.7 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 555 8 1 4 5.6 O=C1CC2(CCN(CCC(CN3C(=O)N[C@H](Cc4ccccc4)C3=O)c3cccc(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(01)00654-0
44404638 260605 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 533 10 1 5 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(N)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL369947 260605 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 533 10 1 5 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(N)cc2)CC1 10.1016/j.bmcl.2005.08.014
44404730 278160 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 605 12 1 6 6.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NOC(C)(C)C)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL382079 278160 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 605 12 1 6 6.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NOC(C)(C)C)cc2)CC1 10.1016/j.bmcl.2005.08.014
44401608 252354 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 487 8 1 6 4.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL363564 252354 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 487 8 1 6 4.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
9869601 182577 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 394 5 3 3 3.9 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL241097 182577 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 394 5 3 3 3.9 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
44565559 372880 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL516027 372880 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
478409 470705 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 530 9 0 3 6.7 CN(C[C@@H](CCN1CCC(c2ccc(Cl)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83963 470705 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 530 9 0 3 6.7 CN(C[C@@H](CCN1CCC(c2ccc(Cl)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481866 221101 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 566 8 0 6 4.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328339 221101 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 566 8 0 6 4.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479865 474033 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 476 9 0 3 5.7 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1 10.1016/s0960-894x(00)00639-9
CHEMBL92094 474033 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 476 9 0 3 5.7 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1 10.1016/s0960-894x(00)00639-9
457679 333908 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 7 0 2 5.8 c1ccc(CCN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)cc1 10.1016/s0960-894x(01)00545-5
CHEMBL441635 333908 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 7 0 2 5.8 c1ccc(CCN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)cc1 10.1016/s0960-894x(01)00545-5
1022078 386095 5 None None None Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at human CCR5 receptorAntagonist activity at human CCR5 receptor
ChEMBL 576 5 0 6 4.9 O=C(CCC(=O)N1CCN(c2ccnc3cc(Cl)ccc23)CC1)N1CCN(c2ccnc3cc(Cl)ccc23)CC1 10.1021/acs.jmedchem.6b01309
CHEMBL5269098 386095 5 None None None Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at human CCR5 receptorAntagonist activity at human CCR5 receptor
ChEMBL 576 5 0 6 4.9 O=C(CCC(=O)N1CCN(c2ccnc3cc(Cl)ccc23)CC1)N1CCN(c2ccnc3cc(Cl)ccc23)CC1 10.1021/acs.jmedchem.6b01309
16728614 182377 0 None None None Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 371 5 3 4 2.7 N#Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
CHEMBL240637 182377 0 None None None Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 371 5 3 4 2.7 N#Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
16728649 333626 0 None None None Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 420 5 2 5 4.0 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCCN2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL439223 333626 0 None None None Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 420 5 2 5 4.0 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCCN2)cc1 10.1016/j.bmcl.2006.09.052
4194712 386063 16 None None None Human 5.7 pIC50 = 5.7 Binding
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 565 7 1 9 7.1 O=C(C1=C(O)C(=O)N(c2nnc(SCc3ccc(Cl)cc3)s2)C1c1cccs1)c1cc2ccccc2o1 10.1021/acs.jmedchem.6b01309
CHEMBL5268295 386063 16 None None None Human 5.7 pIC50 = 5.7 Binding
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 565 7 1 9 7.1 O=C(C1=C(O)C(=O)N(c2nnc(SCc3ccc(Cl)cc3)s2)C1c1cccs1)c1cc2ccccc2o1 10.1021/acs.jmedchem.6b01309
479837 473682 0 None None None Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL89929 473682 0 None None None Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
10445499 352789 1 None None None Human 4.7 pIC50 = 4.7 Binding
Inhibition of MIP1alpha binding to human CCR5 receptorInhibition of MIP1alpha binding to human CCR5 receptor
ChEMBL 264 0 2 5 2.4 CC1OC(=O)c2c3c(c(O)c(O)c21)OC(C)(C)CC3 10.1021/np049974l
CHEMBL469856 352789 1 None None None Human 4.7 pIC50 = 4.7 Binding
Inhibition of MIP1alpha binding to human CCR5 receptorInhibition of MIP1alpha binding to human CCR5 receptor
ChEMBL 264 0 2 5 2.4 CC1OC(=O)c2c3c(c(O)c(O)c21)OC(C)(C)CC3 10.1021/np049974l
53326702 121258 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.2 COC[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683071 121258 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.2 COC[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
53326701 121255 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 497 6 1 5 3.9 CO[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683068 121255 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 497 6 1 5 3.9 CO[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
72712160 183469 0 None None None Human 5.7 pIC50 = 5.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
CHEMBL2435869 183469 0 None None None Human 5.7 pIC50 = 5.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
10416552 371653 0 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 628 8 1 6 4.7 O=C1NCN(c2ccccc2)C12CCN(CCOC1(c3ccc(Cl)c(Cl)c3)CCN(S(=O)(=O)c3ccccc3)C1)CC2 10.1021/jm800598a
CHEMBL502593 371653 0 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 628 8 1 6 4.7 O=C1NCN(c2ccccc2)C12CCN(CCOC1(c3ccc(Cl)c(Cl)c3)CCN(S(=O)(=O)c3ccccc3)C1)CC2 10.1021/jm800598a
53324141 121257 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.3 CCO[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683070 121257 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.3 CCO[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
76312665 176520 0 None None None Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 520 7 1 4 5.7 CC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281956 176520 0 None None None Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 520 7 1 4 5.7 CC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1007/s00044-012-0118-7
25206070 21443 0 None None None Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 584 5 0 6 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085231 21443 0 None None None Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 584 5 0 6 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
44356876 61705 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 554 8 0 4 6.4 C=CCN(c1ccc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137272 61705 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 554 8 0 4 6.4 C=CCN(c1ccc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
16073663 159418 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2ccc(F)c(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL209251 159418 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2ccc(F)c(F)c2)CC1 10.1016/j.bmcl.2006.03.089
44573297 370476 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 499 5 0 4 5.6 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)N(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL492544 370476 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 499 5 0 4 5.6 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)N(C)C)CC1 10.1016/j.bmcl.2009.02.014
6320585 125984 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL179209 125984 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
44590945 350370 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 396 7 1 5 4.0 Cc1noc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)n1 10.1016/j.bmcl.2009.01.009
CHEMBL459599 350370 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 396 7 1 5 4.0 Cc1noc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)n1 10.1016/j.bmcl.2009.01.009
126585469 446190 0 None None None Human 7.7 pIC50 = 7.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 511 9 1 6 6.4 CCC1CCC(C(=O)N[C@@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)c2cccs2)CC1 nan
CHEMBL5969347 446190 0 None None None Human 7.7 pIC50 = 7.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 511 9 1 6 6.4 CCC1CCC(C(=O)N[C@@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)c2cccs2)CC1 nan
11656080 174526 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 488 7 1 5 5.5 Cc1nc2ccccc2n1[C@@H]1C[C@H]2CSC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203620 174526 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 488 7 1 5 5.5 Cc1nc2ccccc2n1[C@@H]1C[C@H]2CSC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
122668175 424784 0 None None None Human 7.7 pIC50 = 7.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 478 8 1 6 5.1 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1cccnc1 nan
CHEMBL5846910 424784 0 None None None Human 7.7 pIC50 = 7.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 478 8 1 6 5.1 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1cccnc1 nan
516344 255765 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL366450 255765 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44431967 292760 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 521 7 1 5 4.3 CN1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL391886 292760 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 521 7 1 5 4.3 CN1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2007.01.050
44392131 138116 2 None None None Human 5.7 pIC50 = 5.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 453 9 1 2 6.4 C=CCN(C(=O)Nc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183492 138116 2 None None None Human 5.7 pIC50 = 5.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 453 9 1 2 6.4 C=CCN(C(=O)Nc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54682467 372422 30 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPADisplacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPA
ChEMBL 276 0 1 5 2.1 CC1OC(=O)C=C2C3=C(OC(C)(C)CC3)C(=O)C(O)=C21 10.1021/np030146m
CHEMBL512035 372422 30 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPADisplacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPA
ChEMBL 276 0 1 5 2.1 CC1OC(=O)C=C2C3=C(OC(C)(C)CC3)C(=O)C(O)=C21 10.1021/np030146m
53325088 121595 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 531 3 1 6 3.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H]3c4ccc(C(F)(F)F)cc4C[C@H]3O)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688241 121595 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 531 3 1 6 3.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H]3c4ccc(C(F)(F)F)cc4C[C@H]3O)[C@@H](C)C2)CC1 10.1021/ml1001536
53389902 337018 0 None None None Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 349 3 2 5 2.8 Nc1nc2[nH]c(C3CC3)c(Cc3ccc(Cl)c(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
CHEMBL4483373 337018 0 None None None Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 349 3 2 5 2.8 Nc1nc2[nH]c(C3CC3)c(Cc3ccc(Cl)c(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
54583459 123644 0 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 566 9 1 5 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(CCNC(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762308 123644 0 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 566 9 1 5 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(CCNC(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1016/j.bmcl.2011.02.058
72712161 183470 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435870 183470 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
25230770 371954 0 None None None Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 577 6 0 6 5.1 CCCCC1CN(C(=O)C2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL505595 371954 0 None None None Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 577 6 0 6 5.1 CCCCC1CN(C(=O)C2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
52949128 42007 0 None None None Human 5.7 pIC50 = 5.7 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 607 7 0 6 4.3 Cc1cccc(Cl)c1S(=O)(=O)C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1269386 42007 0 None None None Human 5.7 pIC50 = 5.7 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 607 7 0 6 4.3 Cc1cccc(Cl)c1S(=O)(=O)C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
25230898 348069 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 589 7 0 7 4.2 CCCCC1CN(S(=O)(=O)C2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL454253 348069 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 589 7 0 7 4.2 CCCCC1CN(S(=O)(=O)C2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
25230827 367332 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 545 7 0 6 4.2 CCCCC1CN(S(=O)(=O)C2CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL481980 367332 0 None None None Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 545 7 0 6 4.2 CCCCC1CN(S(=O)(=O)C2CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
126567256 463630 0 None None None Human 7.7 pIC50 = 7.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 519 6 1 7 4.5 COC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2ccc(Cl)s2)C1 nan
CHEMBL6051484 463630 0 None None None Human 7.7 pIC50 = 7.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 519 6 1 7 4.5 COC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2ccc(Cl)s2)C1 nan
44404642 270915 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 617 11 1 5 6.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)C(C)(C)C)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL370552 270915 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 617 11 1 5 6.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)C(C)(C)C)cc2)CC1 10.1016/j.bmcl.2005.08.014
72714321 183491 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
CHEMBL2435891 183491 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
516344 255765 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL366450 255765 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
46883028 20145 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 495 5 0 6 4.3 CCCC[C@H]1CN(C)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078937 20145 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 495 5 0 6 4.3 CCCC[C@H]1CN(C)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
68767078 239843 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 457 7 1 5 5.0 CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(Cl)cc23)C1=O 10.1021/ml500505q
CHEMBL3577944 239843 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 457 7 1 5 5.0 CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(Cl)cc23)C1=O 10.1021/ml500505q
57656833 156897 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of human CCR5 by FLIPR analysisInhibition of human CCR5 by FLIPR analysis
ChEMBL 427 3 2 4 2.4 CC(C)N1CCN[C@@H](C(=O)N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.04.118
CHEMBL2036782 156897 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibition of human CCR5 by FLIPR analysisInhibition of human CCR5 by FLIPR analysis
ChEMBL 427 3 2 4 2.4 CC(C)N1CCN[C@@H](C(=O)N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.04.118
516344 255765 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL366450 255765 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
44325917 312236 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 553 7 0 4 6.4 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL406552 312236 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 553 7 0 4 6.4 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44325710 474025 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 541 11 0 5 5.2 COC(=O)N(CC1CCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL92013 474025 0 None None None Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 541 11 0 5 5.2 COC(=O)N(CC1CCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
122668252 424973 0 None None None Human 7.7 pIC50 = 7.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 501 7 1 6 4.1 CCC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2ccc(F)s2)C1 nan
CHEMBL5849031 424973 0 None None None Human 7.7 pIC50 = 7.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 501 7 1 6 4.1 CCC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2ccc(F)s2)C1 nan
122668128 464226 0 None None None Human 7.7 pIC50 = 7.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 515 8 1 6 4.5 CCCC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2ccc(F)s2)C1 nan
CHEMBL6057795 464226 0 None None None Human 7.7 pIC50 = 7.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 515 8 1 6 4.5 CCCC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2ccc(F)s2)C1 nan
126595663 428809 0 None None None Human 7.7 pIC50 = 7.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 513 7 1 6 4.1 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C1CC1)C3)C2)c1ccc(F)s1 nan
CHEMBL5891619 428809 0 None None None Human 7.7 pIC50 = 7.7 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 513 7 1 6 4.1 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C1CC1)C3)C2)c1ccc(F)s1 nan
53321427 121256 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.3 CCO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683069 121256 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.3 CCO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
126567301 449137 0 None None None Human 7.6 pIC50 = 7.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 517 7 1 6 4.6 CCC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2ccc(Cl)s2)C1 nan
CHEMBL6001416 449137 0 None None None Human 7.6 pIC50 = 7.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 517 7 1 6 4.6 CCC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2ccc(Cl)s2)C1 nan
54580469 123662 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1cccc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
CHEMBL1762332 123662 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1cccc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
11570431 182778 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 564 13 1 4 7.9 CCN(CC)CCCC(C)NC(=O)CCCc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1 10.1016/j.bmcl.2006.10.060
CHEMBL241502 182778 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 564 13 1 4 7.9 CCN(CC)CCCC(C)NC(=O)CCCc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1 10.1016/j.bmcl.2006.10.060
44325511 222047 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 492 7 0 3 7.5 c1ccc(CN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3cccc(-c4ccsc4)c3)C2)cc1 10.1016/s0960-894x(01)00545-5
CHEMBL330065 222047 0 None None None Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 492 7 0 3 7.5 c1ccc(CN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3cccc(-c4ccsc4)c3)C2)cc1 10.1016/s0960-894x(01)00545-5
44392092 135980 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1cccc(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180095 135980 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1cccc(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54580080 125600 0 None None None Human 5.7 pIC50 = 5.7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 512 5 1 4 6.3 Cc1nc2ccccc2n1C1CC2CCC(C1)C2NCC1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
CHEMBL1784386 125600 0 None None None Human 5.7 pIC50 = 5.7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 512 5 1 4 6.3 Cc1nc2ccccc2n1C1CC2CCC(C1)C2NCC1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
3258407 175858 16 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 389 9 1 5 4.9 C=C(C)Cc1c(C)c(C#N)c2nc3ccccc3n2c1NCCCN(CC)CC 10.1021/jm061389p
CHEMBL223686 175858 16 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 389 9 1 5 4.9 C=C(C)Cc1c(C)c(C#N)c2nc3ccccc3n2c1NCCCN(CC)CC 10.1021/jm061389p
57396949 143277 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 568 10 0 6 3.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951895 143277 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 568 10 0 6 3.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
483334 218185 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 593 13 0 7 6.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(-c3ccccc3)c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL320365 218185 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 593 13 0 7 6.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(-c3ccccc3)c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
505873 61609 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137206 61609 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44401985 143646 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL195930 143646 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44573339 347541 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 602 8 1 6 7.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccc(Cl)s2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL452913 347541 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 602 8 1 6 7.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccc(Cl)s2)CC1 10.1016/j.bmcl.2009.02.014
44573300 385741 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 526 5 0 6 6.1 CS/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL523512 385741 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 526 5 0 6 6.1 CS/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
505873 61609 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137206 61609 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44401985 143646 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL195930 143646 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010258 353000 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471722 353000 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
46882082 19948 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 623 9 0 7 6.0 CCCC[C@H]1CN(C[C@H]2CC[C@H](OC(C)C)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077364 19948 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 623 9 0 7 6.0 CCCC[C@H]1CN(C[C@H]2CC[C@H](OC(C)C)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
53324304 121254 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 497 6 1 5 3.9 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683067 121254 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 497 6 1 5 3.9 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
3010258 353000 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL471722 353000 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516340 122584 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 568 10 1 5 6.1 Cn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL172721 122584 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 568 10 1 5 6.1 Cn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
44384012 317199 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 10 1 6 6.1 CCn1ncc(C(=O)c2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL413058 317199 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 10 1 6 6.1 CCn1ncc(C(=O)c2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
505873 61609 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137206 61609 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44401985 143646 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL195930 143646 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010258 353000 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471722 353000 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
126585498 443551 0 None None None Human 7.6 pIC50 = 7.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 513 10 2 11 2.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cn1ncnn1)c1ccc(CO)s1 nan
CHEMBL5941427 443551 0 None None None Human 7.6 pIC50 = 7.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 513 10 2 11 2.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cn1ncnn1)c1ccc(CO)s1 nan
5482808 473597 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 576 8 1 4 5.6 O=S(=O)(NC[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL89251 473597 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 576 8 1 4 5.6 O=S(=O)(NC[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
44392093 126199 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 502 9 0 2 7.0 CN(C(=O)Cc1ccc(-c2ccccc2)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL179950 126199 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 502 9 0 2 7.0 CN(C(=O)Cc1ccc(-c2ccccc2)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
483361 193614 0 None None None Human 5.6 pIC50 = 5.6 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](C[C@@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL261935 193614 0 None None None Human 5.6 pIC50 = 5.6 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](C[C@@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44590864 350679 0 None None None Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 472 8 2 4 4.9 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(n2cc(-c3ccccc3)[nH]c2=O)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460009 350679 0 None None None Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 472 8 2 4 4.9 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(n2cc(-c3ccccc3)[nH]c2=O)CC1 10.1016/j.bmcl.2009.01.009
3117 474710 66 None None None Human 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
928 474710 66 None None None Human 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
CHEMBL964 474710 66 None None None Human 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
DB00822 474710 66 None None None Human 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
25132945 336988 0 None None None Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 642 8 1 6 5.1 O=C1NCN(c2ccccc2)C12CCN(CCOC1(c3ccc(Cl)c(Cl)c3)CCN(S(=O)(=O)c3ccccc3)CC1)CC2 10.1021/jm800598a
CHEMBL448199 336988 0 None None None Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 642 8 1 6 5.1 O=C1NCN(c2ccccc2)C12CCN(CCOC1(c3ccc(Cl)c(Cl)c3)CCN(S(=O)(=O)c3ccccc3)CC1)CC2 10.1021/jm800598a
5481714 470188 0 None None None Human 4.6 pIC50 = 4.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 538 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CC(O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL79566 470188 0 None None None Human 4.6 pIC50 = 4.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 538 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CC(O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
44590704 373568 0 None None None Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1CCC(N(C)C2CN(C(c3ccccc3)c3ccccc3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL517893 373568 0 None None None Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1CCC(N(C)C2CN(C(c3ccccc3)c3ccccc3)C2)CC1 10.1016/j.bmcl.2009.01.012
46890427 20929 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 514 4 0 5 4.1 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1083126 20929 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 514 4 0 5 4.1 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
118219355 449793 0 None None None Human 7.6 pIC50 = 7.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 497 8 1 6 6.1 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCCC2)s1 nan
CHEMBL6008159 449793 0 None None None Human 7.6 pIC50 = 7.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 497 8 1 6 6.1 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCCC2)s1 nan
44573298 372185 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 527 7 0 4 6.4 CCN(CC)C(=O)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL509179 372185 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 527 7 0 4 6.4 CCN(CC)C(=O)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
10186729 28196 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728786 28196 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196666 28196 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196759 28196 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
46882873 20032 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 525 7 0 5 5.2 CCCCC1N(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078072 20032 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 525 7 0 5 5.2 CCCCC1N(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46883027 20118 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 579 7 0 7 5.1 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078711 20118 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 579 7 0 7 5.1 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
501044 18737 0 None None None Human 7.6 pIC50 = 7.6 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501048 18737 0 None None None Human 7.6 pIC50 = 7.6 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL101333 18737 0 None None None Human 7.6 pIC50 = 7.6 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL322232 18737 0 None None None Human 7.6 pIC50 = 7.6 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
126595711 444663 0 None None None Human 7.6 pIC50 = 7.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 496 7 1 7 3.4 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C1CC1)C3)C2)c1nccs1 nan
CHEMBL5952809 444663 0 None None None Human 7.6 pIC50 = 7.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 496 7 1 7 3.4 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C1CC1)C3)C2)c1nccs1 nan
44392196 137893 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 481 10 1 2 6.4 C=CCN(C(=O)NCc1cccc(C)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183261 137893 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 481 10 1 2 6.4 C=CCN(C(=O)NCc1cccc(C)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
474155 26326 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CC3)cc1 10.1021/jm9906264
CHEMBL1183547 26326 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CC3)cc1 10.1021/jm9906264
5482456 470167 0 None None None Human 5.6 pIC50 = 5.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 511 9 0 4 5.3 Cc1ccccc1N1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
CHEMBL79369 470167 0 None None None Human 5.6 pIC50 = 5.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 511 9 0 4 5.3 Cc1ccccc1N1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
483352 222346 0 None None None Human 4.6 pIC50 = 4.6 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 562 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CCS(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL331007 222346 0 None None None Human 4.6 pIC50 = 4.6 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 562 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CCS(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
483341 218771 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 550 12 0 5 7.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(Cn2c(CC)nc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL321539 218771 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 550 12 0 5 7.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(Cn2c(CC)nc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
44590222 353010 0 None None None Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 419 5 1 3 3.7 CC(=O)NC(c1ccccc1)C1CN(C2CCN(C(=O)c3c(C)cccc3C)CC2)C1 10.1016/j.bmcl.2009.01.012
CHEMBL471844 353010 0 None None None Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 419 5 1 3 3.7 CC(=O)NC(c1ccccc1)C1CN(C2CCN(C(=O)c3c(C)cccc3C)CC2)C1 10.1016/j.bmcl.2009.01.012
489312 19257 0 None None None Human 7.6 pIC50 = 7.6 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 508 9 0 4 5.9 O=S(=O)(c1cccs1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL104628 19257 0 None None None Human 7.6 pIC50 = 7.6 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 508 9 0 4 5.9 O=S(=O)(c1cccs1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
25230829 366583 0 None None None Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 519 6 0 6 3.6 CCCCC1CN(S(C)(=O)=O)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL479627 366583 0 None None None Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 519 6 0 6 3.6 CCCCC1CN(S(C)(=O)=O)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
483339 19225 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 522 11 0 5 6.5 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104474 19225 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 522 11 0 5 6.5 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
489331 19594 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 554 9 2 3 6.3 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
CHEMBL106381 19594 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 554 9 2 3 6.3 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
46890429 21549 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 641 8 0 7 5.5 CCO[C@H]1CC[C@H](CN2C[C@H](c3ccccn3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)cc(C#N)nc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085722 21549 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 641 8 0 7 5.5 CCO[C@H]1CC[C@H](CN2C[C@H](c3ccccn3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)cc(C#N)nc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
46888604 22877 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 545 8 1 5 4.4 Cc1nc(Cl)nc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1094518 22877 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 545 8 1 5 4.4 Cc1nc(Cl)nc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
118219284 442746 0 None None None Human 7.6 pIC50 = 7.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 523 9 1 6 5.9 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)Cc2ccc(F)cc2)s1 nan
CHEMBL5981211 442746 0 None None None Human 7.6 pIC50 = 7.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 523 9 1 6 5.9 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)Cc2ccc(F)cc2)s1 nan
16073666 160017 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 650 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)c(F)c(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL211175 160017 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 650 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)c(F)c(F)c2)CC1 10.1016/j.bmcl.2006.03.089
16073674 161361 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 626 12 0 7 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(OC)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL212408 161361 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 626 12 0 7 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(OC)c2)CC1 10.1016/j.bmcl.2006.03.089
11520480 213275 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 710 17 1 7 9.3 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085312 213275 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 710 17 1 7 9.3 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCCN3CCC)cc1 10.1021/jm0509703
44555481 20049 1 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078231 20049 1 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
11342841 20122 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078723 20122 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46882078 19944 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 581 7 0 7 4.9 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077360 19944 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 581 7 0 7 4.9 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
44461561 470227 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79930 470227 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478410 470703 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 514 9 0 3 6.2 CN(C[C@@H](CCN1CCC(c2ccc(F)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83957 470703 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 514 9 0 3 6.2 CN(C[C@@H](CCN1CCC(c2ccc(F)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
474157 25559 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 465 5 1 1 7.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCC3)cc1 10.1021/jm9906264
CHEMBL1179155 25559 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 465 5 1 1 7.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCC3)cc1 10.1021/jm9906264
44590800 350751 0 None None None Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 9 1 3 5.7 CCN(C(=O)c1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460629 350751 0 None None None Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 9 1 3 5.7 CCN(C(=O)c1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
72711048 183493 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
CHEMBL2435893 183493 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
489328 19358 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 515 9 1 3 5.9 O=C1N[C@H](Cc2ccccc2)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
CHEMBL105109 19358 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 515 9 1 3 5.9 O=C1N[C@H](Cc2ccccc2)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
478413 470231 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 510 10 0 3 6.1 CN(C[C@@H](CCN1CCC(Cc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79958 470231 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 510 10 0 3 6.1 CN(C[C@@H](CCN1CCC(Cc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44415756 161266 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 471 9 1 5 4.9 Cc1nnc(Cc2ccccc2)n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
CHEMBL212017 161266 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 471 9 1 5 4.9 Cc1nnc(Cc2ccccc2)n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
478409 470705 0 None None None Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 530 9 0 3 6.7 CN(C[C@@H](CCN1CCC(c2ccc(Cl)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83963 470705 0 None None None Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 530 9 0 3 6.7 CN(C[C@@H](CCN1CCC(c2ccc(Cl)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
478410 470703 0 None None None Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 514 9 0 3 6.2 CN(C[C@@H](CCN1CCC(c2ccc(F)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83957 470703 0 None None None Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 514 9 0 3 6.2 CN(C[C@@H](CCN1CCC(c2ccc(F)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
124734 473621 72 None None None Human 4.6 pIC50 = 4.6 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
70848 473621 72 None None None Human 4.6 pIC50 = 4.6 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 473621 72 None None None Human 4.6 pIC50 = 4.6 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
DB01912 473621 72 None None None Human 4.6 pIC50 = 4.6 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
54585963 125605 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 547 7 1 5 6.5 CNc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784397 125605 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 547 7 1 5 6.5 CNc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
54580082 125610 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 548 7 0 5 6.5 COc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784402 125610 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 548 7 0 5 6.5 COc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
54581068 125602 0 None None None Human 5.6 pIC50 = 5.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 547 6 0 4 5.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(N2C(=O)c4ccccc4C2=O)C3)(c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784391 125602 0 None None None Human 5.6 pIC50 = 5.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 547 6 0 4 5.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(N2C(=O)c4ccccc4C2=O)C3)(c2ccccc2)CC1 10.1021/jm200279v
124734 473621 72 None None None Human 4.6 pIC50 = 4.6 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
70848 473621 72 None None None Human 4.6 pIC50 = 4.6 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 473621 72 None None None Human 4.6 pIC50 = 4.6 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
DB01912 473621 72 None None None Human 4.6 pIC50 = 4.6 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
456374 473697 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 410 6 0 2 5.8 c1ccc(CN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)cc1 10.1016/s0960-894x(01)00545-5
CHEMBL90015 473697 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 410 6 0 2 5.8 c1ccc(CN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)cc1 10.1016/s0960-894x(01)00545-5
54582104 125604 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 533 6 1 5 6.1 Nc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784396 125604 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 533 6 1 5 6.1 Nc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
489594 213061 0 None None None Human 7.6 pIC50 = 7.6 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00232-3
CHEMBL330528 213061 0 None None None Human 7.6 pIC50 = 7.6 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00232-3
46890340 21431 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 654 6 1 6 4.6 CNC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)cc(C#N)nc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085217 21431 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 654 6 1 6 4.6 CNC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)cc(C#N)nc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
25206071 21433 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 631 6 0 7 4.5 COC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085219 21433 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 631 6 0 7 4.5 COC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
46888526 23241 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 503 8 1 4 4.8 COc1cc(C)c(C(=O)N2C[C@@H]3CN(CC[C@H](NC(=O)C4CCCC4)c4ccccc4)C[C@@H]3C2)c(C)c1 10.1016/j.bmcl.2010.03.095
CHEMBL1097816 23241 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 503 8 1 4 4.8 COc1cc(C)c(C(=O)N2C[C@@H]3CN(CC[C@H](NC(=O)C4CCCC4)c4ccccc4)C[C@@H]3C2)c(C)c1 10.1016/j.bmcl.2010.03.095
44404639 144565 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 575 11 1 5 5.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(C)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198497 144565 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 575 11 1 5 5.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(C)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
489594 213061 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL330528 213061 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
53325639 121260 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)n3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683073 121260 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)n3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
3010257 352859 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470507 352859 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44404710 144640 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 561 11 1 5 4.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198777 144640 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 561 11 1 5 4.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
478399 470682 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 524 8 0 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)Cc1ccccc1O2)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83818 470682 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 524 8 0 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)Cc1ccccc1O2)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
489820 220923 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 425 5 0 3 4.8 O=C(c1cccnc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL327354 220923 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 425 5 0 3 4.8 O=C(c1cccnc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44392132 138388 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.7 CN(C(=O)Cc1ccc(Cl)cc1Cl)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183875 138388 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.7 CN(C(=O)Cc1ccc(Cl)cc1Cl)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
5481747 221048 0 None None None Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2ccccc12 10.1007/s00044-011-9863-2
CHEMBL328025 221048 0 None None None Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2ccccc12 10.1007/s00044-011-9863-2
44532866 371979 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 615 6 1 4 8.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)Nc2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL505908 371979 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 615 6 1 4 8.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)Nc2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2009.02.014
478493 473738 0 None None None Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 557 8 0 4 4.4 CN(C)S(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1007/s00044-011-9863-2
CHEMBL90272 473738 0 None None None Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 557 8 0 4 4.4 CN(C)S(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1007/s00044-011-9863-2
44373672 105684 0 None None None Human 7.6 pIC50 = 7.6 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@H]3CN4O[C@H](c5ccccc5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL159097 105684 0 None None None Human 7.6 pIC50 = 7.6 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@H]3CN4O[C@H](c5ccccc5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
76317476 214497 0 None None None Human 7.6 pIC50 = 7.6 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 996 35 1 15 8.1 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CCCCCCCCCCn1cc(COCCOCCOCCOCCOCc2ccc(C(=O)N3CCC3=O)cc2)nn1)c1ccccc1 10.1021/ml400370w
CHEMBL3109174 214497 0 None None None Human 7.6 pIC50 = 7.6 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 996 35 1 15 8.1 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CCCCCCCCCCn1cc(COCCOCCOCCOCCOCc2ccc(C(=O)N3CCC3=O)cc2)nn1)c1ccccc1 10.1021/ml400370w
25230899 346861 0 None None None Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 585 7 0 8 3.8 CCCCC1CN(S(=O)(=O)c2cn(C)cn2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL450639 346861 0 None None None Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 585 7 0 8 3.8 CCCCC1CN(S(=O)(=O)c2cn(C)cn2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
483331 19564 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cc3ccccc3n2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL106231 19564 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cc3ccccc3n2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
25205921 21441 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 574 6 0 6 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)CC3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085228 21441 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 574 6 0 6 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)CC3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888566 23257 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 8 1 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCC(F)(F)CC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098014 23257 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 8 1 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCC(F)(F)CC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
3010257 352859 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470507 352859 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44431986 332127 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 617 10 3 6 5.8 COc1cccc(OC)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL429442 332127 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 617 10 3 6 5.8 COc1cccc(OC)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44455031 311155 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1ccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)cc1 10.1016/j.bmcl.2007.12.058
CHEMBL402242 311155 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1ccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)cc1 10.1016/j.bmcl.2007.12.058
44555482 20121 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 589 7 0 6 6.0 CCCC[C@H]1CN(CC2CCC(F)(F)CC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078714 20121 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 589 7 0 6 6.0 CCCC[C@H]1CN(CC2CCC(F)(F)CC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46882083 19949 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 621 9 0 7 5.8 CCCC[C@H]1CN(C[C@H]2CC[C@H](OC3CC3)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077365 19949 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 621 9 0 7 5.8 CCCC[C@H]1CN(C[C@H]2CC[C@H](OC3CC3)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
3010257 352859 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL470507 352859 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
122668253 464691 0 None None None Human 7.6 pIC50 = 7.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 493 8 1 6 5.5 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccsc2)CC1 nan
CHEMBL6062824 464691 0 None None None Human 7.6 pIC50 = 7.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 493 8 1 6 5.5 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccsc2)CC1 nan
72713860 183513 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435913 183513 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
122668171 462835 0 None None None Human 7.6 pIC50 = 7.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 484 7 1 7 3.4 CCC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2nccs2)C1 nan
CHEMBL6043899 462835 0 None None None Human 7.6 pIC50 = 7.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 484 7 1 7 3.4 CCC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2nccs2)C1 nan
118219363 449479 0 None None None Human 6.6 pIC50 = 6.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 496 8 1 6 5.2 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccc(F)nc1 nan
CHEMBL6005068 449479 0 None None None Human 6.6 pIC50 = 6.6 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 496 8 1 6 5.2 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccc(F)nc1 nan
5481859 470208 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79716 470208 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481861 332749 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL432040 332749 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
5481859 470208 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL79716 470208 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44392136 137154 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 486 10 0 4 5.4 COc1cc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc(OC)c1 10.1016/j.bmcl.2004.10.044
CHEMBL182010 137154 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 486 10 0 4 5.4 COc1cc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc(OC)c1 10.1016/j.bmcl.2004.10.044
44455103 311676 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1ccccc1NC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL405634 311676 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1ccccc1NC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
44455177 316587 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 452 9 1 5 4.9 CCCNC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL411640 316587 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 452 9 1 5 4.9 CCCNC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
53389637 335118 0 None None None Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 317 3 2 5 2.4 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1cccc(Cl)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4450273 335118 0 None None None Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 317 3 2 5 2.4 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1cccc(Cl)c1 10.1021/acs.jmedchem.9b00742
72712372 183472 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 499 6 0 6 4.7 Cn1nnc(-c2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)n1 10.1021/jm401101p
CHEMBL2435872 183472 0 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 499 6 0 6 4.7 Cn1nnc(-c2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)n1 10.1021/jm401101p
44431944 178954 0 None None None Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 411 5 0 2 5.6 FC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234672 178954 0 None None None Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 411 5 0 2 5.6 FC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
483338 19447 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 518 12 0 8 4.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cncn2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105606 19447 0 None None None Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 518 12 0 8 4.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cncn2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
44404702 144298 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 532 10 0 4 5.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL197714 144298 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 532 10 0 4 5.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C)cc2)CC1 10.1016/j.bmcl.2005.08.014
16728784 27062 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188107 27062 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
5275840 137198 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 483 8 0 4 3.6 CN1C(=O)CCC2CN(CC[C@](C)(CN(C)S(=O)(=O)c3ccccc3)c3ccccc3)CCC21 10.1016/j.bmcl.2004.12.044
CHEMBL182188 137198 0 None None None Human 7.6 pIC50 = 7.6 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 483 8 0 4 3.6 CN1C(=O)CCC2CN(CC[C@](C)(CN(C)S(=O)(=O)c3ccccc3)c3ccccc3)CCC21 10.1016/j.bmcl.2004.12.044
44564984 370312 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 508 8 1 6 4.2 CC(=O)N1CCC(C(=O)N[C@@H](CC(C)N2CCC(n3c(C)nnc3C(C)C)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491154 370312 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 508 8 1 6 4.2 CC(=O)N1CCC(C(=O)N[C@@H](CC(C)N2CCC(n3c(C)nnc3C(C)C)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
56647023 183480 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435880 183480 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
44565558 353138 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472799 353138 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44431944 178954 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 411 5 0 2 5.6 FC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234672 178954 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 411 5 0 2 5.6 FC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
52948162 42246 0 None None None Human 5.6 pIC50 = 5.6 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 531 8 0 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(C(=O)CC(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1271310 42246 0 None None None Human 5.6 pIC50 = 5.6 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 531 8 0 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(C(=O)CC(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
11669935 121244 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 467 5 1 4 4.3 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](NC2CCOCC2)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683055 121244 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 467 5 1 4 4.3 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](NC2CCOCC2)C1 10.1016/j.bmcl.2011.01.015
52949601 42052 0 None None None Human 5.6 pIC50 = 5.6 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 515 7 0 5 3.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1269884 42052 0 None None None Human 5.6 pIC50 = 5.6 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 515 7 0 5 3.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
57392726 140143 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 490 8 0 5 4.2 COc1ccc(OC)c(S(=O)(=O)N2CCC(CN3CCC(Cc4ccc(F)cc4)CC3)CC2)c1 10.1016/j.bmcl.2011.09.013
CHEMBL1910167 140143 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 490 8 0 5 4.2 COc1ccc(OC)c(S(=O)(=O)N2CCC(CN3CCC(Cc4ccc(F)cc4)CC3)CC2)c1 10.1016/j.bmcl.2011.09.013
154572822 335642 1 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 542 7 2 7 2.8 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](NS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL4457723 335642 1 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 542 7 2 7 2.8 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](NS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
16728624 181127 0 None None None Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 452 8 3 4 4.4 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(OCc2ccccc2)cc1 10.1007/s00044-012-0118-7
CHEMBL238546 181127 0 None None None Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 452 8 3 4 4.4 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(OCc2ccccc2)cc1 10.1007/s00044-012-0118-7
44565558 353138 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL472799 353138 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
11569805 27094 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728785 27094 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
491775 27094 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188408 27094 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188807 27094 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196449 27094 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
44565558 353138 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472799 353138 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44455072 195949 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1cccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)c1 10.1016/j.bmcl.2007.12.058
CHEMBL257728 195949 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1cccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)c1 10.1016/j.bmcl.2007.12.058
25133964 203334 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 596 5 0 5 8.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084498 203334 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 596 5 0 5 8.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
122668216 446531 0 None None None Human 7.5 pIC50 = 7.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 488 8 1 6 4.8 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2cccnc2)CC1 nan
CHEMBL5972978 446531 0 None None None Human 7.5 pIC50 = 7.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 488 8 1 6 4.8 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2cccnc2)CC1 nan
44374086 117821 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL161594 117821 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
44392117 137537 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 510 9 0 3 6.3 CN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182684 137537 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 510 9 0 3 6.3 CN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54583458 123641 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 530 9 1 5 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762304 123641 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 530 9 1 5 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
16728624 181127 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 452 8 3 4 4.4 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(OCc2ccccc2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL238546 181127 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 452 8 3 4 4.4 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(OCc2ccccc2)cc1 10.1016/j.bmcl.2006.09.052
162657824 354985 0 None None None Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 482 5 3 4 2.9 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cccc(C(F)(F)F)c2)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4760566 354985 0 None None None Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 482 5 3 4 2.9 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cccc(C(F)(F)F)c2)C1=O 10.1021/acsmedchemlett.1c00082
72711279 183499 0 None None None Human 5.5 pIC50 = 5.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccnc2)CC1 10.1021/jm401101p
CHEMBL2435899 183499 0 None None None Human 5.5 pIC50 = 5.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccnc2)CC1 10.1021/jm401101p
5481715 214126 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 537 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)NC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL310305 214126 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 537 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)NC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
489306 19516 0 None None None Human 8.5 pIC50 = 8.5 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 510 12 0 4 6.3 CN(CC(CCN1CCC(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(01)00652-7
CHEMBL105987 19516 0 None None None Human 8.5 pIC50 = 8.5 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 510 12 0 4 6.3 CN(CC(CCN1CCC(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(01)00652-7
CHEMBL3109172 477880 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 1175 39 3 16 10.2 Cc1nnc(CCCCCCCCCCn2cc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCNC(=O)OC(C)(C)C)cc3)nn2)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
11285792 1815 36 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at CCR5 assessed as inhibition of CCL3 bindingAntagonist activity at CCR5 assessed as inhibition of CCL3 binding
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm300682j
801 1815 36 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at CCR5 assessed as inhibition of CCL3 bindingAntagonist activity at CCR5 assessed as inhibition of CCL3 binding
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm300682j
CHEMBL2110727 1815 36 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at CCR5 assessed as inhibition of CCL3 bindingAntagonist activity at CCR5 assessed as inhibition of CCL3 binding
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm300682j
DB11758 1815 36 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at CCR5 assessed as inhibition of CCL3 bindingAntagonist activity at CCR5 assessed as inhibition of CCL3 binding
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm300682j
44590439 353068 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 6 0 3 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(Cc3ccccc3)C(=O)C3CCC3)CC2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL472260 353068 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 6 0 3 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(Cc3ccccc3)C(=O)C3CCC3)CC2)CC1 10.1016/j.bmcl.2009.01.012
489342 19732 0 None None None Human 8.5 pIC50 = 8.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 667 13 2 5 6.7 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL107128 19732 0 None None None Human 8.5 pIC50 = 8.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 667 13 2 5 6.7 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
46888478 23122 0 None None None Human 8.5 pIC50 = 8.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 487 7 1 3 5.1 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096764 23122 0 None None None Human 8.5 pIC50 = 8.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 487 7 1 3 5.1 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
1635 193594 43 None None None Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/jm300682j
3002977 193594 43 None None None Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/jm300682j
CHEMBL256907 193594 43 None None None Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/jm300682j
44565791 354618 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL475606 354618 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
496971 217198 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/s0960-894x(02)00605-4
CHEMBL318909 217198 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/s0960-894x(02)00605-4
44573253 370511 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 508 7 0 5 6.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ccco2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL492728 370511 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 508 7 0 5 6.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ccco2)CC1 10.1016/j.bmcl.2009.02.014
10438399 372119 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 590 8 1 5 7.4 Cc1cccc(C(C(=O)O)N2CCC(CCN3[C@H]4CC[C@@H]3C[C@H](n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)c1C 10.1016/j.bmcl.2009.02.014
CHEMBL508114 372119 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 590 8 1 5 7.4 Cc1cccc(C(C(=O)O)N2CCC(CCN3[C@H]4CC[C@@H]3C[C@H](n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)c1C 10.1016/j.bmcl.2009.02.014
10030170 372225 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 538 6 0 6 6.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)OC(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL509665 372225 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 538 6 0 6 6.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)OC(C)C)CC1 10.1016/j.bmcl.2009.02.014
3009355 8651 20 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
807 8651 20 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
CHEMBL82301 8651 20 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
DB06652 8651 20 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
501053 18935 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL102675 18935 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501059 217150 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318681 217150 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
496971 217198 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
CHEMBL318909 217198 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
516328 256054 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL366536 256054 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516332 258569 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL368265 258569 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44565791 354618 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL475606 354618 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
3008913 202080 0 None None None Crab-eating macaque 8.5 pIC50 = 8.5 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL301454 202080 0 None None None Crab-eating macaque 8.5 pIC50 = 8.5 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501053 18935 0 None None None Human 8.5 pIC50 = 8.5 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL102675 18935 0 None None None Human 8.5 pIC50 = 8.5 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501059 217150 0 None None None Human 8.5 pIC50 = 8.5 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL318681 217150 0 None None None Human 8.5 pIC50 = 8.5 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44461275 214607 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccc(C)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311261 214607 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccc(C)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461817 461867 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 561 13 0 4 5.4 CCCN(C(=O)Cc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83057 461867 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 561 13 0 4 5.4 CCCN(C(=O)Cc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
486607 470397 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL81245 470397 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
44461699 470684 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1cccc(C)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83823 470684 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1cccc(C)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
68764925 239844 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 477 6 1 5 4.9 CC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
CHEMBL3577946 239844 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 477 6 1 5 4.9 CC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
516328 256054 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL366536 256054 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516332 258569 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL368265 258569 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
478450 176542 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 561 13 0 4 5.4 CCCN(C(=O)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282500 176542 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 561 13 0 4 5.4 CCCN(C(=O)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461275 214607 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccc(C)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL311261 214607 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccc(C)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
486606 470194 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79622 470194 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461699 470684 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1cccc(C)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL83823 470684 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1cccc(C)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
49871007 121597 22 None None None Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm300682j
CHEMBL1688243 121597 22 None None None Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm300682j
DB12960 121597 22 None None None Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm300682j
57395178 143276 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 620 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951894 143276 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 620 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2011.12.117
11285792 1815 36 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
801 1815 36 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
CHEMBL2110727 1815 36 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
DB11758 1815 36 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
516184 122395 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 571 10 1 6 5.5 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172004 122395 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 571 10 1 6 5.5 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
474161 25552 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 513 6 1 3 6.9 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCSCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1179115 25552 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 513 6 1 3 6.9 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCSCC4)cc2)CCO3)cc1 10.1021/jm9906264
44564887 353430 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 425 8 1 5 4.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C(C)C)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL474154 353430 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 425 8 1 5 4.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C(C)C)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
44590752 350855 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 491 10 1 4 5.5 CCN(C(=O)OCc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL461689 350855 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 491 10 1 4 5.5 CCN(C(=O)OCc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44564886 372791 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 437 9 1 5 4.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)CC2CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL515261 372791 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 437 9 1 5 4.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)CC2CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
44447734 195513 0 None None None Crab-eating macaque 8.5 pIC50 = 8.5 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 523 5 0 5 6.1 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255644 195513 0 None None None Crab-eating macaque 8.5 pIC50 = 8.5 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 523 5 0 5 6.1 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2008.01.108
11577846 158762 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 581 8 0 4 5.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC([S+]([O-])c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207654 158762 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 581 8 0 4 5.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC([S+]([O-])c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516183 258114 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 682 10 1 5 7.7 CCn1nc(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367901 258114 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 682 10 1 5 7.7 CCn1nc(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
3008929 391088 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL556314 391088 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3013689 158685 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 583 9 0 4 5.5 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207190 158685 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 583 9 0 4 5.5 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
474163 26308 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 483 8 1 2 7.2 CCC(CC)[N+](C)(C)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C)cc4)ccc3OCC2)cc1 10.1021/jm9906264
CHEMBL1183396 26308 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 483 8 1 2 7.2 CCC(CC)[N+](C)(C)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C)cc4)ccc3OCC2)cc1 10.1021/jm9906264
44590753 350323 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 511 9 1 4 6.1 CCN(C(=O)Oc1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459567 350323 0 None None None Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 511 9 1 4 6.1 CCN(C(=O)Oc1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
122668258 443209 0 None None None Human 8.5 pIC50 = 8.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 493 8 1 6 5.5 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2cccs2)CC1 nan
CHEMBL5937871 443209 0 None None None Human 8.5 pIC50 = 8.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 493 8 1 6 5.5 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2cccs2)CC1 nan
3008929 391088 0 None None None Crab-eating macaque 8.5 pIC50 = 8.5 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL556314 391088 0 None None None Crab-eating macaque 8.5 pIC50 = 8.5 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
68767049 239841 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 553 9 3 4 4.9 CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cc(C(F)(F)F)ccc2NC(=O)NCC)C1=O 10.1021/ml500505q
CHEMBL3577942 239841 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 553 9 3 4 4.9 CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cc(C(F)(F)F)ccc2NC(=O)NCC)C1=O 10.1021/ml500505q
118219287 425410 0 None None None Human 8.5 pIC50 = 8.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 592 10 1 9 3.9 COc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)s1 nan
CHEMBL5853449 425410 0 None None None Human 8.5 pIC50 = 8.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 592 10 1 9 3.9 COc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)s1 nan
118219327 424013 0 None None None Human 8.5 pIC50 = 8.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 580 9 1 8 4.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCN(S(C)(=O)=O)CC1)c1ccc(F)s1 nan
CHEMBL5838316 424013 0 None None None Human 8.5 pIC50 = 8.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 580 9 1 8 4.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCN(S(C)(=O)=O)CC1)c1ccc(F)s1 nan
44565557 353137 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472798 353137 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565557 353137 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL472798 353137 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
57393451 143297 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 671 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(C(F)(F)F)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951918 143297 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 671 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(C(F)(F)F)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
10208679 27106 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16659334 27106 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188565 27106 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1197042 27106 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
44565557 353137 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472798 353137 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
5275766 8155 37 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
800 8155 37 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
CHEMBL207004 8155 37 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
516186 122818 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 624 11 1 7 5.0 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173630 122818 0 None None None Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 624 11 1 7 5.0 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
44565674 352603 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 590 12 1 3 8.3 C=C(Cc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL468150 352603 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 590 12 1 3 8.3 C=C(Cc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
51039119 350183 37 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 in human peripheral T cellsDisplacement of [125I]MIP-1beta from CCR5 in human peripheral T cells
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
CHEMBL4594419 350183 37 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 in human peripheral T cellsDisplacement of [125I]MIP-1beta from CCR5 in human peripheral T cells
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
DB16240 350183 37 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 in human peripheral T cellsDisplacement of [125I]MIP-1beta from CCR5 in human peripheral T cells
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
44565674 352603 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 590 12 1 3 8.3 C=C(Cc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL468150 352603 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 590 12 1 3 8.3 C=C(Cc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44447732 311099 0 None None None Crab-eating macaque 8.4 pIC50 = 8.4 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 504 5 0 4 6.5 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL401929 311099 0 None None None Crab-eating macaque 8.4 pIC50 = 8.4 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 504 5 0 4 6.5 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1016/j.bmcl.2008.01.108
501044 18737 0 None None None Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501048 18737 0 None None None Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL101333 18737 0 None None None Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL322232 18737 0 None None None Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44389412 125250 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(C[C@](C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL178189 125250 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(C[C@](C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
44590798 374066 0 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 9 1 4 5.5 CCN(C(=O)Oc1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL518640 374066 0 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 9 1 4 5.5 CCN(C(=O)Oc1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44565721 371887 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 14 2 5 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(OCCO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL504250 371887 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 14 2 5 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(OCCO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44274022 199037 0 None None None Human 8.4 pIC50 = 8.4 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 568 11 1 5 5.6 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC3(c4ccc(F)cc4)OCCO3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL278383 199037 0 None None None Human 8.4 pIC50 = 8.4 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 568 11 1 5 5.6 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC3(c4ccc(F)cc4)OCCO3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44565721 371887 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 14 2 5 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(OCCO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL504250 371887 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 14 2 5 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(OCCO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
122668192 404370 0 None None None Human 8.4 pIC50 = 8.4 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 469 8 1 6 5.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCC1)c1cccs1 nan
CHEMBL5797359 404370 0 None None None Human 8.4 pIC50 = 8.4 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 469 8 1 6 5.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCC1)c1cccs1 nan
44590684 349659 0 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 489 10 1 3 5.3 CCN(C(=O)Cc1ccc(C)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL458157 349659 0 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 489 10 1 3 5.3 CCN(C(=O)Cc1ccc(C)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
3010269 353005 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471766 353005 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
72711508 183505 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 539 7 1 4 5.6 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435905 183505 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 539 7 1 4 5.6 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
5275765 275610 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL377026 275610 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
3010269 353005 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL471766 353005 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
474169 25554 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 550 7 1 3 7.1 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL1179143 25554 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 550 7 1 3 7.1 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
3010269 353005 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471766 353005 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
505878 237962 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 518 10 1 5 5.5 CCCN(c1ccccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343160 237962 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 518 10 1 5 5.5 CCCN(c1ccccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
11353001 121592 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688239 121592 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
516305 160408 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 587 10 1 6 6.0 CCn1nc(Cc2cccnc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL2112952 160408 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 587 10 1 6 6.0 CCn1nc(Cc2cccnc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
44564929 353157 0 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 423 8 1 5 4.4 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL472953 353157 0 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 423 8 1 5 4.4 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
478451 176543 0 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 577 14 0 5 5.3 CCCN(C(=O)COc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282501 176543 0 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 577 14 0 5 5.3 CCCN(C(=O)COc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
478444 335674 0 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 562 12 1 4 5.9 CCCN(C(=O)Nc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL445836 335674 0 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 562 12 1 4 5.9 CCCN(C(=O)Nc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461707 470489 0 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 577 13 0 5 6.0 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL82048 470489 0 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 577 13 0 5 6.0 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
501045 18682 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501049 18682 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL100958 18682 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL99788 18682 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501057 19090 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL103782 19090 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44374086 117821 0 None None None Human 7.5 pIC50 = 7.5 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL161594 117821 0 None None None Human 7.5 pIC50 = 7.5 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
478307 215509 0 None None None Human 7.5 pIC50 = 7.5 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00652-7
CHEMBL312701 215509 0 None None None Human 7.5 pIC50 = 7.5 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00652-7
25230828 337155 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 595 9 0 6 5.8 CCCCC1C(=O)N(C[C@H]2CC[C@H](OCC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL449621 337155 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 595 9 0 6 5.8 CCCCC1C(=O)N(C[C@H]2CC[C@H](OCC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44570269 351519 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 552 7 0 6 5.8 CCCCC1C(=O)C(CC2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL464054 351519 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 552 7 0 6 5.8 CCCCC1C(=O)C(CC2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
46888564 22981 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 490 7 2 4 3.4 Cc1cc(=O)[nH]c(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095518 22981 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 490 7 2 4 3.4 Cc1cc(=O)[nH]c(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888605 23348 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 547 8 1 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cc(F)cc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098664 23348 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 547 8 1 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cc(F)cc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44374086 117821 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL161594 117821 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
11433740 20130 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 537 7 0 4 6.6 CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078753 20130 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 537 7 0 4 6.6 CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
54581479 123648 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 588 9 1 4 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762313 123648 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 588 9 1 4 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
54583460 123650 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 593 7 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2(c3ccc(C(F)(F)F)cc3)Oc3ccccc3O2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762315 123650 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 593 7 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2(c3ccc(C(F)(F)F)cc3)Oc3ccccc3O2)CC1 10.1016/j.bmcl.2011.02.058
11422270 123669 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 630 10 1 6 7.4 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762339 123669 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 630 10 1 6 7.4 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11180743 123730 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 580 9 1 5 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccn2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762464 123730 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 580 9 1 5 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccn2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
46880775 20712 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.6 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1082201 20712 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.6 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
11844212 198902 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 590 7 1 2 7.7 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](CCN1CCC2(C=Cc3ccccc32)CC1)c1ccc(F)cc1 10.1021/jm060439n
CHEMBL277279 198902 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 590 7 1 2 7.7 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](CCN1CCC2(C=Cc3ccccc32)CC1)c1ccc(F)cc1 10.1021/jm060439n
52947038 42119 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 541 8 0 6 2.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cccc(F)c3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270303 42119 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 541 8 0 6 2.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cccc(F)c3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
478307 215509 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL312701 215509 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44461561 470227 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79930 470227 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478307 215509 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL312701 215509 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
478302 473688 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 538 8 0 5 4.3 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL89958 473688 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 538 8 0 5 4.3 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44461561 470227 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79930 470227 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
25057877 20110 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 6 0 4 5.9 CCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078648 20110 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 6 0 4 5.9 CCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
482150 222214 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 506 9 0 5 5.1 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL330486 222214 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 506 9 0 5 5.1 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479867 473808 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 530 9 0 3 6.7 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL90691 473808 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 530 9 0 3 6.7 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479857 328480 0 None None None Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 496 9 0 3 6.0 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL420242 328480 0 None None None Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 496 9 0 3 6.0 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
65237 275021 69 None None None Human 4.5 pIC50 = 4.5 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
CHEMBL375781 275021 69 None None None Human 4.5 pIC50 = 4.5 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
72711051 183496 0 None None None Human 5.5 pIC50 = 5.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccc(Br)cc2)CC1 10.1021/jm401101p
CHEMBL2435896 183496 0 None None None Human 5.5 pIC50 = 5.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccc(Br)cc2)CC1 10.1021/jm401101p
44431946 178974 0 None None None Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 436 7 1 3 5.3 CCNC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234674 178974 0 None None None Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 436 7 1 3 5.3 CCNC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
49768639 180408 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 591 7 1 6 5.2 CCCCC1C(=O)N(C[C@H]2CC[C@H](O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL2374447 180408 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 591 7 1 6 5.2 CCCCC1C(=O)N(C[C@H]2CC[C@H](O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
72714320 183490 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435890 183490 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
44455223 195704 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 492 8 1 5 5.8 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL256584 195704 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 492 8 1 5 5.8 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
490007 332605 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 503 7 0 4 5.3 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL430905 332605 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 503 7 0 4 5.3 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
54584058 125618 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 568 6 0 4 7.1 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(F)c(F)c2)CC1 10.1021/jm200279v
CHEMBL1784480 125618 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 568 6 0 4 7.1 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(F)c(F)c2)CC1 10.1021/jm200279v
118219267 411732 0 None None None Human 7.5 pIC50 = 7.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 482 8 1 6 4.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCC1)c1ccc(F)nc1 nan
CHEMBL5811099 411732 0 None None None Human 7.5 pIC50 = 7.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 482 8 1 6 4.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCC1)c1ccc(F)nc1 nan
6320579 240759 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 547 10 0 5 5.1 CN(C[C@@H](CCN1CCC(N2C[C@@H](c3ccccc3)OC2=O)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL359752 240759 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 547 10 0 5 5.1 CN(C[C@@H](CCN1CCC(N2C[C@@H](c3ccccc3)OC2=O)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
44392142 137567 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 524 10 0 3 6.7 CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182817 137567 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 524 10 0 3 6.7 CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44392149 137658 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 10 0 4 5.8 O=C(Cc1ccc([N+](=O)[O-])cc1)N(C1CC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182929 137658 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 10 0 4 5.8 O=C(Cc1ccc([N+](=O)[O-])cc1)N(C1CC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44404605 144792 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 536 10 0 4 5.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL199258 144792 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 536 10 0 4 5.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2005.08.014
44455225 195748 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 477 8 0 5 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)C1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL256792 195748 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 477 8 0 5 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)C1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
16728632 182381 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 370 5 3 3 4.0 N=C(N)N/N=C/c1cc(Cl)cc(Cl)c1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240641 182381 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 370 5 3 3 4.0 N=C(N)N/N=C/c1cc(Cl)cc(Cl)c1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
44431946 178974 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 436 7 1 3 5.3 CCNC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234674 178974 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 436 7 1 3 5.3 CCNC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
53321482 121251 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683064 121251 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
44590738 349740 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 494 5 0 4 5.2 Cc1ccnc(C)c1C(=O)N1CCC(N2CC3CCC(C2)N3C(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL458351 349740 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 494 5 0 4 5.2 Cc1ccnc(C)c1C(=O)N1CCC(N2CC3CCC(C2)N3C(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.012
52944644 42105 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 523 8 0 6 2.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270209 42105 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 523 8 0 6 2.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
72714319 183489 0 None None None Human 5.5 pIC50 = 5.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
CHEMBL2435889 183489 0 None None None Human 5.5 pIC50 = 5.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
44564985 370338 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 413 7 1 6 4.2 COC(=O)N[C@@H](CC(C)N1CCC(n2c(C)nnc2C(C)C)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
CHEMBL491328 370338 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 413 7 1 6 4.2 COC(=O)N[C@@H](CC(C)N1CCC(n2c(C)nnc2C(C)C)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
65237 275021 69 None None None Human 4.5 pIC50 = 4.5 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
CHEMBL375781 275021 69 None None None Human 4.5 pIC50 = 4.5 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
76330769 176527 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 592 8 3 3 7.2 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(F)cccc1F 10.1007/s00044-012-0118-7
CHEMBL2281963 176527 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 592 8 3 3 7.2 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(F)cccc1F 10.1007/s00044-012-0118-7
489344 19786 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 681 13 2 5 6.9 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL107439 19786 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 681 13 2 5 6.9 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
25206397 21435 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 630 6 1 6 4.1 CNC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085221 21435 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 630 6 1 6 4.1 CNC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
44392137 137165 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 530 10 0 4 5.3 CS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2005.08.014
CHEMBL182074 137165 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 530 10 0 4 5.3 CS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2005.08.014
72711278 183498 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435898 183498 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
16073669 161324 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)ccc2F)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL212243 161324 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)ccc2F)CC1 10.1016/j.bmcl.2006.03.089
489818 220931 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 482 6 0 4 5.2 COC(=O)c1ccccc1C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL327392 220931 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 482 6 0 4 5.2 COC(=O)c1ccccc1C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
122668211 426130 0 None None None Human 7.5 pIC50 = 7.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 498 7 1 7 3.6 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1nccs1 nan
CHEMBL5861267 426130 0 None None None Human 7.5 pIC50 = 7.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 498 7 1 7 3.6 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1nccs1 nan
118219301 433051 0 None None None Human 7.5 pIC50 = 7.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 389 7 1 6 3.7 CC(=O)NC(CCN1CCC(n2c(C)nnc2C(C)C)CC1)c1cccs1 nan
CHEMBL5933886 433051 0 None None None Human 7.5 pIC50 = 7.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 389 7 1 6 3.7 CC(=O)NC(CCN1CCC(n2c(C)nnc2C(C)C)CC1)c1cccs1 nan
44392213 330998 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 455 8 1 2 6.5 CCN(C(=O)Nc1ccc(C)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL426250 330998 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 455 8 1 2 6.5 CCN(C(=O)Nc1ccc(C)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44573097 385644 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 506 6 0 6 5.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(c2ncccn2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL522669 385644 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 506 6 0 6 5.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(c2ncccn2)CC1 10.1016/j.bmcl.2009.02.014
44431971 179656 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 593 8 3 4 6.1 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(F)cccc1F 10.1016/j.bmcl.2007.01.050
CHEMBL236421 179656 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 593 8 3 4 6.1 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(F)cccc1F 10.1016/j.bmcl.2007.01.050
474153 25571 0 None None None Human 5.5 pIC50 = 5.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 431 5 1 1 6.0 Cc1cccc[n+]1Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
CHEMBL1179232 25571 0 None None None Human 5.5 pIC50 = 5.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 431 5 1 1 6.0 Cc1cccc[n+]1Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
6480206 367674 1 None None None Human 4.5 pIC50 = 4.5 Binding
Displacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPADisplacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPA
ChEMBL 370 1 1 2 5.7 C=C(C)[C@H]1CC[C@@]2(C)CC[C@]3(C)C[C@H]4[C@@H](C)C[C@@]5(O)OC/C(=C/C[C@H]3[C@H]12)[C@@H]45 10.1021/np049844c
CHEMBL484427 367674 1 None None None Human 4.5 pIC50 = 4.5 Binding
Displacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPADisplacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPA
ChEMBL 370 1 1 2 5.7 C=C(C)[C@H]1CC[C@@]2(C)CC[C@]3(C)C[C@H]4[C@@H](C)C[C@@]5(O)OC/C(=C/C[C@H]3[C@H]12)[C@@H]45 10.1021/np049844c
66767933 239832 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 531 12 6 5 3.2 CCC[C@H](O)[C@H](CNCC(C)(C)C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
CHEMBL3577933 239832 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 531 12 6 5 3.2 CCC[C@H](O)[C@H](CNCC(C)(C)C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
44455106 198239 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 9 1 5 5.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NCc1ccccc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272581 198239 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 9 1 5 5.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NCc1ccccc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
155540798 347053 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1cc(Cl)cc(Cl)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4516788 347053 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1cc(Cl)cc(Cl)c1 10.1021/acs.jmedchem.9b00742
44373768 387606 0 None None None Human 7.5 pIC50 = 7.5 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL539943 387606 0 None None None Human 7.5 pIC50 = 7.5 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
46890346 21444 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 612 6 1 6 5.1 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C[C@H]4CC[C@H](O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085232 21444 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 612 6 1 6 5.1 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C[C@H]4CC[C@H](O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
44392125 259679 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 531 10 1 4 4.6 NS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL369352 259679 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 531 10 1 4 4.6 NS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
44373768 387606 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL539943 387606 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
516331 123061 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 598 11 2 6 5.5 O=C(O)Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL174283 123061 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 598 11 2 6 5.5 O=C(O)Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
489823 221861 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 414 5 0 3 5.0 O=C(c1ccoc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL329555 221861 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 414 5 0 3 5.0 O=C(c1ccoc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44373768 387606 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL539943 387606 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
44590801 350168 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 529 9 1 3 6.4 CCN(C(=O)c1ccc(Cl)c(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459378 350168 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 529 9 1 3 6.4 CCN(C(=O)c1ccc(Cl)c(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
72712160 183469 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
CHEMBL2435869 183469 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
483333 19416 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 9 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2nnnc2-c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105460 19416 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 9 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2nnnc2-c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
72712373 183473 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 502 6 0 4 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(N3CCOCC3)cc2)CC1 10.1021/jm401101p
CHEMBL2435873 183473 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 502 6 0 4 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(N3CCOCC3)cc2)CC1 10.1021/jm401101p
3011722 143282 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 539 10 0 5 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951900 143282 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 539 10 0 5 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
54585385 123646 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 513 7 2 4 5.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(O)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762311 123646 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 513 7 2 4 5.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(O)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
5481748 221047 0 None None None Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2ccccc2c1 10.1007/s00044-011-9863-2
CHEMBL328024 221047 0 None None None Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2ccccc2c1 10.1007/s00044-011-9863-2
5481713 470583 0 None None None Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL82880 470583 0 None None None Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
162648673 353834 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 522 6 3 7 3.4 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(OC(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4746510 353834 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 522 6 3 7 3.4 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(OC(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
25206227 21434 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 651 7 0 7 3.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCN(S(C)(=O)=O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085220 21434 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 651 7 0 7 3.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCN(S(C)(=O)=O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888606 23349 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 536 8 1 6 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cccc(C#N)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098665 23349 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 536 8 1 6 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cccc(C#N)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46882081 19947 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 608 9 0 6 6.2 CCCC[C@H]1CN(C[C@H]2CC[C@H](OCC)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ccnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077363 19947 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 608 9 0 6 6.2 CCCC[C@H]1CN(C[C@H]2CC[C@H](OCC)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ccnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
52945332 42150 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 529 7 0 5 4.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(CC(F)(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270493 42150 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 529 7 0 5 4.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(CC(F)(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
489824 474144 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 430 5 0 2 5.7 O=C(C1CCCCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL92861 474144 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 430 5 0 2 5.7 O=C(C1CCCCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
72711049 183494 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
CHEMBL2435894 183494 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
53322810 121262 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 499 6 1 7 2.7 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3nccc(C(F)(F)F)n3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683075 121262 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 499 6 1 7 2.7 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3nccc(C(F)(F)F)n3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
76308986 176533 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 10 3 3 9.2 CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281969 176533 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 10 3 3 9.2 CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
478512 216205 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 594 8 0 6 4.7 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cn(C)cn1 10.1016/s0960-894x(00)00637-5
CHEMBL314077 216205 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 594 8 0 6 4.7 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cn(C)cn1 10.1016/s0960-894x(00)00637-5
478493 473738 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 8 0 4 4.4 CN(C)S(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
CHEMBL90272 473738 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 8 0 4 4.4 CN(C)S(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
44392219 137214 3 None None None Human 5.5 pIC50 = 5.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 392 8 0 2 5.2 CC(C)CC(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182234 137214 3 None None None Human 5.5 pIC50 = 5.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 392 8 0 2 5.2 CC(C)CC(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728631 182380 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 320 5 3 3 2.9 N=C(N)N/N=C/c1cc(F)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240640 182380 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 320 5 3 3 2.9 N=C(N)N/N=C/c1cc(F)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
16728631 182380 0 None None None Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 320 5 3 3 2.9 N=C(N)N/N=C/c1cc(F)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL240640 182380 0 None None None Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 320 5 3 3 2.9 N=C(N)N/N=C/c1cc(F)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
72714318 183488 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
CHEMBL2435888 183488 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
72711050 183495 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435895 183495 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
25130569 371526 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 596 7 1 6 5.2 O=C(c1ccco1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm800598a
CHEMBL500523 371526 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 596 7 1 6 5.2 O=C(c1ccco1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm800598a
155529593 335993 0 None None None Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 518 7 2 5 2.2 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](NS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL4463290 335993 0 None None None Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 518 7 2 5 2.2 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](NS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
25230896 371473 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 569 6 0 7 5.0 CCCCC1CN(C(=O)OC2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL499729 371473 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 569 6 0 7 5.0 CCCCC1CN(C(=O)OC2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44431954 177875 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 477 6 1 4 4.6 Clc1ccc(COc2ccc(Br)cc2CN2CCC(N3CCNCC3)CC2)cc1 10.1007/s00044-012-0118-7
CHEMBL232409 177875 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 477 6 1 4 4.6 Clc1ccc(COc2ccc(Br)cc2CN2CCC(N3CCNCC3)CC2)cc1 10.1007/s00044-012-0118-7
11326950 178527 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 395 5 1 3 4.2 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1007/s00044-012-0118-7
CHEMBL233638 178527 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 395 5 1 3 4.2 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1007/s00044-012-0118-7
5482456 470167 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 511 9 0 4 5.3 Cc1ccccc1N1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
CHEMBL79369 470167 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 511 9 0 4 5.3 Cc1ccccc1N1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
478503 473173 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 9 0 5 6.0 COc1ccc(S(=O)(=O)N(C)C[C@@H](CCN2CCC3(CC2)C[S+]([O-])c2ccccc23)c2ccc(Cl)c(Cl)c2)cc1 10.1007/s00044-011-9863-2
CHEMBL86419 473173 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 9 0 5 6.0 COc1ccc(S(=O)(=O)N(C)C[C@@H](CCN2CCC3(CC2)C[S+]([O-])c2ccccc23)c2ccc(Cl)c(Cl)c2)cc1 10.1007/s00044-011-9863-2
478500 473793 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1 10.1007/s00044-011-9863-2
CHEMBL90620 473793 0 None None None Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1 10.1007/s00044-011-9863-2
44570177 374483 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 498 5 1 5 4.0 CCCC[C@H]1CN(C(=O)NC)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL519278 374483 0 None None None Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 498 5 1 5 4.0 CCCC[C@H]1CN(C(=O)NC)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
471179 470178 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00654-0
CHEMBL79504 470178 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00654-0
5481702 470631 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity against human CCR5 receptor stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against human CCR5 receptor stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00655-2
CHEMBL83338 470631 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity against human CCR5 receptor stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against human CCR5 receptor stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00655-2
471179 470178 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL79504 470178 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
44392235 137688 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 469 9 1 2 6.2 CCN(C(=O)NCc1cccc(C)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182940 137688 0 None None None Human 7.5 pIC50 = 7.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 469 9 1 2 6.2 CCN(C(=O)NCc1cccc(C)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44431984 293576 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 641 10 3 4 8.1 CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL392536 293576 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 641 10 3 4 8.1 CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
46864993 20591 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.2 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1081625 20591 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.2 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
44461603 215640 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 569 12 0 5 6.0 CCOC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL312945 215640 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 569 12 0 5 6.0 CCOC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461494 461854 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 522 8 0 4 4.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL81719 461854 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 522 8 0 4 4.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
471179 470178 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
471179 470178 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL79504 470178 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79504 470178 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
5482453 470628 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)CNC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83311 470628 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)CNC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5482454 470660 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 1 4 5.5 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)Nc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83683 470660 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 1 4 5.5 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)Nc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
478296 313805 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 522 8 0 4 4.6 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL408438 313805 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 522 8 0 4 4.6 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
471179 470178 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL79504 470178 0 None None None Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
126585468 411647 0 None None None Human 7.5 pIC50 = 7.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 454 11 1 6 4.8 CCCCC(C)C(=O)N[C@@H](CCN1CCC(n2c(C)nnc2C(C)C)CC1)c1cccnc1 nan
CHEMBL5810272 411647 0 None None None Human 7.5 pIC50 = 7.5 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 454 11 1 6 4.8 CCCCC(C)C(=O)N[C@@H](CCN1CCC(n2c(C)nnc2C(C)C)CC1)c1cccnc1 nan
25132254 193832 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084492 193832 0 None None None Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
501058 219245 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL322693 219245 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44392162 137168 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 536 11 0 3 6.8 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182083 137168 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 536 11 0 3 6.8 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44431954 177875 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 477 6 1 4 4.6 Clc1ccc(COc2ccc(Br)cc2CN2CCC(N3CCNCC3)CC2)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL232409 177875 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 477 6 1 4 4.6 Clc1ccc(COc2ccc(Br)cc2CN2CCC(N3CCNCC3)CC2)cc1 10.1016/j.bmcl.2007.01.050
11326950 178527 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 395 5 1 3 4.2 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1016/j.bmcl.2007.01.050
CHEMBL233638 178527 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 395 5 1 3 4.2 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1016/j.bmcl.2007.01.050
5275833 232289 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 561 10 0 5 5.5 C[C@@H]1[C@@H](c2ccccc2)OC(=O)N1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
CHEMBL359687 232289 0 None None None Human 6.5 pIC50 = 6.5 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 561 10 0 5 5.5 C[C@@H]1[C@@H](c2ccccc2)OC(=O)N1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
489597 199854 0 None None None Human 5.5 pIC50 = 5.5 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](c2ccccc2)[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)C1 10.1016/s0960-894x(01)00232-3
CHEMBL284380 199854 0 None None None Human 5.5 pIC50 = 5.5 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](c2ccccc2)[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)C1 10.1016/s0960-894x(01)00232-3
44392083 138158 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 532 11 0 3 7.0 CN(C(=O)Cc1ccc(OCc2ccccc2)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183554 138158 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 532 11 0 3 7.0 CN(C(=O)Cc1ccc(OCc2ccccc2)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
483363 38583 0 None None None Human 5.5 pIC50 = 5.5 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](C[C@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL120569 38583 0 None None None Human 5.5 pIC50 = 5.5 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](C[C@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
478387 473602 0 None None None Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 596 8 0 5 6.0 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1007/s00044-011-9863-2
CHEMBL89279 473602 0 None None None Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 596 8 0 5 6.0 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1007/s00044-011-9863-2
501058 219245 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL322693 219245 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501058 219245 0 None None None Human 7.4 pIC50 = 7.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL322693 219245 0 None None None Human 7.4 pIC50 = 7.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
72711277 183497 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435897 183497 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
122668281 446485 0 None None None Human 7.4 pIC50 = 7.4 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 464 8 1 6 4.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCC1)c1cccnc1 nan
CHEMBL5972445 446485 0 None None None Human 7.4 pIC50 = 7.4 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 464 8 1 6 4.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCC1)c1cccnc1 nan
118219304 461239 0 None None None Human 7.4 pIC50 = 7.4 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 493 8 1 6 5.5 Cc1nnc(C(C)C)n1C1CCN(CCC(NC(=O)C2CCC(F)(F)CC2)c2cccs2)CC1 nan
CHEMBL6041505 461239 0 None None None Human 7.4 pIC50 = 7.4 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 493 8 1 6 5.5 Cc1nnc(C(C)C)n1C1CCN(CCC(NC(=O)C2CCC(F)(F)CC2)c2cccs2)CC1 nan
5275832 125356 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 561 10 0 5 5.5 C[C@H]1[C@@H](c2ccccc2)OC(=O)N1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
CHEMBL178337 125356 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 561 10 0 5 5.5 C[C@H]1[C@@H](c2ccccc2)OC(=O)N1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
76324826 214499 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 576 18 1 6 7.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CCCCCCCCCCN=[N+]=[N-])c1ccccc1 10.1021/ml400370w
CHEMBL3109177 214499 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 576 18 1 6 7.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CCCCCCCCCCN=[N+]=[N-])c1ccccc1 10.1021/ml400370w
5481747 221048 0 None None None Human 6.4 pIC50 = 6.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2ccccc12 10.1016/s0960-894x(00)00637-5
CHEMBL328025 221048 0 None None None Human 6.4 pIC50 = 6.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2ccccc12 10.1016/s0960-894x(00)00637-5
44392082 138157 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1ccccc1Cl)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183553 138157 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1ccccc1Cl)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
56750906 241557 3 None None None Human 4.4 pIC50 = 4.4 Binding
Inhibition of CCR5 assessed as reduction in fusion of effector cells expressing JRFL envelope (CCR5-tropic/CD4-dependent) with human HeLa-C14 target cells expressing CD4, CCR5, and CXCR4) by luciferase readoutInhibition of CCR5 assessed as reduction in fusion of effector cells expressing JRFL envelope (CCR5-tropic/CD4-dependent) with human HeLa-C14 target cells expressing CD4, CCR5, and CXCR4) by luciferase readout
ChEMBL 332 5 1 3 3.8 c1ccc(Cc2cn[nH]c2C2CCN(Cc3ccncc3)CC2)cc1 10.1021/acsmedchemlett.5b00036
CHEMBL3608763 241557 3 None None None Human 4.4 pIC50 = 4.4 Binding
Inhibition of CCR5 assessed as reduction in fusion of effector cells expressing JRFL envelope (CCR5-tropic/CD4-dependent) with human HeLa-C14 target cells expressing CD4, CCR5, and CXCR4) by luciferase readoutInhibition of CCR5 assessed as reduction in fusion of effector cells expressing JRFL envelope (CCR5-tropic/CD4-dependent) with human HeLa-C14 target cells expressing CD4, CCR5, and CXCR4) by luciferase readout
ChEMBL 332 5 1 3 3.8 c1ccc(Cc2cn[nH]c2C2CCN(Cc3ccncc3)CC2)cc1 10.1021/acsmedchemlett.5b00036
3011719 143274 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 540 10 0 6 3.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951892 143274 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 540 10 0 6 3.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
76319891 176535 0 None None None Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 382 5 3 3 3.1 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)c(F)c1 10.1007/s00044-012-0118-7
CHEMBL2281970 176535 0 None None None Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 382 5 3 3 3.1 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)c(F)c1 10.1007/s00044-012-0118-7
44570268 371645 0 None None None Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 581 8 0 6 5.4 CCCCC1C(=O)N(C[C@H]2CC[C@H](OC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL502432 371645 0 None None None Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 581 8 0 6 5.4 CCCCC1C(=O)N(C[C@H]2CC[C@H](OC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
11421221 136100 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 530 11 0 4 5.3 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180155 136100 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 530 11 0 4 5.3 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
18442936 143287 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 567 10 0 5 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951905 143287 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 567 10 0 5 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
44590230 352751 0 None None None Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 409 7 1 5 4.0 Cc1nnc(C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL469542 352751 0 None None None Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 409 7 1 5 4.0 Cc1nnc(C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
118219362 446125 0 None None None Human 7.4 pIC50 = 7.4 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 443 8 1 6 4.8 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCCC2)c2ccsc2)CC1 nan
CHEMBL5968679 446125 0 None None None Human 7.4 pIC50 = 7.4 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 443 8 1 6 4.8 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCCC2)c2ccsc2)CC1 nan
44392143 137144 0 None None None Human 6.4 pIC50 = 6.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 495 7 1 2 7.1 CN(C(=O)Nc1ccc(Cl)c(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181967 137144 0 None None None Human 6.4 pIC50 = 6.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 495 7 1 2 7.1 CN(C(=O)Nc1ccc(Cl)c(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44392106 241355 0 None None None Human 6.4 pIC50 = 6.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.4 CN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL360524 241355 0 None None None Human 6.4 pIC50 = 6.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.4 CN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
53325385 121248 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@H]2CCOC[C@@H]2C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683061 121248 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@H]2CCOC[C@@H]2C)C1 10.1016/j.bmcl.2011.01.015
57396951 143290 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 640 11 0 7 2.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)N2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951909 143290 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 640 11 0 7 2.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)N2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
16728627 294230 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 382 5 3 3 3.1 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1F 10.1016/j.bmcl.2006.09.052
CHEMBL393069 294230 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 382 5 3 3 3.1 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1F 10.1016/j.bmcl.2006.09.052
155513284 334295 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 343 3 2 5 2.9 Nc1nc2[nH]c(C3CCCC3)c(Cc3cccc(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
CHEMBL4438407 334295 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 343 3 2 5 2.9 Nc1nc2[nH]c(C3CCCC3)c(Cc3cccc(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
44392167 126184 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 519 10 1 4 4.4 CCN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL179877 126184 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 519 10 1 4 4.4 CCN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
46880847 21869 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 477 7 1 5 4.7 Cc1nnc(C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.01.080
CHEMBL1087533 21869 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 477 7 1 5 4.7 Cc1nnc(C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.01.080
491773 27092 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188399 27092 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
56647076 183481 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435881 183481 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
474150 26303 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCCC1 10.1021/jm9906264
CHEMBL1183377 26303 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCCC1 10.1021/jm9906264
483355 219918 0 None None None Human 5.4 pIC50 = 5.4 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 633 14 0 7 6.8 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL324284 219918 0 None None None Human 5.4 pIC50 = 5.4 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 633 14 0 7 6.8 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
54583462 123661 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1ccc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)nc1 10.1016/j.bmcl.2011.02.058
CHEMBL1762331 123661 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1ccc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)nc1 10.1016/j.bmcl.2011.02.058
44455034 195553 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1ccccc1NC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL255855 195553 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1ccccc1NC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
44590865 350696 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 457 8 2 4 5.1 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(c2[nH]ncc2-c2ccncc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460217 350696 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 457 8 2 4 5.1 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(c2[nH]ncc2-c2ccncc2)CC1 10.1016/j.bmcl.2009.01.009
162656188 354780 0 None None None Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 429 5 3 5 1.4 CN[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(C)(C)C)n3)C2=O)[C@H](NC(C)=O)C1 10.1021/acsmedchemlett.1c00082
CHEMBL4757857 354780 0 None None None Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 429 5 3 5 1.4 CN[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(C)(C)C)n3)C2=O)[C@H](NC(C)=O)C1 10.1021/acsmedchemlett.1c00082
44431949 295707 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 450 6 1 3 4.8 CC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL394256 295707 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 450 6 1 3 4.8 CC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
57400372 143278 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 604 11 0 7 2.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951896 143278 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 604 11 0 7 2.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
44447733 195475 0 None None None Crab-eating macaque 7.4 pIC50 = 7.4 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 469 5 0 5 5.1 Cc1cccnc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255431 195475 0 None None None Crab-eating macaque 7.4 pIC50 = 7.4 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 469 5 0 5 5.1 Cc1cccnc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
72713858 183510 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435910 183510 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
44415821 309077 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1C1CC2COCC(C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
CHEMBL413501 309077 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1C1CC2COCC(C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
72712371 183471 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435871 183471 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
11626984 174527 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1[C@H]1C[C@H]2COC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203621 174527 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1[C@H]1C[C@H]2COC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
76316242 176552 0 None None None Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 521 10 0 5 4.7 CCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282510 176552 0 None None None Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 521 10 0 5 4.7 CCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-012-0138-3
44461581 470712 0 None None None Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 11 0 5 4.4 CCOC(=O)N(CC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL84029 470712 0 None None None Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 11 0 5 4.4 CCOC(=O)N(CC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44431949 295707 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 450 6 1 3 4.8 CC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL394256 295707 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 450 6 1 3 4.8 CC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
489833 220952 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 6 0 2 6.1 Cc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
CHEMBL327540 220952 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 6 0 2 6.1 Cc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
474149 25578 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 437 5 1 1 6.5 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
CHEMBL1179247 25578 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 437 5 1 1 6.5 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
16728620 181552 0 None None None Human 4.4 pIC50 = 4.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 390 6 4 4 2.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(C(=O)O)c1 10.1016/j.bmcl.2006.09.052
CHEMBL239153 181552 0 None None None Human 4.4 pIC50 = 4.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 390 6 4 4 2.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(C(=O)O)c1 10.1016/j.bmcl.2006.09.052
16728620 181552 0 None None None Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 390 6 4 4 2.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(C(=O)O)c1 10.1007/s00044-012-0118-7
CHEMBL239153 181552 0 None None None Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 390 6 4 4 2.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(C(=O)O)c1 10.1007/s00044-012-0118-7
54584052 125603 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 518 6 0 4 6.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(n2cnc4ccccc42)C3)(c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784395 125603 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 518 6 0 4 6.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(n2cnc4ccccc42)C3)(c2ccccc2)CC1 10.1021/jm200279v
25131902 370536 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 518 6 1 5 5.7 CC(C)(C)OC(=O)N1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccccc2)CC1 10.1021/jm800598a
CHEMBL492897 370536 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 518 6 1 5 5.7 CC(C)(C)OC(=O)N1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccccc2)CC1 10.1021/jm800598a
10371054 385368 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 582 7 1 6 4.8 O=C(c1ccco1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL522158 385368 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 582 7 1 6 4.8 O=C(c1ccco1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
76311990 176216 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 500 8 0 4 4.4 C/C=C(\C)[C@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)CN(C)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL2259883 176216 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 500 8 0 4 4.4 C/C=C(\C)[C@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)CN(C)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
16728644 176525 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 408 6 3 3 4.3 CC/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL2281961 176525 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 408 6 3 3 4.3 CC/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
44431951 179153 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 466 6 1 4 5.0 COC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234843 179153 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 466 6 1 4 5.0 COC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
5481705 328454 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL420057 328454 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5481704 329360 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL421356 329360 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
478399 470682 0 None None None Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 524 8 0 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)Cc1ccccc1O2)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83818 470682 0 None None None Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 524 8 0 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)Cc1ccccc1O2)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
489307 220393 0 None None None Human 8.4 pIC50 = 8.4 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 603 13 1 6 6.5 CN(CC(CCN1CCC(O)(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccc(-c2ccccn2)s1 10.1016/s0960-894x(01)00652-7
CHEMBL326111 220393 0 None None None Human 8.4 pIC50 = 8.4 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 603 13 1 6 6.5 CN(CC(CCN1CCC(O)(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccc(-c2ccccn2)s1 10.1016/s0960-894x(01)00652-7
483340 19666 0 None None None Human 8.4 pIC50 = 8.4 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL106803 19666 0 None None None Human 8.4 pIC50 = 8.4 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
489339 19689 0 None None None Human 8.4 pIC50 = 8.4 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 635 12 2 5 6.1 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL106907 19689 0 None None None Human 8.4 pIC50 = 8.4 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 635 12 2 5 6.1 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
46888479 23123 0 None None None Human 8.4 pIC50 = 8.4 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 523 7 1 3 5.4 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096765 23123 0 None None None Human 8.4 pIC50 = 8.4 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 523 7 1 3 5.4 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
5481742 216713 0 None None None Human 8.4 pIC50 = 8.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nMBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nM
ChEMBL 527 8 0 3 6.8 [O-][S+]1CC2(CCN(CC[C@H](COCc3ccccc3)c3ccc(Cl)c(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(00)00637-5
CHEMBL315707 216713 0 None None None Human 8.4 pIC50 = 8.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nMBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nM
ChEMBL 527 8 0 3 6.8 [O-][S+]1CC2(CCN(CC[C@H](COCc3ccccc3)c3ccc(Cl)c(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(00)00637-5
5481743 473459 0 None None None Human 8.4 pIC50 = 8.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nMBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nM
ChEMBL 541 7 0 4 6.5 O=C(OC[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL88319 473459 0 None None None Human 8.4 pIC50 = 8.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nMBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nM
ChEMBL 541 7 0 4 6.5 O=C(OC[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
58282592 277259 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cellsDisplacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cells
ChEMBL 409 6 0 3 6.2 Cc1nc2ccccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2023.115586
CHEMBL3799799 277259 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cellsDisplacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cells
ChEMBL 409 6 0 3 6.2 Cc1nc2ccccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2023.115586
44573338 371946 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 598 8 1 5 7.0 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(F)c2)CCN(C(C(=O)O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL505443 371946 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 598 8 1 5 7.0 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(F)c2)CCN(C(C(=O)O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2009.02.014
44573254 385815 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 513 6 1 4 6.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL524050 385815 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 513 6 1 4 6.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC(C)C)CC1 10.1016/j.bmcl.2009.02.014
501045 18682 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501049 18682 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL100958 18682 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL99788 18682 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501057 19090 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL103782 19090 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44455069 195812 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1ccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)cc1 10.1016/j.bmcl.2007.12.058
CHEMBL257081 195812 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1ccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)cc1 10.1016/j.bmcl.2007.12.058
44454977 198277 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccc(Cl)cc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272716 198277 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccc(Cl)cc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
44555481 20049 1 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1078231 20049 1 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2010.02.004
501045 18682 0 None None None Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501049 18682 0 None None None Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL100958 18682 0 None None None Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL99788 18682 0 None None None Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501057 19090 0 None None None Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL103782 19090 0 None None None Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
486602 215682 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 611 13 0 5 6.6 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL313216 215682 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 611 13 0 5 6.6 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
478444 335674 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 562 12 1 4 5.9 CCCN(C(=O)Nc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL445836 335674 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 562 12 1 4 5.9 CCCN(C(=O)Nc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461823 461878 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 577 14 0 5 5.3 CCCN(C(=O)COc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL84309 461878 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 577 14 0 5 5.3 CCCN(C(=O)COc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461689 470478 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccccc1C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL81926 470478 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccccc1C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
516351 123064 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 578 8 2 4 6.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccc(Cl)cc4)[nH]n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL174303 123064 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 578 8 2 4 6.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccc(Cl)cc4)[nH]n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.004
44325542 221793 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 575 8 0 4 6.8 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL329140 221793 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 575 8 0 4 6.8 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490016 221836 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 531 8 0 4 5.9 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL329417 221836 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 531 8 0 4 5.9 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
516326 123821 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL176392 123821 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516326 123821 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL176392 123821 0 None None None Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
10280445 195514 0 None None None Crab-eating macaque 8.4 pIC50 = 8.4 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 539 5 0 5 5.3 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)c[n+]([O-])cc2Cl)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255645 195514 0 None None None Crab-eating macaque 8.4 pIC50 = 8.4 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 539 5 0 5 5.3 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)c[n+]([O-])cc2Cl)CC1 10.1016/j.bmcl.2008.01.108
516326 123821 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL176392 123821 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
68764898 1384 3 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulationAntagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulation
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
9430 1384 3 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulationAntagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulation
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
CHEMBL3577945 1384 3 None None None Human 8.4 pIC50 = 8.4 Binding
Antagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulationAntagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulation
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
44384642 122614 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 566 9 2 4 6.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3C3(c4ccccc4)CC3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL172845 122614 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 566 9 2 4 6.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3C3(c4ccccc4)CC3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
10117348 28171 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
CHEMBL1196455 28171 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
474162 25560 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 509 6 1 3 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCC(=O)CC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1179157 25560 0 None None None Human 8.4 pIC50 = 8.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 509 6 1 3 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCC(=O)CC4)cc2)CCO3)cc1 10.1021/jm9906264
53319838 121596 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 545 4 0 6 4.4 CO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688242 121596 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 545 4 0 6 4.4 CO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
516327 257649 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL367421 257649 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
5275760 158706 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 623 10 0 6 5.1 COC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL207301 158706 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 623 10 0 6 5.1 COC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
11585625 158726 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 648 10 1 6 4.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NS(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207447 158726 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 648 10 1 6 4.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NS(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516327 257649 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL367421 257649 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516327 257649 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL367421 257649 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
118219274 411383 0 None None None Human 8.3 pIC50 = 8.3 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 547 9 1 6 6.6 CCc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 nan
CHEMBL5806900 411383 0 None None None Human 8.3 pIC50 = 8.3 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 547 9 1 6 6.6 CCc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 nan
11527691 213276 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085313 213276 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CCC)cc1 10.1021/jm0509703
126567365 406573 0 None None None Human 8.3 pIC50 = 8.3 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 486 6 1 8 3.2 COC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2nccs2)C1 nan
CHEMBL5756752 406573 0 None None None Human 8.3 pIC50 = 8.3 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 486 6 1 8 3.2 COC(=O)N1CCc2c(nc(C)n2C2CC3CCC(C2)N3CC[C@H](NC(C)=O)c2nccs2)C1 nan
516334 239081 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL353827 239081 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44274042 328143 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL417825 328143 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44274042 328143 0 None None None Human 8.3 pIC50 = 8.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL417825 328143 0 None None None Human 8.3 pIC50 = 8.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
516334 239081 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL353827 239081 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44274042 328143 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL417825 328143 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
516334 239081 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL353827 239081 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516329 258092 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 622 10 1 5 7.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC(F)(F)F)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL367863 258092 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 622 10 1 5 7.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC(F)(F)F)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
44590799 350750 0 None None None Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 479 9 1 3 5.2 CCN(C(=O)c1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460628 350750 0 None None None Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 479 9 1 3 5.2 CCN(C(=O)c1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44564982 385716 0 None None None Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 499 8 1 6 4.1 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC[S+]([O-])CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL523267 385716 0 None None None Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 499 8 1 6 4.1 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC[S+]([O-])CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
5481746 222256 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 666 9 0 4 7.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/s0960-894x(00)00637-5
CHEMBL330570 222256 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 666 9 0 4 7.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/s0960-894x(00)00637-5
478503 473173 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 620 9 0 5 6.0 COc1ccc(S(=O)(=O)N(C)C[C@@H](CCN2CCC3(CC2)C[S+]([O-])c2ccccc23)c2ccc(Cl)c(Cl)c2)cc1 10.1016/s0960-894x(00)00637-5
CHEMBL86419 473173 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 620 9 0 5 6.0 COc1ccc(S(=O)(=O)N(C)C[C@@H](CCN2CCC3(CC2)C[S+]([O-])c2ccccc23)c2ccc(Cl)c(Cl)c2)cc1 10.1016/s0960-894x(00)00637-5
478500 473793 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1 10.1016/s0960-894x(00)00637-5
CHEMBL90620 473793 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1 10.1016/s0960-894x(00)00637-5
44412984 270570 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL380083 270570 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
44573302 371811 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 580 6 0 6 7.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)SC2CCCC2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL502909 371811 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 580 6 0 6 7.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)SC2CCCC2)CC1 10.1016/j.bmcl.2009.02.014
54580467 123649 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 591 7 1 4 7.2 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2(c3ccc(C(F)(F)F)cc3)Cc3ccccc3O2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762314 123649 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 591 7 1 4 7.2 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2(c3ccc(C(F)(F)F)cc3)Cc3ccccc3O2)CC1 10.1016/j.bmcl.2011.02.058
11365412 123656 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 597 9 1 4 7.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(F)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762324 123656 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 597 9 1 4 7.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(F)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11261876 123665 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1cccc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
CHEMBL1762335 123665 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1cccc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
11478988 123732 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 605 9 1 6 6.7 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C#N)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762467 123732 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 605 9 1 6 6.7 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C#N)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
5479787 232054 2 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL336672 232054 2 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1016/j.bmcl.2011.02.058
44461513 214450 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 487 10 0 5 4.0 CCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL310645 214450 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 487 10 0 5 4.0 CCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461581 470712 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 11 0 5 4.4 CCOC(=O)N(CC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL84029 470712 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 11 0 5 4.4 CCOC(=O)N(CC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
70685193 145333 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cellsDisplacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cells
ChEMBL 410 6 0 4 5.6 Cc1nc2cnccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2023.115586
CHEMBL2011438 145333 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cellsDisplacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cells
ChEMBL 410 6 0 4 5.6 Cc1nc2cnccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2023.115586
44439314 182763 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 438 7 3 4 4.3 CC/C(=N\NC(=N)N)c1cc(Br)cc(OC)c1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL241476 182763 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 438 7 3 4 4.3 CC/C(=N\NC(=N)N)c1cc(Br)cc(OC)c1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
44431951 179153 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 466 6 1 4 5.0 COC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234843 179153 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 466 6 1 4 5.0 COC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
486595 470725 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 510 9 0 3 6.3 Cc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
CHEMBL84120 470725 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 510 9 0 3 6.3 Cc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
479876 221496 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 468 9 0 4 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328888 221496 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 468 9 0 4 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44324386 221023 0 None None None Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 303 6 0 2 3.5 CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL327880 221023 0 None None None Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 303 6 0 2 3.5 CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1ccccc1 10.1016/s0960-894x(00)00639-9
11234566 352788 21 None None None Human 4.4 pIC50 = 4.4 Binding
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 386 5 1 3 5.3 CC(C)=CCC[C@H](C)[C@H]1CC[C@]2(C)C[C@H]3[C@H](C(=O)C[C@@]3(C)O)/C(C=O)=C\C[C@@H]12 10.1021/np049974l
CHEMBL469855 352788 21 None None None Human 4.4 pIC50 = 4.4 Binding
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 386 5 1 3 5.3 CC(C)=CCC[C@H](C)[C@H]1CC[C@]2(C)C[C@H]3[C@H](C(=O)C[C@@]3(C)O)/C(C=O)=C\C[C@@H]12 10.1021/np049974l
489313 19785 0 None None None Human 7.4 pIC50 = 7.4 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 601 10 1 6 6.1 O=S(=O)(c1ccc(-c2ccccn2)s1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL107425 19785 0 None None None Human 7.4 pIC50 = 7.4 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 601 10 1 6 6.1 O=S(=O)(c1ccc(-c2ccccn2)s1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
44590739 372725 0 None None None Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 494 5 0 4 5.2 Cc1ccnc(C)c1C(=O)N1CCC(N2C3CCC2CN(C(c2ccccc2)c2ccccc2)C3)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL514749 372725 0 None None None Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 494 5 0 4 5.2 Cc1ccnc(C)c1C(=O)N1CCC(N2C3CCC2CN(C(c2ccccc2)c2ccccc2)C3)CC1 10.1016/j.bmcl.2009.01.012
44383760 333235 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 2 5 5.6 O=C(c1ccccc1)c1c[nH]nc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL435724 333235 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 2 5 5.6 O=C(c1ccccc1)c1c[nH]nc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
72712159 183467 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435867 183467 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
44392126 138390 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 467 6 0 3 5.4 CN(C(=O)N1Cc2ccccc2C1=O)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183885 138390 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 467 6 0 3 5.4 CN(C(=O)N1Cc2ccccc2C1=O)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
52944231 42008 0 None None None Human 5.4 pIC50 = 5.4 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 618 7 0 7 3.8 CS(=O)(=O)N1CCC(C(CCN2C[C@H]3CN(C(=O)S(=O)(=O)c4ccc(C#N)cc4Cl)C[C@H]3C2)c2ccccc2)CC1 10.1016/j.bmcl.2010.08.118
CHEMBL1269387 42008 0 None None None Human 5.4 pIC50 = 5.4 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 618 7 0 7 3.8 CS(=O)(=O)N1CCC(C(CCN2C[C@H]3CN(C(=O)S(=O)(=O)c4ccc(C#N)cc4Cl)C[C@H]3C2)c2ccccc2)CC1 10.1016/j.bmcl.2010.08.118
16728645 296254 0 None None None Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 376 8 3 3 4.4 CCCC/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(F)cc1 10.1007/s00044-012-0118-7
CHEMBL394684 296254 0 None None None Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 376 8 3 3 4.4 CCCC/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(F)cc1 10.1007/s00044-012-0118-7
44392253 137559 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 485 10 1 3 5.9 CCN(C(=O)NCc1ccc(OC)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182780 137559 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 485 10 1 3 5.9 CCN(C(=O)NCc1ccc(OC)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
505876 61544 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 485 8 0 3 6.0 C=CCN(c1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137154 61544 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 485 8 0 3 6.0 C=CCN(c1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
59458245 183466 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435866 183466 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
16728645 296254 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 376 8 3 3 4.4 CCCC/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(F)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL394684 296254 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 376 8 3 3 4.4 CCCC/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(F)cc1 10.1016/j.bmcl.2006.09.052
44374017 238695 0 None None None Human 7.4 pIC50 = 7.4 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@H]3CN4OC5(CCCCC5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL350027 238695 0 None None None Human 7.4 pIC50 = 7.4 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@H]3CN4OC5(CCCCC5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
25205764 20999 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 554 8 0 6 4.3 CCCCC1CN(CC2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1083437 20999 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 554 8 0 6 4.3 CCCCC1CN(CC2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
46880775 20564 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.6 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1081477 20564 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.6 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
474158 25553 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 467 5 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1179117 25553 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 467 5 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
72712161 183470 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435870 183470 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
474148 25573 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 423 5 1 1 6.1 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCC1 10.1021/jm9906264
CHEMBL1179235 25573 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 423 5 1 1 6.1 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCC1 10.1021/jm9906264
72712159 183467 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435867 183467 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
46888546 23171 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 490 7 1 4 3.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1097170 23171 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 490 7 1 4 3.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46882080 19946 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 609 9 0 7 5.6 CCCC[C@H]1CN(C[C@H]2CC[C@H](OCC)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077362 19946 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 609 9 0 7 5.6 CCCC[C@H]1CN(C[C@H]2CC[C@H](OCC)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
72713858 183510 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435910 183510 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
126585473 425266 0 None None None Human 7.4 pIC50 = 7.4 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 483 8 1 6 5.8 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccsc1 nan
CHEMBL5852046 425266 0 None None None Human 7.4 pIC50 = 7.4 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 483 8 1 6 5.8 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccsc1 nan
73346388 183478 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435878 183478 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
456615 202806 0 None None None Human 6.4 pIC50 = 6.4 Binding
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 603 6 0 7 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL305026 202806 0 None None None Human 6.4 pIC50 = 6.4 Binding
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 603 6 0 7 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
483353 38589 0 None None None Human 5.4 pIC50 = 5.4 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CCS(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL120584 38589 0 None None None Human 5.4 pIC50 = 5.4 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CCS(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
25133271 372195 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 604 7 1 4 6.4 O=C(c1ccccc1)N1CCCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL509298 372195 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 604 7 1 4 6.4 O=C(c1ccccc1)N1CCCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
76330768 176523 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 658 8 3 3 8.9 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cc(Cl)cc1Cl 10.1007/s00044-012-0118-7
CHEMBL2281959 176523 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 658 8 3 3 8.9 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cc(Cl)cc1Cl 10.1007/s00044-012-0118-7
11166533 295521 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 437 7 0 3 5.7 CCOC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL394115 295521 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 437 7 0 3 5.7 CCOC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
5481745 473452 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1Cl 10.1007/s00044-011-9863-2
CHEMBL88261 473452 0 None None None Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1Cl 10.1007/s00044-011-9863-2
177372132 393726 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cellsDisplacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cells
ChEMBL 452 7 1 4 5.5 Cc1nc2ccccc2n1C1CCN(CCC(NC(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2023.115586
CHEMBL5646686 393726 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cellsDisplacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cells
ChEMBL 452 7 1 4 5.5 Cc1nc2ccccc2n1C1CCN(CCC(NC(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2023.115586
46882075 19941 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 595 5 0 6 5.1 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
CHEMBL1077355 19941 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 595 5 0 6 5.1 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
5481715 214126 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 537 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)NC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL310305 214126 0 None None None Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 537 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)NC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44431975 178807 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 659 8 3 4 7.8 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cc(Cl)cc1Cl 10.1016/j.bmcl.2007.01.050
CHEMBL234017 178807 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 659 8 3 4 7.8 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cc(Cl)cc1Cl 10.1016/j.bmcl.2007.01.050
11166533 295521 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 437 7 0 3 5.7 CCOC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL394115 295521 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 437 7 0 3 5.7 CCOC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
479835 473477 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 506 8 0 4 5.6 CN(CC(CCN1CCC2(CC1)CSc1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL88455 473477 0 None None None Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 506 8 0 4 5.6 CN(CC(CCN1CCC2(CC1)CSc1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
25133620 370437 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 518 5 1 5 4.8 CC(C)(C)OC(=O)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)CC1 10.1021/jm800598a
CHEMBL492292 370437 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 518 5 1 5 4.8 CC(C)(C)OC(=O)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)CC1 10.1021/jm800598a
44374136 104944 0 None None None Human 7.3 pIC50 = 7.3 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL158438 104944 0 None None None Human 7.3 pIC50 = 7.3 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
44392088 126179 0 None None None Human 7.3 pIC50 = 7.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 533 10 0 4 4.6 CN(C(=O)Cc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL179858 126179 0 None None None Human 7.3 pIC50 = 7.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 533 10 0 4 4.6 CN(C(=O)Cc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16073661 277301 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 614 11 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(F)cc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL380005 277301 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 614 11 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(F)cc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
44374136 104944 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL158438 104944 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
490006 221026 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 489 8 0 4 5.6 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL327898 221026 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 489 8 0 4 5.6 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
489822 474341 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 430 5 0 3 5.5 O=C(c1cccs1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL94182 474341 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 430 5 0 3 5.5 O=C(c1cccs1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44374136 104944 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL158438 104944 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
76330770 176531 0 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 584 8 3 3 7.6 Cc1cccc(C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281967 176531 0 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 584 8 3 3 7.6 Cc1cccc(C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
24794583 354952 0 None None None Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 464 5 3 6 2.3 CN[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](NC(C)=O)C1 10.1021/acsmedchemlett.1c00082
CHEMBL4760098 354952 0 None None None Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 464 5 3 6 2.3 CN[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](NC(C)=O)C1 10.1021/acsmedchemlett.1c00082
46888498 23049 0 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 383 6 1 3 2.8 CC(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096101 23049 0 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 383 6 1 3 2.8 CC(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44431979 178696 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 585 8 3 4 6.4 Cc1cccc(C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL233846 178696 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 585 8 3 4 6.4 Cc1cccc(C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44392114 138361 0 None None None Human 6.3 pIC50 = 6.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 442 8 1 3 5.1 CN(C(=O)Cc1ccc(O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183709 138361 0 None None None Human 6.3 pIC50 = 6.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 442 8 1 3 5.1 CN(C(=O)Cc1ccc(O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11154101 178964 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 408 5 1 3 4.6 NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234673 178964 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 408 5 1 3 4.6 NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
10008490 385155 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 584 7 1 5 5.1 O=C(C1CCCC1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL521529 385155 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 584 7 1 5 5.1 O=C(C1CCCC1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
16728613 182376 0 None None None Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 371 5 3 4 2.7 N#Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
CHEMBL240636 182376 0 None None None Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 371 5 3 4 2.7 N#Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
44590584 350752 1 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 463 10 2 4 3.9 COc1ccc(CC(=O)NC2CCN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2009.01.009
CHEMBL460630 350752 1 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 463 10 2 4 3.9 COc1ccc(CC(=O)NC2CCN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2009.01.009
483342 217787 0 None None None Human 7.3 pIC50 = 7.3 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 7 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2c(CC)nc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL319622 217787 0 None None None Human 7.3 pIC50 = 7.3 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 7 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2c(CC)nc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
44454972 198129 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 554 8 1 5 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1cccc(Cl)c1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272064 198129 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 554 8 1 5 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1cccc(Cl)c1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
489817 474184 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 502 5 0 2 6.2 O=C(c1ccccc1Br)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93168 474184 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 502 5 0 2 6.2 O=C(c1ccccc1Br)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
489826 474225 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 402 5 0 2 4.9 O=C(C1CCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93457 474225 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 402 5 0 2 4.9 O=C(C1CCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
11189082 293711 0 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 409 5 1 3 4.6 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL392659 293711 0 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 409 5 1 3 4.6 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
16728613 182376 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 371 5 3 4 2.7 N#Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240636 182376 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 371 5 3 4 2.7 N#Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
473081 473979 0 None None None Human 6.3 pIC50 = 6.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 6 0 2 6.3 CC(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL91697 473979 0 None None None Human 6.3 pIC50 = 6.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 6 0 2 6.3 CC(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
11249997 179208 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 563 6 1 3 6.9 OC1(c2ccc(Br)cc2)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234894 179208 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 563 6 1 3 6.9 OC1(c2ccc(Br)cc2)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
489595 332640 0 None None None Human 7.3 pIC50 = 7.3 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 536 5 0 5 3.9 O=S1(=O)CC2(CCN(C[C@H]3CN(S(=O)(=O)c4ccccc4)C[C@@H]3c3ccccc3)CC2)c2ccccc21 10.1016/s0960-894x(01)00232-3
CHEMBL431111 332640 0 None None None Human 7.3 pIC50 = 7.3 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 536 5 0 5 3.9 O=S1(=O)CC2(CCN(C[C@H]3CN(S(=O)(=O)c4ccccc4)C[C@@H]3c3ccccc3)CC2)c2ccccc21 10.1016/s0960-894x(01)00232-3
44392176 137379 0 None None None Human 7.3 pIC50 = 7.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 533 10 1 4 5.3 CCN(C(=O)NCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182380 137379 0 None None None Human 7.3 pIC50 = 7.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 533 10 1 4 5.3 CCN(C(=O)NCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11189082 293711 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 409 5 1 3 4.6 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL392659 293711 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 409 5 1 3 4.6 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44565081 370336 0 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN([C@@H](C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491320 370336 0 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN([C@@H](C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
44392104 330822 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 452 7 1 3 5.7 CN(C(=O)Nc1cccc(C#N)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL425168 330822 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 452 7 1 3 5.7 CN(C(=O)Nc1cccc(C#N)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
4080740 331018 3 None None None Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 464 10 1 6 3.7 O=C(CSc1nc2ccccc2c(=O)n1CCCN1CCCCC1)NCCc1ccccc1 10.1021/jm061389p
CHEMBL426385 331018 3 None None None Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 464 10 1 6 3.7 O=C(CSc1nc2ccccc2c(=O)n1CCCN1CCCCC1)NCCc1ccccc1 10.1021/jm061389p
24794624 353507 0 None None None Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 492 6 3 6 3.1 CC(=O)N[C@@H]1C[C@H](NC(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4742683 353507 0 None None None Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 492 6 3 6 3.1 CC(=O)N[C@@H]1C[C@H](NC(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
44373852 117469 0 None None None Human 8.3 pIC50 = 8.3 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 480 8 0 3 6.9 c1ccc(CCCC2CCN(C[C@H]3CN4O[C@H](c5ccccc5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL161093 117469 0 None None None Human 8.3 pIC50 = 8.3 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 480 8 0 3 6.9 c1ccc(CCCC2CCN(C[C@H]3CN4O[C@H](c5ccccc5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
44373721 330207 0 None None None Human 8.3 pIC50 = 8.3 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN3OC4(CCCCC4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL423427 330207 0 None None None Human 8.3 pIC50 = 8.3 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN3OC4(CCCCC4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
44590585 374188 0 None None None Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 505 11 1 4 5.0 CCN(C(=O)Cc1ccc(OC)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL518794 374188 0 None None None Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 505 11 1 4 5.0 CCN(C(=O)Cc1ccc(OC)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
489343 19270 0 None None None Human 8.3 pIC50 = 8.3 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 647 13 2 5 6.3 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL104698 19270 0 None None None Human 8.3 pIC50 = 8.3 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 647 13 2 5 6.3 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
505879 62306 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137728 62306 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
496974 18573 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
CHEMBL100336 18573 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
3011729 143275 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 602 11 0 6 4.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(c3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951893 143275 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 602 11 0 6 4.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(c3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
57395179 143292 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 633 12 0 7 3.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(OC)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951911 143292 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 633 12 0 7 3.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(OC)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
10348408 334016 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 590 8 1 5 7.4 Cc1cccc(C)c1C(C(=O)O)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL442619 334016 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 590 8 1 5 7.4 Cc1cccc(C)c1C(C(=O)O)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
44573340 372003 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 576 8 0 6 6.9 COC(=O)C(c1ccccc1)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL506273 372003 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 576 8 0 6 6.9 COC(=O)C(c1ccccc1)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
44573336 372125 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 565 5 0 6 5.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)N2CCOCC2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL508250 372125 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 565 5 0 6 5.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)N2CCOCC2)CC1 10.1016/j.bmcl.2009.02.014
11605997 121594 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 515 3 0 5 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(C(F)(F)F)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688240 121594 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 515 3 0 5 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(C(F)(F)F)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
496974 18573 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL100336 18573 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/j.ejmech.2008.01.040
501046 18620 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501050 18620 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL100596 18620 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL322603 18620 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
505879 62306 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137728 62306 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
46880887 21818 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 503 7 1 5 5.3 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
CHEMBL1087153 21818 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 503 7 1 5 5.3 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
46880849 21871 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.5 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(F)(F)C1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
CHEMBL1087535 21871 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.5 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(F)(F)C1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
501046 18620 0 None None None Human 8.3 pIC50 = 8.3 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501050 18620 0 None None None Human 8.3 pIC50 = 8.3 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL100596 18620 0 None None None Human 8.3 pIC50 = 8.3 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL322603 18620 0 None None None Human 8.3 pIC50 = 8.3 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44461476 213884 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.2 CN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL309619 213884 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.2 CN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478414 214474 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 538 12 0 3 6.9 CN(C[C@@H](CCN1CCC(CCCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL310780 214474 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 538 12 0 3 6.9 CN(C[C@@H](CCN1CCC(CCCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44461677 332766 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 14 0 5 6.4 CCCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL432182 332766 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 14 0 5 6.4 CCCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481713 470583 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481713 470583 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL82880 470583 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL82880 470583 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
44415847 161370 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 457 9 1 5 4.6 O=C(N[C@@H](CCN1CCC(n2cnc(Cc3ccccc3)n2)CC1)c1ccccc1)C1CCC1 10.1016/j.bmcl.2006.06.012
CHEMBL212437 161370 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 457 9 1 5 4.6 O=C(N[C@@H](CCN1CCC(n2cnc(Cc3ccccc3)n2)CC1)c1ccccc1)C1CCC1 10.1016/j.bmcl.2006.06.012
516180 258467 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2ccc(F)cc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368098 258467 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2ccc(F)cc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
490013 474134 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 525 8 0 4 5.7 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL92803 474134 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 525 8 0 4 5.7 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44461476 213884 0 None None None Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.2 CN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL309619 213884 0 None None None Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.2 CN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
54584059 125619 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 566 6 0 4 7.4 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2cccc(Cl)c2)CC1 10.1021/jm200279v
CHEMBL1784481 125619 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 566 6 0 4 7.4 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2cccc(Cl)c2)CC1 10.1021/jm200279v
25132254 193832 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084492 193832 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
25132604 203336 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 562 5 0 5 7.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084500 203336 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 562 5 0 5 7.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
122668268 463004 0 None None None Human 8.3 pIC50 = 8.3 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 469 8 1 6 5.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCC1)c1ccsc1 nan
CHEMBL6045344 463004 0 None None None Human 8.3 pIC50 = 8.3 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 469 8 1 6 5.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCC1)c1ccsc1 nan
10278617 195556 3 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 195556 3 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008902 466725 0 None None None Crab-eating macaque 8.3 pIC50 = 8.3 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL61536 466725 0 None None None Crab-eating macaque 8.3 pIC50 = 8.3 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
5275763 197118 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 622 10 1 5 4.7 CNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL264832 197118 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 622 10 1 5 4.7 CNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
126585472 450592 0 None None None Human 8.3 pIC50 = 8.3 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 511 9 1 6 6.4 CCC1CCC(C(=O)N[C@@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)c2ccsc2)CC1 nan
CHEMBL6016733 450592 0 None None None Human 8.3 pIC50 = 8.3 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 511 9 1 6 6.4 CCC1CCC(C(=O)N[C@@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)c2ccsc2)CC1 nan
1635 193594 43 None None None Mouse 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.ejmech.2018.01.085
3002977 193594 43 None None None Mouse 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.ejmech.2018.01.085
CHEMBL256907 193594 43 None None None Mouse 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.ejmech.2018.01.085
25133963 203332 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 6 0 4 7.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084496 203332 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 6 0 4 7.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
50992246 121261 6 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683074 121261 6 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
5275842 136171 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 604 11 0 6 5.1 CN(C[C@@](C)(CCN1CCC2C(CCC(=O)N2Cc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL180274 136171 0 None None None Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 604 11 0 6 5.1 CN(C[C@@](C)(CCN1CCC2C(CCC(=O)N2Cc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
57396843 142838 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 671 12 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(S(=O)(=O)CC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1949696 142838 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 671 12 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(S(=O)(=O)CC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
516368 251268 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 10 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@](C)(C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL368637 251268 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 10 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@](C)(C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
72711958 183464 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435864 183464 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
11947758 915 28 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsDisplacement of MIP-1alpha from human CCR5 expressed in CHO cells
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
3001322 915 28 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsDisplacement of MIP-1alpha from human CCR5 expressed in CHO cells
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 915 28 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsDisplacement of MIP-1alpha from human CCR5 expressed in CHO cells
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 915 28 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsDisplacement of MIP-1alpha from human CCR5 expressed in CHO cells
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1739499 915 28 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsDisplacement of MIP-1alpha from human CCR5 expressed in CHO cells
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 915 28 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsDisplacement of MIP-1alpha from human CCR5 expressed in CHO cells
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
44404640 144748 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 651 13 1 5 6.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)Cc3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL199118 144748 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 651 13 1 5 6.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)Cc3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
72711955 183461 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccn3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435861 183461 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccn3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
501054 18934 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL102674 18934 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
496984 328427 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL419895 328427 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
496973 332813 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
CHEMBL432596 332813 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
478414 214474 0 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 538 12 0 3 6.9 CN(C[C@@H](CCN1CCC(CCCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL310780 214474 0 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 538 12 0 3 6.9 CN(C[C@@H](CCN1CCC(CCCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5481744 473506 0 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 596 8 0 4 6.2 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCCC1 10.1007/s00044-011-9863-2
CHEMBL88644 473506 0 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 596 8 0 4 6.2 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCCC1 10.1007/s00044-011-9863-2
11376667 123651 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 579 9 1 4 7.4 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762316 123651 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 579 9 1 4 7.4 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11215601 123653 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 7.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C#N)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762318 123653 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 7.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C#N)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11238728 123664 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1ccnc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.02.058
CHEMBL1762334 123664 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1ccnc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.02.058
5481712 215591 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 523 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CNc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL312808 215591 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 523 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CNc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44415784 161284 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 395 7 1 5 3.6 Cc1nnc(C)n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
CHEMBL212087 161284 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 395 7 1 5 3.6 Cc1nnc(C)n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
482148 328305 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 544 8 0 6 4.4 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL418954 328305 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 544 8 0 6 4.4 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
15950679 183468 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435868 183468 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
72712374 183474 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
CHEMBL2435874 183474 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
16073671 335914 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 652 11 0 6 5.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(C)(C)C)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL446187 335914 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 652 11 0 6 5.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(C)(C)C)c2)CC1 10.1016/j.bmcl.2006.03.089
16728621 181560 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 360 5 3 3 3.2 Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL239154 181560 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 360 5 3 3 3.2 Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
479860 473928 0 None None None Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 530 9 0 3 6.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccc(C(F)(F)F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL91413 473928 0 None None None Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 530 9 0 3 6.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccc(C(F)(F)F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
16728621 181560 0 None None None Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 360 5 3 3 3.2 Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
CHEMBL239154 181560 0 None None None Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 360 5 3 3 3.2 Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
478496 473288 0 None None None Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 582 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCC1 10.1007/s00044-011-9863-2
CHEMBL87167 473288 0 None None None Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 582 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCC1 10.1007/s00044-011-9863-2
25133617 203326 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 536 7 0 5 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccccc2)CCN(C(=O)c2ccco2)CC1 10.1021/jm800598a
CHEMBL3084489 203326 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 536 7 0 5 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccccc2)CCN(C(=O)c2ccco2)CC1 10.1021/jm800598a
12425 11 80 None None None Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 11 80 None None None Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 11 80 None None None Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 11 80 None None None Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
44273850 199802 0 None None None Human 7.3 pIC50 = 7.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 554 12 2 4 5.6 O=C(O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL284010 199802 0 None None None Human 7.3 pIC50 = 7.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 554 12 2 4 5.6 O=C(O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
44392137 137165 0 None None None Human 7.3 pIC50 = 7.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 530 10 0 4 5.3 CS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL182074 137165 0 None None None Human 7.3 pIC50 = 7.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 530 10 0 4 5.3 CS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
46883507 20439 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 523 7 0 4 6.3 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1080794 20439 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 523 7 0 4 6.3 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44392168 251367 3 None None None Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 457 8 0 4 5.4 CN(C(=O)c1cccc([N+](=O)[O-])c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL361414 251367 3 None None None Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 457 8 0 4 5.4 CN(C(=O)c1cccc([N+](=O)[O-])c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
53389710 336805 0 None None None Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 331 5 2 5 2.6 CCCCc1[nH]c2nc(N)nn2c(=O)c1Cc1cccc(Cl)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4474757 336805 0 None None None Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 331 5 2 5 2.6 CCCCc1[nH]c2nc(N)nn2c(=O)c1Cc1cccc(Cl)c1 10.1021/acs.jmedchem.9b00742
489808 221926 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1ccccc1Cl)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL329813 221926 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1ccccc1Cl)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
73347894 183463 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435863 183463 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
44564885 353206 0 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 10 1 6 4.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)COCC(F)(F)F)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL473353 353206 0 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 10 1 6 4.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)COCC(F)(F)F)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
25130903 370939 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 8 1 5 5.9 O=C1NCN(c2ccccc2)C12CCN(CCCC1(c3ccc(Cl)c(Cl)c3)CCN(Cc3ccco3)C1)CC2 10.1021/jm800598a
CHEMBL495297 370939 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 8 1 5 5.9 O=C1NCN(c2ccccc2)C12CCN(CCCC1(c3ccc(Cl)c(Cl)c3)CCN(Cc3ccco3)C1)CC2 10.1021/jm800598a
10186729 28196 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728786 28196 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196666 28196 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196759 28196 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
44455033 195552 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1cccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)c1 10.1016/j.bmcl.2007.12.058
CHEMBL255854 195552 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1cccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)c1 10.1016/j.bmcl.2007.12.058
12425 11 80 None None None Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 11 80 None None None Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 11 80 None None None Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 11 80 None None None Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
44454975 311440 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 554 8 1 5 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1c(Cl)cccc1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL404056 311440 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 554 8 1 5 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1c(Cl)cccc1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
44590943 350365 0 None None None Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 439 9 1 6 3.7 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(c2nnc(CN(C)C)o2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459598 350365 0 None None None Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 439 9 1 6 3.7 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(c2nnc(CN(C)C)o2)CC1 10.1016/j.bmcl.2009.01.009
44392258 138366 2 None None None Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 469 9 1 2 6.5 CCN(C(=O)NC(C)c1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183746 138366 2 None None None Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 469 9 1 2 6.5 CCN(C(=O)NC(C)c1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
1907637 180793 9 None None None Human 5.3 pIC50 = 5.3 Binding
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 360 4 1 6 1.3 CN(C)c1ccc(/C=C2\SC(N3CCN(CCO)CC3)=NC2=O)cc1 10.1021/acs.jmedchem.6b01309
CHEMBL2381216 180793 9 None None None Human 5.3 pIC50 = 5.3 Binding
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 360 4 1 6 1.3 CN(C)c1ccc(/C=C2\SC(N3CCN(CCO)CC3)=NC2=O)cc1 10.1021/acs.jmedchem.6b01309
53324140 121252 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683065 121252 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
72712371 183471 0 None None None Human 6.3 pIC50 = 6.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435871 183471 0 None None None Human 6.3 pIC50 = 6.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
483345 19312 0 None None None Human 7.3 pIC50 = 7.3 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 588 10 2 6 5.4 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(c2ccccc2)C2Nc3ccccc3S(=O)(=O)N2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104867 19312 0 None None None Human 7.3 pIC50 = 7.3 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 588 10 2 6 5.4 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(c2ccccc2)C2Nc3ccccc3S(=O)(=O)N2)CC1 10.1016/s0960-894x(01)00655-2
489821 221106 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 414 5 0 3 5.0 O=C(c1ccco1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL328373 221106 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 414 5 0 3 5.0 O=C(c1ccco1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44392109 331133 3 None None None Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 406 7 0 2 5.6 CN(C(=O)CC(C)(C)C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL427137 331133 3 None None None Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 406 7 0 2 5.6 CN(C(=O)CC(C)(C)C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44590850 350671 0 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 441 8 1 3 5.4 Cc1ccnc(C)c1C(=O)NCCN1CCCC(CC(c2ccccc2)c2ccccc2)C1 10.1016/j.bmcl.2009.01.012
CHEMBL459986 350671 0 None None None Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 441 8 1 3 5.4 Cc1ccnc(C)c1C(=O)NCCN1CCCC(CC(c2ccccc2)c2ccccc2)C1 10.1016/j.bmcl.2009.01.012
16073673 159432 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 621 11 0 7 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C#N)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL209278 159432 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 621 11 0 7 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C#N)c2)CC1 10.1016/j.bmcl.2006.03.089
72712158 183465 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 609 9 2 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC(C(=O)O)CC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435865 183465 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 609 9 2 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC(C(=O)O)CC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711506 183502 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 511 8 1 4 4.8 CCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435902 183502 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 511 8 1 4 4.8 CCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
72711049 183494 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
CHEMBL2435894 183494 0 None None None Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
44392204 137926 0 None None None Human 6.3 pIC50 = 6.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 472 9 0 3 6.1 CSc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL183409 137926 0 None None None Human 6.3 pIC50 = 6.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 472 9 0 3 6.1 CSc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
16073668 161247 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2c(F)cccc2F)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL211903 161247 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2c(F)cccc2F)CC1 10.1016/j.bmcl.2006.03.089
10159218 28178 0 None None None Human 6.3 pIC50 = 6.3 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1196504 28178 0 None None None Human 6.3 pIC50 = 6.3 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
54585383 123642 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 544 9 0 5 4.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCN(C)C(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762306 123642 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 544 9 0 5 4.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCN(C)C(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
44431972 180022 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 625 8 3 4 7.1 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cccc1Cl 10.1016/j.bmcl.2007.01.050
CHEMBL236622 180022 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 625 8 3 4 7.1 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cccc1Cl 10.1016/j.bmcl.2007.01.050
73346389 183479 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435879 183479 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
489827 221764 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 418 7 0 2 5.5 CCC(CC)C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL329107 221764 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 418 7 0 2 5.5 CCC(CC)C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
76312666 176528 0 None None None Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 3 3 8.3 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cccc1Cl 10.1007/s00044-012-0118-7
CHEMBL2281964 176528 0 None None None Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 3 3 8.3 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cccc1Cl 10.1007/s00044-012-0118-7
479870 216084 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 498 9 0 3 5.6 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccc(F)c(F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL313950 216084 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 498 9 0 3 5.6 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccc(F)c(F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
5481871 473548 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 540 8 0 4 4.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(F)cc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL88927 473548 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 540 8 0 4 4.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(F)cc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
6475311 25574 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 425 6 1 1 6.4 Cc1ccc(-c2cccc(/C=C/C(=O)Nc3ccc(C[N+]4(C)CCCCC4)cc3)c2)cc1 10.1021/jm9906264
CHEMBL1179236 25574 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 425 6 1 1 6.4 Cc1ccc(-c2cccc(/C=C/C(=O)Nc3ccc(C[N+]4(C)CCCCC4)cc3)c2)cc1 10.1021/jm9906264
16728617 182383 0 None None None Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1[N+](=O)[O-] 10.1016/j.bmcl.2006.09.052
CHEMBL240655 182383 0 None None None Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1[N+](=O)[O-] 10.1016/j.bmcl.2006.09.052
16728617 182383 0 None None None Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1[N+](=O)[O-] 10.1007/s00044-012-0118-7
CHEMBL240655 182383 0 None None None Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1[N+](=O)[O-] 10.1007/s00044-012-0118-7
53318854 121259 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.2 COC[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683072 121259 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.2 COC[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
53389845 347079 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 315 3 2 5 2.1 Nc1nc2[nH]c(C3CC3)c(Cc3cccc(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
CHEMBL4517518 347079 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 315 3 2 5 2.1 Nc1nc2[nH]c(C3CC3)c(Cc3cccc(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
44431962 179209 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 438 6 2 4 4.0 NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234896 179209 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 438 6 2 4 4.0 NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
44431959 294135 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 477 5 1 3 5.6 OC1(C(F)(F)F)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL393004 294135 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 477 5 1 3 5.6 OC1(C(F)(F)F)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
44404692 144367 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 552 10 0 4 5.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL197907 144367 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 552 10 0 4 5.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2005.08.014
46882948 20111 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 541 7 0 7 4.4 CCCCC1N(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078659 20111 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 541 7 0 7 4.4 CCCCC1N(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44392110 136233 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 456 9 0 3 5.4 COc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL180498 136233 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 456 9 0 3 5.4 COc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
44392166 136286 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 504 8 0 2 6.1 CN(C(=O)Cc1ccc(Br)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180685 136286 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 504 8 0 2 6.1 CN(C(=O)Cc1ccc(Br)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
177372134 393727 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cellsDisplacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cells
ChEMBL 452 7 1 4 5.5 Cc1nc2ccccc2n1C1CCN(CC[C@@H](NC(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2023.115586
CHEMBL5646702 393727 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cellsDisplacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cells
ChEMBL 452 7 1 4 5.5 Cc1nc2ccccc2n1C1CCN(CC[C@@H](NC(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2023.115586
44431962 179209 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 438 6 2 4 4.0 NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234896 179209 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 438 6 2 4 4.0 NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44431959 294135 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 477 5 1 3 5.6 OC1(C(F)(F)F)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL393004 294135 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 477 5 1 3 5.6 OC1(C(F)(F)F)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44590441 352926 0 None None None Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 445 6 0 3 4.0 Cc1cccc(C)c1C(=O)N1CCC(N2CC(N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL471218 352926 0 None None None Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 445 6 0 3 4.0 Cc1cccc(C)c1C(=O)N1CCC(N2CC(N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
16726107 174492 2 None None None Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 475 7 1 6 4.4 Cc1ccc(CN2CCC(CNC(=O)C3CCN(c4ccc(-c5cccs5)nn4)CC3)C2)cc1 10.1021/jm061389p
CHEMBL220199 174492 2 None None None Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 475 7 1 6 4.4 Cc1ccc(CN2CCC(CNC(=O)C3CCN(c4ccc(-c5cccs5)nn4)CC3)C2)cc1 10.1021/jm061389p
5481754 473432 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 604 9 0 4 6.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)Cc1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL88159 473432 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 604 9 0 4 6.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)Cc1ccccc1 10.1016/s0960-894x(00)00637-5
44392135 137422 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 440 8 0 3 5.0 CN(C(=O)C(=O)c1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182403 137422 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 440 8 0 3 5.0 CN(C(=O)C(=O)c1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44392115 138362 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 441 7 1 2 6.1 Cc1cccc(NC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)c1 10.1016/j.bmcl.2004.10.044
CHEMBL183710 138362 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 441 7 1 2 6.1 Cc1cccc(NC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)c1 10.1016/j.bmcl.2004.10.044
5481749 176359 0 None None None Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 8 0 4 6.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2c(c1)CCC2 10.1007/s00044-011-9863-2
CHEMBL2263647 176359 0 None None None Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 8 0 4 6.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2c(c1)CCC2 10.1007/s00044-011-9863-2
76308345 176217 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 9 1 6 5.5 CN(C[C@@H](CCN1CCC2(CC1)CNC(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
CHEMBL2259884 176217 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 9 1 6 5.5 CN(C[C@@H](CCN1CCC2(CC1)CNC(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
76327119 176526 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 339 4 0 2 4.7 CN(C)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL2281962 176526 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 339 4 0 2 4.7 CN(C)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
11210440 178891 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL234461 178891 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
16728635 182566 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 327 5 3 4 2.6 N#Cc1ccc(OCc2ccc(Cl)cc2)c(/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
CHEMBL241057 182566 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 327 5 3 4 2.6 N#Cc1ccc(OCc2ccc(Cl)cc2)c(/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
16728609 332196 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL429641 332196 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
5481859 470208 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL79716 470208 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5482457 470693 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 524 11 0 3 6.5 CN(C[C@@H](CCN1CCC(CCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83882 470693 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 524 11 0 3 6.5 CN(C[C@@H](CCN1CCC(CCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
44373926 105329 0 None None None Human 8.2 pIC50 = 8.2 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 596 10 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL158754 105329 0 None None None Human 8.2 pIC50 = 8.2 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 596 10 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
183790 8163 6 None None None Human 8.2 pIC50 = 8.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/acs.jmedchem.9b00742
783 8163 6 None None None Human 8.2 pIC50 = 8.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL1178786 8163 6 None None None Human 8.2 pIC50 = 8.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/acs.jmedchem.9b00742
25205923 21437 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 8 0 6 5.6 CCO[C@H]1CC[C@H](CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085223 21437 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 8 0 6 5.6 CCO[C@H]1CC[C@H](CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
46888453 23077 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 473 7 1 3 4.7 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096445 23077 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 473 7 1 3 4.7 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888525 23240 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 491 7 1 3 4.9 Cc1cc(F)cc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1097815 23240 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 491 7 1 3 4.9 Cc1cc(F)cc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
5479844 219984 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1016/j.bmcl.2010.03.095
CHEMBL324643 219984 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1016/j.bmcl.2010.03.095
505869 61927 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137419 61927 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
11503459 174295 1 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of MIP-1beta from human CCR5 expressed in HEK293 cellsDisplacement of MIP-1beta from human CCR5 expressed in HEK293 cells
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1021/acs.jmedchem.8b00180
CHEMBL2203615 174295 1 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of MIP-1beta from human CCR5 expressed in HEK293 cellsDisplacement of MIP-1beta from human CCR5 expressed in HEK293 cells
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1021/acs.jmedchem.8b00180
496973 332813 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/s0960-894x(02)00605-4
CHEMBL432596 332813 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/s0960-894x(02)00605-4
496984 328427 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL419895 328427 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
11503459 385099 1 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cellsDisplacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cells
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.ejmech.2023.115586
CHEMBL5646668 385099 1 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cellsDisplacement of [125I]MIP-1alpha from CCR5 receptor (unknown origin) expressed in HEK293 cells
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.ejmech.2023.115586
44573256 352919 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 553 6 1 4 7.0 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC2CCCCC2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL471149 352919 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 553 6 1 4 7.0 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC2CCCCC2)CC1 10.1016/j.bmcl.2009.02.014
11503459 174296 1 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203616 174296 1 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
501054 18934 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL102674 18934 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
496984 328427 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL419895 328427 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
496973 332813 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
CHEMBL432596 332813 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
46880774 20563 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.2 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1081476 20563 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.2 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
46880774 20708 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.2 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1082191 20708 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.2 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
501054 18934 0 None None None Human 8.2 pIC50 = 8.2 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL102674 18934 0 None None None Human 8.2 pIC50 = 8.2 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44461274 214575 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 645 13 0 5 7.0 CCCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311052 214575 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 645 13 0 5 7.0 CCCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478446 470212 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 1 4 6.1 CCCN(C(=O)N[C@H](C)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79770 470212 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 1 4 6.1 CCCN(C(=O)N[C@H](C)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461713 470248 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 555 11 0 5 5.6 COC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL80043 470248 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 555 11 0 5 5.6 COC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44415820 161723 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 468 7 1 4 5.6 Cc1nc2ccccc2n1C1CC12CC1CCC2N1CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
CHEMBL213914 161723 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 468 7 1 4 5.6 Cc1nc2ccccc2n1C1CC12CC1CCC2N1CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
9827221 219263 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibitory activity against C-C chemokine receptor type 5Inhibitory activity against C-C chemokine receptor type 5
ChEMBL 497 4 0 3 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Br)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL322817 219263 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibitory activity against C-C chemokine receptor type 5Inhibitory activity against C-C chemokine receptor type 5
ChEMBL 497 4 0 3 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Br)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
44461713 470248 0 None None None Human 8.2 pIC50 = 8.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 555 11 0 5 5.6 COC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL80043 470248 0 None None None Human 8.2 pIC50 = 8.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 555 11 0 5 5.6 COC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
10280945 27104 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188557 27104 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
10280945 27104 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1188557 27104 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
44564983 370311 0 None None None Human 8.2 pIC50 = 8.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 515 8 1 7 3.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCS(=O)(=O)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491153 370311 0 None None None Human 8.2 pIC50 = 8.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 515 8 1 7 3.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCS(=O)(=O)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
3010259 372321 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511154 372321 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010259 372321 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511154 372321 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010259 372321 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL511154 372321 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
44404719 271713 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 548 11 0 5 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(OC)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL371691 271713 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 548 11 0 5 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(OC)cc2)CC1 10.1016/j.bmcl.2005.08.014
44401765 140227 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 514 8 1 5 5.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(Cn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL191139 140227 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 514 8 1 5 5.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(Cn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
118219334 406617 0 None None None Human 8.2 pIC50 = 8.2 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 458 8 1 7 4.2 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CC#N)c1ccc(F)s1 nan
CHEMBL5757166 406617 0 None None None Human 8.2 pIC50 = 8.2 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 458 8 1 7 4.2 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CC#N)c1ccc(F)s1 nan
72711507 183503 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435903 183503 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
5275839 330965 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 559 10 0 4 4.8 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)Cc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL426048 330965 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 559 10 0 4 4.8 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)Cc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
489316 218625 0 None None None Human 8.2 pIC50 = 8.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 458 9 0 2 7.0 c1ccc(CCCC2CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00652-7
CHEMBL321267 218625 0 None None None Human 8.2 pIC50 = 8.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 458 9 0 2 7.0 c1ccc(CCCC2CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00652-7
489305 329543 0 None None None Human 8.2 pIC50 = 8.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 526 12 1 5 5.4 CN(CC(CCN1CCC(O)(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(01)00652-7
CHEMBL421598 329543 0 None None None Human 8.2 pIC50 = 8.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 526 12 1 5 5.4 CN(CC(CCN1CCC(O)(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(01)00652-7
49871007 121597 22 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 121597 22 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
DB12960 121597 22 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
44447733 195475 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 469 5 0 5 5.1 Cc1cccnc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255431 195475 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 469 5 0 5 5.1 Cc1cccnc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
126585501 449052 0 None None None Human 8.2 pIC50 = 8.2 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 470 9 2 8 3.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CC#N)c1ccc(CO)s1 nan
CHEMBL6000348 449052 0 None None None Human 8.2 pIC50 = 8.2 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 470 9 2 8 3.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CC#N)c1ccc(CO)s1 nan
122668178 449770 0 None None None Human 8.2 pIC50 = 8.2 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 487 6 1 6 3.7 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(C)=O)C3)C2)c1ccc(F)s1 nan
CHEMBL6007913 449770 0 None None None Human 8.2 pIC50 = 8.2 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 487 6 1 6 3.7 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(C)=O)C3)C2)c1ccc(F)s1 nan
505880 61388 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137038 61388 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505880 61388 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137038 61388 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
16041224 183450 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 556 8 1 6 5.2 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1 10.1021/jm401101p
CHEMBL2435850 183450 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 556 8 1 6 5.2 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1 10.1021/jm401101p
505880 61388 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137038 61388 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
11700429 213274 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085311 213274 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
478352 26307 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 471 8 2 3 5.4 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)CCCO)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1183391 26307 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 471 8 2 3 5.4 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)CCCO)cc2)CCO3)cc1 10.1021/jm9906264
126585467 450490 0 None None None Human 8.2 pIC50 = 8.2 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 516 11 1 6 5.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C(C)CCC(C)(F)F)c1cccnc1 nan
CHEMBL6015622 450490 0 None None None Human 8.2 pIC50 = 8.2 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 516 11 1 6 5.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C(C)CCC(C)(F)F)c1cccnc1 nan
516358 352298 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 10 1 5 7.2 CCn1nc(C(C)(C)c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL465416 352298 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 10 1 5 7.2 CCn1nc(C(C)(C)c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44384705 239444 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 596 10 1 5 7.2 CCn1ncc(C(C)(C)c2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL355749 239444 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 596 10 1 5 7.2 CCn1ncc(C(C)(C)c2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516358 352298 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 10 1 5 7.2 CCn1nc(C(C)(C)c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL465416 352298 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 10 1 5 7.2 CCn1nc(C(C)(C)c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
496983 219409 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL323370 219409 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010266 353004 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471765 353004 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
489314 19744 0 None None None Human 7.2 pIC50 = 7.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 585 10 0 5 6.9 O=S(=O)(c1ccc(-c2ccccn2)s1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL107170 19744 0 None None None Human 7.2 pIC50 = 7.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 585 10 0 5 6.9 O=S(=O)(c1ccc(-c2ccccn2)s1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
25206204 371584 0 None None None Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 610 7 0 7 4.7 CCCCC1C(=O)N(CC2CCN(C(=O)OC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL501383 371584 0 None None None Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 610 7 0 7 4.7 CCCCC1C(=O)N(CC2CCN(C(=O)OC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
25230897 374500 0 None None None Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 548 7 0 6 3.5 CCCCC1CN(S(=O)(=O)N(C)C)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL519298 374500 0 None None None Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 548 7 0 6 3.5 CCCCC1CN(S(=O)(=O)N(C)C)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
478502 215663 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(00)00637-5
CHEMBL313071 215663 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(00)00637-5
5481748 221047 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2ccccc2c1 10.1016/s0960-894x(00)00637-5
CHEMBL328024 221047 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2ccccc2c1 10.1016/s0960-894x(00)00637-5
478387 473602 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 596 8 0 5 6.0 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(00)00637-5
CHEMBL89279 473602 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 596 8 0 5 6.0 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(00)00637-5
44392161 136268 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 451 8 0 3 5.2 CN(C(=O)Cc1ccc(C#N)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180656 136268 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 451 8 0 3 5.2 CN(C(=O)Cc1ccc(C#N)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11157818 123655 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 613 9 1 4 8.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762320 123655 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 613 9 1 4 8.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11204141 123663 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1cccnc1OC(c1ccc(C(F)(F)F)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762333 123663 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1cccnc1OC(c1ccc(C(F)(F)F)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
479871 216788 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 9 0 3 6.0 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1C 10.1016/s0960-894x(00)00639-9
CHEMBL316189 216788 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 9 0 3 6.0 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1C 10.1016/s0960-894x(00)00639-9
11210440 178891 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL234461 178891 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
16728612 182180 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 424 5 3 3 3.6 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Br)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240260 182180 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 424 5 3 3 3.6 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Br)cc1 10.1016/j.bmcl.2006.09.052
16728629 182379 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 336 5 3 3 3.4 N=C(N)N/N=C/c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240639 182379 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 336 5 3 3 3.4 N=C(N)N/N=C/c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
16728635 182566 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 327 5 3 4 2.6 N#Cc1ccc(OCc2ccc(Cl)cc2)c(/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
CHEMBL241057 182566 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 327 5 3 4 2.6 N#Cc1ccc(OCc2ccc(Cl)cc2)c(/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
11210440 178891 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL234461 178891 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
3010251 38469 0 None None None Human 5.2 pIC50 = 5.2 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 571 14 0 7 5.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(=O)(=O)CC)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL120419 38469 0 None None None Human 5.2 pIC50 = 5.2 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 571 14 0 7 5.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(=O)(=O)CC)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
3010250 233157 0 None None None Human 5.2 pIC50 = 5.2 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 557 13 0 7 5.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(C)(=O)=O)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL332908 233157 0 None None None Human 5.2 pIC50 = 5.2 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 557 13 0 7 5.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(C)(=O)=O)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44559501 337134 1 None None None Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 523 3 2 7 2.4 CC(=O)O[C@@H]1[C@@H]2O[C@H]2[C@@](C)(O)C(=O)[C@@H](C)C/C=C/[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)[C@H]3[C@H](Cc4ccccc4)NC(=O)[C@@]123 10.1021/np049974l
CHEMBL449278 337134 1 None None None Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 523 3 2 7 2.4 CC(=O)O[C@@H]1[C@@H]2O[C@H]2[C@@](C)(O)C(=O)[C@@H](C)C/C=C/[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)[C@H]3[C@H](Cc4ccccc4)NC(=O)[C@@]123 10.1021/np049974l
16728629 182379 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 336 5 3 3 3.4 N=C(N)N/N=C/c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL240639 182379 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 336 5 3 3 3.4 N=C(N)N/N=C/c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
489325 328332 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 541 7 1 4 5.7 O=C1CC2(CCN(CCC(CN3C(=O)N[C@H](c4ccccc4)C3=O)c3cccc(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(01)00654-0
CHEMBL419172 328332 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 541 7 1 4 5.7 O=C1CC2(CCN(CCC(CN3C(=O)N[C@H](c4ccccc4)C3=O)c3cccc(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(01)00654-0
46883025 20144 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 554 7 0 6 5.2 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ccnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078936 20144 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 554 7 0 6 5.2 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ccnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46882079 19945 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 605 7 0 7 5.3 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077361 19945 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 605 7 0 7 5.3 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
11598797 27141 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
11634966 27141 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188808 27141 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1189134 27141 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
489805 474252 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 439 5 1 2 5.8 O=C(Nc1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93644 474252 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 439 5 1 2 5.8 O=C(Nc1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
9909684 137250 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 413 7 0 3 4.8 CN(C(=O)c1ccncc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182266 137250 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 413 7 0 3 4.8 CN(C(=O)c1ccncc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44565037 384935 0 None None None Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL522259 384935 0 None None None Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
46890341 21436 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 602 7 0 6 5.2 CO[C@H]1CC[C@H](CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085222 21436 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 602 7 0 6 5.2 CO[C@H]1CC[C@H](CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
44392244 136120 2 None None None Human 7.2 pIC50 = 7.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 455 9 1 2 5.9 CCN(C(=O)NCc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180184 136120 2 None None None Human 7.2 pIC50 = 7.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 455 9 1 2 5.9 CCN(C(=O)NCc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
72711048 183493 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
CHEMBL2435893 183493 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
72712597 183476 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
CHEMBL2435876 183476 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
44401593 143299 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL195199 143299 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
10840677 25558 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 528 15 1 1 10.2 CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)/C=C/c2cccc(-c3ccc(C)cc3)c2)cc1 10.1021/jm9906264
CHEMBL1179151 25558 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 528 15 1 1 10.2 CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)/C=C/c2cccc(-c3ccc(C)cc3)c2)cc1 10.1021/jm9906264
44401593 143299 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL195199 143299 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44401593 143299 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL195199 143299 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44439155 182770 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 594 12 4 6 5.2 COC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1 10.1016/j.bmcl.2006.10.060
CHEMBL241497 182770 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 594 12 4 6 5.2 COC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1 10.1016/j.bmcl.2006.10.060
52947044 42134 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 559 8 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cc(F)cc(F)c3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270401 42134 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 559 8 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cc(F)cc(F)c3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
25132253 203328 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 528 5 0 5 6.9 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084491 203328 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 528 5 0 5 6.9 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
25133961 203329 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 562 7 0 5 7.3 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084493 203329 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 562 7 0 5 7.3 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm800598a
44392103 137548 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 484 9 0 4 5.2 COC(=O)c1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL182731 137548 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 484 9 0 4 5.2 COC(=O)c1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
11606411 176258 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of MIP1alpha from CCR5 receptorDisplacement of MIP1alpha from CCR5 receptor
ChEMBL 550 4 1 2 7.2 C[C@H]1CN([C@@H]2CC[C@](C)(C(=O)NCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C2)CC[C@@]12C=Cc1ccccc12 10.1021/jm070166b
CHEMBL226066 176258 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of MIP1alpha from CCR5 receptorDisplacement of MIP1alpha from CCR5 receptor
ChEMBL 550 4 1 2 7.2 C[C@H]1CN([C@@H]2CC[C@](C)(C(=O)NCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C2)CC[C@@]12C=Cc1ccccc12 10.1021/jm070166b
93149 216841 57 None None None Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 216841 57 None None None Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
25231041 372041 0 None None None Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 8 0 7 3.6 CCCCC1CN(S(=O)(=O)C2CCN(C=O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL506958 372041 0 None None None Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 8 0 7 3.6 CCCCC1CN(S(=O)(=O)C2CCN(C=O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44590862 373851 0 None None None Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 491 10 1 4 5.1 CCN(C(=O)c1ccc(OC)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL518326 373851 0 None None None Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 491 10 1 4 5.1 CCN(C(=O)c1ccc(OC)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
5481736 216344 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 568 8 0 3 6.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Cc1ccccc1 10.1016/s0960-894x(01)00654-0
CHEMBL314342 216344 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 568 8 0 3 6.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Cc1ccccc1 10.1016/s0960-894x(01)00654-0
5481736 216344 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 568 8 0 3 6.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Cc1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL314342 216344 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 568 8 0 3 6.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Cc1ccccc1 10.1016/s0960-894x(00)00637-5
44590751 350854 0 None None None Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 490 9 1 3 5.5 CCN(C(=O)N(C)c1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL461688 350854 0 None None None Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 490 9 1 3 5.5 CCN(C(=O)N(C)c1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
25205600 21550 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 564 7 0 6 4.5 CCCCC1CN(C2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085723 21550 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 564 7 0 6 4.5 CCCCC1CN(C2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
20664160 354775 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL475777 354775 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
20664160 354775 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL475777 354775 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
5482457 470693 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 524 11 0 3 6.5 CN(C[C@@H](CCN1CCC(CCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83882 470693 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 524 11 0 3 6.5 CN(C[C@@H](CCN1CCC(CCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
20664160 354775 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL475777 354775 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
72713859 183511 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435911 183511 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
44392124 137536 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 486 10 0 4 5.4 COc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1OC 10.1016/j.bmcl.2004.10.044
CHEMBL182682 137536 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 486 10 0 4 5.4 COc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1OC 10.1016/j.bmcl.2004.10.044
58282592 277259 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibition of human recombinant CCR5 encoding an HIV-1-longterminal-repeat-regulated beta-galactosidase reporter gene expressed in human HeLaP4 cells assessed as reduction of interaction with HIV-1 gp160 expressed in CHO cells by cell-cell fusion assayInhibition of human recombinant CCR5 encoding an HIV-1-longterminal-repeat-regulated beta-galactosidase reporter gene expressed in human HeLaP4 cells assessed as reduction of interaction with HIV-1 gp160 expressed in CHO cells by cell-cell fusion assay
ChEMBL 409 6 0 3 6.2 Cc1nc2ccccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.5b00497
CHEMBL3799799 277259 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibition of human recombinant CCR5 encoding an HIV-1-longterminal-repeat-regulated beta-galactosidase reporter gene expressed in human HeLaP4 cells assessed as reduction of interaction with HIV-1 gp160 expressed in CHO cells by cell-cell fusion assayInhibition of human recombinant CCR5 encoding an HIV-1-longterminal-repeat-regulated beta-galactosidase reporter gene expressed in human HeLaP4 cells assessed as reduction of interaction with HIV-1 gp160 expressed in CHO cells by cell-cell fusion assay
ChEMBL 409 6 0 3 6.2 Cc1nc2ccccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.5b00497
478413 470231 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 510 10 0 3 6.1 CN(C[C@@H](CCN1CCC(Cc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL79958 470231 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 510 10 0 3 6.1 CN(C[C@@H](CCN1CCC(Cc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
44392153 137259 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 465 9 0 3 5.6 CCN(C(=O)Cc1ccc(C#N)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182279 137259 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 465 9 0 3 5.6 CCN(C(=O)Cc1ccc(C#N)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
505874 62228 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137650 62228 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505874 62228 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137650 62228 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
5275761 158760 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 609 10 1 5 5.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207633 158760 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 609 10 1 5 5.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
505874 62228 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137650 62228 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44392169 136197 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180334 136197 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
474156 25567 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 453 5 1 2 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CO3)cc1 10.1021/jm9906264
CHEMBL1179200 25567 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 453 5 1 2 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CO3)cc1 10.1021/jm9906264
93149 216841 57 None None None Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 216841 57 None None None Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
489806 221013 0 None None None Human 7.2 pIC50 = 7.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 424 5 0 2 5.4 O=C(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL327846 221013 0 None None None Human 7.2 pIC50 = 7.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 424 5 0 2 5.4 O=C(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
11520510 213269 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 724 17 1 7 9.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085305 213269 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 724 17 1 7 9.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCCN3CC(C)C)cc1 10.1021/jm0509703
489806 221013 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 5 0 2 5.4 O=C(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL327846 221013 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 5 0 2 5.4 O=C(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
478296 313805 0 None None None Human 7.2 pIC50 = 7.2 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 522 8 0 4 4.6 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00232-3
CHEMBL408438 313805 0 None None None Human 7.2 pIC50 = 7.2 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 522 8 0 4 4.6 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00232-3
144878057 461628 0 None None None Human 7.2 pIC50 = 7.2 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 465 7 1 6 5.4 CC(=O)NC(CCN1C2CCC1CC(n1c(C)nnc1C(C)C)C2)c1csc2ccccc12 nan
CHEMBL6195813 461628 0 None None None Human 7.2 pIC50 = 7.2 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 465 7 1 6 5.4 CC(=O)NC(CCN1C2CCC1CC(n1c(C)nnc1C(C)C)C2)c1csc2ccccc12 nan
10208679 27106 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16659334 27106 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188565 27106 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1197042 27106 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
11342750 20025 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 6 5.4 CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078013 20025 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 6 5.4 CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44392148 137583 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 483 9 1 3 5.3 CC(=O)Nc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL182878 137583 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 483 9 1 3 5.3 CC(=O)Nc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
44392203 138368 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 456 9 0 3 5.4 COc1cccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)c1 10.1016/j.bmcl.2004.10.044
CHEMBL183769 138368 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 456 9 0 3 5.4 COc1cccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)c1 10.1016/j.bmcl.2004.10.044
44392160 251759 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 440 8 0 2 5.9 CC(C(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1)c1ccccc1 10.1016/j.bmcl.2004.10.044
CHEMBL362168 251759 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 440 8 0 2 5.9 CC(C(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1)c1ccccc1 10.1016/j.bmcl.2004.10.044
483354 26086 0 None None None Human 5.2 pIC50 = 5.2 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 576 12 0 5 6.7 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL118196 26086 0 None None None Human 5.2 pIC50 = 5.2 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 576 12 0 5 6.7 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44373767 333302 0 None None None Human 7.2 pIC50 = 7.2 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 472 7 0 3 6.8 c1ccc(CCCC2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL436245 333302 0 None None None Human 7.2 pIC50 = 7.2 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 472 7 0 3 6.8 c1ccc(CCCC2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
44392084 137255 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 462 8 0 2 5.7 CN(C(=O)Cc1ccc(F)c(F)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182274 137255 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 462 8 0 2 5.7 CN(C(=O)Cc1ccc(F)c(F)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728623 181125 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 376 6 3 4 2.9 COc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
CHEMBL238545 181125 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 376 6 3 4 2.9 COc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
478502 215663 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1 10.1007/s00044-011-9863-2
CHEMBL313071 215663 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1 10.1007/s00044-011-9863-2
5481727 470205 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 497 9 0 4 5.0 CN(C[C@@H](CCN1CCN(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL79697 470205 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 497 9 0 4 5.0 CN(C[C@@H](CCN1CCN(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5481702 470631 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83338 470631 0 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
76315544 176218 0 None None None Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 9 1 6 6.1 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)Nc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
CHEMBL2259885 176218 0 None None None Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 9 1 6 6.1 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)Nc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
489341 19292 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 633 13 2 5 6.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
489341 19292 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 633 13 2 5 6.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104793 19292 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 633 13 2 5 6.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL104793 19292 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 633 13 2 5 6.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
46888456 23125 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 459 7 1 3 4.4 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096768 23125 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 459 7 1 3 4.4 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888545 23170 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 474 7 1 4 4.1 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1097169 23170 0 None None None Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 474 7 1 4 4.1 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
20664141 160497 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 533 8 1 6 5.0 Cc1cc(C)n2ncc(C3CCN(C[C@H]4CN([C@H](CC5CCC5)C(=O)O)C[C@@H]4c4cccc(F)c4)CC3)c2n1 10.1016/j.bmcl.2005.02.030
CHEMBL2113084 160497 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 533 8 1 6 5.0 Cc1cc(C)n2ncc(C3CCN(C[C@H]4CN([C@H](CC5CCC5)C(=O)O)C[C@@H]4c4cccc(F)c4)CC3)c2n1 10.1016/j.bmcl.2005.02.030
496983 219409 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL323370 219409 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
10461319 334062 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 606 8 1 7 6.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccc3c(c2)OCO3)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL443106 334062 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 606 8 1 7 6.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccc3c(c2)OCO3)CC1 10.1016/j.bmcl.2009.02.014
44573255 335103 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 527 5 1 4 6.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC(C)(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL445003 335103 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 527 5 1 4 6.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC(C)(C)C)CC1 10.1016/j.bmcl.2009.02.014
44573337 371425 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 592 9 1 6 6.8 COc1ccc(C(C(=O)O)N2CCC(CCN3[C@H]4CC[C@@H]3C[C@H](n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)cc1 10.1016/j.bmcl.2009.02.014
CHEMBL499109 371425 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 592 9 1 6 6.8 COc1ccc(C(C(=O)O)N2CCC(CCN3[C@H]4CC[C@@H]3C[C@H](n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)cc1 10.1016/j.bmcl.2009.02.014
10325578 372028 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 564 6 0 6 6.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)OC2CCCC2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL506795 372028 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 564 6 0 6 6.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)OC2CCCC2)CC1 10.1016/j.bmcl.2009.02.014
496983 219409 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL323370 219409 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010266 353004 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471765 353004 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
46882947 20012 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 6 5.5 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1077912 20012 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 6 5.5 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46880848 21870 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.5 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCOC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
CHEMBL1087534 21870 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.5 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCOC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
3010266 353004 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL471765 353004 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
5275829 470818 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL85086 470818 0 None None None Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44404709 144291 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 576 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(=O)OC)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL197680 144291 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 576 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(=O)OC)cc2)CC1 10.1016/j.bmcl.2005.08.014
10008425 203333 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 580 5 0 4 7.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084497 203333 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 580 5 0 4 7.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm800598a
122668272 423914 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 533 8 1 6 6.3 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 nan
CHEMBL5922640 423914 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 533 8 1 6 6.3 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 nan
1635 193594 43 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
3002977 193594 43 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
CHEMBL256907 193594 43 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
118219348 426693 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 440 8 1 7 4.1 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CC#N)c1cccs1 nan
CHEMBL5867493 426693 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 440 8 1 7 4.1 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CC#N)c1cccs1 nan
44590557 350331 0 None None None Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 8 1 5 5.4 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459571 350331 0 None None None Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 8 1 5 5.4 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
516348 255759 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 576 8 2 4 7.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4cccc5ccccc45)[nH]n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL366439 255759 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 576 8 2 4 7.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4cccc5ccccc45)[nH]n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516347 257656 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 551 8 2 5 5.9 N#Cc1ccc(-c2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4ccccc4)CC3)n[nH]2)cc1 10.1016/j.bmcl.2003.12.004
CHEMBL367446 257656 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 551 8 2 5 5.9 N#Cc1ccc(-c2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4ccccc4)CC3)n[nH]2)cc1 10.1016/j.bmcl.2003.12.004
72711741 183459 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435859 183459 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
138106803 451486 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 587 9 1 8 4.4 [C-]#[N+]c1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)s1 nan
CHEMBL6026272 451486 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 587 9 1 8 4.4 [C-]#[N+]c1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)s1 nan
44404657 271012 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 593 11 1 5 5.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NC(C)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL370826 271012 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 593 11 1 5 5.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NC(C)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
138106806 411964 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 465 8 1 7 4.7 [C-]#[N+]c1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)CC#N)s1 nan
CHEMBL5813732 411964 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 465 8 1 7 4.7 [C-]#[N+]c1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)CC#N)s1 nan
118219292 463254 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 483 9 1 10 2.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cn1ncnn1)c1cccs1 nan
CHEMBL6047788 463254 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 483 9 1 10 2.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cn1ncnn1)c1cccs1 nan
25231038 336955 0 None None None Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 9 0 6 5.2 CCCCC1C(=O)N(CC2CCN(CC(F)F)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL447808 336955 0 None None None Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 9 0 6 5.2 CCCCC1C(=O)N(CC2CCN(CC(F)F)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
478499 473462 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc(Cl)c1 10.1016/s0960-894x(00)00637-5
CHEMBL88344 473462 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc(Cl)c1 10.1016/s0960-894x(00)00637-5
44322729 473754 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 629 8 1 4 6.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2[nH]ccc2c1 10.1016/s0960-894x(00)00637-5
CHEMBL90385 473754 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 629 8 1 4 6.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2[nH]ccc2c1 10.1016/s0960-894x(00)00637-5
11250534 123667 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cc(Cl)ccn2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762337 123667 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cc(Cl)ccn2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
478412 332719 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 526 10 0 4 6.0 COc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
CHEMBL431795 332719 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 526 10 0 4 6.0 COc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
44415783 161524 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 382 7 1 5 3.6 Cc1nc(C2CCN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)no1 10.1016/j.bmcl.2006.06.012
CHEMBL213009 161524 0 None None None Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 382 7 1 5 3.6 Cc1nc(C2CCN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)no1 10.1016/j.bmcl.2006.06.012
16728623 181125 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 376 6 3 4 2.9 COc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL238545 181125 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 376 6 3 4 2.9 COc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
5481727 470205 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 497 9 0 4 5.0 CN(C[C@@H](CCN1CCN(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79697 470205 0 None None None Human 6.2 pIC50 = 6.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 497 9 0 4 5.0 CN(C[C@@H](CCN1CCN(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
56754672 241559 5 None None None Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]-MIP-1beta form CCR5 (unknown origin)Displacement of [125I]-MIP-1beta form CCR5 (unknown origin)
ChEMBL 363 6 1 5 3.2 COc1ncc(CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)cn1 10.1021/acsmedchemlett.5b00036
CHEMBL3608771 241559 5 None None None Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]-MIP-1beta form CCR5 (unknown origin)Displacement of [125I]-MIP-1beta form CCR5 (unknown origin)
ChEMBL 363 6 1 5 3.2 COc1ncc(CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)cn1 10.1021/acsmedchemlett.5b00036
12093170 1801 36 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 1 3 4.2 Clc1ccc(c(c1)F)N1[C@H](C2CCCCC2)C(=C(C1=O)O)C(=O)C 10.1021/acs.jmedchem.9b00742
9431 1801 36 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 1 3 4.2 Clc1ccc(c(c1)F)N1[C@H](C2CCCCC2)C(=C(C1=O)O)C(=O)C 10.1021/acs.jmedchem.9b00742
CHEMBL4519152 1801 36 None None None Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 1 3 4.2 Clc1ccc(c(c1)F)N1[C@H](C2CCCCC2)C(=C(C1=O)O)C(=O)C 10.1021/acs.jmedchem.9b00742
25133270 335036 0 None None None Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 594 7 0 5 5.9 CN1CN(c2ccccc2)C2(CCN(CCCC3(c4ccc(Cl)c(Cl)c4)CCN(C(=O)c4ccco4)C3)CC2)C1=O 10.1021/jm800598a
CHEMBL444915 335036 0 None None None Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 594 7 0 5 5.9 CN1CN(c2ccccc2)C2(CCN(CCCC3(c4ccc(Cl)c(Cl)c4)CCN(C(=O)c4ccco4)C3)CC2)C1=O 10.1021/jm800598a
50992246 121261 6 None None None Mouse 7.2 pIC50 = 7.2 Binding
Binding affinity to mouse CCR5Binding affinity to mouse CCR5
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683074 121261 6 None None None Mouse 7.2 pIC50 = 7.2 Binding
Binding affinity to mouse CCR5Binding affinity to mouse CCR5
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
11843813 159615 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 566 8 1 2 7.5 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](CCN1CCC(c2ccccc2)CC1)c1ccc(F)cc1 10.1021/jm060439n
9873546 159615 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 566 8 1 2 7.5 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](CCN1CCC(c2ccccc2)CC1)c1ccc(F)cc1 10.1021/jm060439n
CHEMBL209899 159615 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 566 8 1 2 7.5 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](CCN1CCC(c2ccccc2)CC1)c1ccc(F)cc1 10.1021/jm060439n
CHEMBL386865 159615 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 566 8 1 2 7.5 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](CCN1CCC(c2ccccc2)CC1)c1ccc(F)cc1 10.1021/jm060439n
23285265 221800 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 512 9 0 3 6.5 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccc2ccccc2c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL329190 221800 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 512 9 0 3 6.5 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccc2ccccc2c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44392154 138394 2 None None None Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 430 7 0 2 5.6 CN(C(=O)c1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183907 138394 2 None None None Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 430 7 0 2 5.6 CN(C(=O)c1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
483351 232400 0 None None None Human 5.1 pIC50 = 5.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 633 15 0 7 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(CC)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL331754 232400 0 None None None Human 5.1 pIC50 = 5.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 633 15 0 7 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(CC)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44590863 350678 0 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 461 9 1 3 5.0 CCN(C(=O)c1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460008 350678 0 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 461 9 1 3 5.0 CCN(C(=O)c1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
11578088 159704 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 612 9 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NC(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL210327 159704 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 612 9 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NC(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
57335017 142582 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP-1beta from CCR5Displacement of [125I]MIP-1beta from CCR5
ChEMBL 595 8 4 6 2.8 N[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)N2CCC2)C[C@@H]1CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2011.12.057
CHEMBL1944776 142582 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP-1beta from CCR5Displacement of [125I]MIP-1beta from CCR5
ChEMBL 595 8 4 6 2.8 N[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)N2CCC2)C[C@@H]1CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2011.12.057
44573127 370475 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 508 7 1 5 5.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ncc[nH]2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL492503 370475 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 508 7 1 5 5.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ncc[nH]2)CC1 10.1016/j.bmcl.2009.02.014
44404645 144675 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 673 13 1 6 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(=O)(=O)c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198884 144675 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 673 13 1 6 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(=O)(=O)c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
44392218 136876 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 390 7 0 2 4.9 CN(C(=O)C1CCC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181502 136876 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 390 7 0 2 4.9 CN(C(=O)C1CCC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
52942078 42204 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 505 6 0 6 3.8 COC(=O)N1CCC(C(CCN2C[C@H]3CN(C(=O)c4c(C)ncnc4C)C[C@H]3C2)c2ccccc2)CC1 10.1016/j.bmcl.2010.08.118
CHEMBL1270900 42204 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 505 6 0 6 3.8 COC(=O)N1CCC(C(CCN2C[C@H]3CN(C(=O)c4c(C)ncnc4C)C[C@H]3C2)c2ccccc2)CC1 10.1016/j.bmcl.2010.08.118
16728647 296256 0 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 406 5 2 5 3.6 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCN2)cc1 10.1007/s00044-012-0118-7
CHEMBL394685 296256 0 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 406 5 2 5 3.6 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCN2)cc1 10.1007/s00044-012-0118-7
478447 470602 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 1 4 6.1 CCCN(C(=O)N[C@@H](C)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83113 470602 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 1 4 6.1 CCCN(C(=O)N[C@@H](C)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
16728647 296256 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 406 5 2 5 3.6 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCN2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL394685 296256 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 406 5 2 5 3.6 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCN2)cc1 10.1016/j.bmcl.2006.09.052
489810 216764 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1ccc(Cl)cc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL316073 216764 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1ccc(Cl)cc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44570270 334864 0 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 567 7 1 6 4.8 CCCCC1C(=O)N(C[C@H]2CC[C@H](O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL444667 334864 0 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 567 7 1 6 4.8 CCCCC1C(=O)N(C[C@H]2CC[C@H](O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44392096 259667 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 518 10 0 4 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL369311 259667 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 518 10 0 4 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11787124 20027 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 541 7 0 7 4.2 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078015 20027 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 541 7 0 7 4.2 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
516315 258098 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1Cc1ccccc1 10.1016/j.bmcl.2003.12.004
CHEMBL367894 258098 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1Cc1ccccc1 10.1016/j.bmcl.2003.12.004
44404601 272927 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372852 272927 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2005.08.014
489340 217465 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 669 12 2 5 6.8 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL319233 217465 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 669 12 2 5 6.8 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
72713859 183511 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435911 183511 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
53318853 121246 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@H]2CCOC[C@H]2C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683059 121246 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@H]2CCOC[C@H]2C)C1 10.1016/j.bmcl.2011.01.015
44392123 257843 3 None None None Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 426 8 0 2 5.4 CN(C(=O)Cc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL367586 257843 3 None None None Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 426 8 0 2 5.4 CN(C(=O)Cc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
25130901 203337 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 582 5 0 5 7.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)C1 10.1021/jm800598a
CHEMBL3084501 203337 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 582 5 0 5 7.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)C1 10.1021/jm800598a
25231105 348164 0 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 630 7 0 7 4.0 CCCCC1CN(S(=O)(=O)C2CCN(C(C)=O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL454493 348164 0 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 630 7 0 7 4.0 CCCCC1CN(S(=O)(=O)C2CCN(C(C)=O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44404697 272228 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL371865 272228 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2005.08.014
44455180 198233 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 478 8 1 5 5.4 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC1CCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272556 198233 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 478 8 1 5 5.4 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC1CCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
516319 122813 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against human Chemokine receptor 5 when co-administered with compound 8fInhibitory activity against human Chemokine receptor 5 when co-administered with compound 8f
ChEMBL 568 10 1 5 6.4 CCc1cc(Cc2ccccc2)n(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL173609 122813 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against human Chemokine receptor 5 when co-administered with compound 8fInhibitory activity against human Chemokine receptor 5 when co-administered with compound 8f
ChEMBL 568 10 1 5 6.4 CCc1cc(Cc2ccccc2)n(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
11598 1386 13 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
23725177 1386 13 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
CHEMBL4442783 1386 13 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
11598 1386 13 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.1c00082
23725177 1386 13 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.1c00082
CHEMBL4442783 1386 13 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.1c00082
5481737 216215 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 570 7 0 4 6.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Oc1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL314124 216215 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 570 7 0 4 6.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Oc1ccccc1 10.1016/s0960-894x(00)00637-5
44392116 241090 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.7 CN(C(=O)Cc1ccc(Cl)c(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL360120 241090 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.7 CN(C(=O)Cc1ccc(Cl)c(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16073659 144757 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 554 10 0 4 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL199147 144757 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 554 10 0 4 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2005.08.014
16073659 144757 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 554 10 0 4 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL199147 144757 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 554 10 0 4 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2006.03.089
122668201 424457 0 None None None Human 7.1 pIC50 = 7.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 438 8 1 6 4.2 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCCC2)c2cccnc2)CC1 nan
CHEMBL5843027 424457 0 None None None Human 7.1 pIC50 = 7.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 438 8 1 6 4.2 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCCC2)c2cccnc2)CC1 nan
72711277 183497 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435897 183497 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
44392095 251878 3 None None None Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 402 7 0 3 5.0 CN(C(=O)c1ccco1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL362388 251878 3 None None None Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 402 7 0 3 5.0 CN(C(=O)c1ccco1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
77281926 371016 0 None None None Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cellsDisplacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cells
ChEMBL 447 5 4 5 3.4 C/C=C(\C)[C@@H]1CC[C@@H]2C[C@H](C)C[C@H](C)[C@H]2[C@@H]1/C(O)=C1/C(=O)N[C@H](C[C@@](C)(O)C(=O)O)C1=O 10.1021/np060121y
CHEMBL495854 371016 0 None None None Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cellsDisplacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cells
ChEMBL 447 5 4 5 3.4 C/C=C(\C)[C@@H]1CC[C@@H]2C[C@H](C)C[C@H](C)[C@H]2[C@@H]1/C(O)=C1/C(=O)N[C@H](C[C@@](C)(O)C(=O)O)C1=O 10.1021/np060121y
57400375 143291 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 681 12 0 8 3.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(S(C)(=O)=O)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951910 143291 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 681 12 0 8 3.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(S(C)(=O)=O)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
44461804 470750 0 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 631 13 0 5 7.2 CN(C[C@@H](CCN1CCC(N(CC2CCCCC2)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
CHEMBL84351 470750 0 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 631 13 0 5 7.2 CN(C[C@@H](CCN1CCC(N(CC2CCCCC2)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
3209888 274995 2 None None None Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 452 6 0 6 4.0 Fc1ccc(Cn2nnnc2C(c2ccccc2F)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm061389p
CHEMBL375591 274995 2 None None None Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 452 6 0 6 4.0 Fc1ccc(Cn2nnnc2C(c2ccccc2F)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm061389p
667748 174773 59 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
CHEMBL2205805 174773 59 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
25133618 370526 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 586 6 1 5 7.0 CC(C)(C)OC(=O)N1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm800598a
CHEMBL492854 370526 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 586 6 1 5 7.0 CC(C)(C)OC(=O)N1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm800598a
1474 310449 80 None None None Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
46936282 310449 80 None None None Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 310449 80 None None None Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
DB03871 310449 80 None None None Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
478501 215664 0 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
CHEMBL313072 215664 0 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
16728611 299326 0 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 364 5 3 3 3.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1 10.1007/s00044-012-0118-7
CHEMBL397296 299326 0 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 364 5 3 3 3.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1 10.1007/s00044-012-0118-7
44374016 105620 0 None None None Human 8.1 pIC50 = 8.1 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 472 7 0 3 6.8 c1ccc(CCCC2CCN(C[C@H]3CN4OC5(CCCCC5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL159018 105620 0 None None None Human 8.1 pIC50 = 8.1 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 472 7 0 3 6.8 c1ccc(CCCC2CCN(C[C@H]3CN4OC5(CCCCC5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
46890343 21440 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 588 7 0 6 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CCC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085226 21440 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 588 7 0 6 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CCC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888480 23124 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 481 7 1 3 4.9 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)c3ccccc3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096766 23124 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 481 7 1 3 4.9 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)c3ccccc3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
72711956 183462 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435862 183462 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
25256857 334369 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 562 8 1 5 6.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL443936 334369 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 562 8 1 5 6.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
11641131 174522 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 458 7 1 4 5.8 Cc1nc2ccccc2n1[C@H]1C[C@H](C)N(CC[C@H](NC(=O)C2CCC2)c2ccccc2)[C@H](C)C1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203613 174522 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 458 7 1 4 5.8 Cc1nc2ccccc2n1[C@H]1C[C@H](C)N(CC[C@H](NC(=O)C2CCC2)c2ccccc2)[C@H](C)C1 10.1111/j.1747-0285.2006.00376.x
23650547 352980 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125]Mip1beta form CCR5 receptor expressed in MIP34.10 cellsDisplacement of [125]Mip1beta form CCR5 receptor expressed in MIP34.10 cells
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL471623 352980 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125]Mip1beta form CCR5 receptor expressed in MIP34.10 cellsDisplacement of [125]Mip1beta form CCR5 receptor expressed in MIP34.10 cells
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
46866599 20713 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 503 7 1 5 5.0 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1082202 20713 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 503 7 1 5 5.0 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
52946506 42225 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 541 7 0 6 3.1 Cc1cc(=O)oc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1271108 42225 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 541 7 0 6 3.1 Cc1cc(=O)oc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
10278617 195556 3 None None None Crab-eating macaque 8.1 pIC50 = 8.1 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 195556 3 None None None Crab-eating macaque 8.1 pIC50 = 8.1 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
118219321 429203 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 517 8 1 6 6.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccc(Cl)s1 nan
CHEMBL5895442 429203 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 517 8 1 6 6.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccc(Cl)s1 nan
20664159 143664 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3nnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL196087 143664 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3nnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
118219307 408464 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 576 9 2 7 6.0 CC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 nan
CHEMBL5775661 408464 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 576 9 2 7 6.0 CC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 nan
138106804 410970 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 508 9 1 10 3.4 [C-]#[N+]c1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)Cn2ncnn2)s1 nan
CHEMBL5802373 410970 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 508 9 1 10 3.4 [C-]#[N+]c1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)Cn2ncnn2)s1 nan
122668272 423914 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 533 8 1 6 6.3 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 nan
CHEMBL5922640 423914 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 533 8 1 6 6.3 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 nan
122668238 413444 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 515 7 1 6 4.4 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1ccc(F)s1 nan
CHEMBL5829874 413444 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 515 7 1 6 4.4 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1ccc(F)s1 nan
11237537 375137 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 509 7 1 5 4.3 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1 nan
CHEMBL5203084 375137 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 509 7 1 5 4.3 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1 nan
118219332 442380 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 454 8 1 7 4.4 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)CC#N)s1 nan
CHEMBL5939357 442380 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 454 8 1 7 4.4 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)CC#N)s1 nan
11569805 27094 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728785 27094 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
491775 27094 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188408 27094 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188807 27094 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196449 27094 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
122668181 404403 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 601 8 1 6 6.0 Cc1nc2c(n1C1CC3CCC(C1)N3CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1)CCN(C(=O)C(C)C)C2 nan
CHEMBL5825921 404403 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 601 8 1 6 6.0 Cc1nc2c(n1C1CC3CCC(C1)N3CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1)CCN(C(=O)C(C)C)C2 nan
118219266 423509 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 491 8 1 6 5.8 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)c2ccccc2)s1 nan
CHEMBL5847158 423509 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 491 8 1 6 5.8 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)c2ccccc2)s1 nan
138106805 406017 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 508 9 2 9 3.5 [C-]#[N+]c1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)Cc2nnn[nH]2)s1 nan
CHEMBL5750994 406017 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 508 9 2 9 3.5 [C-]#[N+]c1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)Cc2nnn[nH]2)s1 nan
118219289 430943 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 540 9 2 7 5.1 CNC(=O)c1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCCC2)s1 nan
CHEMBL5912589 430943 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 540 9 2 7 5.1 CNC(=O)c1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCCC2)s1 nan
53325460 121283 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 538 6 1 6 3.6 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](CC(F)(F)F)(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683190 121283 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 538 6 1 6 3.6 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](CC(F)(F)F)(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)C1 10.1016/j.bmcl.2011.01.015
44404596 144496 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 552 10 0 4 5.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198277 144496 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 552 10 0 4 5.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2005.08.014
122668188 426654 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 522 7 1 7 4.1 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1ccc(C#N)s1 nan
CHEMBL5867098 426654 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 522 7 1 7 4.1 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1ccc(C#N)s1 nan
59458159 183508 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 567 8 1 5 5.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435908 183508 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 567 8 1 5 5.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
118219331 428704 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 497 9 2 9 3.3 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)Cc2nnn[nH]2)s1 nan
CHEMBL5890779 428704 0 None None None Human 8.1 pIC50 = 8.1 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 497 9 2 9 3.3 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)Cc2nnn[nH]2)s1 nan
57391720 143281 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 672 12 0 7 3.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)N2CCN(S(=O)(=O)CC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951899 143281 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 672 12 0 7 3.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)N2CCN(S(=O)(=O)CC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
3011723 143286 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 615 12 0 5 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951904 143286 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 615 12 0 5 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
5275762 158735 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207485 158735 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
54585964 125612 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 546 7 0 4 7.0 CCc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784404 125612 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 546 7 0 4 7.0 CCc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
505866 62083 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137524 62083 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
25230971 351521 0 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 547 7 0 7 3.2 CCCOC1CN(S(=O)(=O)C2CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL464055 351521 0 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 547 7 0 7 3.2 CCCOC1CN(S(=O)(=O)C2CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
489331 19594 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 554 9 2 3 6.3 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
CHEMBL106381 19594 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 554 9 2 3 6.3 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
5481745 473452 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1Cl 10.1016/s0960-894x(00)00637-5
CHEMBL88261 473452 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1Cl 10.1016/s0960-894x(00)00637-5
46883026 20117 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 570 7 0 6 4.5 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078710 20117 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 570 7 0 6 4.5 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
5481867 221499 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 582 8 0 7 4.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328898 221499 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 582 8 0 7 4.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479883 473440 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 476 9 0 3 5.7 Cc1cccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
CHEMBL88197 473440 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 476 9 0 3 5.7 Cc1cccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
44392105 137899 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1ccc(Cl)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183293 137899 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1ccc(Cl)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728611 299326 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 364 5 3 3 3.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL397296 299326 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 364 5 3 3 3.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1 10.1016/j.bmcl.2006.09.052
44461804 470750 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 631 13 0 5 7.2 CN(C[C@@H](CCN1CCC(N(CC2CCCCC2)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL84351 470750 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 631 13 0 5 7.2 CN(C[C@@H](CCN1CCC(N(CC2CCCCC2)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
10445499 352789 1 None None None Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPADisplacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPA
ChEMBL 264 0 2 5 2.4 CC1OC(=O)c2c3c(c(O)c(O)c21)OC(C)(C)CC3 10.1021/np030146m
CHEMBL469856 352789 1 None None None Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPADisplacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPA
ChEMBL 264 0 2 5 2.4 CC1OC(=O)c2c3c(c(O)c(O)c21)OC(C)(C)CC3 10.1021/np030146m
24794585 353415 0 None None None Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 478 5 2 6 2.6 CC(=O)N[C@@H]1C[C@H](N(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4741305 353415 0 None None None Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 478 5 2 6 2.6 CC(=O)N[C@@H]1C[C@H](N(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
10585 2226 1 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 2226 1 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 2226 1 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
44392123 257843 3 None None None Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 426 8 0 2 5.4 CN(C(=O)Cc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL367586 257843 3 None None None Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 426 8 0 2 5.4 CN(C(=O)Cc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
57391591 142584 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1beta from CCR5Displacement of [125I]MIP-1beta from CCR5
ChEMBL 637 10 4 6 3.8 CC(C)N[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)N2CCC2)C[C@@H]1CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2011.12.057
CHEMBL1944778 142584 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1beta from CCR5Displacement of [125I]MIP-1beta from CCR5
ChEMBL 637 10 4 6 3.8 CC(C)N[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)N2CCC2)C[C@@H]1CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2011.12.057
489829 474317 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 444 6 0 2 6.4 Clc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
CHEMBL94032 474317 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 444 6 0 2 6.4 Clc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
667748 174773 59 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
CHEMBL2205805 174773 59 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
11597 1388 8 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00082
23725180 1388 8 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00082
CHEMBL4781426 1388 8 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00082
3011721 143284 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 567 11 0 6 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951902 143284 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 567 11 0 6 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
11569805 27094 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
16728785 27094 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
491775 27094 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1188408 27094 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1188807 27094 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1196449 27094 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
76327118 176521 0 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(Cl)c1 10.1007/s00044-012-0118-7
CHEMBL2281957 176521 0 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(Cl)c1 10.1007/s00044-012-0118-7
25205601 20778 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 540 7 0 6 4.0 CCCCC1CN(C2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1082487 20778 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 540 7 0 6 4.0 CCCCC1CN(C2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
16728609 332196 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL429641 332196 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
474152 26296 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 8 1 1 6.7 CC[N+](CC)(CC)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
CHEMBL1183357 26296 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 8 1 1 6.7 CC[N+](CC)(CC)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
483364 308733 0 None None None Human 5.1 pIC50 = 5.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](C[C@@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL402701 308733 0 None None None Human 5.1 pIC50 = 5.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](C[C@@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
10585 2226 1 None None None Human 4.1 pIC50 = 4.1 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 2226 1 None None None Human 4.1 pIC50 = 4.1 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 2226 1 None None None Human 4.1 pIC50 = 4.1 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
1474 310449 80 None None None Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
46936282 310449 80 None None None Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 310449 80 None None None Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
DB03871 310449 80 None None None Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
5481750 473581 0 None None None Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 8 0 5 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccnc1 10.1007/s00044-011-9863-2
CHEMBL89167 473581 0 None None None Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 8 0 5 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccnc1 10.1007/s00044-011-9863-2
44404720 272668 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 594 11 0 4 6.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(-c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372297 272668 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 594 11 0 4 6.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(-c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
72712597 183476 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
CHEMBL2435876 183476 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
44564884 353205 0 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 465 8 1 5 4.9 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)CC(F)(F)F)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL473352 353205 0 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 465 8 1 5 4.9 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)CC(F)(F)F)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
478494 473591 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 528 7 0 4 4.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(C)(=O)=O 10.1016/s0960-894x(00)00637-5
CHEMBL89221 473591 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 528 7 0 4 4.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(C)(=O)=O 10.1016/s0960-894x(00)00637-5
16728642 182023 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 350 5 3 3 3.8 C/C(=N/NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240018 182023 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 350 5 3 3 3.8 C/C(=N/NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
11259200 178976 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 437 6 1 3 5.0 O=C(O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234676 178976 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 437 6 1 3 5.0 O=C(O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
25133619 385828 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 1 5 5.2 CC(C)(C)OC(=O)N1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)CC1 10.1021/jm800598a
CHEMBL524159 385828 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 1 5 5.2 CC(C)(C)OC(=O)N1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)CC1 10.1021/jm800598a
44373748 117791 0 None None None Human 7.1 pIC50 = 7.1 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL161480 117791 0 None None None Human 7.1 pIC50 = 7.1 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
10281316 155411 0 None None None Mouse 7.1 pIC50 = 7.1 Binding
Binding affinity to mouse CCR5Binding affinity to mouse CCR5
ChEMBL 565 13 6 5 3.6 CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NCC 10.1016/j.bmcl.2012.03.007
CHEMBL2018386 155411 0 None None None Mouse 7.1 pIC50 = 7.1 Binding
Binding affinity to mouse CCR5Binding affinity to mouse CCR5
ChEMBL 565 13 6 5 3.6 CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NCC 10.1016/j.bmcl.2012.03.007
44373748 117791 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL161480 117791 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
44373748 117791 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL161480 117791 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
11598797 27141 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
11634966 27141 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188808 27141 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1189134 27141 0 None None None Human 6.1 pIC50 = 6.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
483348 39189 0 None None None Human 5.1 pIC50 = 5.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 562 12 0 5 6.5 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL121321 39189 0 None None None Human 5.1 pIC50 = 5.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 562 12 0 5 6.5 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44392078 136686 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 418 7 0 3 5.5 CN(C(=O)c1cccs1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181260 136686 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 418 7 0 3 5.5 CN(C(=O)c1cccs1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728628 181142 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 421 7 3 6 2.8 COc1ccc([N+](=O)[O-])cc1COc1ccc(Br)cc1/C=N/NC(=N)N 10.1016/j.bmcl.2006.09.052
CHEMBL238549 181142 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 421 7 3 6 2.8 COc1ccc([N+](=O)[O-])cc1COc1ccc(Br)cc1/C=N/NC(=N)N 10.1016/j.bmcl.2006.09.052
16728628 181142 0 None None None Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 421 7 3 6 2.8 COc1ccc([N+](=O)[O-])cc1COc1ccc(Br)cc1/C=N/NC(=N)N 10.1007/s00044-012-0118-7
CHEMBL238549 181142 0 None None None Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 421 7 3 6 2.8 COc1ccc([N+](=O)[O-])cc1COc1ccc(Br)cc1/C=N/NC(=N)N 10.1007/s00044-012-0118-7
483350 38544 0 None None None Human 4.1 pIC50 = 4.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 576 13 0 5 6.9 CCC(CC(CCN1CCC(N(CC)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.03.112
CHEMBL120513 38544 0 None None None Human 4.1 pIC50 = 4.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 576 13 0 5 6.9 CCC(CC(CCN1CCC(N(CC)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.03.112
10290194 160516 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 651 11 1 6 6.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NC(=O)OC(C)(C)C)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL2113131 160516 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 651 11 1 6 6.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NC(=O)OC(C)(C)C)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
11215950 20026 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 5 5.4 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078014 20026 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 5 5.4 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
489816 474040 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 500 6 0 2 7.1 O=C(c1ccccc1-c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL92133 474040 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 500 6 0 2 7.1 O=C(c1ccccc1-c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44564835 353204 0 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 397 7 1 5 4.0 CC(=O)N[C@@H](CC(C)N1CCC(n2c(C)nnc2C(C)C)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
CHEMBL473348 353204 0 None None None Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 397 7 1 5 4.0 CC(=O)N[C@@H](CC(C)N1CCC(n2c(C)nnc2C(C)C)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
16728615 297362 0 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc([N+](=O)[O-])cc1 10.1007/s00044-012-0118-7
CHEMBL395607 297362 0 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc([N+](=O)[O-])cc1 10.1007/s00044-012-0118-7
5481711 470753 0 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 522 8 0 3 6.1 CN(C[C@@H](CCN1CCC2(CCc3ccccc32)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL84374 470753 0 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 522 8 0 3 6.1 CN(C[C@@H](CCN1CCC2(CCc3ccccc32)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
46888584 22955 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 529 8 1 5 3.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095191 22955 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 529 8 1 5 3.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888499 23050 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 493 7 1 3 5.1 Cc1cccc(Cl)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096102 23050 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 493 7 1 3 5.1 Cc1cccc(Cl)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
505870 61292 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 500 8 0 4 5.6 O=C(C1CCCCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ccccn3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00988-5
CHEMBL136977 61292 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 500 8 0 4 5.6 O=C(C1CCCCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ccccn3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00988-5
505866 62083 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137524 62083 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
72711742 183460 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435860 183460 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
11626984 174521 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1[C@@H]1C[C@H]2COC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203612 174521 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1[C@@H]1C[C@H]2COC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
505866 62083 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137524 62083 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516350 122128 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 612 8 2 4 7.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccc(Cl)cc4Cl)[nH]n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL170717 122128 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 612 8 2 4 7.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccc(Cl)cc4Cl)[nH]n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.004
516341 259423 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 596 12 1 5 7.0 CCCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL369189 259423 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 596 12 1 5 7.0 CCCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
516330 258776 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 626 12 1 7 6.0 CCOC(=O)Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL368517 258776 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 626 12 1 7 6.0 CCOC(=O)Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
5275837 126219 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 575 10 0 5 5.4 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)OCc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL180013 126219 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 575 10 0 5 5.4 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)OCc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
490012 221003 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 511 9 0 4 6.0 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL327801 221003 0 None None None Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 511 9 0 4 6.0 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44404658 273526 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 629 12 1 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NS(C)(=O)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL373214 273526 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 629 12 1 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NS(C)(=O)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
122668256 430012 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 457 8 1 6 5.2 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCCCC2)c2cccs2)CC1 nan
CHEMBL5903573 430012 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 457 8 1 6 5.2 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCCCC2)c2cccs2)CC1 nan
118218951 443154 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 533 8 1 6 6.3 Cc1csc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1 nan
CHEMBL6030353 443154 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 533 8 1 6 6.3 Cc1csc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1 nan
118219310 443751 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 503 8 1 6 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCC1)c1ccc(Cl)s1 nan
CHEMBL5943513 443751 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 503 8 1 6 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCC1)c1ccc(Cl)s1 nan
73347894 183463 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435863 183463 0 None None None Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
118219268 404409 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 501 8 1 6 5.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccc(F)s1 nan
CHEMBL5829565 404409 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 501 8 1 6 5.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccc(F)s1 nan
122668156 443021 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 537 8 1 6 6.2 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)s1 nan
CHEMBL6012846 443021 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 537 8 1 6 6.2 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)s1 nan
118219361 447264 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 483 9 1 10 2.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cn1cnnn1)c1cccs1 nan
CHEMBL5981516 447264 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 483 9 1 10 2.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cn1cnnn1)c1cccs1 nan
118219311 426139 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 544 8 1 7 5.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(C#N)s1 nan
CHEMBL5861352 426139 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 544 8 1 7 5.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(C#N)s1 nan
118219314 410084 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 526 9 2 7 4.7 CNC(=O)c1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCC2)s1 nan
CHEMBL5792509 410084 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 526 9 2 7 4.7 CNC(=O)c1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCC2)s1 nan
73346388 183478 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435878 183478 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
72714079 183486 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435886 183486 0 None None None Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
118219305 450062 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 540 9 2 7 5.7 CC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCCC2)s1 nan
CHEMBL6011011 450062 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 540 9 2 7 5.7 CC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCCC2)s1 nan
118219272 442966 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 483 8 1 6 5.7 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCC2)s1 nan
CHEMBL6007195 442966 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 483 8 1 6 5.7 Cc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCC2)s1 nan
44447731 195474 0 None None None Crab-eating macaque 8.0 pIC50 = 8.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255430 195474 0 None None None Crab-eating macaque 8.0 pIC50 = 8.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
118219353 424214 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 517 9 1 10 3.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cn1ncnn1)c1ccc(Cl)s1 nan
CHEMBL5840366 424214 0 None None None Human 8.0 pIC50 = 8.0 Binding
Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.Calcium Flux Inhibition Experiment: 1. HEK293 cells which can stably express CCR5 were inoculated in a 96-well plate and incubated overnight.2. The medium in each well into which cells were innoculated was removed and 40 μl/well of freshly prepared dye was added. The plate was placed in a 37° C. incubator and incubated for 40 minutes at constant temperature.3. The medicament to be determined was diluted with calcium buffer to eight concentration gradients, which is 1×10−4 M, 1×10−5 M, 1×10−6 M, 1×10−7 M, 1×10−8 M, 1×10−9 M, 1×10−10 M, and 1×10−11 M, respectively, and homogeneously mixed.4. The dye was removed. Freshly prepared calcium buffer was used to wash for one time, 50 μl of calcium buffer was added.5. FlexStation II was used for detection. 25 μl of calcium buffer containing the medicament to be determined was added automatically from the 15th second. The fluorescence value at 525 nm was read ultimately.
ChEMBL 517 9 1 10 3.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)Cn1ncnn1)c1ccc(Cl)s1 nan
456319 469022 0 None None None Human 7.1 pIC50 = 7.1 Binding
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 5 5.7 Cc1ccccc1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL70124 469022 0 None None None Human 7.1 pIC50 = 7.1 Binding
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 5 5.7 Cc1ccccc1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
25206069 21432 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 560 5 0 6 4.2 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085218 21432 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 560 5 0 6 4.2 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
5481751 216628 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2cccnc12 10.1016/s0960-894x(00)00637-5
CHEMBL315084 216628 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2cccnc12 10.1016/s0960-894x(00)00637-5
479846 474043 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 590 8 0 4 5.9 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL92147 474043 0 None None None Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 590 8 0 4 5.9 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
16728615 297362 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc([N+](=O)[O-])cc1 10.1016/j.bmcl.2006.09.052
CHEMBL395607 297362 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc([N+](=O)[O-])cc1 10.1016/j.bmcl.2006.09.052
6480205 374514 5 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPADisplacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPA
ChEMBL 368 2 0 2 5.8 C=C(C)[C@H]1CC[C@@]2(C)CC[C@]3(C)C[C@H]4[C@@H](C)CC(=O)[C@H]4/C(C=O)=C\C[C@H]3[C@H]12 10.1021/np049844c
CHEMBL519317 374514 5 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPADisplacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPA
ChEMBL 368 2 0 2 5.8 C=C(C)[C@H]1CC[C@@]2(C)CC[C@]3(C)C[C@H]4[C@@H](C)CC(=O)[C@H]4/C(C=O)=C\C[C@H]3[C@H]12 10.1021/np049844c
72713861 183482 0 None None None Human 5.0 pIC50 = 5.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435882 183482 0 None None None Human 5.0 pIC50 = 5.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
72711280 183500 0 None None None Human 6.0 pIC50 = 6.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccn2)CC1 10.1021/jm401101p
CHEMBL2435900 183500 0 None None None Human 6.0 pIC50 = 6.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccn2)CC1 10.1021/jm401101p
44392074 137079 0 None None None Human 7.0 pIC50 = 7.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 505 9 1 4 4.0 CN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181913 137079 0 None None None Human 7.0 pIC50 = 7.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 505 9 1 4 4.0 CN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
10008921 371564 0 None None None Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 612 8 1 5 5.1 O=C1NCN(c2ccccc2)C12CCN(CCCC1(c3ccc(Cl)c(Cl)c3)CN(S(=O)(=O)c3ccccc3)C1)CC2 10.1021/jm800598a
CHEMBL501077 371564 0 None None None Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 612 8 1 5 5.1 O=C1NCN(c2ccccc2)C12CCN(CCCC1(c3ccc(Cl)c(Cl)c3)CN(S(=O)(=O)c3ccccc3)C1)CC2 10.1021/jm800598a
46882073 19939 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 571 5 0 6 4.7 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
CHEMBL1077353 19939 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 571 5 0 6 4.7 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
73352463 183446 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 553 8 1 4 7.0 O=C(O)c1cccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)c1 10.1021/jm401101p
CHEMBL2435846 183446 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 553 8 1 4 7.0 O=C(O)c1cccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)c1 10.1021/jm401101p
16655051 176524 0 None None None Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 385 5 3 4 3.1 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(C#N)cc1 10.1007/s00044-012-0118-7
CHEMBL2281960 176524 0 None None None Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 385 5 3 4 3.1 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(C#N)cc1 10.1007/s00044-012-0118-7
44439313 182762 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 415 6 3 5 3.1 COc1cc(Br)cc(/C(C)=N/NC(=N)N)c1OCc1ccc(C#N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL241475 182762 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 415 6 3 5 3.1 COc1cc(Br)cc(/C(C)=N/NC(=N)N)c1OCc1ccc(C#N)cc1 10.1016/j.bmcl.2006.09.052
52947748 42085 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 525 8 0 6 2.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(S(=O)(=O)C(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270101 42085 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 525 8 0 6 2.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(S(=O)(=O)C(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
25132946 370938 1 None None None Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 576 7 1 4 5.5 O=C1CC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
CHEMBL495291 370938 1 None None None Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 576 7 1 4 5.5 O=C1CC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
25130571 370940 0 None None None Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 498 6 1 5 3.9 O=C(c1ccco1)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)C1 10.1021/jm800598a
CHEMBL495298 370940 0 None None None Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 498 6 1 5 3.9 O=C(c1ccco1)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)C1 10.1021/jm800598a
489809 474302 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1cccc(Cl)c1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93949 474302 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1cccc(Cl)c1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44590946 350371 0 None None None Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 424 8 1 5 4.8 CC(C)c1noc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)n1 10.1016/j.bmcl.2009.01.009
CHEMBL459600 350371 0 None None None Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 424 8 1 5 4.8 CC(C)c1noc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)n1 10.1016/j.bmcl.2009.01.009
44455143 311237 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 452 8 1 5 4.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC(C)C)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL402776 311237 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 452 8 1 5 4.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC(C)C)c1ccccc1 10.1016/j.bmcl.2007.12.058
489815 473714 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 442 5 0 2 5.6 O=C(c1ccccc1F)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL90129 473714 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 442 5 0 2 5.6 O=C(c1ccccc1F)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
46883030 20120 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 623 7 0 7 5.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078713 20120 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 623 7 0 7 5.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
489814 474251 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 492 5 0 2 6.4 O=C(c1ccccc1C(F)(F)F)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93625 474251 0 None None None Human 7.0 pIC50 = 7.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 492 5 0 2 6.4 O=C(c1ccccc1C(F)(F)F)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44455313 195494 0 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 463 7 0 5 5.5 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCN(C(=O)C1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL255535 195494 0 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 463 7 0 5 5.5 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCN(C(=O)C1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
54584427 123658 0 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 590 9 1 5 6.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccnc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762327 123658 0 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 590 9 1 5 6.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccnc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
46882074 19940 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 570 5 0 5 5.3 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)ccnc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
CHEMBL1077354 19940 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 570 5 0 5 5.3 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)ccnc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
457845 317321 0 None None None Human 6.0 pIC50 = 6.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 320 4 1 2 3.9 c1ccc(C2CCN(C[C@H]3CNC[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00545-5
CHEMBL414222 317321 0 None None None Human 6.0 pIC50 = 6.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 320 4 1 2 3.9 c1ccc(C2CCN(C[C@H]3CNC[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00545-5
52943283 42214 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 553 8 0 6 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(=O)(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1271000 42214 0 None None None Human 7.0 pIC50 = 7 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 553 8 0 6 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(=O)(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
1676 7995 24 None -67 9 Mouse 8.0 pKd = 8.0 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
1878 7995 24 None -67 9 Mouse 8.0 pKd = 8.0 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
5284596 7995 24 None -67 9 Mouse 8.0 pKd = 8.0 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
CHEMBL80 7995 24 None -67 9 Mouse 8.0 pKd = 8.0 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
2984051 118146 4 None None None Human 5.0 pKd = 5 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 333 6 1 2 4.5 CC(C)NCc1cc(Br)ccc1OCc1ccccc1 10.1021/ml2000017
CHEMBL1618631 118146 4 None None None Human 5.0 pKd = 5 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 333 6 1 2 4.5 CC(C)NCc1cc(Br)ccc1OCc1ccccc1 10.1021/ml2000017
10287138 145335 0 None None None Human 5.0 pKd = 5.0 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assayBinding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assay
ChEMBL 373 4 1 6 3.3 COc1nc(Cl)c(Cl)nc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
CHEMBL2011440 145335 0 None None None Human 5.0 pKd = 5.0 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assayBinding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assay
ChEMBL 373 4 1 6 3.3 COc1nc(Cl)c(Cl)nc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
10287138 145335 0 None None None Human 4.8 pKd = 4.8 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 373 4 1 6 3.3 COc1nc(Cl)c(Cl)nc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
CHEMBL2011440 145335 0 None None None Human 4.8 pKd = 4.8 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 373 4 1 6 3.3 COc1nc(Cl)c(Cl)nc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
2964123 139946 9 None None None Human 4.7 pKd = 4.7 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 375 7 1 3 4.3 Brc1ccc(OCc2ccccc2)c(CNCC2CCCO2)c1 10.1021/ml2000017
CHEMBL1907216 139946 9 None None None Human 4.7 pKd = 4.7 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 375 7 1 3 4.3 Brc1ccc(OCc2ccccc2)c(CNCC2CCCO2)c1 10.1021/ml2000017
1676 7995 24 None -67 9 Mouse 7.7 pKd = 7.7 Binding
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
1878 7995 24 None -67 9 Mouse 7.7 pKd = 7.7 Binding
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
5284596 7995 24 None -67 9 Mouse 7.7 pKd = 7.7 Binding
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
CHEMBL80 7995 24 None -67 9 Mouse 7.7 pKd = 7.7 Binding
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
10215932 145336 1 None None None Human 4.7 pKd = 4.7 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 383 4 1 6 2.8 COc1nc(Br)cnc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
CHEMBL2011441 145336 1 None None None Human 4.7 pKd = 4.7 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 383 4 1 6 2.8 COc1nc(Br)cnc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
11598 1386 13 None None None Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5 in T-cell (unknown origin)Binding affinity to CCR5 in T-cell (unknown origin)
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
23725177 1386 13 None None None Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5 in T-cell (unknown origin)Binding affinity to CCR5 in T-cell (unknown origin)
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
CHEMBL4442783 1386 13 None None None Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5 in T-cell (unknown origin)Binding affinity to CCR5 in T-cell (unknown origin)
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
1635 193594 43 None None None Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml2000017
3002977 193594 43 None None None Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml2000017
CHEMBL256907 193594 43 None None None Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml2000017
1017290 118675 9 None None None Human 4.6 pKd = 4.6 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 363 7 2 3 3.9 CC(C)(CO)NCc1cc(Br)ccc1OCc1ccccc1 10.1021/ml2000017
CHEMBL1623307 118675 9 None None None Human 4.6 pKd = 4.6 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 363 7 2 3 3.9 CC(C)(CO)NCc1cc(Br)ccc1OCc1ccccc1 10.1021/ml2000017
10215932 145336 1 None None None Human 4.5 pKd = 4.5 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assayBinding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assay
ChEMBL 383 4 1 6 2.8 COc1nc(Br)cnc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
CHEMBL2011441 145336 1 None None None Human 4.5 pKd = 4.5 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assayBinding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assay
ChEMBL 383 4 1 6 2.8 COc1nc(Br)cnc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
11947758 915 28 None None None Human 8.5 pKd = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1021/jm300682j
3001322 915 28 None None None Human 8.5 pKd = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1021/jm300682j
805 915 28 None None None Human 8.5 pKd = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1021/jm300682j
CHEMBL1255794 915 28 None None None Human 8.5 pKd = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1021/jm300682j
CHEMBL1739499 915 28 None None None Human 8.5 pKd = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1021/jm300682j
DB06497 915 28 None None None Human 8.5 pKd = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1021/jm300682j
49871007 121597 22 None None None Human 8.5 pKd = 8.5 Binding
Activation of CCR5 in human PBMC cellsActivation of CCR5 in human PBMC cells
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 121597 22 None None None Human 8.5 pKd = 8.5 Binding
Activation of CCR5 in human PBMC cellsActivation of CCR5 in human PBMC cells
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
DB12960 121597 22 None None None Human 8.5 pKd = 8.5 Binding
Activation of CCR5 in human PBMC cellsActivation of CCR5 in human PBMC cells
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
178321738 467671 0 None None None Human 5.3 pKd = 5.3 Binding
Competitive binding affinity to full length CCR5 (unknown origin) expressed in HEK293F cells assessed as dissociation constant incubated for 3 hrs by dISA assayCompetitive binding affinity to full length CCR5 (unknown origin) expressed in HEK293F cells assessed as dissociation constant incubated for 3 hrs by dISA assay
ChEMBL 467 6 3 10 3.1 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2NC2CCCCC2)c1O 10.1016/j.ejmech.2025.117600
CHEMBL6191234 467671 0 None None None Human 5.3 pKd = 5.3 Binding
Competitive binding affinity to full length CCR5 (unknown origin) expressed in HEK293F cells assessed as dissociation constant incubated for 3 hrs by dISA assayCompetitive binding affinity to full length CCR5 (unknown origin) expressed in HEK293F cells assessed as dissociation constant incubated for 3 hrs by dISA assay
ChEMBL 467 6 3 10 3.1 CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2nc3nonc3nc2NC2CCCCC2)c1O 10.1016/j.ejmech.2025.117600
3373405 118512 21 None None None Human 4.3 pKd = 4.3 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 394 4 0 3 3.7 COc1ccc(Br)cc1CN1CCCC(C(=O)N2CCCCC2)C1 10.1021/ml2000017
CHEMBL1621896 118512 21 None None None Human 4.3 pKd = 4.3 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 394 4 0 3 3.7 COc1ccc(Br)cc1CN1CCCC(C(=O)N2CCCCC2)C1 10.1021/ml2000017
1017997 145334 8 None None None Human 5.1 pKd = 5.1 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 382 7 1 3 4.7 Brc1ccc(OCc2ccccc2)c(CNCc2ccccn2)c1 10.1021/ml2000017
CHEMBL2011439 145334 8 None None None Human 5.1 pKd = 5.1 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 382 7 1 3 4.7 Brc1ccc(OCc2ccccc2)c(CNCc2ccccn2)c1 10.1021/ml2000017
6532436 65272 0 None None None Human 10.0 pKi = 10 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 616 7 0 5 7.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(-c4ccncc4)cc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140484 65272 0 None None None Human 10.0 pKi = 10 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 616 7 0 5 7.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(-c4ccncc4)cc3C)CC2)CC1 10.1021/jm030265z
1635 193594 43 None -6 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1039/c3md00080j
3002977 193594 43 None -6 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1039/c3md00080j
CHEMBL256907 193594 43 None -6 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1039/c3md00080j
1635 193594 43 None -6 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmc.2016.09.059
3002977 193594 43 None -6 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmc.2016.09.059
CHEMBL256907 193594 43 None -6 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1016/j.bmc.2016.09.059
1635 193594 43 None 6 2 Human 9.6 pKi = 9.6 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
3002977 193594 43 None 6 2 Human 9.6 pKi = 9.6 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
CHEMBL256907 193594 43 None 6 2 Human 9.6 pKi = 9.6 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
6532435 234597 0 None None None Human 9.5 pKi = 9.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 668 6 0 5 6.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)cncc3Br)CC2)CC1 10.1021/jm030265z
CHEMBL335365 234597 0 None None None Human 9.5 pKi = 9.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 668 6 0 5 6.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)cncc3Br)CC2)CC1 10.1021/jm030265z
5482301 238591 0 None None None Human 9.5 pKi = 9.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 668 6 0 5 6.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)cncc3Br)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL349008 238591 0 None None None Human 9.5 pKi = 9.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 668 6 0 5 6.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)cncc3Br)CC2)CC1 10.1016/s0960-894x(02)01063-6
6532434 235075 0 None None None Human 9.4 pKi = 9.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 580 6 0 5 6.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1021/jm030265z
CHEMBL335794 235075 0 None None None Human 9.4 pKi = 9.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 580 6 0 5 6.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1021/jm030265z
5482300 238745 0 None None None Human 9.4 pKi = 9.4 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 580 6 0 5 6.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL350563 238745 0 None None None Human 9.4 pKi = 9.4 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 580 6 0 5 6.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1016/s0960-894x(02)01063-6
463616 65677 0 None 2884 2 Human 9.2 pKi = 9.2 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 542 4 0 4 6.2 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00918-6
CHEMBL140827 65677 0 None 2884 2 Human 9.2 pKi = 9.2 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 542 4 0 4 6.2 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00918-6
463616 65677 0 None 2884 2 Human 9.2 pKi = 9.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 4 0 4 6.2 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
CHEMBL140827 65677 0 None 2884 2 Human 9.2 pKi = 9.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 4 0 4 6.2 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
5495582 232066 0 None None None Human 9.2 pKi = 9.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 684 6 0 5 5.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)c[n+]([O-])cc3Br)CC2)CC1 10.1021/jm030265z
CHEMBL337776 232066 0 None None None Human 9.2 pKi = 9.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 684 6 0 5 5.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)c[n+]([O-])cc3Br)CC2)CC1 10.1021/jm030265z
9579116 119080 0 None None None Human 9.2 pKi = 9.2 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 684 6 0 5 5.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)c[n+]([O-])cc3Br)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL162880 119080 0 None None None Human 9.2 pKi = 9.2 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 684 6 0 5 5.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)c[n+]([O-])cc3Br)CC2)CC1 10.1016/s0960-894x(02)01063-6
71462570 163992 0 None 1 3 Human 9.0 pKi = 9 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 518 5 2 5 5.6 CC1(C)CN(CC/C=C2/c3cc(C(=O)O)ccc3OCc3ncccc32)C[C@H](c2ccc(Cl)cc2)[C@H]1O 10.1021/jm300682j
CHEMBL2178569 163992 0 None 1 3 Human 9.0 pKi = 9 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 518 5 2 5 5.6 CC1(C)CN(CC/C=C2/c3cc(C(=O)O)ccc3OCc3ncccc32)C[C@H](c2ccc(Cl)cc2)[C@H]1O 10.1021/jm300682j
44337326 22284 0 None 1 3 Human 9.0 pKi = 9 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 600 7 0 5 6.4 COc1ccc(S(=O)(=O)c2ccc(CC3CCN(C4CCN(C(=O)c5ccc(F)c6ccccc56)CC4)CC3)cc2)cc1 10.1021/jm015526o
CHEMBL109051 22284 0 None 1 3 Human 9.0 pKi = 9 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 600 7 0 5 6.4 COc1ccc(S(=O)(=O)c2ccc(CC3CCN(C4CCN(C(=O)c5ccc(F)c6ccccc56)CC4)CC3)cc2)cc1 10.1021/jm015526o
456375 24398 0 None None None Human 9.0 pKi = 9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 501 4 0 3 6.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL115487 24398 0 None None None Human 9.0 pKi = 9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 501 4 0 3 6.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
183790 8163 6 None 6 2 Human 9.0 pKi = 9.0 Binding
Antagonist at CCR5 (unknown origin) assessed as inhibitory constantAntagonist at CCR5 (unknown origin) assessed as inhibitory constant
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2020.112311
783 8163 6 None 6 2 Human 9.0 pKi = 9.0 Binding
Antagonist at CCR5 (unknown origin) assessed as inhibitory constantAntagonist at CCR5 (unknown origin) assessed as inhibitory constant
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2020.112311
CHEMBL1178786 8163 6 None 6 2 Human 9.0 pKi = 9.0 Binding
Antagonist at CCR5 (unknown origin) assessed as inhibitory constantAntagonist at CCR5 (unknown origin) assessed as inhibitory constant
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2020.112311
9575320 19490 0 None 1 2 Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm015526o
CHEMBL105821 19490 0 None 1 2 Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm015526o
9574357 212993 0 None 1 2 Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 526 5 0 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm015526o
CHEMBL323172 212993 0 None 1 2 Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 526 5 0 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm015526o
9575320 19490 0 None -1 2 Mouse 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm0200815
CHEMBL105821 19490 0 None -1 2 Mouse 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm0200815
9574357 212993 0 None -1 2 Mouse 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 5 0 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm0200815
CHEMBL323172 212993 0 None -1 2 Mouse 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 5 0 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm0200815
5482298 57633 0 None None None Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 540 6 0 5 5.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL138285 57633 0 None None None Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 540 6 0 5 5.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm030265z
5479841 64392 0 None None None Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 5 0 5 5.2 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL139559 64392 0 None None None Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 5 0 5 5.2 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm030265z
6533781 63349 0 None None None Human 8.9 pKi = 8.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 596 6 0 5 5.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CC1 10.1021/jm030265z
CHEMBL138640 63349 0 None None None Human 8.9 pKi = 8.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 596 6 0 5 5.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CC1 10.1021/jm030265z
5495581 116512 0 None None None Human 8.9 pKi = 8.9 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 596 6 0 5 5.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL164484 116512 0 None None None Human 8.9 pKi = 8.9 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 596 6 0 5 5.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CC1 10.1016/s0960-894x(02)01063-6
5495597 65215 0 None None None Human 8.9 pKi = 8.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 587 7 0 7 5.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(SC)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140418 65215 0 None None None Human 8.9 pKi = 8.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 587 7 0 7 5.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(SC)nc3C)CC2)CC1 10.1021/jm030265z
5495597 65215 0 None None None Human 8.9 pKi = 8.9 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 587 7 0 7 5.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(SC)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140418 65215 0 None None None Human 8.9 pKi = 8.9 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 587 7 0 7 5.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(SC)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
183790 8163 6 None 6 2 Human 8.9 pKi = 8.9 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptorInhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00639-9
783 8163 6 None 6 2 Human 8.9 pKi = 8.9 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptorInhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00639-9
CHEMBL1178786 8163 6 None 6 2 Human 8.9 pKi = 8.9 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptorInhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00639-9
5479844 219984 0 None 1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL324643 219984 0 None 1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
502259 235686 0 None 61 2 Human 8.0 pKi = 8 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 571 4 0 5 5.9 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL337820 235686 0 None 61 2 Human 8.0 pKi = 8 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 571 4 0 5 5.9 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
462571 237583 0 None 97 2 Human 8.0 pKi = 8 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 517 4 0 5 5.2 Cc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1016/s0960-894x(02)00918-6
CHEMBL342137 237583 0 None 97 2 Human 8.0 pKi = 8 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 517 4 0 5 5.2 Cc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1016/s0960-894x(02)00918-6
502259 235686 0 None 61 2 Human 8.0 pKi = 8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 571 4 0 5 5.9 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL337820 235686 0 None 61 2 Human 8.0 pKi = 8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 571 4 0 5 5.9 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
462571 237583 0 None 97 2 Human 8.0 pKi = 8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 517 4 0 5 5.2 Cc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1021/jm030265z
CHEMBL342137 237583 0 None 97 2 Human 8.0 pKi = 8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 517 4 0 5 5.2 Cc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1021/jm030265z
44337326 22284 0 None -1000 3 Mouse 6.0 pKi = 6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 600 7 0 5 6.4 COc1ccc(S(=O)(=O)c2ccc(CC3CCN(C4CCN(C(=O)c5ccc(F)c6ccccc56)CC4)CC3)cc2)cc1 10.1021/jm0200815
CHEMBL109051 22284 0 None -1000 3 Mouse 6.0 pKi = 6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 600 7 0 5 6.4 COc1ccc(S(=O)(=O)c2ccc(CC3CCN(C4CCN(C(=O)c5ccc(F)c6ccccc56)CC4)CC3)cc2)cc1 10.1021/jm0200815
463892 65504 0 None 18 2 Human 8.0 pKi = 8.0 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 533 5 0 6 4.9 COc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1016/s0960-894x(02)00918-6
CHEMBL140706 65504 0 None 18 2 Human 8.0 pKi = 8.0 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 533 5 0 6 4.9 COc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1016/s0960-894x(02)00918-6
463209 239743 0 None 6 2 Human 8.0 pKi = 8.0 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 519 5 0 6 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(OC(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL357557 239743 0 None 6 2 Human 8.0 pKi = 8.0 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 519 5 0 6 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(OC(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
463210 329830 0 None 15 2 Human 8.0 pKi = 8.0 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 561 4 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL422326 329830 0 None 15 2 Human 8.0 pKi = 8.0 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 561 4 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
457874 23951 0 None 3 2 Human 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
5479845 23951 0 None 3 2 Human 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL112760 23951 0 None 3 2 Human 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL2111747 23951 0 None 3 2 Human 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
5479846 213015 0 None None None Mouse 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL324671 213015 0 None None None Mouse 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
463892 65504 0 None 18 2 Human 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 533 5 0 6 4.9 COc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1021/jm030265z
CHEMBL140706 65504 0 None 18 2 Human 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 533 5 0 6 4.9 COc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1021/jm030265z
5495587 238130 0 None None None Human 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 567 7 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC3CC3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL344435 238130 0 None None None Human 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 567 7 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC3CC3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
5495587 238130 0 None None None Human 8.0 pKi = 8.0 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 567 7 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC3CC3)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL344435 238130 0 None None None Human 8.0 pKi = 8.0 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 567 7 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC3CC3)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
511295 23563 0 None 1 2 Human 7.0 pKi = 7.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 418 4 0 2 5.6 Cc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
CHEMBL110786 23563 0 None 1 2 Human 7.0 pKi = 7.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 418 4 0 2 5.6 Cc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
511295 23563 0 None -1 2 Mouse 7.0 pKi = 7.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 418 4 0 2 5.6 Cc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
CHEMBL110786 23563 0 None -1 2 Mouse 7.0 pKi = 7.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 418 4 0 2 5.6 Cc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
463319 238154 0 None 102 2 Human 7.9 pKi = 7.9 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 579 5 0 5 6.5 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL344607 238154 0 None 102 2 Human 7.9 pKi = 7.9 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 579 5 0 5 6.5 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
462409 220212 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 561 4 1 4 5.1 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL326020 220212 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 561 4 1 4 5.1 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
44337251 19772 0 None None None Mouse 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 569 8 0 5 5.8 COCCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL107363 19772 0 None None None Mouse 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 569 8 0 5 5.8 COCCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
456323 24007 0 None None None Human 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 580 4 1 4 5.3 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm030265z
CHEMBL113154 24007 0 None None None Human 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 580 4 1 4 5.3 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm030265z
463319 238154 0 None 102 2 Human 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 579 5 0 5 6.5 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL344607 238154 0 None 102 2 Human 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 579 5 0 5 6.5 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
483746 64949 0 None None None Human 5.9 pKi = 5.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 661 4 0 3 5.4 C[C@H]1CN(C2CCN(C(=O)c3c(F)cccc3I)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm030265z
CHEMBL140183 64949 0 None None None Human 5.9 pKi = 5.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 661 4 0 3 5.4 C[C@H]1CN(C2CCN(C(=O)c3c(F)cccc3I)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm030265z
5495585 66133 0 None None None Human 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 595 6 0 6 5.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(F)(F)F)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL141201 66133 0 None None None Human 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 595 6 0 6 5.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(F)(F)F)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
5495585 66133 0 None None None Human 7.9 pKi = 7.9 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 595 6 0 6 5.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(F)(F)F)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL141201 66133 0 None None None Human 7.9 pKi = 7.9 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 595 6 0 6 5.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(F)(F)F)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
456339 23851 0 None None None Human 7.8 pKi = 7.8 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 513 5 1 6 3.9 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL112299 23851 0 None None None Human 7.8 pKi = 7.8 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 513 5 1 6 3.9 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
456339 23851 0 None None None Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 513 5 1 6 3.9 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL112299 23851 0 None None None Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 513 5 1 6 3.9 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
90666578 218971 0 None None None Rhesus macaque 7.8 pKi = 7.8 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 528 8 2 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(N)cc1 10.1039/c3md00080j
CHEMBL3219780 218971 0 None None None Rhesus macaque 7.8 pKi = 7.8 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 528 8 2 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(N)cc1 10.1039/c3md00080j
112500049 260353 0 None None None Human 7.8 pKi = 7.8 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 642 11 2 7 6.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COC(C)(C)C)cc1 nan
CHEMBL3697626 260353 0 None None None Human 7.8 pKi = 7.8 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 642 11 2 7 6.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COC(C)(C)C)cc1 nan
71718930 178691 0 None -75 2 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 601 5 1 7 4.4 CO[C@@H]1COCC[C@@H]1NC1CCN(C(=O)c2nc(C(F)(F)F)nc(N3CCc4cc(C(F)(F)F)ccc4C3)c2C)CC1 10.1021/ml400055e
CHEMBL2338390 178691 0 None -75 2 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 601 5 1 7 4.4 CO[C@@H]1COCC[C@@H]1NC1CCN(C(=O)c2nc(C(F)(F)F)nc(N3CCc4cc(C(F)(F)F)ccc4C3)c2C)CC1 10.1021/ml400055e
90666577 218970 0 None None None Rhesus macaque 6.8 pKi = 6.8 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
CHEMBL3219779 218970 0 None None None Rhesus macaque 6.8 pKi = 6.8 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
101577042 365815 0 None None None Rhesus macaque 6.8 pKi = 6.8 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4795179 365815 0 None None None Rhesus macaque 6.8 pKi = 6.8 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
112500047 252493 0 None None None Human 6.8 pKi = 6.8 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 643 13 3 8 4.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(N)=O)cc1 nan
CHEMBL3639964 252493 0 None None None Human 6.8 pKi = 6.8 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 643 13 3 8 4.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(N)=O)cc1 nan
511306 19593 0 None -1 2 Mouse 6.8 pKi = 6.8 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 434 5 0 3 5.3 COc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
CHEMBL106369 19593 0 None -1 2 Mouse 6.8 pKi = 6.8 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 434 5 0 3 5.3 COc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
511306 19593 0 None 1 2 Human 6.8 pKi = 6.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 434 5 0 3 5.3 COc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
CHEMBL106369 19593 0 None 1 2 Human 6.8 pKi = 6.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 434 5 0 3 5.3 COc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
9579325 212925 0 None None None Mouse 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 6 0 5 4.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccc[n+]3[O-])CC2)CC1 10.1021/jm0200815
CHEMBL317644 212925 0 None None None Mouse 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 6 0 5 4.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccc[n+]3[O-])CC2)CC1 10.1021/jm0200815
5496112 64421 0 None None None Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 6 0 5 4.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccc[n+]3[O-])CC2)CC1 10.1021/jm030265z
CHEMBL139607 64421 0 None None None Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 6 0 5 4.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccc[n+]3[O-])CC2)CC1 10.1021/jm030265z
462989 66723 0 None 14 2 Human 7.8 pKi = 7.8 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 0 4 4.7 Cc1c[n+]([O-])cc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL141699 66723 0 None 14 2 Human 7.8 pKi = 7.8 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 0 4 4.7 Cc1c[n+]([O-])cc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
9574356 19539 0 None 1 2 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 542 5 0 5 4.5 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm015526o
CHEMBL106098 19539 0 None 1 2 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 542 5 0 5 4.5 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm015526o
9574359 19658 0 None 1 2 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 527 5 1 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm015526o
CHEMBL106767 19658 0 None 1 2 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 527 5 1 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm015526o
9574359 19658 0 None -1 2 Mouse 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 527 5 1 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm0200815
CHEMBL106767 19658 0 None -1 2 Mouse 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 527 5 1 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm0200815
5479851 57643 0 None None None Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 527 5 1 5 5.2 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm030265z
CHEMBL139459 57643 0 None None None Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 527 5 1 5 5.2 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm030265z
462989 66723 0 None 14 2 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 0 4 4.7 Cc1c[n+]([O-])cc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL141699 66723 0 None 14 2 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 0 4 4.7 Cc1c[n+]([O-])cc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
456292 197076 0 None 42 2 Human 7.8 pKi = 7.8 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 553 6 0 5 6.0 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL264442 197076 0 None 42 2 Human 7.8 pKi = 7.8 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 553 6 0 5 6.0 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
3117 474710 66 None -8 16 Human 4.7 pKi = 4.7 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
928 474710 66 None -8 16 Human 4.7 pKi = 4.7 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
CHEMBL964 474710 66 None -8 16 Human 4.7 pKi = 4.7 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
DB00822 474710 66 None -8 16 Human 4.7 pKi = 4.7 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
9574356 19539 0 None -1 2 Mouse 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 5 0 5 4.5 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106098 19539 0 None -1 2 Mouse 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 5 0 5 4.5 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5479840 57631 0 None None None Human 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 5 0 5 4.5 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138198 57631 0 None None None Human 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 5 0 5 4.5 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
511298 219479 0 None -1 2 Mouse 6.7 pKi = 6.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 498 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL323454 219479 0 None -1 2 Mouse 6.7 pKi = 6.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 498 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
511298 219479 0 None 1 2 Human 6.7 pKi = 6.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 498 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL323454 219479 0 None 1 2 Human 6.7 pKi = 6.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 498 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
464036 24050 3 None 1174 2 Human 8.7 pKi = 8.7 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL113436 24050 3 None 1174 2 Human 8.7 pKi = 8.7 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
802 7877 17 None 1 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm300682j
9574343 7877 17 None 1 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm300682j
CHEMBL78535 7877 17 None 1 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm300682j
44341106 23937 0 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 511 5 0 4 5.4 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL112686 23937 0 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 511 5 0 4 5.4 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
5479846 213015 0 None None None Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL324671 213015 0 None None None Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
5479844 219984 0 None -1 2 Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL324643 219984 0 None -1 2 Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
457874 23951 0 None 3 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
5479845 23951 0 None 3 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL112760 23951 0 None 3 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL2111747 23951 0 None 3 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
5495584 65175 0 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 7 0 6 5.4 CCCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140390 65175 0 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 7 0 6 5.4 CCCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
5479843 222514 0 None 4 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL331140 222514 0 None 4 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
5495584 65175 0 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 7 0 6 5.4 CCCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140390 65175 0 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 7 0 6 5.4 CCCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
802 7877 17 None 1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm015526o
9574343 7877 17 None 1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm015526o
CHEMBL78535 7877 17 None 1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm015526o
802 7877 17 None -1 2 Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm0200815
9574343 7877 17 None -1 2 Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm0200815
CHEMBL78535 7877 17 None -1 2 Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm0200815
802 7877 17 None 1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm030265z
9574343 7877 17 None 1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm030265z
CHEMBL78535 7877 17 None 1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm030265z
5495589 234431 0 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 6 0 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL335120 234431 0 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 6 0 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C)nc3C)CC2)CC1 10.1021/jm030265z
3009355 8651 20 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/s0960-894x(02)01063-6
807 8651 20 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/s0960-894x(02)01063-6
CHEMBL82301 8651 20 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/s0960-894x(02)01063-6
DB06652 8651 20 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/s0960-894x(02)01063-6
5495589 234431 0 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 6 0 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL335120 234431 0 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 6 0 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
6532433 67107 0 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 541 6 0 6 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL142021 67107 0 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 541 6 0 6 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
5482299 232216 0 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 541 6 0 6 5.0 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL351625 232216 0 None None None Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 541 6 0 6 5.0 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
464036 24050 3 None 1174 2 Human 8.6 pKi = 8.6 Binding
Binding affinity at C-C chemokine receptor type 5Binding affinity at C-C chemokine receptor type 5
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL113436 24050 3 None 1174 2 Human 8.6 pKi = 8.6 Binding
Binding affinity at C-C chemokine receptor type 5Binding affinity at C-C chemokine receptor type 5
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
464036 24050 3 None 1174 2 Human 8.6 pKi = 8.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL113436 24050 3 None 1174 2 Human 8.6 pKi = 8.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
6533779 62530 0 None None None Human 8.6 pKi = 8.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 540 6 0 5 5.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cncc3C)CC2)CC1 10.1021/jm030265z
CHEMBL137934 62530 0 None None None Human 8.6 pKi = 8.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 540 6 0 5 5.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cncc3C)CC2)CC1 10.1021/jm030265z
CHEMBL5071060 477459 0 None 21 2 Rhesus macaque 8.6 pKi = 8.6 Binding
Displacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assayDisplacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assay
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1021/acs.jmedchem.1c00408
462395 234187 0 None 128 2 Human 8.6 pKi = 8.6 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 558 4 0 4 5.4 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00918-6
CHEMBL334470 234187 0 None 128 2 Human 8.6 pKi = 8.6 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 558 4 0 4 5.4 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00918-6
462395 234187 0 None 128 2 Human 8.6 pKi = 8.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 558 4 0 4 5.4 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
CHEMBL334470 234187 0 None 128 2 Human 8.6 pKi = 8.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 558 4 0 4 5.4 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
462902 238564 0 None 8 2 Human 7.7 pKi = 7.7 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 460 4 0 6 3.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C#N)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL348667 238564 0 None 8 2 Human 7.7 pKi = 7.7 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 460 4 0 6 3.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C#N)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
483744 23932 0 None None None Human 7.7 pKi = 7.7 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 545 4 0 3 5.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL112659 23932 0 None None None Human 7.7 pKi = 7.7 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 545 4 0 3 5.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
9579332 19623 0 None None None Mouse 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 7 0 7 3.5 CCO/N=C(\c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106558 19623 0 None None None Mouse 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 7 0 7 3.5 CCO/N=C(\c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
483744 23932 0 None None None Human 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 545 4 0 3 5.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL112659 23932 0 None None None Human 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 545 4 0 3 5.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5496119 57632 0 None None None Human 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 7 0 7 3.5 CCO/N=C(/c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138263 57632 0 None None None Human 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 7 0 7 3.5 CCO/N=C(/c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
71718331 178692 0 None -208 2 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 663 8 2 8 5.7 Cc1c(NC[C@H]2CCC[C@@H](c3ccc(C(F)(F)F)cc3)O2)nc(C2CCOCC2)nc1C(=O)N1CCC(N[C@H]2CCOC[C@H]2F)CC1 10.1021/ml400055e
CHEMBL2338391 178692 0 None -208 2 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 663 8 2 8 5.7 Cc1c(NC[C@H]2CCC[C@@H](c3ccc(C(F)(F)F)cc3)O2)nc(C2CCOCC2)nc1C(=O)N1CCC(N[C@H]2CCOC[C@H]2F)CC1 10.1021/ml400055e
9827221 219263 0 None None None Human 7.6 pKi = 7.6 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 497 4 0 3 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Br)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL322817 219263 0 None None None Human 7.6 pKi = 7.6 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 497 4 0 3 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Br)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
5495579 116509 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cncc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL162946 116509 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cncc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
461838 468644 0 None 1 2 Human 6.6 pKi = 6.6 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 611 6 0 7 4.9 C[C@H]1CN(C2CCN(C(=O)c3c(F)cccc3F)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
CHEMBL67281 468644 0 None 1 2 Human 6.6 pKi = 6.6 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 611 6 0 7 4.9 C[C@H]1CN(C2CCN(C(=O)c3c(F)cccc3F)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
89702731 218968 0 None -4 3 Rhesus macaque 6.6 pKi = 6.6 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1039/c3md00080j
CHEMBL3219777 218968 0 None -4 3 Rhesus macaque 6.6 pKi = 6.6 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1039/c3md00080j
162650661 346788 0 None -74 2 Rhesus macaque 6.6 pKi = 6.6 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4748891 346788 0 None -74 2 Rhesus macaque 6.6 pKi = 6.6 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
89702731 218968 0 None -4 3 Human 6.6 pKi = 6.6 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 nan
CHEMBL3219777 218968 0 None -4 3 Human 6.6 pKi = 6.6 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 nan
9579329 19540 0 None None None Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 498 5 0 5 4.3 CO/N=C(\c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106099 19540 0 None None None Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 498 5 0 5 4.3 CO/N=C(\c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496116 57630 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 498 5 0 5 4.3 CO/N=C(/c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138143 57630 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 498 5 0 5 4.3 CO/N=C(/c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
457874 23951 0 None 3 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
5479845 23951 0 None 3 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL112760 23951 0 None 3 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL2111747 23951 0 None 3 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
511304 19726 0 None -1 2 Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 472 4 0 2 6.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL107092 19726 0 None -1 2 Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 472 4 0 2 6.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm0200815
457874 23951 0 None -3 2 Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
5479845 23951 0 None -3 2 Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL112760 23951 0 None -3 2 Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL2111747 23951 0 None -3 2 Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
511304 19726 0 None 1 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 472 4 0 2 6.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL107092 19726 0 None 1 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 472 4 0 2 6.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm030265z
457874 23951 0 None 3 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
5479845 23951 0 None 3 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL112760 23951 0 None 3 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL2111747 23951 0 None 3 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
5495595 64078 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 581 7 0 6 5.9 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C4CC4)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL139246 64078 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 581 7 0 6 5.9 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C4CC4)nc3C)CC2)CC1 10.1021/jm030265z
5495595 64078 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 581 7 0 6 5.9 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C4CC4)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL139246 64078 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 581 7 0 6 5.9 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C4CC4)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
9579318 327815 0 None None None Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 6 0 5 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3cccnc3C)CC2)CC1 10.1021/jm0200815
CHEMBL443999 327815 0 None None None Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 6 0 5 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3cccnc3C)CC2)CC1 10.1021/jm0200815
5496105 62630 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 6 0 5 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3cccnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL138028 62630 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 6 0 5 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3cccnc3C)CC2)CC1 10.1021/jm030265z
11069824 220195 0 None None None Human 6.6 pKi = 6.6 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 419 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccccc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL325957 220195 0 None None None Human 6.6 pKi = 6.6 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 419 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccccc3)[C@@H](C)C2)CC1 10.1021/jm0155401
456293 461773 0 None 17 2 Human 7.6 pKi = 7.6 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 603 6 0 7 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL70010 461773 0 None 17 2 Human 7.6 pKi = 7.6 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 603 6 0 7 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
11079978 23486 0 None None None Mouse 6.6 pKi = 6.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 404 4 0 2 5.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccccc3)CC2)CC1 10.1021/jm0200815
CHEMBL110270 23486 0 None None None Mouse 6.6 pKi = 6.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 404 4 0 2 5.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccccc3)CC2)CC1 10.1021/jm0200815
457672 21543 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
CHEMBL108569 21543 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
457672 21543 0 None -1 2 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL108569 21543 0 None -1 2 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
457672 21543 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL108569 21543 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
483747 215103 1 None 177 4 Human 8.5 pKi = 8.5 Binding
Ability of compound to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility of compound to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL311795 215103 1 None 177 4 Human 8.5 pKi = 8.5 Binding
Ability of compound to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility of compound to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
484578 23996 0 None None None Human 8.5 pKi = 8.5 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 511 5 0 5 4.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL113072 23996 0 None None None Human 8.5 pKi = 8.5 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 511 5 0 5 4.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
9579312 218726 0 None None None Mouse 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 597 6 0 4 6.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(F)cccc3C(F)(F)F)CC2)CC1 10.1021/jm0200815
CHEMBL321413 218726 0 None None None Mouse 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 597 6 0 4 6.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(F)cccc3C(F)(F)F)CC2)CC1 10.1021/jm0200815
484578 23996 0 None None None Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 511 5 0 5 4.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL113072 23996 0 None None None Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 511 5 0 5 4.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
483747 215103 1 None 177 4 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL311795 215103 1 None 177 4 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5496099 327578 0 None None None Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 597 6 0 4 6.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(F)cccc3C(F)(F)F)CC2)CC1 10.1021/jm030265z
CHEMBL423000 327578 0 None None None Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 597 6 0 4 6.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(F)cccc3C(F)(F)F)CC2)CC1 10.1021/jm030265z
5495590 65337 0 None None None Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 609 6 0 6 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140552 65337 0 None None None Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 609 6 0 6 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC2)CC1 10.1021/jm030265z
5495590 65337 0 None None None Human 8.5 pKi = 8.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 609 6 0 6 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140552 65337 0 None None None Human 8.5 pKi = 8.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 609 6 0 6 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL5074744 478529 0 None 1 2 Rhesus macaque 8.5 pKi = 8.5 Binding
Displacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assayDisplacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assay
ChEMBL 1211 30 7 15 6.0 CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
5495588 65785 0 None None None Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 6 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL140912 65785 0 None None None Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 6 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
5495588 65785 0 None None None Human 8.5 pKi = 8.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 6 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140912 65785 0 None None None Human 8.5 pKi = 8.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 6 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
9574358 19486 0 None 1 2 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 546 5 1 5 5.4 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm015526o
CHEMBL105784 19486 0 None 1 2 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 546 5 1 5 5.4 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm015526o
9574358 19486 0 None -1 2 Mouse 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 546 5 1 5 5.4 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm0200815
CHEMBL105784 19486 0 None -1 2 Mouse 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 546 5 1 5 5.4 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm0200815
5479842 232059 0 None None None Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 546 5 1 5 5.4 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm030265z
CHEMBL337340 232059 0 None None None Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 546 5 1 5 5.4 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm030265z
9579330 19619 0 None None None Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 546 6 0 5 5.1 CCO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106533 19619 0 None None None Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 546 6 0 5 5.1 CCO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496117 193615 0 None None None Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 546 6 0 5 5.1 CCO/N=C(/c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL261950 193615 0 None None None Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 546 6 0 5 5.1 CCO/N=C(/c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
456647 24513 1 None None None Human 7.5 pKi = 7.5 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL116008 24513 1 None None None Human 7.5 pKi = 7.5 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
9579334 20307 0 None None None Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 6 0 5 4.2 CCO/N=C(\c1ccc(F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL107999 20307 0 None None None Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 6 0 5 4.2 CCO/N=C(\c1ccc(F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
9579328 327706 0 None None None Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 6 0 7 3.1 CO/N=C(\c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL432636 327706 0 None None None Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 6 0 7 3.1 CO/N=C(\c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
456647 24513 1 None None None Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL116008 24513 1 None None None Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5496121 57659 0 None None None Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 6 0 5 4.2 CCO/N=C(/c1ccc(F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL141345 57659 0 None None None Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 6 0 5 4.2 CCO/N=C(/c1ccc(F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
5496115 63366 0 None None None Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 6 0 7 3.1 CO/N=C(/c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138655 63366 0 None None None Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 6 0 7 3.1 CO/N=C(/c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
73345281 180097 0 None None None Human 4.5 pKi = 4.5 Binding
Inhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cellsInhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cells
ChEMBL 942 8 10 19 -0.6 C[C@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@]4(C)C5=C[C@H](O)C67C(=O)O[C@@](C)(C8CCC(C)(C)O8)[C@@]6(O)CC[C@@]7(C)C5CCC4C3(C)C)OC[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O 10.1016/s0960-894x(02)00599-1
CHEMBL2367888 180097 0 None None None Human 4.5 pKi = 4.5 Binding
Inhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cellsInhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cells
ChEMBL 942 8 10 19 -0.6 C[C@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@]4(C)C5=C[C@H](O)C67C(=O)O[C@@](C)(C8CCC(C)(C)O8)[C@@]6(O)CC[C@@]7(C)C5CCC4C3(C)C)OC[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O 10.1016/s0960-894x(02)00599-1
455656 468966 0 None 3 2 Human 7.5 pKi = 7.5 Binding
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5 expressed in membrane preparation of CHO cellsAbility to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5 expressed in membrane preparation of CHO cells
ChEMBL 604 6 1 8 4.5 Cc1cccc(N)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL69670 468966 0 None 3 2 Human 7.5 pKi = 7.5 Binding
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5 expressed in membrane preparation of CHO cellsAbility to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5 expressed in membrane preparation of CHO cells
ChEMBL 604 6 1 8 4.5 Cc1cccc(N)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
71717723 178693 0 None -51 2 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 525 7 2 7 4.3 CO[C@@H]1COCC[C@@H]1NC1CCN(C(=O)c2nc(CF)nc(Nc3ccc(Cl)c(Cl)c3)c2C)CC1 10.1021/ml400055e
CHEMBL2338392 178693 0 None -51 2 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 525 7 2 7 4.3 CO[C@@H]1COCC[C@@H]1NC1CCN(C(=O)c2nc(CF)nc(Nc3ccc(Cl)c(Cl)c3)c2C)CC1 10.1021/ml400055e
5495593 237871 0 None None None Human 6.5 pKi = 6.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 634 8 1 8 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NS(C)(=O)=O)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL342706 237871 0 None None None Human 6.5 pKi = 6.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 634 8 1 8 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NS(C)(=O)=O)nc3C)CC2)CC1 10.1021/jm030265z
5495593 237871 0 None None None Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 634 8 1 8 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NS(C)(=O)=O)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL342706 237871 0 None None None Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 634 8 1 8 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NS(C)(=O)=O)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
455657 468962 0 None 3 2 Human 7.5 pKi = 7.5 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 624 6 1 8 4.9 C[C@H]1CN(C2CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
CHEMBL69642 468962 0 None 3 2 Human 7.5 pKi = 7.5 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 624 6 1 8 4.9 C[C@H]1CN(C2CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
9579315 19484 0 None None None Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 597 8 0 6 5.8 CCOC(=O)CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL105779 19484 0 None None None Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 597 8 0 6 5.8 CCOC(=O)CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
511303 19598 0 None -1 2 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 530 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106406 19598 0 None -1 2 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 530 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0200815
9579316 19662 0 None None None Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 582 7 1 5 4.9 CNC(=O)CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL106790 19662 0 None None None Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 582 7 1 5 4.9 CNC(=O)CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
511307 19709 0 None -1 2 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 5 0 4 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106982 19709 0 None -1 2 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 5 0 4 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1021/jm0200815
511303 19598 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 530 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106406 19598 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 530 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
511307 19709 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 482 5 0 4 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106982 19709 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 482 5 0 4 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1021/jm030265z
5496102 57665 0 None None None Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 597 8 0 6 5.8 CCOC(=O)CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL141802 57665 0 None None None Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 597 8 0 6 5.8 CCOC(=O)CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
5496103 232124 0 None None None Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 582 7 1 5 4.9 CNC(=O)CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL341928 232124 0 None None None Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 582 7 1 5 4.9 CNC(=O)CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
474465 468118 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 6 0 5 5.0 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(Cc4ccc5c(c4)OCO5)cc3)CC2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL63757 468118 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 6 0 5 5.0 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(Cc4ccc5c(c4)OCO5)cc3)CC2)CC1 10.1016/s0960-894x(01)00381-x
511297 19570 0 None 1 2 Human 6.4 pKi = 6.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 480 5 0 2 6.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106264 19570 0 None 1 2 Human 6.4 pKi = 6.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 480 5 0 2 6.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm030265z
511297 19570 0 None -1 2 Mouse 6.4 pKi = 6.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 480 5 0 2 6.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106264 19570 0 None -1 2 Mouse 6.4 pKi = 6.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 480 5 0 2 6.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm0200815
474188 65276 0 None 28 2 Human 7.4 pKi = 7.4 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 1 6 4.5 Cc1nc(N)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL140490 65276 0 None 28 2 Human 7.4 pKi = 7.4 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 1 6 4.5 Cc1nc(N)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
474188 65276 0 None 28 2 Human 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 1 6 4.5 Cc1nc(N)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL140490 65276 0 None 28 2 Human 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 1 6 4.5 Cc1nc(N)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
9579314 22206 0 None None None Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 553 6 0 4 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL109008 22206 0 None None None Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 553 6 0 4 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
5496101 57637 0 None None None Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 553 6 0 4 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL138975 57637 0 None None None Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 553 6 0 4 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
9579331 212931 0 None None None Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 562 7 0 6 5.0 CCO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL318311 212931 0 None None None Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 562 7 0 6 5.0 CCO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496118 62927 0 None None None Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 562 7 0 6 5.0 CCO/N=C(/c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138274 62927 0 None None None Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 562 7 0 6 5.0 CCO/N=C(/c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
9574360 22424 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 526 5 1 5 5.1 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm015526o
CHEMBL109158 22424 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 526 5 1 5 5.1 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm015526o
9574360 22424 0 None -1 2 Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 5 1 5 5.1 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm0200815
CHEMBL109158 22424 0 None -1 2 Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 5 1 5 5.1 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm0200815
5479852 57638 0 None None None Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 5 1 5 5.1 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm030265z
CHEMBL139029 57638 0 None None None Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 5 1 5 5.1 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm030265z
5495583 66136 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 527 5 0 6 4.6 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL141202 66136 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 527 5 0 6 4.6 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
9579117 116472 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 527 5 0 6 4.6 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL161587 116472 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 527 5 0 6 4.6 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL5094690 479667 0 None None None Rhesus macaque 7.4 pKi = 7.4 Binding
Displacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells by competitive radioligand binding assayDisplacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells by competitive radioligand binding assay
ChEMBL 900 27 5 11 4.3 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)NCCc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
9579321 23551 0 None None None Mouse 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 1 6 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C)nc3O)CC2)CC1 10.1021/jm0200815
CHEMBL110730 23551 0 None None None Mouse 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 1 6 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C)nc3O)CC2)CC1 10.1021/jm0200815
5496108 57636 0 None None None Human 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C)nc3O)CC2)CC1 10.1021/jm030265z
CHEMBL138879 57636 0 None None None Human 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C)nc3O)CC2)CC1 10.1021/jm030265z
5495594 64484 0 None None None Human 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 583 7 0 6 6.1 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(C)C)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL139701 64484 0 None None None Human 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 583 7 0 6 6.1 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(C)C)nc3C)CC2)CC1 10.1021/jm030265z
5495594 64484 0 None None None Human 7.4 pKi = 7.4 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 583 7 0 6 6.1 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(C)C)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL139701 64484 0 None None None Human 7.4 pKi = 7.4 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 583 7 0 6 6.1 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(C)C)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
456611 468561 0 None None None Human 7.4 pKi = 7.4 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 5 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL66623 468561 0 None None None Human 7.4 pKi = 7.4 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 5 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
461546 23785 0 None None None Human 6.4 pKi = 6.4 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 517 4 0 3 4.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0155401
CHEMBL111982 23785 0 None None None Human 6.4 pKi = 6.4 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 517 4 0 3 4.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0155401
461546 23785 0 None None None Human 6.4 pKi = 6.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 517 4 0 3 4.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL111982 23785 0 None None None Human 6.4 pKi = 6.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 517 4 0 3 4.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
463517 468694 0 None -436 2 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 589 6 0 7 4.8 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)CC2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL67563 468694 0 None -436 2 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 589 6 0 7 4.8 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)CC2)CC1 10.1016/s0960-894x(01)00381-x
461871 317295 0 None None None Human 7.4 pKi = 7.4 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 543 6 0 3 6.9 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4cccc(Cl)c4)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL413972 317295 0 None None None Human 7.4 pKi = 7.4 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 543 6 0 3 6.9 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4cccc(Cl)c4)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
503637 119147 0 None None None Human 7.3 pKi = 7.3 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
CHEMBL163078 119147 0 None None None Human 7.3 pKi = 7.3 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
5479843 222514 0 None 4 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL331140 222514 0 None 4 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
5479843 222514 0 None -4 2 Mouse 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL331140 222514 0 None -4 2 Mouse 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
5479843 222514 0 None 4 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL331140 222514 0 None 4 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
462772 202396 0 None 5 2 Human 7.3 pKi = 7.3 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 643 6 0 7 5.9 C[C@H]1CN(C2CCN(C(=O)c3c(Cl)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
CHEMBL303503 202396 0 None 5 2 Human 7.3 pKi = 7.3 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 643 6 0 7 5.9 C[C@H]1CN(C2CCN(C(=O)c3c(Cl)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
484577 23787 0 None None None Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 503 4 1 4 5.5 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL111998 23787 0 None None None Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 503 4 1 4 5.5 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
484579 23991 0 None None None Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 532 5 1 6 4.1 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm0155401
CHEMBL113042 23991 0 None None None Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 532 5 1 6 4.1 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm0155401
456323 24007 0 None None None Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 580 4 1 4 5.3 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm0155401
CHEMBL113154 24007 0 None None None Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 580 4 1 4 5.3 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm0155401
456372 24437 0 None None None Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 559 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL115716 24437 0 None None None Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 559 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
461327 220088 0 None None None Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 522 4 1 4 5.7 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm0155401
CHEMBL325276 220088 0 None None None Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 522 4 1 4 5.7 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm0155401
484577 23787 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 503 4 1 4 5.5 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL111998 23787 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 503 4 1 4 5.5 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
484579 23991 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 532 5 1 6 4.1 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm030265z
CHEMBL113042 23991 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 532 5 1 6 4.1 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm030265z
456372 24437 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 559 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL115716 24437 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 559 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
461327 220088 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 522 4 1 4 5.7 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
CHEMBL325276 220088 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 522 4 1 4 5.7 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
503637 119147 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
CHEMBL163078 119147 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
462573 63183 0 None 316 2 Human 8.3 pKi = 8.3 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 502 4 0 4 5.5 Cc1cncc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL138502 63183 0 None 316 2 Human 8.3 pKi = 8.3 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 502 4 0 4 5.5 Cc1cncc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
462573 63183 0 None 316 2 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 502 4 0 4 5.5 Cc1cncc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL138502 63183 0 None 316 2 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 502 4 0 4 5.5 Cc1cncc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
9579326 212962 0 None None None Mouse 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 532 5 0 5 4.7 CO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL320502 212962 0 None None None Mouse 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 532 5 0 5 4.7 CO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496113 66274 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 532 5 0 5 4.7 CO/N=C(/c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL141301 66274 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 532 5 0 5 4.7 CO/N=C(/c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
5495596 238017 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 571 7 0 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(OC)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL343520 238017 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 571 7 0 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(OC)nc3C)CC2)CC1 10.1021/jm030265z
5495596 238017 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 571 7 0 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(OC)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL343520 238017 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 571 7 0 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(OC)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
9579333 327523 0 None None None Mouse 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 512 6 0 5 4.7 CCO/N=C(\c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL419735 327523 0 None None None Mouse 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 512 6 0 5 4.7 CCO/N=C(\c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496120 238052 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 512 6 0 5 4.7 CCO/N=C(/c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL343826 238052 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 512 6 0 5 4.7 CCO/N=C(/c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL5089300 479370 0 None 1 2 Rhesus macaque 8.2 pKi = 8.2 Binding
Displacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assayDisplacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assay
ChEMBL 1239 32 7 15 6.8 CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
5495591 66704 0 None None None Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 7 4.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(N)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL141683 66704 0 None None None Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 7 4.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(N)nc3C)CC2)CC1 10.1021/jm030265z
5495591 66704 0 None None None Human 8.2 pKi = 8.2 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 556 6 1 7 4.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(N)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL141683 66704 0 None None None Human 8.2 pKi = 8.2 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 556 6 1 7 4.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(N)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
71719547 178694 0 None -50 2 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 660 8 2 9 5.8 Cc1cc(-c2nc(NC[C@H]3CCC[C@@H](c4ccc(C(F)(F)F)cc4)O3)c(C)c(C(=O)N3CCC(N[C@@H]4CCOC[C@@H]4F)CC3)n2)no1 10.1021/ml400055e
CHEMBL2338393 178694 0 None -50 2 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 660 8 2 9 5.8 Cc1cc(-c2nc(NC[C@H]3CCC[C@@H](c4ccc(C(F)(F)F)cc4)O3)c(C)c(C(=O)N3CCC(N[C@@H]4CCOC[C@@H]4F)CC3)n2)no1 10.1021/ml400055e
CHEMBL2367887 477575 0 None None None Human 5.3 pKi = 5.3 Binding
Inhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cellsInhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cells
ChEMBL 1427 22 16 32 -4.0 COC1[C@@H](O)C(OC2[C@@H](O)[C@H](O[C@@H]3[C@@H](C)O[C@@H](O[C@H]4[C@H](O[C@H]5CC[C@]6(C)C7=C[C@H](O)C89C(=O)O[C@@](C)(CCCC(C)C)C8CC[C@@]9(C)C7CCC6C5(C)C)OC[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](OC6O[C@H](CO)[C@@H](O)[C@H](OC)[C@H]6O)[C@H]5O)[C@@H]4O)[C@H](O)[C@H]3O)O[C@H](CO)[C@H]2O)O[C@H](CO)[C@H]1O 10.1016/s0960-894x(02)00599-1
457671 19556 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
CHEMBL106209 19556 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
457671 19556 0 None -1 2 Mouse 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106209 19556 0 None -1 2 Mouse 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
457671 19556 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106209 19556 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
511305 216957 0 None -1 2 Mouse 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 488 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL317476 216957 0 None -1 2 Mouse 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 488 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1021/jm0200815
511305 216957 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 488 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL317476 216957 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 488 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1021/jm030265z
457875 19567 0 None 1 3 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106247 19567 0 None 1 3 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
457875 19567 0 None -1 3 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106247 19567 0 None -1 3 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
483741 67108 0 None None None Human 6.2 pKi = 6.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 504 4 0 2 6.6 CC1(N2CCC(Cc3ccc(Br)cc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm030265z
CHEMBL142022 67108 0 None None None Human 6.2 pKi = 6.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 504 4 0 2 6.6 CC1(N2CCC(Cc3ccc(Br)cc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm030265z
511308 21981 0 None -1 2 Mouse 6.2 pKi = 6.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 446 5 0 3 5.5 CC(=O)c1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
CHEMBL108845 21981 0 None -1 2 Mouse 6.2 pKi = 6.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 446 5 0 3 5.5 CC(=O)c1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
511308 21981 0 None 1 2 Human 6.2 pKi = 6.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 446 5 0 3 5.5 CC(=O)c1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
CHEMBL108845 21981 0 None 1 2 Human 6.2 pKi = 6.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 446 5 0 3 5.5 CC(=O)c1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
5495592 64974 0 None None None Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 598 7 1 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NC(C)=O)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140201 64974 0 None None None Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 598 7 1 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NC(C)=O)nc3C)CC2)CC1 10.1021/jm030265z
5495592 64974 0 None None None Human 7.2 pKi = 7.2 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 598 7 1 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NC(C)=O)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140201 64974 0 None None None Human 7.2 pKi = 7.2 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 598 7 1 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NC(C)=O)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
456298 24092 0 None None None Human 7.2 pKi = 7.2 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0155401
CHEMBL113648 24092 0 None None None Human 7.2 pKi = 7.2 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0155401
44337265 19612 0 None None None Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 555 7 1 5 5.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OCCO)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106507 19612 0 None None None Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 555 7 1 5 5.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OCCO)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
511299 23585 0 None -1 2 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 4 0 2 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL110871 23585 0 None -1 2 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 4 0 2 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
511299 23585 0 None 1 2 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 4 0 2 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL110871 23585 0 None 1 2 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 4 0 2 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
456298 24092 0 None None None Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL113648 24092 0 None None None Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
3497 2447 26 None 1 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 482 11 4 6 2.5 O[C@H]([C@@H](NC(=O)c1cnc2c(n1)cccc2)Cc1cccc(c1)F)C[C@H](C(=O)N)CCC(O)(C)C 10.1021/jm300682j
44309353 2447 26 None 1 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 482 11 4 6 2.5 O[C@H]([C@@H](NC(=O)c1cnc2c(n1)cccc2)Cc1cccc(c1)F)C[C@H](C(=O)N)CCC(O)(C)C 10.1021/jm300682j
5311123 2447 26 None 1 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 482 11 4 6 2.5 O[C@H]([C@@H](NC(=O)c1cnc2c(n1)cccc2)Cc1cccc(c1)F)C[C@H](C(=O)N)CCC(O)(C)C 10.1021/jm300682j
CHEMBL1628706 2447 26 None 1 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 482 11 4 6 2.5 O[C@H]([C@@H](NC(=O)c1cnc2c(n1)cccc2)Cc1cccc(c1)F)C[C@H](C(=O)N)CCC(O)(C)C 10.1021/jm300682j
CHEMBL308473 2447 26 None 1 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 482 11 4 6 2.5 O[C@H]([C@@H](NC(=O)c1cnc2c(n1)cccc2)Cc1cccc(c1)F)C[C@H](C(=O)N)CCC(O)(C)C 10.1021/jm300682j
457875 19567 0 None -1 3 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
CHEMBL106247 19567 0 None -1 3 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
10961907 23571 0 None None None Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3cccc(Br)c3)CC2)CC1 10.1021/jm0200815
CHEMBL110809 23571 0 None None None Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3cccc(Br)c3)CC2)CC1 10.1021/jm0200815
511294 19576 0 None -1 2 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 438 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106299 19576 0 None -1 2 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 438 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1021/jm0200815
511294 19576 0 None 1 2 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 438 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106299 19576 0 None 1 2 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 438 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1021/jm030265z
511332 219195 3 None 35 3 Human 8.2 pKi = 8.2 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL322251 219195 3 None 35 3 Human 8.2 pKi = 8.2 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
511332 219195 3 None 35 3 Human 8.2 pKi = 8.2 Binding
Binding affinity at C-C chemokine receptor type 5Binding affinity at C-C chemokine receptor type 5
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL322251 219195 3 None 35 3 Human 8.2 pKi = 8.2 Binding
Binding affinity at C-C chemokine receptor type 5Binding affinity at C-C chemokine receptor type 5
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
456375 24398 0 None None None Human 8.2 pKi = 8.2 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 501 4 0 3 6.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL115487 24398 0 None None None Human 8.2 pKi = 8.2 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 501 4 0 3 6.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
457871 200869 0 None None None Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
CHEMBL292625 200869 0 None None None Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
9579320 23557 0 None None None Mouse 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 1 6 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(O)nc3C)CC2)CC1 10.1021/jm0200815
CHEMBL110757 23557 0 None None None Mouse 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 1 6 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(O)nc3C)CC2)CC1 10.1021/jm0200815
457871 200869 0 None None None Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL292625 200869 0 None None None Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
511332 219195 3 None 35 3 Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL322251 219195 3 None 35 3 Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
462409 220212 0 None None None Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 561 4 1 4 5.1 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL326020 220212 0 None None None Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 561 4 1 4 5.1 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5496107 232049 0 None None None Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(O)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL336246 232049 0 None None None Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(O)nc3C)CC2)CC1 10.1021/jm030265z
9579327 19667 0 None None None Mouse 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 548 6 0 6 4.6 CO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106813 19667 0 None None None Mouse 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 548 6 0 6 4.6 CO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496114 232125 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 548 6 0 6 4.6 CO/N=C(/c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL341945 232125 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 548 6 0 6 4.6 CO/N=C(/c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
463502 468954 0 None None None Human 7.1 pKi = 7.1 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 589 6 0 7 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL69581 468954 0 None None None Human 7.1 pKi = 7.1 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 589 6 0 7 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
5496098 19604 0 None -1 2 Mouse 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
9579311 19604 0 None -1 2 Mouse 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106468 19604 0 None -1 2 Mouse 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL342452 19604 0 None -1 2 Mouse 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
5496098 19604 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
9579311 19604 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106468 19604 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL342452 19604 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
484581 220124 0 None None None Human 8.1 pKi = 8.1 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 545 4 0 3 5.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL325556 220124 0 None None None Human 8.1 pKi = 8.1 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 545 4 0 3 5.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
511309 19738 0 None -1 2 Mouse 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 494 4 0 2 6.5 C=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL107154 19738 0 None -1 2 Mouse 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 494 4 0 2 6.5 C=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
511309 19738 0 None 1 2 Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 494 4 0 2 6.5 C=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL107154 19738 0 None 1 2 Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 494 4 0 2 6.5 C=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
484581 220124 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 545 4 0 3 5.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL325556 220124 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 545 4 0 3 5.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5495586 237530 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 569 7 0 6 5.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL341758 237530 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 569 7 0 6 5.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
5495586 237530 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 569 7 0 6 5.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL341758 237530 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 569 7 0 6 5.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
6533780 62439 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)c[n+]([O-])cc3C)CC2)CC1 10.1021/jm030265z
CHEMBL137856 62439 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)c[n+]([O-])cc3C)CC2)CC1 10.1021/jm030265z
5495580 116473 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)c[n+]([O-])cc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL161664 116473 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)c[n+]([O-])cc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
2600 8239 59 None -4 12 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
2608 8239 59 None -4 12 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
5405 8239 59 None -4 12 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
CHEMBL17157 8239 59 None -4 12 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
DB00342 8239 59 None -4 12 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
511296 23513 0 None -1 2 Mouse 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 450 5 0 3 6.0 CSc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
CHEMBL110463 23513 0 None -1 2 Mouse 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 450 5 0 3 6.0 CSc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
511296 23513 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 450 5 0 3 6.0 CSc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
CHEMBL110463 23513 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 450 5 0 3 6.0 CSc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
9579313 327516 0 None None None Mouse 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 567 5 0 4 7.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL418997 327516 0 None None None Mouse 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 567 5 0 4 7.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
5496100 235619 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 567 5 0 4 7.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL337364 235619 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 567 5 0 4 7.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
503637 119147 0 None None None Human 7.0 pKi = 7.0 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
CHEMBL163078 119147 0 None None None Human 7.0 pKi = 7.0 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
503637 119147 0 None None None Human 7.0 pKi = 7.0 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
CHEMBL163078 119147 0 None None None Human 7.0 pKi = 7.0 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
1635 193594 43 None None None Mouse 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 None
3002977 193594 43 None None None Mouse 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 None
CHEMBL256907 193594 43 None None None Mouse 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 None
11598 1386 13 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5
Guide to Pharmacology 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 30891130
23725177 1386 13 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5
Guide to Pharmacology 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 30891130
CHEMBL4442783 1386 13 None None None Human 6.1 pIC50 = 6.1 Binding
Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5
Guide to Pharmacology 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 30891130
11614352 1138 1 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cells
Guide to Pharmacology 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 22266038
7686 1138 1 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cells
Guide to Pharmacology 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 22266038
CHEMBL1951914 1138 1 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cells
Guide to Pharmacology 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 22266038
10416 3843 37 None None None Human 5.2 pIC50 = 5.2 Binding
IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.
Guide to Pharmacology 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 23409871
46861584 3843 37 None None None Human 5.2 pIC50 = 5.2 Binding
IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.
Guide to Pharmacology 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 23409871
CHEMBL2018969 3843 37 None None None Human 5.2 pIC50 = 5.2 Binding
IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.
Guide to Pharmacology 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 23409871
1635 193594 43 None None None Human 8.1 pKd = 8.1 Binding
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 None
3002977 193594 43 None None None Human 8.1 pKd = 8.1 Binding
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 None
CHEMBL256907 193594 43 None None None Human 8.1 pKd = 8.1 Binding
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 None
1638 5552 0 None -1 5 Mouse 8.1 pKd = 8.1 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
1878 5552 0 None -1 5 Mouse 8.1 pKd = 8.1 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
5284596 5552 0 None -1 5 Mouse 8.1 pKd = 8.1 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
6321250 5552 0 None -1 5 Mouse 8.1 pKd = 8.1 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
CHEMBL1482236 5552 0 None -1 5 Mouse 8.1 pKd = 8.1 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
CHEMBL80 5552 0 None -1 5 Mouse 8.1 pKd = 8.1 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
DB01183 5552 0 None -1 5 Mouse 8.1 pKd = 8.1 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
799 7612 0 None None None Human 9.6 pKd = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
802 7877 17 None None None Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
9574343 7877 17 None None None Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
CHEMBL78535 7877 17 None None None Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
3002977 7980 0 None None None Human 9.1 pKd None 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
803 7980 0 None None None Human 9.1 pKd None 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
3117 474710 66 None -8 16 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC None
928 474710 66 None -8 16 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC None
CHEMBL964 474710 66 None -8 16 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC None
DB00822 474710 66 None -8 16 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC None
2600 8239 59 None -4 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
2608 8239 59 None -4 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
5405 8239 59 None -4 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
CHEMBL17157 8239 59 None -4 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
DB00342 8239 59 None -4 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
1635 193594 43 None -6 2 Rhesus macaque 8.0 pKi = 8.0 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 None
3002977 193594 43 None -6 2 Rhesus macaque 8.0 pKi = 8.0 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 None
CHEMBL256907 193594 43 None -6 2 Rhesus macaque 8.0 pKi = 8.0 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 None
753 1716 0 None -1 2 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
Q16627 1716 0 None -1 2 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
771 1732 0 None -1 2 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
P13500 1732 0 None -1 2 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
759 1793 0 None -25 4 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
P80098 1793 0 None -25 4 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
183790 8163 6 None 6 2 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 16476734
783 8163 6 None 6 2 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 16476734
CHEMBL1178786 8163 6 None 6 2 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 16476734
804 858 0 None None None Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 11585437
804 858 0 None None None Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
804 858 0 None None None Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16476734
9574343 858 0 None None None Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 11585437
9574343 858 0 None None None Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
9574343 858 0 None None None Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16476734
CHEMBL78535 858 0 None None None Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 11585437
CHEMBL78535 858 0 None None None Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
CHEMBL78535 858 0 None None None Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16476734
756 1775 0 None -3 2 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11170631
756 1775 0 None -3 2 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
756 1775 0 None -3 2 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
P10147 1775 0 None -3 2 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11170631
P10147 1775 0 None -3 2 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
P10147 1775 0 None -3 2 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
11947758 915 28 None None None Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 16476734
3001322 915 28 None None None Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 16476734
805 915 28 None None None Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 16476734
CHEMBL1255794 915 28 None None None Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 16476734
CHEMBL1739499 915 28 None None None Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 16476734
DB06497 915 28 None None None Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 16476734
3009355 8651 20 None None None Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 16304152
807 8651 20 None None None Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 16304152
CHEMBL82301 8651 20 None None None Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 16304152
DB06652 8651 20 None None None Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 16304152
772 1795 0 None None None Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
P80075 1795 0 None None None Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
758 1785 0 None 3 4 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10318947
758 1785 0 None 3 4 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
758 1785 0 None 3 4 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
P13501 1785 0 None 3 4 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10318947
P13501 1785 0 None 3 4 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
P13501 1785 0 None 3 4 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
757 1781 0 None 112 2 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
757 1781 0 None 112 2 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
P13236 1781 0 None 112 2 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
P13236 1781 0 None 112 2 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
760 3401 0 None 3 2 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11170631
752 1464 0 None -12 2 Human 7.7 pKi None 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11170631
770 1714 0 None 79 2 Human 9.1 pKi None 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
Q99616 1714 0 None 79 2 Human 9.1 pKi None 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730